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Bindeglied zwischen den Lebenswissenschaften und der klassischen analytischen Chemie 
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Mit der vorliegenden kumulativen Habilitationsschrift werden eigene Original- und 
Übersichtsarbeiten zur Isolierung und Strukturaufklärung peptidischer und niedermolekularer 
bioaktiver Naturstoffe mittels HPLC-gekoppelter Elektrosprayionisations-
Massenspektrometrie (LC/ESI-MS) und und Gaschromatographie/Elektronenstoßionisations-
Massenspektrometrie (GC/MS) vorgestellt. Die Arbeit ist untergliedert in folgende drei Teile: 
im ersten werden Arbeiten zur Isolierung und Sequenzierung neuer Peptaibiotika, 
nicht-ribosomal biosynthetisierter, α,α-dialkylaminosäurehaltiger Peptidantibiotika aus Pilzen 
sowie deren Bedeutung für den biologischen Pflanzenschutz und die moderne Pilztaxonomie 
dargestellt; 
im zweiten wird der Einsatz moderner massenspektrometrischer Methoden im 
Rahmen des „Metabolite Profiling“ in der Pflanzenbiochemie erörtert; 
und im dritten werden die Perspektiven der Peptaibiotikaforschung im nächsten 
Jahrzehnt sowie die Rolle und Bedeutung der Massenspektrometrie als Schlüsseltechnologie 
in den Lebenswissenschaften beleuchtet. 
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Zusammenfassung 
Im Rahmen der vorliegenden Habilitationsschrift, die auf 13 Original- und Übersichtsarbeiten 
beruht, werden Beiträge zur Isolierung und Strukturaufklärung peptidischer und 
niedermolekularer bioaktiver Naturstoffe mittels LC/ESI-MS und GC/MS kumulativ 
vorgestellt: 
Der erste Teil dieser Arbeit ist der Isolierung und Sequenzierung neuer und bereits 
bekannter Peptaibiotika – nicht-ribosomal biosynthetisierter, α,α-dialkylaminosäurehaltiger 
Peptidantibiotika aus Pilzen – gewidmet. Im Mittelpunkt standen hierbei die Suche nach 
neuen peptidischen Wirkstoffen für einen potentiellen Einsatz in der Medizin bzw. im 
biologischen Pflanzenschutz sowie die Bedeutung der gefundenen Sekundärmetaboliten für 
die moderne Pilztaxonomie. Unter Verwendung moderner massenspektrometrischer 
Verfahren wie der HPLC-gekoppelten ESI-Quadrupol/TOF-Hybrid-MS mit Pulsarfunktion 
(ESI-QqTOF-MS), der Kopplung der nicht-wäßrigen Kapillarelektrophorese (NACE) mit 
ESI-MS und der HPLC-gekoppelten ESI-Ionenfallen-MS (ion trap, IT) sowie einer 
peptaibiomischen Vorgehensweise als neuartigem methodisch-analytischem Ansatz wurden 
aus Pilzen der Gattung Trichoderma/Hypocrea etwa 100 größtenteils neue Sequenzen linearer 
Peptaibiotika ermittelt. Diese fielen entweder durch ihre neuroleptische Aktivität oder ihre 
antifungale Wirkung auf die Erreger latenter Rebholzkranheiten der Weinrebe auf. Erstmalig 
wurde über den Nachweis von N-terminalem Pyroglutamat und C-terminalem L-Alaninol als 
neue Strukturelemente von Peptaibiotika berichtet. Die Kombination von phylogenetisch-
molekulartaxonomischer Methoden mit modernen massenspektrometrischen Verfahren führte 
zur Beschreibung des Brevicompactum-Cladus als neuem Zweig mit vier neuen Arten 
(Trichoderma arundinaceum, T. protrudens, T. turrialbense und Hypocrea/Trichoderma 
rodmanii) im Stammbaum der Gattung Trichoderma/Hypocrea. Außerdem wird auf neue 
bzw. ungewöhnliche Produzenten, Strukturelemente und Baupläne von Peptaibiotika, so z. B. 
die neue Unterfamilie der Cyclopeptaibiotika, eingegangen, die Geschichte und Perspektiven 
der Peptaibiotikaforschung werden beleuchtet sowie das Vorkommen von α,α-
Dialkylaminosäuren in der belebten und unbelebten Natur thematisiert. Schließlich wurden 
die Trifluoracetolyse und die sich anschließende Analyse der Spaltprodukte mittels ESI-MS 
als geeignetes Verfahren zur Sequenzierung und Strukturaufklärung von Modellpeptiden und 
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Peptaibiotika untersucht und ein repetitiver Spaltmechanismus für homo-Aib-haltige Peptide 
und Peptaibiotika postuliert. 
Der zweite Teil der Arbeit stellt die Kopplung von HPLC und hochauflösender ESI-
Massenspektrometrie als eine unentbehrliche Komplementärtechnologie für die GC/MS beim 
so genannten „Metabolic Profiling“ am Beispiel von Arabidopsis thaliana als pflanzlichen 
Modellorganismus dar. 
Der dritte Teil der Arbeit beleuchtet die Perspektiven der Peptaibiotikaforschung im 
nächsten Jahrzehnt sowie die Massenspektrometrie als analytische Hochleistungsmethode in 
den Lebenswissenschaften. 
Zusammenfassend ist die Massenspektrometrie als derzeit vielseitigster und 
leistungsfähigster Zweig der Bioanalytik einzuschätzen, deren interdisziplinäre Rolle und 
Bedeutung für die Lebenswissenschaften in den kommenden Jahren noch weiter wachsen 
wird. 
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Summary 
This cumulative habilitation thesis, which is divided into three chapters, comprises of 13 
original research and review articles on the isolation and structural elucidation of bioactive 
peptidic and low-molecular weight natural products by LC/ESI-MS and GC/MS: 
The first part of this work is devoted to the isolation and sequencing of new and 
recurrent peptaibiotics, i. e. fungal peptide antibiotics of non-ribosomal origin containing α-
dialkyl α-amino acids. It is focussed on the search for novel peptidic components for potential 
use in medicine or as biocontrol agents (BCA) in agriculture. A second important aspect is the 
significance to modern fungal taxonomy of the secondary metabolites discovered. Using 
state-of-the-art mass spectrometric tools such as HPLC coupled to a pulsar ESI-QqTOF-MS, 
nonaqueous capillary electrophoresis coupled to ESI-MS, HPLC coupled to ESI-ion-trap-MS, 
as well as the recently established method of peptaibiomics, more than 100 novel and 
recurrent linear peptaibiotics produced by strains and species of the genus 
Trichoderma/Hypocrea were sequenced. Notably, some of them displayed neuroleptic 
activity, whereas others were highly effective against fungal diseases of grapevine trunks. 
Furthermore, N-terminal pyroglutamate and C-terminal L-Alaninol are reported as novel 
constituents of peptaibiotics for the first time. The combination of morphological analyses, 
molecular phylogenetics and state-of-the-art mass spectrometric tools culminated in the 
recognition of the Brevicompactum clade as a separate, novel lineage, including T. 
brevicompactum s. s. as well as four new species, T. arundinaceum, T. protrudens, T. 
turrialbense, and H./T. rodmanii. New and uncommon fungal producers, structural elements, 
and building schemes of peptaibiotics as well as the history of research in this field are 
reviewed, and a new subfamily of peptaibiotics, the so-called cyclopeptaibiotics, is 
introduced. Future prospects for peptaibiotic research are discussed, and the distribution of 
biotic and abiotic α-dialkyl α-amino acids is critically scrutinised. Finally, trifluoroacetolysis 
of peptaibiotics as well as peptides and subsequent analysis of its cleavage products by ESI-
MS are presented as an effective tool for sequencing and structural elucidation of model 
peptides and peptaibiotics, and a repetitive cleavage mechanism for Aib-containing peptides 
is postulated. 
The second part of this work introduces the benefits of HPLC coupled to electrospray 
ionisation quadrupole time-of-flight mass spectrometry as an indispensable, complementary 
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technique to GC/MS for profiling of secondary metabolites of Arabidopsis thaliana as a plant 
model organism.  
The third part of this work discusses the future prospects for peptaibiotic research in 
the next decade and the role of mass spectrometry as an anaqlytical key technology in life 
sciences. 
In conclusion, mass spectrometry can be characterised as the most versatile and 
powerful discipline in bioanalytics whose interdisciplinary role and importance in life 
sciences is predicted to grow further in the forthcoming years. 
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1. Isolierung und Strukturaufklärung neuer Peptaibiotika 
aus Pilzen der Gattung Hypocrea/Trichoderma 
 
1.1. Allgemeine Bemerkungen zur Biosynthese nicht-ribosomaler Peptide  
Die Knüpfung einer Peptidbindung kann in vivo durch drei grundlegende Mechanismen 
realisiert werden: 
− die ribosomale Biosynthese linearer Polypeptide unter Verwendung der 20 
proteinogenen Aminosäuren und eventuelle Prozessierung der gebildeten Proteine, so 
z. B. durch Proteolyse und/oder posttranslationale Modifikationen wie 
Glykosylierungen, Hydroxylierungen (Lys → Hyl, Pro → Hyp), Phosphorylierungen, 
Methylierungen, Acetylierungen u. a. Reaktionen; 
− die enzymatische Synthese von Di- und Tripeptiden durch lösliche Enzyme; 
− die nucleinsäure-unabhängige Biosynthese an modular organisierten 
Multienzymkomplexen, so genannten nicht-ribosomalen Peptidsynthetasen (NRPS), 
die – unter Verwendung ungewöhnlicher, nichtproteinogener Aminosäuren und 
gegebenenfalls nicht-peptidischer Bausteine – lineare und cyclische Peptide aus bis zu 
21 Aminosäuren1 generieren. 
Durch die begrenzte Spezifität der beteiligten NRPS bedingt, werden nicht nur proteinogene 
L-Aminosäuren, sondern auch deren Isomere oder D-Enantiomere, aber auch N- oder C-
Methylaminosäuren, β-Aminosäuren, Hydroxysäuren, Dehydroaminosäuren, schwefelhaltige 
Aminosäuren, Iminosäuren, Lipoaminosäuren, Fettsäuren,   Aminoalkohole   und    andere 
ungewöhnliche Bausteine in nicht-ribosomal biosynthetisierte Peptidantibiotika eingebaut. 
Neben Bakterien wie dem Gramicidin-Bildner Bacillus brevis und dem Actinomycin-Bildner 
Streptomyces antibioticus sind auch Asco- und Basidiomyceten sowie vor allem anamorphe 
Pilze zur Biosynthese solcher Verbindungen befähigt [Gräfe, 1992]. Als Beispiele für 
praktisch bedeutsame, nicht-ribosomale Peptide aus Pilzen sind zu nennen: 
                                                           
1
 Das aus 21 Resten bestehende SCH 643432 [Hegde et al., 2003] gilt als das derzeit größte Peptaibiotikum. 
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− die insektizid wirksamen cyclischen Depsipeptide aus entomopathogenen, im Rahmen 
der biologischen Schädlingsbekämpfung verwendeten Pilzarten, wie z. B. die 
Destruxine aus Metarhizium anisopliae  und Aschersonia sp., das Beauvericin aus 
Beauveria bassiana und Isaria fumosorosea (syn. Paecilomyces fumosoroseus), die 
Beauveriolide aus Beauveria sp., Isaria sp. und Lecanicillium (syn. Verticillium) 
lecanii sowie die Enniatine aus Fusarium spp. [Anke & Sterner, 2002; Anke & 
Antelo, 2009]. 
− die insektizid und immunsuppressiv wirksamen Cyclosporine, cyclische 
Undecapeptide [Kleinkauf & von Döhren, 1999; Kürnsteiner et al., 2002], welche vor 
allem aus Tolypocladium-Arten, besonders T. inflatum (syn. T. niveum u. a., siehe 
www.cbs.knaw.nl) und dessen Teleomorphe Elaphocordyceps [Sung et al., 2007] 
subsessilis (syn. Cordyceps subsessilis [Hodge et al., 1996]), isoliert werden. 
Neben der Hauptkomponente, dem Cyclosporin A, weisen weitere 14 der bislang 32 aus 
natürlichen Quellen isolierten oder durch gerichtete Biosynthese (precursor-directed 
biosynthesis) erzeugten Cyclosporine mindestens einen L-α-Aminobuttersäure-Rest (Abu) als 
strukturelles Charakteristikum in ihrem Ring auf. Diese Aminosäure ist wegen ihres auf 
wenige natürliche Quellen beschränkten Vorkommens bemerkenswert: exemplarisch seien 
hier folgende von Bakterien ribosomal produzierten Lantibiotika genannt: 
Nisin (Streptococcus lactis), Subtilin (Bacillus subtilis), Gallidermin (Staphylococcus 
gallinarum) [Gräfe, 1992] und die Lantibiotika des Duramycins-Typs, welche aus 
Actinomyceten der Gattungen Streptomyces und Streptoverticillium isoliert worden sind 
[Fredenhagen et al., 1991]. Außer in den Lantibiotika ist Abu bislang auch in Cyclosporin-
produzierenden Pilzen nachgewiesen worden. [Übersicht der Bildner in: Kürnsteiner et al., 
2002]. 
 
1.2. Peptaibiotika – eine Klasse ungewöhnlicher nicht-ribosomaler Peptid-
Antibiotika aus Pilzen 
Ein Isomer der oben genannten L-α-Aminobuttersäure ist die achirale α-Aminoisobuttersäure 
(Aib), der namensgebende Bestandteil einer Klasse linearer und cyclischer, ebenfalls durch 
nicht-ribosomale Biosynthese gebildeter Peptid-Antibiotika, der Peptaibiotika [Brückner et 
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al., 1991(a) und (b)]. Seit etwa 15 Jahren erlebt diese Klasse von Peptidantibiotika eine 
Renaissance in der mikrobiologischen und naturstoffchemischen Forschung. Dies ist vor 
allem bedingt durch ihre einzigartigen Konformationen [Toniolo & Benedetti, 1991] und 
Bioaktivitäten, wie beispielsweise die neuroleptische Wirkung der Ampullosporine [Ritzau et 
al., 1997; Kronen et al., 2001; Krügel et al., 2006; Berek et al., 2009] und Trichofumine (siehe 
Abschnitt 1.5. bzw. Anhang B), die Inhibition der HIV-1-Integrase [Singh et al., 2002; de 
Zotti et al., 2009; de Zotti et al., 2010(a)], die Hemmung der Bildung von Amyloid-β-
Peptiden [Hosotani et al., 2007] sowie die Ionenkanalbildung in Biomembranen [Boheim et 
al., 1983; Leitgeb et al., 2007]. Letztere trägt mit großer Wahrscheinlichkeit zur Wirksamkeit 
der im biologischen Pflanzenschutz eingesetzten Präparate auf Basis von Trichoderma-
Konidien (siehe Abschnitt 1.7. bzw. Anhang D) bei. 
Peptaibiotika sind durch folgende charakteristische Merkmale gekennzeichnet (siehe auch 
Anhang J):  
− Es handelt sich um lineare oder cyclische, antibiotisch wirksame Polypeptide mit 
einem Molekulargewicht zwischen 500 und 2.200 Da, die aus 4 bis 21 monomeren 
Einzelbausteinen bestehen und durch NRPS biosynthetisiert werden [Reiber et al., 
2003]. 
− In den meisten (> 98%) dieser Verbindungen ist α-Aminoisobuttersäure (Aib) als 
Marker-Aminosäure enthalten2. In manchen Sequenzen, z. B. dem Adenopeptin 
[Hayakawa et al., 1998], einigen Stilboflavinen [Jaworski & Brückner, 2001] oder 
dem Peptaibiotikum SCH 643432 [Hegde et al., 2003], liegt der Anteil der Aib-Reste 
bei 40 bis 50%. Andere Peptaibiotika, z. B. das Trichobrachin III A a, besitzen 
hingegen nur einen einzigen Aib-Rest [Brückner et al., 1993]. 
− Neben Aib können noch weitere nicht-proteinogene α,α-Dialkylaminosäuren im 
Molekül enthalten sein. Dabei handelt es sich um vor allem um das chirale Homologe 
der Aib, das Isovalin (Iva), welches entweder in der L- bzw. (S)-, oder in der D- bzw. 
(R)-Form vorliegen kann. Außerdem ist L- bzw. (S)-Ethylnorvalin (α-Amino-α-ethyl-
                                                           
2
 Auf Ausnahmen wird im Text explizit hingewiesen. Die Massendifferenzen am N-Terminus der 
Trichobrachine III A b und III B b lassen den Schluß zu, daß in diesen Verbindungen kein Aib- bzw. Iva-Rest 
mehr enthalten sein kann. Die N-terminale Sequenz beider Peptide erwies sich letztendlich als nicht bestimmbar; 
denn bei diesen beiden Partialsequenzen handelt es sich lediglich um Minorkomponenten in einem 
hochkomplexen, mikroheterogenen Gemisch homologer und positionsisomerer Peptide [Brückner et al., 1993]. 
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n-valeriansäure, EtNva) als Bestandteil von Peptaibiotika nachgewiesen worden 
[Tsantrizos et al., 1996] sowie die achirale 1-Aminocyclopropan-1-carbonsäure (Acc) 
[Fredenhagen et al., 2006; siehe auch Abschnitt 1.9. bzw. Anhang F]. In einzelnen 
Sequenzen ist die Aib vollständig durch Iva- oder Acc-Reste substituiert, so z. B. in 
den Cyclotetrapeptaibiotika Phoenistatin [Masuoka et al., 2001], FR 235222 [Mori et 
al., 2003(a), (b)] und AS1387392 [Sasamura et al., 2010(a)] sowie den Acc-haltigen 
Cycloheptapeptaibiotika Serinocyclin A und B [Krasnoff et al., 2007]. 
− Neben den bereits genannten nicht-proteinogenen Aminosäuren können auch weitere 
ungewöhnliche Bestandteile, wie β-Aminosäuren oder N-Methylaminosäuren, 
vorhanden sein. 
− Der N-Terminus linearer Peptaibiotika ist stets acyliert, während ihr C-Terminus meist 
aus einem freien oder acetylierten, amidartig gebundenen 2-Aminoalkohol besteht. 
Alternative C-terminale Strukturvarianten umfassen die Substitution durch ein Amin, 
Amid, eine freie Aminosäure oder ein 2,5-Diketopiperazin als Kondensationsprodukt 
zweier Aminosäuren. 
Die überwiegende Mehrheit der bislang bekannten Peptaibiotika, die Peptaibole [Benedetti et 
al., 1982; Brückner & Graf, 1983], besitzt einen acetylierten N-Terminus, während ihr C-
Terminus durch einen 2-Aminoalkohol gebildet wird. Stärker lipophile Peptaibiotika, deren 
N-Terminus durch einen n-Octan-, n-Decan- oder cis-Dec-4-ensäurerest substituiert ist, sind 
die Lipopeptaibole. Eine dritte Unterfamilie stellen die Lipoaminopeptide dar, die 
gelegentlich auch als Aminolipopeptide bezeichnet werden. Ihr N-Terminus ist durch 
unverzweigte, α- oder γ-methylverzweigte gesättigte oder ungesättigte Fettsäuren mit einer 
Kettenlänge zwischen vier und 15 C-Atomen substituiert. In Position 1 der Peptidkette findet 
sich ein L-Prolin-, trans-4-Hydroxy-L-prolin- oder cis-4-Methyl-L-prolin-Rest. Auf diesen 
folgt in Position 2 zumeist der namensgebende Lipoaminosäure-Rest. Bei diesem handelt es 
sich überwiegend um 2-Amino-6-hydroxy-4-methyl-8-oxodecansäure (AHMOD), es können 
statt dessen jedoch Desmethyl-AHMOD (siehe Abschnitt 1.8. bzw. Anhang E] oder 2-
Amino-4-methyl-8-oxodec-6-ensäure (AMOD) [Pruksakorn et al., 2010] vorhanden sein. 
Außerdem kann sich eine zweite Lipoaminosäure in der Kette befinden, so z. B. die 2-Amino-
4-methyldecansäure (AMD) in den Culicininen A–D [He et al., 2006]. Alle linearen 
Peptaibiotika, die nicht in eine der drei vorgenannten eingeordnet werden können, werden in 
19 
 
einer vierten Unterfamilie gruppiert. Die fünfte und zugleich kleinste Unterfamilie bilden die 
Cyclopeptaibiotika, die durch das Vorhandensein von α,α-Dialkylaminosäuren in 
Ringstrukturen gekennzeichnet sind3. 
Die bislang beschriebenen rund 900 Einzelsequenzen von Peptaibiotika werden 
ausschließlich von Pilzen biosynthetisiert4. Die meisten Bildner sind in Anamorphen-
Gattungen zu finden, deren Teleomorphen zur Ordnung Hypocreales zählen. Dabei ist die 
Gattung Trichoderma mit Teleomorphen in Hypocrea als weitaus wichtigste Quelle für 
Peptaibiotika zu benennen, gefolgt von den Gattungen Acremonium, Emericellopsis (Incertae 
sedis) und Sepedonium (Hypocreaceae; Teleomorphe in Hypomyes) sowie Tolypocladium 
(mit Elaphocordyceps-Teleomorphen in den Ophiocordycipitaceae: Sung et al., 2007). 
Weitere peptaibiotika-bildende  Arten und Stämmen finden sich in folgenden Gattungen der 
Hypocreales: Stilbella, Myrothecium, Culicinomyces (Incertae sedis), Mycogone 
(Hypocreaceae), Mariannaea (Nectriaceae), Clonostachys (Bionectriaceae), Dendrodochium5 
und Pochonia (Clavicipitaceae; Teleomorphe in Metacordyceps: Sung et al., 2007). Als 
Bildner außerhalb der Hypocreales sind folgende Arten zu erwähnen: 
− Paecillium lilacinum (Thom) Luangsa-ard, Hywell-Jones & Samson (syn. 
Paecilomyces lilacinus) und Paranomuraea marquandii (Massee) Luangsa-ard, 
Hywell-Jones & Samson6 (syn. Paecilomyces marquandii) gelten als klassische 
Quellen der Leucinostatine (Literaturübersicht in Anhang J). 
− Paecilomyces variotii, die Typusart der Gattung, bildet zwei antifungale Peptaibiotika 
[Hegde et al., 2003]. Die drei vorgenannten Species gehören zur Familie 
Trichocomaceae der Ordnung Eurotiales. 
                                                           
3
 Auf diese neu eingeführte Unterfamilie wird bei der Besprechung der entsprechenden Übersichtsarbeit 
(siehe Abschnitt 1.12. bzw. Anhang I) näher eingegangen 
4
 In diesem Zusammenhang ist bemerkenswert, daß biotisches Aib, Iva und EtNva bisher nur aus 
pilzlichen Organismen isoliert worden sind, abiotisches Aib/Iva und andere α-Dialkyl-α-aminosäuen auch in 
Meteoriten vorkommen können. Darauf wird im Abschnitt 1.14. dieser Arbeit bzw. in Anhang K näher 
eingegangen. 
5
 Die Nennung der Gattung Dendrodochium folgt lediglich den Angaben in Singh et al. [2002]. Die Identität des 
Integramid-Bildners ist als zweifelhaft werten, da sie nicht durch Daten zu Isolierung und Identifizierung des 
Stammes verifiziert worden ist. 
6
  Die Nomenklatur folgt hier Domsch et al. [2007]. Dabei ist jedoch zu berücksichtigen, daß eine gültige 
Beschreibung der Gattungen Paecillium und Paranomuraea bislang noch nicht publiziert worden ist. 
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− Eine taxonomisch nicht näher bestimmte Chrysosporium sp. (Onygenaceae, 
Onygenales) ist als Bildner des Adenopeptins angegeben worden [Hayakawa et al., 
1998]. 
− Aus Geotrichum candidum (Teleomorphe: Galactomyces candidus; Dipodascaceae, 
Saccharomycetales) wurden von Fredenhagen et al. [2006] die Neoefrapeptine isoliert. 
− Peniophora cf. nuda (Peniophoraceae, Russulales), aus dessen Kulturen Chlamydocin 
und zwei seiner Analoga isoliert wurden, gilt als bislang einziger verifizierter 
peptaibiotika-produzierender Basidiomycet [Tani et al., 2001].7  
 
1.3. Massenspektrometrische Methoden als unentbehrliche Werkzeuge bei der 
Sequenzierung und Strukturaufklärung von Peptaibiotika 
Die Sequenzierung und Strukturaufklärung der „klassischen“ Peptaibole wurde zu Beginn der 
systematischen Beschäftigung mit diesen Verbindungen durch mehrere Faktoren erschwert: 
− Aufgrund der negativen Ninhydrin-Reaktion wurde irrtümlich davon 
ausgegangen, daß Alamethicin (ALM) [Meyer & Reusser, 1967], Antiamoebin 
(AAM) [Vaidya et al., 1968] und Trichotoxin A (TXT-A) [Hou et al., 1972] 
eine cyclische Struktur besitzen. Daher wurden zunächst weder die 
Acetylierung des N-Terminus, noch die C-terminale Position des 2-
Aminoalkohols erkannt. 
− Obwohl die Aminosäurezusammensetzung der jeweiligen mikrokristallin 
vorliegenden Hauptkomponenten ermittelt worden war, ergab die Analyse bei 
einigen Aminosäuren keine ganzzahlige Stöchiometrie, so z. B. im Falle des 
TXT [Irmscher et al., 1978]. 
                                                           
7
 Berichte über die Bildung von Peptaibiotika in Fruchtkörpern von Basidiomyceten [Aretz et al., 1997; 
Lee et al., 1999(a) und (b)] wurden bereits von Kiet et al. [2002] mit einer nicht erkannten Infektion der 
betreffenden Fruchtkörper durch einen peptaibolbildenden Mykoparasiten der Gattung Sepedonium  in 
Verbindung gebracht. Dieses Phänomen wird in den Anhängen A, F und J diskutiert und gilt seit dem Nachweis 
der Tylopeptin-Bildung durch Kulturen von Sepedonium chalcipori [Neuhof et al., 2007(a)] als widerlegt. 
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Letzteres Phänomen wurde folgerichtig auf die so genannte Mikroheterogenität 
zurückgeführt, d. h. das Vorliegen chromatographisch nur schwer oder gar nicht trennbarer 
Gemische homologer und positionsisomerer Peptide. Diese ergibt sich aus der nicht-
ribosomalen Biosynthese der Peptaibiotika, die bereits 1967 von Reusser für ALM postuliert 
wurde. Später wurde gezeigt, daß dieser bereits in Bakterien beschriebene, an 
Multienzymkomplexen mit reduzierter Spezifität ablaufende Prozeß ebenfalls in Pilzen 
stattfindet [Rindfleisch & Kleinkauf, 1976]. 
Zur Sequenzierung und Strukturaufklärung von Peptaibolen wurden Methoden wie 
Edman-Abbau und hochauflösende Felddesorptions-Massenspektrometrie (FD-HR-MS), 
Kopplung aus Gaschromatographie und hochauflösender Elektronenstoß- 
Massenspektrometrie (GC/HR-EI-MS) bzw. Feldionisations-Massenspektrometrie (FI-HR-
MS) angewendet. Von besonderem Wert erwies sich dabei, beruhend auf der Erkenntnis einer 
relativen Labilität der Bindung zwischen Aib und Pro, die Verwendung wasserfreier 
Trifluoressigsäure (TFA) als Reagenz zur selektiven Spaltung von Peptaibolen und die 
nachfolgende Analyse der entsprechend derivatisierten Spaltprodukte mittels GC/MS 
[Brückner et al., 1979; Brückner & Jung, 1980; Brückner et al., 1980; siehe auch Anhang L]. 
Ein weiterer Fortschritt ergab sich aus der Einführung der Fast-Atom-Bombardment-
Massenspektrometrie (FAB-MS) [Rinehart, 1983], die allein oder in Kopplung mit der 
Hochdruckflüssigchromatographie (HPLC) eine Analytik intakter, nicht-derivatisierter 
Peptaibiotika, so z. B. der Leucinostatine, ermöglichte [Isogai et al., 1992 und darin zitierte 
Referenzen]. Mit Hilfe dieser beiden hochenergetischen, so genannten „harten“, 
Ionisierungsmethoden EI- und FAB-MS wurden bis 1988 etwa 60 Peptaibiotika sequenziert.  
In diesem Zusammenhang sei abschließend noch auf den relativ hohen Probenbedarf, den 
erheblichen apparativen sowie den vergleichsweise großen Zeit- und Arbeitsaufwand 
verwiesen, den eine Peptid-Sequenzierung mittels dieser beiden klassischen Methoden der 
Massenspektrometrie nach sich zog. 
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1.4. Die Elektrosprayionisations-Massenspektrometrie revolutioniert die 
Sequenzierung und Strukturaufklärung von Peptaibiotika 
Selbst bei Verwendung von FAB-MS können oftmals weitere sekundäre oder tertiäre Serien 
mehr oder minder unspezifischer Fragment-Ionen auftreten, welche die Sequenzierung 
zusätzlich erschweren. Mit der Einführung der Elektrosprayionisations-Massenspektrometrie 
(ESI-MS) steht seit etwa 20 Jahren ein niederenergetisches, so genanntes „weiches“ 
Ionisierungsverfahren zur Verfügung, das hervorragend zur Sequenzierung von Peptaibiotika 
geeignet ist. Dies wird durch die Tatsache illustriert, daß bis Februar 2003 bereits etwa 300 
Einzelsequenzen von Peptaibiotika beschrieben worden sind. 
Bei der ESI-MS werden nicht primär Fragment-Ionen gebildet, sondern es kommt − 
durch Abstraktion ([M−H]-) oder Anlagerung von Protonen, Na+ oder K+ − zur Bildung von 
Addukten, so genannten Quasi-Molekülionen. Diese geben Auskunft über das 
Molekulargewicht der betreffenden Analyten, während Fragmentierungsreaktionen 
größtenteils unterbleiben. Diagnostische Fragment-Ionen, die meist den a-, b- oder c- bzw. x-, 
y- oder z-Serien, entsprechend der  Roepstorff/Fohlman/Biemann-Nomenklatur [Roespstorff 
et al., 1984, 1985; Biemann, 1992], zuzuordnen sind, werden erst durch Kollision 
ausgewählter Quasi-Molekülionen mit einem inerten Stoßgas in einer so genannten 
Kollisionzelle erzeugt. 
Das vorrangige Ziel dieser Übersichtarbeit besteht darin, die verschiedenen 
massenspektrometrischen Methoden zur Sequenzierung von Peptaibiotika kurz darzustellen, 
relevante Strukturdaten (diagnostische Fragment-Ionen, Molekulargewichte), einschließlich 
möglicher Modifikationen des N- bzw. C-Terminus der bislang bekannten Peptaibiotika, in 
Tabellenform zu vermitteln, und proteinogene8 und ungewöhnliche nicht-proteinogene 
Aminosäure-Bausteine vorzustellen. Außerdem werden Aspekte der Nomenklatur bei der 
Klassifizierung von Peptaibiotika sowie der Ökophysiologie und der Einordnung der Bildner 
ins System der Pilze diskutiert.  
                                                           
8
 Schwefelhaltige (Cys, Met) sowie L-Lys und L-His als basische proteinogene Aminosäuren sind bisher 
noch nicht als Bausteine von Peptaibiotika beschrieben worden. Auch L-Orn (Bacillus sp.: Gramicidin S, 
Tyrocidin) bzw. D-Orn (Bacitracin A: Bacillus licheniformis) und die bisweilen in Peptid-Antibiotika 
(Polymyxin-Gruppe: Bacillus polymyxa) vorkommende 2,4-L-Diaminobuttersäure (Dab) [Gräfe, 1992] wurden 
in Peptaibiotika noch nicht nachgewiesen. D-Lys wurde bislang lediglich einmal – als Baustein des 
Cycloheptapeptaibiotikums Serinocyclin B – beschrieben [Krasnoff et al., 2007]. 
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1.5. Die Trichofumine – vier neuroleptisch wirksame, neue Peptaibole aus 
Trichoderma sp. HKI 0276 
Aus Oberflächenkulturen des taxonomisch nicht näher bestimmten Stammes Trichoderma sp. 
HKI 0276 wurden vier Peptaibole, die Trichofumine A, B, C und D, präparativ isoliert. 
Trichofumin A und B bestehen aus elf, Trichofumin C und D aus dreizehn Resten. Sie sind in 
der Lage, die Morphogenese der Hyphen des Coelomyceten Phoma destructiva (Pleosporales) 
zu beeinflussen. Dieser Effekt macht sich, wie bei der Referenzsubstanz Cyclosporin A, durch 
die zeitlich beschleunigte Bildung eines bräunlich pigmentierten Hofes um das Testloch auf 
einer Agardiffusionsplatte bemerkbar [Dornberger et al., 1995] und ist als Vortest für eine 
neuroleptische (antipsychotische) Wirkung geeignet. Diese wird schließlich durch die 
Auslösung von Hypothermie bei Mäusen bestätigt, wobei sich letztere in der Abnahme 
spontaner lokomotorischer Aktivität widerspiegelt [Bansinath & Ramabadran, 1990]. Die 
neuroleptische Aktivität der vier Trichofumine war der der Ampullosporine A, B und D 
vergleichbar [Ritzau et al. 1997; Kronen et al., 2001]. 
Die massenspektrometrische Sequenzierung der Trichofumine konnte durch den Einsatz eines 
ESI-Qq-TOF-Geräts mit Pulsar-Funktion wesentlich erleichtert und beschleunigt werden. Mit 
Hilfe des so genannten „Pulsars“ können Ionen über einen bestimmten m/z-Bereich in der 
Stoßzelle zuerst gesammelt und nachfolgend − gewissermaßen „gebündelt“ − ins Flugrohr des 
MS weitergeleitet („gepulst“) werden. Dies führte zu einer erheblichen Verbesserung der 
Sensitivität des Gerätes. Dadurch war es möglich, die Trichofumine mit Hilfe der gebildeten 
b-Typ-Fragmente komplett zu sequenzieren. 
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1.6. Detektion neuer, modifizierter Alamethicine F30 durch Kopplung von 
nicht-wäßriger Kapillarelektrophorese und ESI-Massenspektrometrie 
In Abhängigkeit von den Fermentationsbedingungen produziert Trichoderma arundinaceum 
CBS 1237939 ein Gemisch mehrerer, als Alamethicin (ALM) bezeichneter Polypeptide, die 
aufgrund ihres unterschiedlichen dünnschichtchromatographischen Laufverhaltens als ALM 
F30 (ca. 85%) und ALM F50 (ca. 12%) bezeichnet werden; daneben wurden ALM F20 (2%) 
sowie ALM F40, F60 und F70 (insgesamt 1%) nachgewiesen [Melling & McMullen, 1975]. 
Mittels Direkteinlaß sowie Kopplung aus HPLC und Ionenfallen-Massenspektrometrie (ESI-
IT-MSn) und GC/MS-Analyse der derivatisierten Aminosäuren in den salzsauren 
Hydrolysaten wurden die einzelnen Peptaibole im ALM F30 bzw. ALM F50 sequenziert. 
Insgesamt wurden zehn saure ALM F30 (Glu18−Gln19) und 13 neutrale ALM F50 
(Gln18−Gln19) beschrieben [Kirschbaum et al., 2003]. 
 
Das Ziel dieser Arbeit bestand darin, das Potential einer Kopplung aus nicht-wäßriger 
Kapillarelektrophorese (NACE) und ESI-IT-MS bzw. ESI-TOF-MS für die Analyse und 
Sequenzierung von Peptaibolen zu untersuchen. Mittels beider Methoden konnten zehn ALM 
F30-Sequenzen identifiziert werden. Unter diesen befanden sich drei, die bereits von 
Kirschbaum et al. [2003] beschrieben worden sind: 
die beiden Hauptkomponenten ALM F30/3 (ca. 46%) und F30/7 (ca. 40%) sowie 
ALM F30/6 (ca. 2%), das durch einen Austausch Gln→Glu in Position 6 charakterisiert ist. 
Die restlichen von Kirschbaum et al. [2003] gefundenen Minorkomponenten konnten mittels 
NACE nicht nachgewiesen werden. Dies wird auf die zu geringe Massendifferenz zwischen 
den in ohnehin geringen Konzentrationen vorliegenden Homologen von ± 14 Da 
zurückgeführt, die für eine kapillarelektrophoretische Trennung unzureichend war. 
Das Potential der Methode wird jedoch durch die Tatsache verdeutlicht, daß mittels 
NACE/MS-Kopplung die Sequenzen von sieben neuen Alamethicinen aus der F30-Reihe 
ermittelt werden konnten, die mit Hilfe der HPLC/MS-Kopplung nicht identifiziert werden 
                                                           
9
 Dieser Stamm wurde ursprünglich als Trichoderma viride NRRL 3199 hinterlegt und ist unter dieser 
Bezeichnung als Alamethicin-Produzent patentiert worden [Coats et al., 1974]. In den meisten Publikationen 
zum Thema „Alamethicin“ wird diese mittlerweile veraltete Nomenklatur verwendet. Zur Revision der 
systematischen Einordnung des Stammes siehe Abschnitt 1.11. und die Originalarbeit H des Anhangs. 
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konnten. Diese Minorkomponenten zeichnen sich durch eine zusätzliche Carboxyl-Gruppe 
aus, die durch einen Gln→Glu-Austausch bzw. den Verlust des C-terminalen Aminoalkohols 
generiert wird. Diese strukturellen Veränderungen sind offensichtlich der Grund dafür, daß 
diese Substanzen mittels CE detektiert werden konnten, während sie durch die HPLC nicht 
erfaßt wurden. Im Hinblick auf eine Erhöhung der strukturellen Vielfalt der Peptaibiotika ist 
der Nachweis zweier drastisch verkürzter Sequenzen, die einen N-terminalen 
Pyroglutaminsäure-Rest (Pyr) tragen, von besonderer Bedeutung. Diese repräsentieren die 
jeweiligen Hauptkomponente ALM F30/3 bzw. ALM F50/5, denen das N-terminale 
Hexapeptid fehlt. Somit wurde der erstmalige Nachweis von Pyr als ungewöhnlicher 
Bestanteil von Peptaibiotika erbracht. Nachdem Spuren dieser Peptide auch im 
Ausgangsmaterial detektiert werden konnten, wurde ALM F30 verschiedenen 
Erhitzungsversuchen unterworfen, um die Bedingungen der Aufarbeitung zu simulieren. 
Diese Experimente erbrachten keine Erhöhung des Gehalts an Pyr-Peptiden im 
Ausgangsmaterial. Dies erhöht die Wahrscheinlichkeit, daß diese Verbindungen tatsächlich 
nativ in der Probe vorliegen könnten. Pyr ist als Bestandteil von Peptiden bei Bakterien, 
Pflanzen, Invertebraten und Vertebraten bereits mehrfach beschrieben worden, was anhand 
von Beispielen aus der Literatur diskutiert wird. 
 
1.7. Peptaibiomics − das zielgerichtete Screening nach Peptaibiotika in 
phytoprotektiven Trichoderma-Arten 
Die von Krause et al. [2006(a)] eingeführte Methode der „Peptaibiomics“ zielt darauf ab, die 
Gesamtheit der von einem Pilzstamm unter definierten Kulturbedingungen gebildeten 
Peptaibiotika, das so genannte „Peptaibiom“, zu erfassen. Mit dieser Vorgehensweise ist es 
u. a. möglich, die zeitabhängige Dynamik der Biosynthese und des Abbaus von Peptaibiotika 
zu verfolgen, wie am Beispiel der extrem mikroheterogenen Trichobrachine aus Trichoderma 
ghanense CBS 936.69 demonstriert wurde [Krause et al., 2007]. Methodisch wird wie folgt 
vorgegangen: 
 An die Extraktion der Pilzkultur mit organischen Lösungsmitteln schließt sich eine 
Festphasenextraktion (SPE) über C18-Kartuschen an. Das organische Eluat wird danach 
mittels ESI-MS analysiert. Als besonders geeignet hierfür hat sich die Ionenfallen (ion trap)-
Massenspektrometrie (IT-MS) erwiesen; denn diese ermöglicht es, wie in der Publikation A 
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des Anhangs dargestellt, die Genealogie von Produkt-Ionen zu verfolgen. In einem ersten 
Schritt wird die Probe durch Applikation verschiedener Spannungsdifferenzen 
(typischerweise 0, 45 und 65%) in der Skimmer-Region des IT-MS der so genannten 
„Quellenfragmentierung“ (collision-induced decomposition, CID-MS) unterworfen. Somit 
können ausgewählten Quasimolekül-Ionen eine Reihe von zugehörigen Fragment-Ionen 
zugeordnet werden. Von besonderer Bedeutung ist dabei das Auftreten der Differenz ∆ (m/z) 
85, da diese das Vorhandensein eines Aib-Restes im Molekül anzeigt. Eine weitere 
diagnostische Differenz ist ∆ (m/z) 99, die Hinweise auf das Vorliegen eines Vxx-Restes (D- 
oder L-Iva bzw. L-Val10) gibt. Die durch CID-MS ermittelten Partialsequenzen werden in 
einem nächsten Schritt durch Stoßexperimente (MS2, MS3, MS4, MSn) nach Auswahl 
geeigneter Vorläufer-Ionen bestätigt. 
 
 Acht Stämme aus sieben Trichoderma-Arten (T. erinaceus, T. pubescens, T. spirale, T. 
strigosum und T. stromaticum sowie T. cf. pubescens und T. cf. strigosum) wurden mittels der 
oben vorgestellten Methode auf die Bildung von Peptaibiotika untersucht. Diese Isolate 
wurden im Rahmen eines Screenings von mehr als 400 Stämmen aus etwa 30 Trichoderma-
Arten aufgrund ihrer antimikrobiellen Wirkung auf die Erreger der Eutypiose, Eutypa lata, 
und der Esca-Krankheit, Phaeomoniella chlamydospora und Phaeoacremonium aleophilum, 
für eine vertiefende Bearbeitung ausgewählt. Beide traten in Deutschland in den vergangenen 
Jahren verstärkt als Erkrankung von Stamm und mehrjährigem Holz der Weinrebe (Vitis 
vinifera) auf [Gräfenhan, 2006]. In allen untersuchten Stämmen wurden Peptaibiotika 
nachgewiesen, die zur antifungalen Aktivität der Bildner beitragen könnten: 
Neben bekannten Sequenzen wurden neue, aus sieben, zehn und elf Resten bestehende 
Lipopeptaibole mit N-terminalen Alkanoyl- und C-terminalen Leucinol- (Leuol) oder 
Isoleucinol-Resten (Ileol) nachgewiesen11. Diese werden als Lipostrigocine (LSG) bzw. 
Lipopubescine (LPB) bezeichnet. Zwei neue, aus 19 Resten bestehende Peptaibole, die 
Trichostrigocine (TSG) A und B, werden von T. strigosum und T. erinaceus gebildet. In 
                                                           
10
 Über den Nachweis von D-Val in Peptaibiotika ist bislang noch nicht berichtet worden. 
11
 Alle bislang in linearen Peptaibiotika nachgewiesenen C-terminalen Aminoalkohole sind L-konfiguriert. 
Da eine Konfigurationsanalyse mittels GC/MS nicht durchgeführt werden konnte, sind die isobaren 
Aminosäuren bzw. -alkohole der in den Anhängen D, E und H gefundenen Peptaibiotika mit Vxx und Lxx bzw. 
Vxxol und Lxxol angegeben. 
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Kulturen von T. stromaticum [Samuels et al., 2000] wurden fünf neue Peptaibole, die 
Trichstromaticine (TSM) A−E, detektiert, die aus 18 Resten bestehen und zum Erfolg dieser 
Art bei der biologischen Bekämpfung des Erregers der Hexenbesenkrankheit des Kakaos 
(Theobroma cacao), Moniliophthora (syn. Crinipellis) perniciosa, beitragen könnten. 
Schließlich wird die chemotaxonomische Relevanz der gefundenen Peptaibiotika 
diskutiert. Für die Systematik besitzen diese Peptid-Antibiotika bei isolierter Betrachtung 
keine Bedeutung, wohl aber im Kontext mit anderen, für die Einordnung der Bildner ins 
System der Pilze wichtigen Merkmalen, wie klassisch-morphologischen Daten und 
molekularbiologischen Markern, aber auch der Bildung von Mykotoxinen und anderen 
niedermolekularen Sekundärmetaboliten. 
 
1.8. Der Trichoderma brevicompactum-Komplex als reiche Fundgrube 
bekannter und neuer Sequenzen von Peptaibiotika  
Im Rahmen des im vorherigen Abschnitt besprochenen Screenings nach Trichodermen, die 
zur biologischen Bekämpfung von Eutypiose und Esca-Krankheit im Weinbau geeignet sind, 
wurden drei Isolate von T. brevicompactum sowie vier mit dieser Art nahe verwandte Stämme 
(vorläufig als Trichoderma cf. brevicompactum klassifiziert)12 eingehend auf die Bildung von 
Peptaibiotika untersucht.  
Die Auswahl der sieben oben genannten Stämme erfolgte aufgrund ihrer besonders stark 
ausgeprägten antibiotischen Aktivität gegen die Erreger der beiden Rebholz-Krankheiten. 
Methodisch wurde in dieser Arbeit, wie bereits im Abschnitt 1.7. beschrieben, vorgegangen. 
Alle untersuchten Stämme produzierten die aus 20 Resten bestehenden Alamethicine F30.13 
Insgesamt wurden folgende Peptaibole sequenziert: 14 aus zwölf Resten bestehende 
Trichocryptine B (TCT-B), zwölf aus elf Resten bestehende Trichocryptine A (TCT-A), 19 
                                                           
12
 Zur endgültigen taxonomischen Einordnung und Hinterlegung der betreffenden Stämme siehe Anhang 
H. Zu einer dieser Arten gehört auch der ALM-Patentstamm Trichoderma „viride“ NRRL 3199, der als 
„klassische“ Quelle dieser aus 20 Resten bestehenden Peptaibole bekannt ist. 
13
 ALM gilt allgemein als  d a s  klassische Beispiel für membranaktive Peptaibole [vgl. Übersichtsarbeit: 
Leitgeb et al., 2007]. Deren antibiotische Aktivität beruht auf der Bildung von spannungsabhängigen 
Ionenkanälen nach dem „Flip-Flop-Modell“ [Boheim et al., 1983], das aus dem „barrel stave“-Modell [Boheim, 
1974] hervorgegangen ist. 
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aus elf Resten bestehende Trichobrevine (TBV) A und B. Außerdem bildeten die Isolate sechs 
aus zehn Resten bestehende Lipoaminopeptide, die Trichoferine (TFR), und 17 aus sieben 
Resten bestehende Lipopeptaibole, die Trichocompactine (TCT). Somit konnten − allein aus 
diesen sieben Stämmen − fast 70 neue Sequenzen von Peptaibiotika ermittelt werden. 
Die gefundenen Peptaibiotika, insbesondere die als Hauptkomponenten auftretenden ALM 
F309, könnten − wegen ihrer ionenkanalbildenden Eigenschaften − als  d a s  maßgebliche 
antibiotische Prinzip der sieben untersuchten Stämme interpretiert werden. Aufgrund der 
distinkten HPLC-Elutionsprofile der einzelnen Stämme und des in zwei Gruppen 
aufspaltenden Musters der gebildeten, auf Warmblüter cytotoxisch wirkenden Mykotoxine14 
Trichodermin [Godtfredsen & Vangedal, 1964; 1965] und Harzianum A [Corley et al., 1994] 
ergab sich die Notwendigkeit einer taxonomischen Revision der Sammelart Trichoderma 
brevicompactum, d. h. ihre Neubeschreibung und die Schaffung zusätzlicher Arten. Diese 
Studie verdeutlicht zwei Tatsachen:  
Einerseits illustriert sie eindrucksvoll das Potential einer peptaibiomischen 
Vorgehensweise bei der Suche nach neuen Peptabiotika mit interessanten Bioaktivitäten. 
Andererseits bestätigt sie bereits im Anhang D niedergelegten Aussagen zur Relevanz von 
Peptaibiotika in der Pilzsystematik, da die Ergebnisse der morphologischen und 
molekulartaxonomischen Untersuchung dieser Isolate im Einklang mit chemotaxonomischen 
Befunden stehen. 
 
 
 
 
 
 
 
                                                           
14
  Auf die Sicherheitsrisiken, die sich aus einem Einsatz mykotoxinbildender Trichodermen in der 
landwirtschaftlichen Praxis ergäben, wurde bereits von Nielsen et al. [2005] verwiesen. 
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1.9. Neue Sequenzen, Bausteine und Produzenten von Peptaibiotika  
In den vier Jahren seit dem Erscheinen von Anhang A sind etwa 300 neue Peptaibiotika 
vollständig oder zumindest partiell sequenziert worden; darüber hinaus wurden neue Bildner 
und weitere ungewöhnliche, nicht-proteinogene Bausteine beschrieben. Hieraus ergab sich im 
Jahre 2007 die Notwendigkeit, diese neuen Befunde in einer Übersichtarbeit, welche im 
Anhang F aufgelistet ist, darzustellen: 
 Neue Arten von Peptaibiotikabildnern werden vorgestellt und deren Position im 
System der Pilze diskutiert. Außerdem wird auf weitere, potentielle Quellen von Peptaibiotika 
eingegangen. Dabei handelt es sich um solche Arten und Stämme, für die zwar bereits der 
Nachweis von peptidisch gebundenem Aib, D- oder L-Iva mittels GC/MS erbracht wurde, in 
denen aber bislang noch keine Peptaibiotika sequenziert worden sind15.  
Repräsentative Sequenzen von Peptaibiotika und ungewöhnliche monomere Bausteine 
werden im Formelbild illustriert. Auf die erfolgreiche Anwendung der Peptaibiomics bei der 
Untersuchung neuer Bildner aus der Gattung Trichoderma/Hypocrea sowie bei der 
Sequenzierung der Suzukacilline [Krause et al., 2006(b)] und der extrem mikroheterogenen 
Trichobrachine [Krause et al., 2007] wird eingegangen. Als besonders interessanter Befund 
wird die erstmalige Isolierung von Antiamoebinen (AAM) aus dem natürlichen, von Stilbella 
fimetaria (syn. S. erythrocephala) besiedelten Substrat ausführlich diskutiert, d. h. der 
Nachweis der Peptaibiotikabildung in vivo. Hierbei ist hervorzuheben, daß die gefundenen 
Mengen an Antiamoebin im deutlich inhibitorischen Bereich lagen und somit für den 
koprophilen Bildner einen bemerkenswerten Vorteil bei der Besiedlung von Herbivoren-Dung 
als ökologische Nische darstellen. 
Als Gründe für die erwähnte Verdopplung der in der Literatur beschriebenen Peptaibiotika 
innerhalb von nur vier Jahren werden die Einführung neuer analytischer Methoden, die 
zielorientierte Auswahl und Optimierung von Trennmethoden und der Einsatz neuester 
massenspektrometrischer Verfahren diskutiert. In diesem Zusammenhang werden analytische 
Aspekte der Trennung stereoisomerer Aminosäuren an zwei für die Sequenzierung von 
Peptaibiotika relevanten Beispielen (DL-Iva sowie 3- und 4-Hyp) erörtert. 
                                                           
15
  Auf diese bislang nur in Ansätzen bearbeiteten Bildner nicht-proteinogener α,α-Dialkylaminosäuren 
wird im Anhang K eingegangen. 
30 
 
Als ein weiterer Grund für die rapide Zunahme der in der Literatur beschriebenen 
Peptaibiotika wird die Erforschung von Bildnern aus hochkompetitiven bzw. ungewöhnlichen 
Substraten besprochen. Der Bearbeitung von Pilzen aus ökologischen Nischen, so z. B. aus 
koprophilen (AAM aus Stilbella-Arten), entomopathogenen (Cicadapeptine aus Cordyceps 
heteropoda), und fungicolen Assoziationen (Acretocin aus Acremonium crotocinigenum; 
Trichoderma stromaticum als Hyperparasit des Erregers der Hexenbesenkrankheit des 
Kakaos, Moniliophthora [syn. Crinipellis] perniciosa), erhöht die Wahrscheinlichkeit des 
Auffindens von neuartigen Sequenzen und interessanten Bioaktivitäten. 
 
1.10. Die Bedeutung und künftige Perspektiven aktueller Ergebnisse auf den 
Gebieten der Peptaibiotika-, Hydrophobin- und Mykotoxinforschung für 
die Chemotaxonomie der Gattung Trichoderma/Hypocrea  
Auf die überragende Bedeutung der Anamorphen-Gattung Trichoderma und ihrer Hypocrea-
Teleomorphen als Bildner von Peptaibiotika wurde im Rahmen dieser Ausführungen schon 
mehrfach verwiesen. Ungeachtet dessen ist es, wie in Anhang G ausgeführt, stets notwendig, 
Aussagen zur Bildung von Sekundärmetaboliten durch bestimmte Arten der Gattung 
Trichoderma/Hypocrea kritisch zu hinterfragen. Dies beruht vor allem auf der Tatsache, daß 
deren Systematik seit etwa Mitte der 1990er Jahre, bedingt durch die Einführung 
molekulartaxonomischer und phylogenetischer Methoden, bedeutsamen Veränderungen 
unterworfen ist. Diese finden jedoch erst seit etwa zehn Jahren ihren Niederschlag in der 
naturstoffchemischen und bioanalytischen Natur. Von wenigen Ausnahmen abgesehen, wurde 
die Bildung von Sekundärmetaboliten, einschließlich der Peptaibiotika, bis zu diesem 
Zeitpunkt meist den vier verbreitetesten Trichoderma-Arten, T. viride, T. koningii, T. 
harzianum und T. longibrachiatum, zugeschrieben. Diese Zuordnung kann nach heutigem 
Kenntnisstand nicht mehr aufrecht erhalten werden, da die ursprüngliche Identifizierung 
dieser Produzenten in der Zwischenzeit entweder bereits revidiert wurde oder fortwährend 
Gegenstand berechtigter Zweifel ist16. Derzeit sind etwa 140 Trichoderma-Arten gültig 
                                                           
16
  Es sei an dieser Stelle auf die nach wie vor bestehende, da nicht verbindlich gelöste Problematik 
verwiesen, daß etliche Peptaibiotikabildner nicht in einer anerkannten, öffentlich zugänglichen Stammsammlung 
(International Depositary Authority; IDA) hinterlegt sind. Diese Tatsache erschwert nicht nur die 
Nachbestimmung eines peptaibiotika-bildenden Stammes, dessen publizierte Identität zweifelhaft erscheint, 
sondern hat in der Vergangenheit bereits zum wahrscheinlich endgültigen Verlust von Isolaten geführt. 
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beschrieben. Daher gelten moderne Methoden der DNA-Sequenzierung − neben klassisch-
morphologischen Bestimmungsmethoden − als derzeitiger Standard in der Pilztaxonomie. Als 
weitere vielversprechende Methode hat sich in diesem Zusammenhang die „Intact Cell 
MALDI-TOF MS“ (IC-MS) [Neuhof et al., 2007(a), (b), (c)] erwiesen. Im Falle intakter 
pilzlicher Zellen werden die im Solvens löslichen Komponenten der Zellwand, vor allem 
Proteine, sowie niedermolekulare Metaboliten, einschließlich der Peptaibiotika, detektiert. 
Dabei gelten die Hydrophobine (HFB) als exzellente Biomarker, die eine Differenzierung 
von Isolaten unterhalb der Artebene ermöglichen und somit für die Aufspaltung von 
Sammelarten, wie Trichoderma brevicompactum17, besonders gut geeignet sind. 
Wann immer möglich, sollten molekulargenetische und chemotaxonomische Methoden, wie 
z. B. die Bestimmung der HFB mittels IC-MS, ein LC/MS-basierenden Mykotoxin-Screening 
[Nielsen et al., 2005] und ein peptaibiomischen Ansatz (siehe Abschnitte 1.7., 1.8. und 1.11.), 
miteinander kombiniert werden. Eine solche interdisziplinäre Vorgehensweise, die der 
genomischen, proteomischen und metabolomischen Komplexität der Pilze Rechnung trägt, 
wird bei der Besprechung des Trichoderma brevicompactum-Cladus im folgenden Abschnitt 
ausführlich erörtert. 
Die praktische Bedeutung von Sekundärmetaboliten der Gattung 
Trichoderma/Hypocrea wird einerseits dadurch verdeutlicht, daß nicht nur stetig neue 
Sequenzen und Bioaktivitäten von Peptaibiotika, wie die Hemmung der Amyloid-β-Peptide 
[Hosotani et al., 2007], beschrieben werden, sondern mittlerweile auch bekannte 
phytoprotektive Wirkungen von so genannten pflanzenstärkenden oder im biologischen 
Pflanzenschutz eingesetzten Präparaten auf Trichoderma-Basis durch die Präsenz von 
Peptaibiotika erklärbar sind. Andererseits ist zu berücksichtigen, daß solche Präparate, die 
potentiell in die Nahrungskette gelangen können, frei von Metaboliten unterschiedlichster 
Strukturklassen, die als Mykotoxine im engeren Sinne [i. e. S.: Frisvad et al., 2006(b)] 
klassifiziert worden sind, sein müssen. Anhand repräsentativer Beispiele wird erläutert, 
warum manche Peptaibiotika – allein aufgrund ihres irreführenden Namens (vgl. 
Trichotoxin!) oder einer toxischen Wirkung gegenüber Invertebraten – nicht pauschal als 
Mykotoxine (i. e. S.) eingestuft werden sollten. 
                                                           
17
  Weitere Beispiele aus der neuesten Literatur werden im Kapitel 3 diskutiert. 
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1.11. Der Trichoderma brevicompactum-Cladus: ein separater Zweig im 
Stammbaum mit neuen peptaibiotika- und mykotoxinbildenden Arten 
Ausgehend von den im Abschnitt 1.8. dargestellten Diskrepanzen, die sich aus der 
Untersuchung des Peptaibioms und des Mykotoxin-Musters ausgewählter Isolate des 
Brevicompactum-Komplexes ergaben, resultierte die Notwendigkeit einer taxonomischen 
Revision des nunmehr als Sammelart zu bezeichnenden Trichoderma brevicompactum. Mit 
Hilfe des interdisziplinären im Anhang H beschriebenen Ansatzes, der  
− die morphologische Analyse und deren nachfolgender statistische Auswertung (MDS); 
− die phylogenetische Analyse (tef1, rpb2, ITS); 
− die Peptaibiom-Analyse (durch HPLC/ESI-IT-MSn, MALDI-TOF-MS und GC/MS); 
− die Hydrophobin-Analyse der sporulierenden Mycelien (durch IC-MALDI-TOF-MS) 
und 
− die Mykotoxin-Analyse (durch Kopplung von DAD-HPLC und hochauflösender ESI-
TOF-MS) 
umfaßte, konnte dieses Ziel erreicht werden. Die in Anhang E temporär als Trichoderma cf. 
brevicompactum klassifizierte Stämme und weitere Isolate gehören den folgenden drei neuen 
Arten an und zwar 
− Trichoderma arundinaceum sp. nov. Zafari, Gräfenhan & Samuels; 
− Trichoderma protrudens sp. nov. Samuels & Chaverri sowie 
− Trichoderma turrialbense sp. nov. Samuels, Degenkolb, K. F. Nielsen & Gräfenhan. 
 
Gemeinsam mit Trichoderma brevicompactum, dessen Artbeschreibung revidiert wurde, und 
Hypocrea rodmanii sp. nov. Samuels & Chaverri (Anamorphe: Trichoderma rodmanii) bilden 
sie den neuen Brevicompactum-Cladus, der systematisch dem Lutea-Cladus am nächsten 
steht. Dabei unterscheidet sich die neue Hypocrea-Art durch das Fehlen von einfachen, nicht-
makrocyclischen Trichothecenen von den vier übrigen Arten, die entweder Trichodermin (T. 
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brevicompactum)18 oder Harzianum A (T. arundinaceum19, T. protrudens und T. turrialbense) 
bilden. Außerdem ist das Peptaibiotika-Muster von H. rodmanii völlig verschieden von dem 
der übrigen Arten des Cladus – neben sieben neuen, aus sieben Resten bestehenden 
Lipopeptaibolen, den Hypocompactinen (HCP), und fünf neuen, aus 14 Resten bestehenden 
Peptaibolen, den Hyporodicinen (HRC), bildet diese Art aus 19 Resten bestehende 
Trichokonine (TKO). Im Gegensatz dazu bilden die sieben untersuchten Isolate von 
Trichoderma brevicompactum hauptsächlich ALM20 sowie die TCT der A- und B-Reihe. Als 
Minorkomponenten wurden Lipoaminopeptide der TFR-Gruppe gefunden. In Abhängigkeit 
vom untersuchten Isolat können Spuren von TBV vorhanden sein. T. turrialbense 
unterscheidet sich durch die Bildung von Harzianum A von T. brevicompactum. Das Muster 
der produzierten TCT ist vom Isolat abhängig; besonders bemerkenswert ist in diesem 
Zusammenhang der erstmalige Nachweis von L-Alaninol (L-Alaol) als C-terminaler 2-
Aminoalkohol von Peptaibolen mittels GC/MS. Ferner wurden TBV und TFR als 
Minorkomponenten nachgewiesen. Somit ist T. turrialbense als Bindeglied zwischen T. 
brevicompactum und T. arundinaceum einzuordnen. Das Peptaibiom der beiden Harzianum 
A-bildenden Species T. arundinaceum und T. protrudens ist identisch; die Abgrenzung der 
letzteren erfolgt hier anhand ihres einzigartigen Hydrophobin-Musters und morphologisch-
physiologischer Parameter. 
 
 
 
 
                                                           
18
  Der ursprünglich als T. viride beschriebene Trichodermin-Bildner [Godtfredsen & Vangedal, 1964; 
1965] gehört zu T. brevicompactum.   
19
  Zu T. arundinaceum gehören u. a. der von Corley et al., [1994] als T. harzianum ATCC 90237 
klassifizierte Harzianum A-Bildner sowie „Hypocrea sp.“ F000527, die von Lee et al. [2005] und Jin et al. 
[2007] als Bildner von Harzianum A bzw. B publiziert wurde. Auch der ALM-Patentstamm T. „viride“ NRRL 
3199 ist nunmehr als T. arundinaceum eingeordnet. 
20
  Das Verhältnis zwischen ALM F30 und F50 hängt vom jeweiligen Isolat und von den 
Fermentationsbedingungen ab. Die verwendeten Abkürzungen werden im Abschnitt 1.6. erläutert. 
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1.12. Natürlich vorkommende Cyclopeptaibiotika und verwandte cyclische 
Tetrapeptide: ihre strukturelle Vielfalt und biologischen Aktivitäten 
Wird deren Linearität nicht mehr als ein notwendiges Kriterium zur Einordnung von 
bioaktiven Peptiden als Peptaibiotika betrachtet, so bietet dies die Möglichkeit, die klassische 
Definition eines Peptaibiotikums [Brückner et al., 1991(a) und (b); Anhang A und Anhang 
F] auf cyclische, α,α-dialkylaminosäure-haltige Peptide zu erweitern. Diese schließt nunmehr 
eine kleine Gruppe von Verbindungen ein, die – wie in Anhang I dargestellt – als fünfte 
Unterfamilie der Peptaibiotika, die Cyclopeptaibiotika, in die Literatur eingeführt wurden. 
Dabei werden auch taxonomische und ökophysiologische Aspekte der Bildner diskutiert. 
Strukturell lassen sich die bisher bekannten Verbindungen in dieser Unterfamilie in die 
Cyclotetrapeptaibiotika und die Cycloheptapeptaibiotika unterteilen. 
Cyclotetrapeptaibiotika sind durch einen vergleichsweise einheitlichen Bauplan 
gekennzeichnet: in ihrem Ring befinden sich ein substituierter L-2-Aminodecansäure-, ein D-
Pro- oder  trans-4-D-MePro-21, ein Phenylalanyl-22 und ein α,α-Dialkylaminosäure-Rest. 
Letzterer wird in sieben von neun bislang beschriebenen Cyclotetrapeptaibiotika durch Aib 
gebildet, welche im Phoenistatin [Masuoka et al., 2001]23 durch Iva24 sowie im FR235222 
und im AS138739225 durch L-Iva substituiert ist. In den drei Cycloheptapeptaibiotika fehlt 
hingegen der Lipoaminosäure-Rest; stattdessen sind in den Syctalidamiden A und B als 
ungewöhnliche Bausteine neben Aib N-Methylaminosäuren vorhanden sowie Pro bzw. 
(2S,3S)-3-MePro. In den Serinocyclinen ist Acc als α,α-Dialkylaminosäure enthalten; 
                                                           
21
 Bislang nur im FR235222 nachgewiesen; alle übrigen Cyclotetrapeptaibiotika besitzen einen D-Pro-
Rest. 
22
  Als eine Ausnahme hiervon ist AS1429716 zu nennen, das statt des Phe-Restes einen Tyr-Rest trägt. Es 
wird aus AS1387392, cyclo(Aoh-D-Pro-L-Phe-L-Iva) [Sasamura et al., 2010(a)], durch Biokonversion m. H. 
verschiedener Actinomyceten erzeugt [Sasamura et al., 2010(b)]. Weitere Derivate des AS1387392 sind 
cyclo(Aoh-D-Pro-L-m-Tyr-L-Iva), cyclo(Add-D-Pro-L-Phe-L-Iva), cyclo(Add-D-Pro-L-Tyr-L-Iva) und cyclo(Add-
D-Pro-L-m-Tyr-L-Iva). Sie werden durch Biokonversion mit Amycolatopsis azurea JCM 3275 gewonnen 
[Sasamura et al., 2010(c)]. Aoh = 2-Amino-8-oxo-9-hydroxydecansäure; Add = 2-Amino-8,9-
dihydroxydecansäure. 
23
  Das von Acremonium fusigerum produczierte Phoenistatin [Masuoka et al., 2001] und die 
Serinocycline A und B aus Metarhizium anisopliae [Krasnoff et al., 2007] werden im Anhang I nicht 
abgehandelt. 
24
  Die Konfiguration des Iva-Rests im Phoenistatin ist bisher noch nicht bestimmt worden. 
25
  AS1387392 [Sasamura et al., 2010(a)] und FR235222 wurden aus Acremonium sp. No. 27082 isoliert. 
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weiterhin ein D-Ser-, zwei L-Ser-, ein (2S,4R)-Hyp, ein β-Ala- und ein 2-(R,4S)-γ-Hylys- bzw. 
D-Lys-Rest [Krasnoff et al., 2007]. 
Alle bisher beschriebenen Cyclotetrapeptaibiotika und natürlich vorkommende, 
strukturell verwandte α,α-dialkylaminosäurefreie Cyclotetrapeptide26 werden von Pilzen 
gebildet. Sie besitzen eine stark inhibierende Wirkung auf Histon-Deacetylasen (HDAC), 
durch die das breite Spektrum der biologischen Aktivitäten dieser Verbindungen, auf die in 
Anhang I ausführlich eingegangen wird, im allgemeinen erklärt werden kann. Als Beispiele 
mit möglicher praktischer Relevanz sind zu nennen die immunsuppressive Wirkung des 
FR235222 oder die TGF-β-artige Aktivität27 des Diheteropeptins.  
Im Falle der beiden Cycloheptapeptaibiotika Scytalidamid A und B wurde eine in vitro-
Hemmung von Krebszell-Linien beobachtet, während das von Metarhizium anisopliae var. 
anisopliae und M. anisopliae var. acridum28 biosynthetisierte Serinocyclin A subletale 
lokomotorische Defekte bei Aedes aegypti-Larven hervorruft [Krasnoff et al., 2007]. 
Eine durch das Vorkommen nicht-proteinogener Aminosäuren wahrscheinliche nicht-
ribosomale Biosynthese dieser Verbindungen schlägt sich im Falle der Apicidine, Azumamide 
und der Analoga der HC-Toxine [Kim et al., 1985; Tanis et al., 1986; Rasmussen & Scheffer, 
1988] in einer Mikroheterogenität nieder: 
Die im letzteren Falle beschriebenen Substitutionen von D-Ala gegen Gly (HC-Toxin 
II) bzw. von D-Pro gegen trans-3-Hyp (HC-Toxin III) geben Anlaß zu der Hypothese eines 
möglichen Austauschs von Ala gegen einen α,α-Dialkylaminosäure-Rest. Die bislang noch 
ausstehende systematische Untersuchung dieser Mikroheterogenität, z. B. durch Applikation 
eines peptaibiomischen Ansatzes, erscheint als interessante Alternative zur potentiellen 
                                                           
26
  Hierzu zählt auch JM47, cyclo(Aoh-D-Pro-Ala-D-Ala), das von einem marinen Fusarium sp. [Jiang et 
al., 2002] gebildet wird. Die beiden Ala-Reste erscheinen ebenfalls als für einen hypothetischen Austausch 
gegen Aib geeignet. 
27
  Hierbei handelt es sich um den Transformierenden Wachstumsfaktor Beta, ein Cytokin, das u. a. 
Hirnzellen vor Zerstörungen schützt, wie sie nach ischämischen Verletzungen oder infolge der Alzheimer-
Krankheit auftreten können.  
28
  Beide Subspecies werden bei der biologischen Bekämpfung von Schadinsekten kommerziell 
eingesetzt. Der verwendete Stamm von M. anisopliae var. acridum wurde aus dem Präparat „Green Muscle“® 
isoliert, das in Westafrika sehr effektiv zur biologischen Bekämpfung von Wanderheuschrecken verwendet wird. 
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Auffindung von Analoga bzw. Minorkomponenten mit neuen monomeren Bausteinen und 
interessanten Bioaktivitäten. 
 
1.13. Peptaibiomics: auf dem Wege zu einer Myriade von bioaktiven, α,α-
dialkylaminosäure-haltigen Peptiden? 
Bereits aus den bisherigen Ausführungen ist erkennbar, daß Pilze eine buchstäblich 
unerschöpfliche Quelle bioaktiver Peptide darstellen. Daher wird in der als Anhang J 
aufgelisteten Übersichtsarbeit eingangs die Definition des Terminus „Peptaibiotikum“ 
aktualisiert und präzisiert. Chronologisch wird die Geschichte der Peptaibiotika-Forschung 
von den Anfängen im Jahre 1958 bis 2008 vorgestellt und die dabei wichtigsten 
Literaturreferenzen besprochen. Diese Arbeit fokussiert einerseits auf die Darstellung der 
strukturellen Diversität und Mikroheterogenität der bis dahin etwa 850 beschriebenen 
Sequenzen von Peptaibiotika, andererseits auf die Biodiversität der sie produzierenden Pilze.
 Ausgehend von der Entdeckung von peptidisch gebundener Aib im Hydrolysat des 
nicht-kristallinen Antibiotikums ICI 13959 werden die ersten zwei Dekaden der 
Peptaibiotika-Forschung geschildert. Daran schließen sich Ausführungen über Entwicklung 
und Relevanz von hochenergetischen Ionisierungstechniken, wie EI-MS und FAB-MS, für die 
Sequenzierung von Peptaibiotika an; und es wird auf die Bedeutung von GC/MS-, GC-FID, 
FD- und CI-MS sowie HPLC-Methoden zur Aminosäure-Analytik, einschließlich der 
Bestimmung des N-terminalen Aminosäure-Rests eingegangen. Danach wird die Einführung 
von Spray-Ionisationstechniken als entscheidender, die Sequenzierung von Peptaibiotika 
revolutionierender Schritt geschildert. Einen breiten Raum nimmt die Darstellung der 
strukturellen Diversifizierung in den Jahren 1996 bis 2008 ein. Es werden Beispiele für 
Verbindungen mit ungewöhnlichen Bausteinen29 und Bioaktivitäten (vgl. Abschnitt 1.2.) 
vorgestellt. Dabei kommen auch taxonomisch-systematische Aspekte und die Ökophysiologie 
der Bildner zur Sprache. Beispielsweise wird die Frage der Peptaibiotika-Bildung in 
Fruchtkörpern von Basidiomyceten abschließend diskutiert; und es wird auf die erstmalige 
                                                           
29
  In diesem Zusammenhang sei auf eine Problematik verwiesen, die sich im Rahmen von 
Literaturrecherchen nach neuen Sequenzen, Strukturelementen, Bildnern oder  biologischen Aktivitäten von 
Peptaibiotika gelegentlich ergibt: Ungeachtet des Nachweises von α,α-Dialkylaminosäure-Resten, vor allem von 
Aib, werden die gefundenen bioaktiven Peptide nicht von allen Autoren als Peptaibiotika erkannt und 
entsprechend klassifiziert. Dies führt vereinzelt zu dazu, daß relevante Literatur nicht zeitnah erfaßt wird. 
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Isolierung von Peptaibolen aus dem natürlichen Substrat verwiesen. Weiterhin werden anhand 
von Beispielen aus der neuesten Literatur peptaibiomische und auf die Verwendung der IC-
MS beruhende methodische Ansätze vorgestellt, die ein beschleunigtes Screening potentieller 
Bildner und eine rasche Sequenzierung von Peptaibiotika ermöglichen. Schließlich werden 
künftige Perspektiven der Peptaibiotika-Forschung auf dem Wege zu einer sprichwörtlichen 
Myriade einzelner Sequenzen diskutiert, so z. B. Möglichkeiten zur weiteren strukturellen 
Diversifizierung durch Untersuchung von aus ökologischen Nischen isolierten Bildnern und 
die Erweiterung des auf bislang kaum bzw. noch nicht bearbeitete  systematische Gruppen 
von Pilzen. Auf letzteren Aspekt wird im folgenden Abschnitt näher eingegangen. 
 
1.14. Aib und Iva in der Biosphäre – weder selten noch zwangsläufig 
extraterrestrischen Ursprungs 
Gegenwärtig wird von einer geschätzten Gesamtzahl von nahezu anderthalb Millionen 
rezenten Pilzarten ausgegangen, wovon rund 98.000 gültig beschrieben sind [Kirk et al., 
2008]. Demgegenüber stehen bisher nur einige Tausend Arten, aus denen bioaktive 
Sekundärmetaboliten isoliert worden sind. Noch deutlicher wird dieses bislang unerforschte 
Potential im Falle der Peptaibiotika: als Quellen der annähernd 900 publizierten 
Einzelsequenzen kommen annähernd 100 Pilzarten in ca. 25 Gattungen30 in Frage, wobei die 
weitaus meisten Sequenzen von Trichoderma/Hypocrea (siehe auch Abschnitt 1.2.) 
biosynthetisiert werden. Die überwiegende Mehrheit der Pilze wurde noch nicht auf die 
Bildung von Peptaibiotika untersucht. 
Aus diesem Grunde wurden organische Extrakte aus 49 Stämmen filamentöser Pilze 
hydrolysiert und nach entsprechender Derivatisierung auf das Vorhandensein von 
peptidgebundenem Aib, D- und/oder L-Iva mittels GC/SIM-MS untersucht. In 37 der 
untersuchten Isolate konnte mindestens eine der drei oben genannten α,α-Dialkylaminosäuren 
nachgewiesen werden. Eine Übersicht der geprüften Stämme gibt Tabelle 1 der als Anhang K 
bezeichneten Originalarbeit. Von besonderem Interesse sind hierbei die positiv getesteten 
Arten und Stämme aus den Gattungen Lecythophora (Teleomorphe: Coniochaeta, 
Coniochaetaceae, Coniochaetales), Nectriopsis (Bionectriaceae, Hypocreales), Monocillium, 
                                                           
30
  Die hier genannten Zahlenangaben ergeben sich aus einer Schätzung zum Zeitpunkt des Einreichens 
dieser Habilitationsarbeit im November 2010. 
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Niesslia (Niessliaceae, Hypocreales) und Wardomyces (Microascaceae, Microascales); denn 
über Peptaibiotika-Bildung in den drei genannten Familien ist bisher kaum bzw. noch nicht 
berichtet worden. Weitere Arten, wie Bionectria pityrodes, Clonostachys rosea und 
Clonostachys candelabrum (Bionectriaceae, Hypocreales), sind ebenfalls für eine vertiefende 
Bearbeitung prädestiniert, da in deren Hydrolysaten sowohl Aib als auch beide Iva-
Enantiomere nachgewiesen wurden. 
 Die Ergebnisse dieses GC/MS-Screenings widerlegen langjährige Postulate von 
Astrochemikern und Meteoritenforschern, daß Aib und Iva ausschließlich extraterrestrischen 
Ursprungs sind und in der Biosphäre extrem selten vorkommen. 
 Hinzu kommt die an sich ubiquitäre Verbindung möglicher Produzenten, welche 
anhand von Beispielen illustriert wird. Trichoderma/Hypocrea ist als Pilzgattung mit vielen 
bodenbürtigen Arten weltweit verbreitet. In diesem Zusammenhang spielt die mögliche 
Verbreitung von Pilzsporen als Bestandteile von Bioaerosolen eine nicht zu unterschätzende 
Rolle; außerdem können sie Sand- und Staubpartikeln anhaften und so über Hunderte oder gar 
Tausende von Kilometern verbreitet werden. Daher kann eine möglicherweise biotische 
Herkunft von Aib und Iva, die in marinen und nicht-marinen Sedimenten nahe (aber nicht in!) 
der sog. Kreide-Tertiar (K/T)-Grenze gefunden wurden, nicht ausgeschlossen werden31. 
Selbst über eine nachträgliche mikrobielle Kontamination von aminosäurehaltigen 
Meteoriten, wie dem Murchinson oder dem Murray, wurde berichtet, da diese nicht unter 
streng aseptischen Bedingungen gelagert werden. Seit einigen Jahren wird eine stetig 
wachsende Anzahl von Sekundärmetaboliten aus psychrotoleranten, kälteadaptierten 
Pilzspecies [Frisvad et al., 2006(a); Frisvad 2008] publiziert. Selbst aus Meteoriten oder 
Eisbohrkernen antarktischen Ursprungs werden regelmäßig lebensfähige Mikroorganismen, 
einschließlich psychrophiler Pilze, isoliert32. Darunter befinden sich auch bereits als 
Peptaibiotika-Bildner beschriebene Pilzgattungen, wie Acremonium, Paecilomyces und 
Trichoderma33. 
                                                           
31
  Beispiele für die Sequenzierung und Isolierung von Peptaibiotika aus Pilzstämmen mariner Herkunft 
und aus marinen Sedimenten wurden bereits im Anhang J vorgestellt. 
32
  Die Pilzarten des antarktischen Festlands werden eingehend von Onofri et al. [2007] abgehandelt. 
33
  Auf die erstmalige Isolierung von Peptaibolen aus einem marinen Trichoderma asperellum 
antarktischer Herkunft wird im Kapitel 3 eingegangen. 
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Zusammenfassend ist festzustellen, daß ein Screening von bislang noch nicht oder wenig 
bearbeiteten Pilzarten, die aus ökologischen Nischen und Extremstandorten, so z. B. 
Eisbohrkernen, Boden-, oder marinen Sedimentproben aus arktischen oder antarktischen 
Habitaten, die Wahrscheinlichkeit des Auffindens neuer Bildner, Bausteine und Sequenzen 
von Peptaibiotika beträchtlich erhöht. Eine vertiefende Bearbeitung der in Tabelle 1 des 
Anhangs K aufgelisteten, positiv auf peptidisches Aib, D- und/oder L-Iva getesteten Stämme 
erscheint daher folgerichtig und naheliegend. 
 
1.15. Untersuchungen zur selektiven trifluoracetolytischen Spaltung von 
nativen Peptaibolen und Modellpeptiden mittels HPLC und ESI-CID-MS 
Unerwartete, obgleich selektive Spaltreaktionen von Peptidbindungen, insbesondere bei 
Anwesenheit nicht-proteinogener Aminosäuren im Molekül, gelten allgemein als 
Herausforderung für die Planung manueller oder automatisierter Peptidsynthesen bzw. bei der 
Aufarbeitung, Aufreinigung oder Sequenzierung von Peptiden. 
Demgegenüber steht der zielgerichtete Einsatz acidolytischer Spaltungen der von speziellen 
Aminosäuren gebildeten Amidbindungen, beispielsweise bei der Strukturaufklärung von 
Peptaibiotika, z. B. Chlamydocin [Closse & Huguenin, 1974], AAM [Pandey et al., 1977(a), 
1978], ALM [Pandey et al., 1977(b); Brückner & Jung, 1980], TXT-A40 [Brückner et al., 
1979] und TXT-A50 [Przybylski et al., 1984]. 
Untersucht wurde, wie in der Originalarbeit im Anhang L geschildert, das Spaltverhalten 
folgender Peptaibole: der nativen, mikroheterogenen AAM- und ALM-F30-Mischungen, des 
aufgereinigten nativen Paracelsins A (PC-A) und des synthetischen TXT-A50/E. Als 
Vergleichssubstanzen wurden drei Homo-Aib-Peptide analysiert, und zwar Z- und Ac-
(Aib)10-OtBu sowie Ac-(Aib)7-OtBu. Alle untersuchten Peptide wurden bei 37 °C für 0,5 bis 
26 h mit wasserfreier Trifluoressigsäure (TFA) inkubiert, die acidolytisch erzeugten 
Fragmente mittels HPLC aufgetrennt und schließlich durch ESI-CID-MS analysiert. 
 Im Falle der nativen Peptaibole war bereits nach 30-minütiger Inkubation eine 
selektive Spaltung der Bindung zwischen Aib (bzw. Iva) und Pro (bzw. Hyp) festzustellen. 
Außerdem wurde eine rasche Veresterung der Hydroxylgruppe des C-terminalen 
Aminoalkohols durch TFA beobachtet. In Abhängigkeit von der Inkubationszeit kam es zur 
40 
 
Freisetzung C-terminaler Tri- bzw. Tetrapeptide sowie zur Abspaltung einzelner Aminosäure-
Reste aus den dominanten, trifluoracetolytisch erzeugten Fragmenten. 
 Bei der Trifluoracetolyse des Z34-(Aib)10-OtBu wurde schon nach 30-minütiger 
Spaltung eine reguläre Fragment-Serie von Z-(Aib)10-OH bis Z-(Aib)5-OH erzeugt. 
Außerdem wurden gleichzeitig Fragment-Serien H-(Aib)10-OH bis H-(Aib)3-OH generiert. 
Nach dreistündiger Inkubation des Z-(Aib)7-OtBu kam es zur Freisetzung einer 
regulären Fragment-Serie von Z-(Aib)7-OH bis Z-(Aib)3-OH. 
Von diesen experimentellen Daten ausgehend, wurde ein repetitiver Spaltmechanismus für 
Homo-(Aib)n-Peptide vorgeschlagen, der über die sich wiederholende Bildung intermediärer 
Oxazolinolium/Oxazolinium-Ionen verläuft: 
Ein interner nucleophiler Angriff des Sauerstoff-Atoms der Carbonylgruppe in der 
Carboxamid-Bindung wird dabei wahrscheinlich durch den so genannten geminalen 
Dimethyl- oder Thorpe-Ingold-Effekt begünstigt. Dabei kommt es zur schnellen Bildung 
instabiler vierbündiger Zwischenstufen, die nachfolgend durch einen Protonentransfer und die 
Abspaltung des ursprünglich C-terminalen Aib-Rests stabilisiert werden. Die somit 
entstandenen Oxazolonium-Peptide werden bereits durch die überall – selbst in wasserfreier 
TFA – vorhandenen Wasserspuren leicht hydrolysiert. Dieser Mechanismus ist auf die 
Spaltung der Aib(Iva)–Pro(Hyp)-Bindung in Peptaibiotika übertragbar. 
Die gezielte Anwendung der Trifluoracetolyse ist von größtem Wert für die Sequenzierung 
und Strukturaufklärung von Peptaibiotika, da diese aufgrund ihrer nicht-ribosomalen 
Biosynthese einem enzymatischen Abbau nicht oder nur in sehr begrenztem Umfange 
[Fredenhagen et al., 2006] zugänglich sind. In solchen Fällen ist eine zielgerichtete 
acidolytische Spaltung von besonderer Bedeutung. Sie ermöglicht die Erzeugung von 
Fragmenten, welche für die Positions- und Konfigurationsanalyse von Aminosäuren, 
beispielsweise der Iva-Enantiomere, geeignet sind. 
                                                           
34
  Die Abkürzung „Z“ steht hierbei für die Benzoyloxycarbonyl-, die Abkürzung „tBu“ für die tert-Butyl-
Schutzgruppe. 
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2. Profiling von Sekundärmetaboliten aus Arabidopsis 
thaliana durch Kopplung von Kapillar-HPLC und ESI-
QqTOF-Massenspektrometrie 
Im ersten Teil dieser Habilitationsschrift wurde anhand ausgewählter Beispiele ein 
peptaibiomischer Ansatz vorgestellt. Dieser zielt darauf ab, die Gesamtheit der von einem 
Pilzstamm unter definierten Kulturbedingungen gebildeten Peptaibiotika, das Peptaibiom, 
mittels Kopplung aus HPLC und ESI-MS zu erfassen. In Analogie zu dieser 
peptaibiomischen Vorgehensweise werden – insbesondere in der Pflanzenbiochemie – 
metabolomische Ansätze dazu verwendet, die Gesamtheit der von einer pflanzlichen 
Zelle, einem Gewebe, Organ oder Organismus unter definierten Bedingungen gebildeten 
Primär- und Sekundärmetaboliten, das Metabolom, vergleichend zu analysieren. 
Metabolomische Ansätze stellen somit – neben der Analyse von Transkriptom (mRNA-
Profiling) und Proteom – die dritte Säule der funktionellen Genomforschung dar. Der 
überwiegende Teil der vor 2004 publizierten Arbeiten zum Profiling pflanzlicher 
Metaboliten fußt auf der Verwendung von auf GC/MS-Methoden basierenden 
analytischen Strategien. Diese sind jedoch vorwiegend zur Analyse sehr polarer sowie 
unpolarer Metaboliten geeignet, während Substanzen mittlerer Polarität kaum erfaßt 
werden. 
In der als Anhang M aufgeführten Originalarbeit wurde daher untersucht, ob die 
Verwendung einer Kopplung aus Kapillar-HPLC und ESI-QqTOF-MS geeignet ist, die 
Lücke im Spektrum der für das Profiling von Sekundärmetaboliten bisher verwendeten 
analytischen Methoden schließen zu können. Durch den Einsatz einer aseptischen 
hydroponischen Kultivierungsmethode war die Anzucht der Pflanzen unter 
hochstandardisierten Kultivierungsbedingungen möglich; zur Schonung empfindlicher 
Metaboliten wurde das Pflanzenmaterial in flüssigem Stickstoff homogenisiert und mit 
Methanol/Wasser (8:2) extrahiert. 
 Insgesamt konnten, ungeachtet der hohen Komplexität der untersuchten Proben, durch 
Kombination von Retentionszeit und hochaufgelöster Masse in Wurzelextrakten rund 800 
Peaks im Bereich zwischen [m/z] 106 und 1000 reproduzierbar detektiert werden, 
während in Blättern etwa 1400 Peaks nachgewiesen wurden. Die technische Varianz lag 
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hierbei unter 30%, die biologische bei etwa 40%. Nach umfangreicher Optimierung der 
geräteeigenen Software wurde schließlich eine automatische Dekonvolution und 
Prozessierung der generierten Daten ermöglicht, die somit der Strukturaufklärung und 
Quantifizierung zur Verfügung standen. Durch die hochauflösende, auf der QqTOF-
Technologie basierenden Arbeitsweise des Massenspektrometers kann prinzipiell jedem 
einzelnen detektierten Ion eine Präzisionsmasse (∆ m zwischen 5 und 15 ppm) zugeordnet 
werden, die nach Abgleich des berechneten gegen das gemessene Isotopenmuster zur 
Ermittlung einer möglichen Summenformel führten. Nach entsprechenden Tandem-MS-
Experimenten (CID-MS, MS/MS) und darauffolgenden Literaturrecherchen konnte eine 
Anzahl von Sekundärmetaboliten des Arabidopsis-Wildtyps (Columbia, Col-O) in ihrer 
Struktur aufgeklärt sowie Unterschiede im Metabolom des Ökotyps Landsberg erecta 
(Ler) und seiner tt4-Mutante analysiert werden. 
Zusammenfassend ist festzustellen, daß die Kopplung von HPLC und hochauflösender 
ESI-Massenspektrometrie eine unentbehrliche Komplementärtechnologie für die GC/MS 
beim so genannten „Metabolic Profiling“ darstellt – erfordert doch die hohe strukturelle 
Diversität pflanzlicher Sekundärmetaboliten die Kombination unterschiedlicher 
analytischer Technologien zur Erfassung von Naturstoffen mit unterschiedlichsten 
Polaritäten. 
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3. Ausblick 
3.1. Quo vadis? – Perspektiven der Peptaibiotika-Forschung im nächsten 
Jahrzehnt 
Die im ersten Teil dieser Arbeit diskutierten ungewöhnlichen Bioaktivitäten ausgewählter 
Peptaibiotika, beispielsweise Neurolepsie, Inhibition der Histon-Decacetylase, Hemmung der 
Bildung von Amyloid-β-Peptiden sowie die phytoprotektive und antimikrobielle Wirkung der 
Pflanzenstärkungsmittel und Biofungizide auf Trichoderma-Basis, sprechen für eine weiterhin 
intensive Bearbeitung dieser hochinteressanten Gruppe nicht-ribosomal biosynthetisierter 
Peptidantibiotika. 
Im Abschnitt 1.13. und Anhang J ist auf die Perspektiven einer weiteren strukturellen 
Diversifizierung der Peptaibiotika durch zielgerichtete Untersuchung potentieller Bildner aus 
ökologischen Nischen verwiesen worden. Dieser Aspekt wurde in Abschnitt 1.14. und 
Anhang K u. a. durch Beispiele für die Isolierung von Sekundärmetaboliten aus 
kältetoleranten und psychrophilen Pilzen aus arktischen und antarktischen Habitaten präzisiert 
Schließlich wurde die Hypothese einer möglichen Peptaibiotika-Bildung an allen Standorten, 
an denen potentiell zur Produktion dieser Metaboliten befähigte Pilzstämme vorkommen 
könnten, aufgestellt. Die Bildung von Peptaibiotika unter in vivo-Bedingungen wurde 
erstmals von Lehr et al. [2006] als Standortvorteil bei der Besiedlung ungewöhnlicher 
Habitate beschrieben und in Abschnitt 1.9. bzw. Anhang F diskutiert. 
 Bereits fünf Monate nach dem Erscheinen von Anhang K berichteten Ren et al. [2009] 
über die Isolierung und Strukturaufklärung der Aspereline A–F aus Kulturen von 
Trichoderma asperellum Y19-07, eines aus marinen Sedimenten vor Penguin Island (Südliche 
Shetlandinseln) isolierten Stammes. Diese sechs, aus zehn Resten bestehenden Peptaibole 
zeichnen sich durch den erstmaligen Nachweis von (S)-Prolinol (= L-Prolinol) als C-
terminalen Bestandteil35 von Peptaibiotika aus36.  
                                                           
35
  N-terminales AcPro wurde bislang nur in dem aus 14 Resten bestehenden Peptaibiotikum Adenopeptin 
nachgewiesen [Hayakawa et al., 1998]. 
36
  Die Chiralität der Aminosäuren wurde nach Komplexbildung zwischen den im Hydrolysat befindlichen 
Aminosäuren und dem chiralen Reagenz Rutheniumporphyrin, Ru((+)D4-Por*)CO, mittels 1H-NMR bestimmt. 
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Von Maddau et al. wurde ebenfalls 2009 über die Isolierung eines aus homologen und 
positionsisomeren Sequenzen bestehenden Peptaibol-Gemischs berichtet, das von 
Trichoderma citrinoviride S25 gebildet wird. Dieser endophytische Stamm wurde aus 
gesundem Gewebe einer sardischen Korkeiche (Quercus suber L.) isoliert und ist in der Lage, 
das Wachstum von sieben  korkeichenpathogenen Pilzen zu hemmen. In dem bioaktiven 
Gemisch fanden sich mindestens 28, aus 20 Resten bestehende Peptaibole vom Paracelsin-
Typ, von denen sieben als neu eingeordnet wurden. Dies verdeutlicht, wie bereits im 
Abschnitt 1.7. und Anhang D ausgeführt, das Potential ausgewählter Trichoderma-Arten für 
einen möglichen Einsatz als Biofungizide. Auf einen möglichen Einsatz endophytischer 
Trichodermen bei der biologischen Bekämpfung pilzlicher Kakao-Pathogene in den 
Anbaugebieten Südamerikas und Westafrikas ist bereits von Holmes et al. [2004], Tondje et 
al. [2007], Mejía et al. [2008] und Bailey et al. [2008; 2009] verwiesen worden. Eine 
Übersicht über in jüngster Zeit isolierte endophytische Trichoderma-Species, wie T. evansii, 
T. lieckfeldtiae [Samuels & Ismaiel, 2009] und T. amazonicum u. a., geben Chaverri et al. 
[2010]. Eine vertiefende chemisch-analytische Bearbeitung dieser ausnahmslos neuen Arten, 
einschließlich eines Peptaibiotika-Screenings, ist als vordringlich zu bewerten, da 
beispielsweise T. paucisporum und T. theobromicola in vitro und in 
Inokulationsexperimenten hemmend auf den Erreger der Monilia-Fruchtfäule des Kakaos 
(Moniliophthora roreri) wirkten [Samuels et al., 2006(a)], während T. martiale im Rahmen 
von in situ-Feldversuchen Symptomatik und Ausbreitung der Braunfäule des Kakaos 
(Phytophthora palmivora) reduzierte [Hanada et al., 2008; 2009]. 
 Ein weiteres Beispiel für die Bedeutung mariner endophytischer Pilze als Quelle neuer 
Naturstoffe gaben kürzlich Pruksakorn et al. [2010] mit ihrem Bericht über die Isolierung 
neuer Lipoaminopeptide vom Helioferin/Roseoferin-Typus [Gräfe et al., 1995; Degenkolb et 
al., 2000, Anhänge E und H]. Diese drei als Trichoderine A, A1 und B bezeichneten, aus 
neun Resten bestehenden Peptaibiotika wurden aus dem taxonomisch nicht näher bestimmten, 
schwammassoziierten Trichoderma sp. 05FI48 isoliert. Als für Peptaibiotika neues 
Strukturelement im Trichoderin A1 wird erstmals 2-Amino-4-methyl-8-oxodec-6-ensäure 
(AMOD) angegeben. Besonders bemerkenswert ist die potente inhibitorische in vitro-
Aktivität der Trichoderine gegen wachsende und dormante Mykobakterien, einschließlich M. 
tuberculosis H37Rv [Pruksakorn et al., 2010]. 
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Aus dem bodenbürtigen Trichoderma polysporum FKI-4452 wurden unlängst fünf 
bereits beschriebene und zwei neue, antitrypanosomal wirksame Trichosporin-Analoga, TSP 
B-VIIa und B-VIIb, isoliert [Iwatsuki et al., 2010]. 
Die bereits erwähnten extremophilen und endophytischen Isolate illustrieren das überaus 
reiche Potential der Gattung Trichoderma/Hypocrea als nach wie vor wichtigste Quelle von 
Peptaibiotika. Während der vergangenen sieben Jahre sind eine Reihe weiterer 
Hypocrea/Trichoderma-Arten erstbeschrieben worden, deren eingehende chemische 
Bearbeitung noch aussteht. Viele dieser Species kommen in ökologischen Nischen vor 
[Chaverri et al., 2003; Bissett et al., 2003; Lu et al., 2004; Jaklitsch et al., 2005; 2006(a) und 
(b), 2008(a) und (b), 2009; Overton et al., 2006(a) und (b); Samuels et al., 2006(a) und (b); 
Yu et al., 2007; Zhang et al., 2007] – ein Faktum, welches das Auffinden von Peptaibiotika 
mit neuen Bioaktivitäten, Strukturelementen, oder Bauplänen überaus wahrscheinlich macht. 
 Weitere Pilzstämme, die aufgrund des bereits erfolgten Nachweises peptidisch 
gebundener α,α-Dialkylaminosäuren als  Quelle neuer Peptaibiotika in Frage kommen, sind in 
Tabelle 1 des Anhangs K aufgelistet. Als eine sprichwörtliche Fundgrube empfiehlt sich die 
Gattung Acremonium. Dies wird u. a. durch die zwei Publikationen belegt, in denen über die 
Isolierung und Bioaktivitäten der Acrebole A und B berichtet wurde. Hierbei handelt es sich 
um zwei lediglich partiell sequenzierte Peptaibiotika mit freiem Serin am C-Terminus, die 
von A. exuviarum DSM 21752 gebildet werden [Andersson et al., 2009; Kruglov et al., 
2009]37.  
Besondere Aufmerksamkeit ist in diesem Jahrzehnt den Integramiden A und B 
zuteilgeworden. Dabei handelt es sich um zwei aus 16 Resten bestehende Peptaibiotika aus 
Dendrodochium sp.38, die als Inhibitoren der HIV-1-Integrase fungieren [Singh et al., 2002]. 
                                                           
37
 Die Einordnung von Peptaibiotika als Mykotoxine wird in der Literatur teilweise kontrovers diskutiert, 
siehe dazu auch Abschnitt 1.10. und Anhang G. Zwar weisen die längerkettigen Peptaibole (Alamethicin, 
Suzukacillin und Trichotoxin) amphiphile, detergensähnliche Eigenschaften auf, so daß eine lytische Wirkung 
auf die Membran isolierter Human-Erythrocyten beobachtet werden kann [Irmscher & Jung, 1977]. Weder eine 
solche Hämolyse, noch die in vitro beobachtete Hemmung der Motilität von Eberspermatozoen, oder die 
Hemmung des Komplexes III der Atmungskette isolierter Rattenleber-Mitochondrien rechtfertigt die von 
Andersson et al. [2009] und Kruglov et al. [2009] vorgenommene Einordnung der Acrebole als Mykotoxine. Es 
ist vielmehr zu vermuten, daß der Bildner neben den Acrebolen nicht detektierte Mykotoxine i. e. S. [Frisvad et 
al., 2006(b)] produzieren könnte, welche die von den Autoren nicht näher spezifizierten Krankheitssymptome 
bei den Bewohnern eines durch Wasserschaden zerstörten Hauses auslösten. 
38
 Siehe Kommentar zur Identifizierung des Integramid-Bildners in Fußnote 3. 
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Die Strukturaufklärung der Integramide erwies sich als analytische Herausforderung, da drei 
der fünf in der Kette befindlichen Iva-Reste L-konfiguriert sind, während die restlichen zwei 
die D-Konfiguration aufwiesen. Zur Ermittlung der Chiralität der beiden Iva-Reste in Position 
14 und 15 wurden die LD- und DL-Diasteromeren synthetisiert und ihre physikochemischen, 
analytischen und biologischen Eigenschaften mit denen der isolierten Naturstoffe verglichen. 
Dies führte letztendlich zur Zuordnung der korrekten Stereochemie  –L-Iva14–D-Iva15. 
Ungeachtet dessen wirkte sich die Inversion der Sequenz zu –D-Iva14–L-Iva15– nicht nachteilig 
auf die Hemmung der HIV-Integrase aus [de Zotti et al., 2009 und 2010(a)]. In diesem 
Zusammenhang wurde kürzlich eine nicht-destruktive, auf der Verwendung von 2D-NMR 
basierende Methode zur Ermittlung der Konfiguration von D- und L-Iva-Resten in Peptiden 
ausgearbeitet, die derzeit auf ihre Eignung zur Sequenzierung anderer Iva-haltiger 
Peptaibiotika untersucht wird [de Zotti et al., 2010(b)]. 
 
Mit Blick auf das System der Pilze ist festzustellen, daß bisher nur etwa 100 der derzeit rund 
2.700 Arten der Ordnung Hypocreales [Kirk et al., 2008] auf die Produktion von Peptaibiotika 
geprüft worden sind. Noch deutlicher wird dieses bisher wenig erforschte Potential bei 
Hochrechnung auf die über 64.000 Arten der Ascomycota [Kirk et al., 2008]; finden sich doch 
einige Peptaibiotika-Bildner in den Ordnungen Eurotiales, Onygenales und 
Saccharomycetales. Ein umfangreiches, MS-basiertes Screening peptaibiotika-bildender Pilze 
außerhalb der Ascomyceten und ihrer Anamorphen ist bislang noch nicht Gegenstand der 
Forschung gewesen; lediglich Tani et al. berichteten 2001 über einen einzigen 
Cyclopeptaibiotika-Bildner unter den Basidiomycota (siehe Abschnitt 1.2.). Infolge der 
systematischen Erforschung neuer  ökologischer Nischen werden jedoch, wie vorab 
dargestellt, fortwährend neue Pilzspecies beschrieben, die als potentielle Produzenten von 
Peptaibiotika in Frage kommen könnten. 
In den vergangenen zehn Jahren haben moderne Methoden der Molekularbiologie, so z. B. die 
Multilocus-Sequenzierung repräsentativer, voneinander unabhängiger Genregionen, Einzug in 
die Pilztaxonomie gehalten. Von besonderer Bedeutung sind dabei  die Sequenzierung der 
RNA-Polymerase II-Untereinheit (rpb2), des Translationselongationsfaktors 1 α (tef1) und der 
„internal transcribed spacer“-Regionen (ITS1; 5,8 S und ITS2); häufig werden jedoch auch 
andere Genabschnitte, z. B.  Actin (act) oder GH18-Chitinase (chi18-5), sequenziert. Dadurch 
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ist die Systematik der Pilze gegenwärtig einem tiefgreifenden Wandel hin zu einer 
phylogenetischen Klassifizierung unterworfen; so wurde u. a. eine Auflösung der 
Zygomycota als poly- oder paraphyletisches Taxon vorgeschlagen [Hibbett et al., 2007]. 
Diese Entwicklung schlägt sich selbstverständlich auch in der Systematik peptaibiotika-
bildender Gattungen nieder. Besonders deutlich wird dies im Falle der Gattung Hypocrea und 
ihrer Trichoderma-Anamorphen; gibt es doch Species, die morphologisch nicht oder nur 
kaum voneinander zu unterscheiden sind, wohl aber molekulargenetisch. Ein Beispiel hierfür 
stellt T. reesei s. l. dar, welches eine große ökonomische Bedeutung als industrieller 
Produzent von Cellulasen und Hemicellulasen [Druzhinina et al., 2010(a)] und somit für die 
Herstellung von Bioethanol [Xu et al., 2009] besitzt. Eine genetisch isolierte, sympatrische 
Schwesterart, T. parareesei sp. nov. ist erst kürzlich beschrieben worden. Diese wird als 
Vorfahr von T. reesei und seiner Teleomorphe H. jecorina interpretiert; und es wurde gezeigt, 
daß die Mehrheit der bislang als T. reesei identifizierten anamorphen Stämme zu dieser neuen 
Art gehört [Atanasova et al., 2010]. Weiterhin ist die Sammelart Trichoderma asperellum s. l. 
[Lieckfeldt et al., 1999; Samuels et al., 1999] zu nennen, die erst kürzlich in zwei Species, T. 
asperellum s. s. und T. asperelloides sp. nov., aufgespalten wurde [Samuels et al., 2010]. 
Moderne massenspektrometrische Methoden, z. B. Peptaibiomics und IC-MS, zeigen 
eindrucksvoll die Komplementarität molekulargenetischer und chemotaxonomischer Ansätze 
in der Pilzsystematik. So ist beispielsweise das einzigartige Hydrophobin-Muster Art das 
sicherste Unterscheidungsmerkmal von T. arundinaceum und T. protrudens (siehe Abschnitt 
1.11. bzw. Anhang H). Desweiteren gelten T. stromaticum s. l. [Samuels et al., 2000] und T. 
harzianum s. l. als Sammelarten, [de Respinis et al., 2010; Druzhinina et al., 2010(b)], bei 
denen Unterschiede in Hydrophobin-Muster und Peptaibiom für die ausstehende, notwendige 
Artabgrenzung verwendet werden könnten. Eine detaillierte chemische Untersuchung der 
genannten Sammelarten unter Verwendung moderner massenspektrometrischer Methoden 
wäre bereits aufgrund der praktischen Relevanz dieser Pilzspecies als Enzymproduzenten 
bzw. aktive Bestandteile von Präparaten im biologischen Pflanzenschutz von erheblicher 
Bedeutung Darüber hinaus kann die Chemotaxonomie, wie in Anhang H dargestellt, 
wichtigen Beiträge zur Weiterentwicklung der modernen phylogenetischen Pilzsystematik des 
21. Jahrhunderts leisten. 
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Zusammenfassend ist festzustellen, daß sich in neuester Zeit neue Perspektiven für eine 
mögliche praktische Anwendung von Peptaibiotika – sowohl in der Medizin als auch in Land- 
und Forstwirtschaft – ergeben: 
Beispielsweise wird das auf Reis mit Konidien von T. stromaticum formulierte 
Präparat „Tricovab“ seit einigen Jahren mit Erfolg zur biologischen Bekämpfung im Südosten 
des Bundesstaates Bahia, dem Zentrum des  brasilianischen Kakaoanbaus, eingesetzt 
[Pomella et al., 2007], wobei das Mikroklima in der Plantage entscheidend für die Sporulation 
und den Antagonismus gegenüber Moniliophthora perniciosa ist [Loguercio et al., 2009]. 
Erste Formulierungen zur biologischen Bekämpfung der Braunfäule des Kakaos 
(Phytophthora palmivora) auf Basis von T. martiale ALF 247 haben sich als unter 
Freilandbedingungen effizient erwiesen [Hanada et al., 2009]. 
Ferner läßt der aktuelle Stand der Forschung auf dem Gebiet der Ampullosporine begründeten 
Bedarf für eine weitere intensive Bearbeitung im Hinblick auf die mögliche Entwicklung 
eines potentiellen Neuroleptikums erkennen [Berek et al., 2009]. Nicht zuletzt besitzen 
Peptaibiotika wie die Integramide, das SPF-5506-A4, die Tricoderine und Trichosporine 
wegen ihrer – im Rahmen dieser Arbeit erörterten – anti-HIV-, antituberkulotischen bzw. 
antiprotozoischen Aktivitäten eine  große Bedeutung für die human- und 
veterinärmedizinische Forschung, sind sie doch als Modellsequenzen geeignet zur 
Entwicklung neuer pharmakologisch aktiver Leitstrukturen. 
 
3.2. Massenspektromtrie als analytische Schlüsseltechnologie in den 
Lebenswissenschaften 
Gegenüber anderen instrumentell-analytischen Methoden bieten massensprektrometrische 
Verfahren eine Reihe von Vorteilen: 
Erstens sind die Anforderungen an die Reinheit der zu analysierenden Proben nicht so 
hoch, z. B. im Falle der NMR-Spektroskopie oder Röntgenstrukturanalyse. Somit kann die 
ESI-MS beispielsweise für bioaktivitätsbasierende Screening-Ansätze partiell aufgereingter 
Proben verwendet werden, während die MALDI-TOF-MS zur Analyse intakter Zellen (IC-
MS) prädestiniert ist. Eine – zumindest partielle – Aufreinigung wird vielfach durch 
Vortrennung der Probe bei Kopplung von HPLC und ESI-MS erreicht. Zudem wird durch die 
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Verwendung von Streulicht-Detektoren („Diodenarray-Detektoren“, DAD) während der 
HPLC-Trennung zusätzlich ein UV/VIS-Spektrum jedes einzelnen Peaks erzeugt, das im 
Idealfalle Rückschlüsse auf bestimmte Strukturelemente des jeweiligen Analyten erlaubt. 
Hinzu kommen der relativ geringe Probenbedarf moderner Massenspektrometer und ihre hohe 
Empfindlichkeit, die bei Triple-Quadrupol-Geräten im unteren Femtogramm-Bereich liegen 
kann. 
Zweitens sind beide Methoden prinzipiell automatisierbar; somit besteht die Möglichkeit, 
in vergleichsweise kurzer Zeit Hochdurchsatz-Screenings durchzuführen, die selbst 
industriellen Anforderungen genügen. Dies eröffnet neue Perspektiven zur schnellen 
Auffindung biologisch aktiver Substanzen, die als Leitstrukturen für die Entwicklung neuer 
Arznei- und Pflanzenschutzmittel dienen können. 
Drittens kann der Informationsgehalt einer massenspektrometrischen Analyse 
vergleichsweise hoch sein. Im Allgemeinen gestatten niederauflösende Spray- oder 
Laserdesorptions-Verfahren die Ermittlung der Nominalmasse ausgewählter Substanzen 
durch die Bildung von Quasi-Molekülionen. Mit Hilfe hochauflösender Verfahren ist es 
prinzipiell möglich, die Elementarzusammensetzung und das Isotopenmuster jedes einzelnen 
Peaks in der Probe zu ermitteln und dadurch Rückschlüsse auf mögliche Summenformeln zu 
ziehen. Die Verwendung von Tandem-Massenspektrometern ermöglicht darüber hinaus die 
Fragmentierung ausgewählter Ionen durch Stoßexperimente mit Inertgasen in einer so 
genannten Kollisionszelle. Die Fragmentierung des Analyten erfolgt überwiegend an so 
genannten Sollbruchstellen, so daß durch die Masse der entstehenden Produkt-Ionen und die 
Massendifferenzen zwischen ihnen Aussagen zu möglichen Strukturen der einzelnen 
Fragmente, Abgangsgruppen bzw. Vorläufer-Ionen  ermöglicht werden. Darauf beruht nicht 
zuletzt die de novo-Sequenzierung von Proteinen und Peptiden, einschließlich der 
Peptaibiotika. Als für die massenspektrometrische Naturstoffanalytik besonders wertvoll 
haben sich Ionenfallen erwiesen, gestatten diese doch,  die  Genealogie  von  Produkt-Ionen 
nachzuverfolgen und somit positionsisomere bzw. homologe Substanzen zu untersuchen. Die 
letztere Option ist von unschätzbarem Wert bei der Analyse chromatographisch nur schwer 
oder nicht trennbarer hochkomplexer Gemische, wie die von Peptaibiotika. 
Viertens sind die analytischen Möglichkeiten der modernen GC/MS-Kopplung zur 
Analyse flüchtiger, aber auch hochpolarer und unpolarer Metaboliten den im Rahmen dieser 
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Arbeit dargestellten LC/MS-Ansätzen komplementär. So wurde u. a., in Analogie zum in 
Kapitel 2 diskutierten LC/MS-Profiling von Arabidopsis-Sekundärmetaboliten, die 
hochauflösende GC/TOF-MS-Kopplung zur Analyse löslicher Primär- und 
Sekundärmetaboliten sowie von zellwandgebundenen Phenolen von Medicago truncatula 
(Fabaceae, Fabales) verwendet, um das Metabolom nicht-mykorrhizierter Wurzeln mit den 
metabolischen Veränderungen nach Besiedlung mit dem arbuskulären Mykorrhizapilz 
Glomus intraradices (Glomeraceae, Glomerales, Glomeromycota) zu vergleichen 
[Schliemann et al., 2008]. Ferner bietet auch die Kopplung aus GC und Ionenfalle eine 
Möglichkeit zur massenspektrometrischen Strukturaufklärung flüchtiger Naturstoffe [de 
Pinho et al., 2009; Fernandes et al., 2009]. 
Somit ist die Massenspektrometrie als derzeit vielseitigster und leistungsfähigster Zweig 
der Bioanalytik einzuschätzen, deren interdisziplinäre Rolle und Bedeutung für die 
Lebenswissenschaften in den kommenden Jahren ständig weiter wachsen wird. 
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INTRODUCTION
Peptaibols and peptaibiotics (lipopeptaibols, lipo-
aminopeptaibols, lipoaminopeptides) constitute a
constantly growing family of peptide antibiotics of
fungal origin.
They show interesting physico-chemical and bio-
logical activities depending on particular structural
properties, such as the formation of pores in bilayer
lipid membranes as well as antibacterial, antifungal,
occasionally antiviral [1] and antiparasitic activities
[2]. Inhibition of mitochondrial ATPase, uncoupling
of oxidative phosphorylation, immunosuppression
[3–7], inhibition of platelet aggregation [8], induc-
tion of fungal morphogenesis and neuroleptic effects
[9–12] have been reported.
The broad-spectrum antibiotic and membrane-
disrupting activities of peptaibiotics could, to some
* Correspondence to: Dr Thomas Degenkolb, Leipzig University,
Faculty of Chemistry and Mineralogy, Centre for Biomedicine and
Biotechnology, Deutscher Platz 5, D-04103 Leipzig, Germany;
e-mail: thomas.degenkolb@bbz.uni-leipzig.de
‡ Presented at Peptaibols, October 2002, Jena, Germany.
§ Deceased.
extent, account for their action against plant and
fungal hosts of the producing microorganisms.
Peptaibols and related peptaibiotics are composed
of 5–20 amino acids, and amongst them there
are several α-aminoisobutyric acid (Aib) moieties
as a characteristic of these structures. Their
structural diversity is caused by the varying amount
and nature of the constituting amino acids, and
different substitutions of the N- and C-terminus
(see below). The name peptaibol was originally
proposed by Benedetti et al. [13], but also by
Bru¨ckner and co-workers [14] — independently of
each other.
We recommend that the name should be used
for linear peptide antibiotics that exhibit the fol-
lowing characteristics, thus expanding the original
definition [15 and tables 3–4]:
(i) have a molecular weight between 500 and 2200
Dalton; (ii) show a high content of α-aminoisobutyric
acid; (iii) are characterized by the presence of
non-proteinogenic amino acids and (iv) possess an
acetylated N-terminus, whereas the C-terminus is
reduced to an amino alcohol.
Copyright  2003 European Peptide Society and John Wiley & Sons, Ltd.
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In 1991, Bru¨ckner et al. [16,17] introduced the
comprehensive term peptaibiotic to include such
components lacking the amino alcohol. To further
expand their definition, considering recent findings
in this area of research, we suggest the term
peptaibiotic for linear peptide antibiotics that
(i) have a molecular weight between 500 and 2200
Dalton; (ii) show a high content of α-aminoisobutyric
acid; (iii) are characterized the presence of non-
proteinogenic amino acids and/or lipoamino acids
and (iv) possess an acylated N-terminus, whereas
the C-terminus may consist of a free or methoxy-
substituted 2-amino alcohol, amine, amide, free
amino acid, diketopiperazine or sugar alcohol [see
tables 3–4].
A common feature of this heterogeneous class of
substances is their biosynthesis via non-ribosomal
pathways following the so-called ‘thio-template
mechanism’. This mode of biosynthesis enables
the presence of unusual, non-proteinogenic amino
acids, amino alcohols, lipoamino acids, amines and
fatty acids in these structures [18,19].
Presently, the family of peptaibols and related
peptaibiotics amounts to more than 300 mem-
bers. For information on special compounds
‘The Peptaibol Database’ can be recommended
which is available on the World Wide Web at:
http://www.cryst.bbk.ac.uk/peptaibol/welcome.
html [20,21]. However, searching for structures and
producers of peptaibols and peptaibiotics is enabled,
too, by other databases, such as the Chapman &
Hall, Dictionary of Natural Products on CD ROM,
and Antibase 2.0 [22]. An excellent review, summa-
rizing related sub-families of peptaibols, has recently
been presented by Chugh and Wallace [23]. Lipopep-
taibol antibiotics were reviewed by Toniolo et al.
[24]; and detailed information on mass spectrom-
etry of leucinostatin antibiotics was given by Isogai
et al. [25]. Due to the still growing number of pep-
taibiotics, recurrent isolations may occur frequently.
Therefore, assistance in preventing re-isolations or
disclosure of new structures may be welcome.
Mass spectrometric methods such as fast atom
bombardment ionization (FAB-MS) including linked
B/E-MIKES scan approaches, ESI-CID-MS/MS,
ESI-CID-MSn and MALDI-TOF-PSD-MS have been
indispensable tools for the determination of molec-
ular weights via the pseudo-molecular ions such
as [M + H]+ and [M + Na]+ as well as sequence
analysis via the generation of diagnostic frag-
ment ions. Such ions can be generated by
collision-induced dissociation (CID, synonymous:
cone-voltage fragmentation, CVF) of the selected
parent ion(s) using triple quadrupole or ion-trap
mass spectrometers.
The present paper compiles data on the mass
spectrometric behaviour of peptaibols and peptaibi-
otics including pseudo-molecular ions and the for-
mation of diagnostic fragment ions. This compilation
is intended to serve as a guide to a more rational
identification of recurrent as well as novel represen-
tatives of these fungal peptides.
MICROORGANISMS PRODUCING
PEPTAIBIOTICS
Peptaibols and related peptides (peptaibiotics) are
biosynthesized exclusively by fungi, mainly soil-
borne and plant-pathogenic, as well as fungicolous
(also known as mycophilic) taxa. The latter occur on,
as well as within, the fruit-bodies of asco- and basid-
iomycetes. Genera containing fungicolous species or
fungicolous species themselves mentioned in this
paper are marked with a superscript #.
More detailed information on modern taxonomic
aspects of the producers of peptide antibiotics has
been given [26–29].
Most of the structures reviewed here were iso-
lated from fungi imperfecti belonging to the gen-
era Trichoderma#, Acremonium#, Paecilomyces# and
Emericellopsis#. Less commonly reported producers
are listed in Table 1.
The occurrence of peptaibols such as boletusin
[30] as well as the tylopeptins A and B [31] has been
reported for a few basidiomycete fruit-bodies such
as Boletus ssp. and Tylopilus neofelleus.
There are doubts, however, about the isolation of a
peptaibiotic from the fruit-bodies of basidiomycetes.
The authors making this claim pointed out the
obvious structural homologies with the even co-
isolated chrysospermins A–D [32], but they did not
mention whether the fresh (in the case of boletusin)
or dried material (in the case of the tylopeptins),
used for extraction, showed any sign of decay or
infection by mycophilic fungi.
In some cases, an infection of an asco- or basid-
iomycete fruiting-body by the genus Sepedonium# is
easily recognized by the presence of large quantities
of yellow aleurioconidia (synonym: chlamydospores),
the colour of which is mainly due to the presence
of sepedonin and its derivatives as well as skyrin
[33]. However, the colour starts to appear rela-
tively late, when masses of chlamydospores become
mature. For that reason, it cannot be excluded
that accidentally younger stages of infection were
Copyright  2003 European Peptide Society and John Wiley & Sons, Ltd. J. Peptide Sci. 9: 666–678 (2003)
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Table 1 A Survey of the Less Frequently Reported Fungal Producers of Peptaibiotics
Name of peptaibiotic Isolated from Reference(s)
Chrysospermins Sepedonium chrysospermum# [32]
(Teleomorph: Hypomyces chrysospermus (Bull.) Tul. Synonym: Apiocrea
chrysosperma)
Peptaibolin Sepedonium sp.# [89]
Ampullosporins Sepedonium ampullosporum# [9,10]
Hypomurocins A and B Hypocrea muroiana# Hino & Katsumoto [90]
Some of the hypelcins Hypocrea peltata# (Jungh.) Sacc. [91]
Lipohexin, Acremonium lindtneri (Kirschstein) Samuels & Rogerson [67,68]
Texenomycin A (Synonyms: Moeszia lindtneri (Kirschstein) G. Arnold
Cylindrocarpon lindtneri);
Teleomorph: Sporophagomyces chrysostomus [92]
(Synonym: Hypomyces chrysostomus Berk. & Broome [93])
Clonostachin Clonostachys sp. [8]
Aibellin Verticimonosporium ellipticum Matsushima [63,64]
LP237-F5, -F7, -F8 Tolypocladium geodes W. Gams [42,43]
Some of the Stilbella fimentaria [94] [94–96]
Antiamoebins (Synonym: Stilbella erythrocephala)
Gliocladium catenulatum# Gilman & Abbott
Stilboflavins Stilbella flavipes (Peck) Seifert [96]
Antiamoebin I Verticillium epiphytum Hansford [97] [76]
(Synonym: Cephalosporium pimprina#)
Antiamoebin I Clonostachys rosea f. catenulata [77]
Gilman and Abbott [98]
(Synonym: Gliocladium catenulatum#)
Gliodeliquescin Gliocladium deliquescens [99]
Efrapeptins Tolypocladium inflatum W. Gams [100]
(Synonym: Tolypocladium niveum (Rostrupp) Bisset)
and other Tolypocladium species
not recognized macroscopically, thus leading to the
extraction of infected material.
Moreover, it is well known from the literature [34]
that a primary infection by Sepedonium chrysosper-
mum#, attacking its preferred hosts in the order
Boletales, e.g. Boletus, Paxillus, Tylopilus and Scle-
roderma species, [for a review see: 33,35] normally
causes total necrosis of the infected host cells. How-
ever, if ‘weak pathogens’, such as Botrytis cinerea#
or Trichothecium roseum#, invade fruit-bodies, previ-
ously colonized by Sepedonium chrysospermum, the
latter can grow biotrophically within the mycelium
of these so-called ‘secondary parasites’ [36].
NOMENCLATURE OF PEPTAIBOLS AND
PEPTAIBIOTICS
The name peptaibol was introduced originally
for small fungal peptides containing a high
portion of the non-proteinogenic amino acid
Aib (α-aminoisobutyric acid or α-methyl alanine;
Figure 1). The Aib residues may number two, as
in the pentameric peptaibolin from Sepedonium
strains, or up to nine in some of the stilboflavins.
The term ‘peptaibol’ should be applied only to
peptides having an acetylated N-terminus, and an
2-amino alcohol as C-terminus (see above).
X-Aaa-(Aaa)n-AaaY 
Figure 1 A general, simplified building scheme of the
peptaibiotics. n = in the range of 3 [89] to 19 [106]
residues, containing a high proportion of Aib as well as
other non-proteinogenic amino acids; Xaa = N-terminal
amino acid substituted with unbranched, or 2- or
4-methyl branched, saturated or unsaturated fatty acid;
Yaa = substituent covalently linked to the C-terminal
amino acid: free or methoxy-substituted amino alcohol,
amine, amide, free amino acid, diketopiperazine, or sugar
alcohol. A peptaibol synthetase from Trichoderma virens
has recently been cloned [107].
Copyright  2003 European Peptide Society and John Wiley & Sons, Ltd. J. Peptide Sci. 9: 666–678 (2003)
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Structurally varying compounds such as lipopep-
taibols have been named ‘peptaibiotics’ [16,17].
Variations of N-acetylated peptaibol-type sub-
stances concern a heterologous C-terminal moiety,
such as a mannitol residue [clonostachin: 8], a free
carboxy group formed by glycine [XR 586: 37], glu-
tamine, valine [16,17] or serine [cephaibols P and Q:
2], a methoxylated Aib [NA VII: 38], L-prolineamide,
or a diketopiperazine such as cyclo-L-Pro-Aib [pseu-
dokonins KL III and KL VI: 39].
In the so-called lipopeptaibols, the N-terminus
is substituted by a fatty acid with more than four
carbons [38] and the C-terminus is substituted by
an amino alcohol. This group comprises trichogin
GA IV [38], the trikoningins KB I and KB [40],
trichodecenins TD-I and TD-II [41] as well as
LP237 F7 and LP237 F8 [42,43].
In the subfamily of lipoaminopeptides (also
reported as aminolipopeptides) the N-terminus is
substituted by long-chain, α-methyl-branched fatty
acids (Figure 1). An L- proline-, L-4-hydroxy-proline
or cis-4-methyl-L-proline residue is found in
position 2 of the peptide chain, and in most cases it
is followed by a lipoamino acid residue in position 3.
To our present knowledge, this compound, 2-amino-
4-methyl-6-hydroxy-8-oxo-decanoic acid (AHMOD),
has only been recorded from this subfamily.
In some of the leucinostatins the AHMOD moiety
is replaced by L-Leu or L-Val [25,44–46]. The C-
terminus of leucinostatin is substituted, too, by an
amino alcohol (cf Table 2).
It should be mentioned that the primary struc-
tures of some leucinostatins remain uncertain,
because the assignment of structures by LC-Frit-
FAB-MS/MS was not entirely conclusive [25].
Up to now, the following lipoaminopeptides have
been published in the literature:
• 22 leucinostatins from different strains of Pae-
cilomyces marquandii# (Massee) Hughes and Pae-
cilomyces lilacinus# (Thom) Samson [5,25,47–53]
Table 2 Reference Masses of the Amino Acid Residues Occurring in Peptaibiotics ([M + H − H2O]+)
Amino acid Abbreviation Monoisotopic Molecular formula
3-letter codea 1-letter codeb
molecular weight of the residue
Alanine Ala A 71.0371 C3H5NO
α-Aminoisobutyric acid Aib U 85.0528 C4H7NO
2-Amino-4-methyl-6-hydroxy-
8-oxo-decanoic acid
AHMOD — 213.1365 C11H19NO3
Asparagine Asn N 114.0429 C4H6N2O2
Aspartic acid Asp D 115.0269 C4H5NO3
α-Ethyl-norvaline EtNor Z 127.0997 C7H13NO
Glutamine Gln Q 128.0586 C5H8N2O2
Glutamic acid Glu E 129.0426 C5H7NO3
Glycine Gly G 57.0215 C2H3NO
β-Hydroxyleucine Hyleu — 129.0790 C6H11NO2
4-Hydroxyproline Hyp O 113.0477 C5H7NO2
Isoleucine Ile I 113.0841 C6H11NO
Isovaline Iva J 99.0684 C5H9NO
Leucine Leu L 113.0841 C6H11NO
4-Methylproline MePro — 111.0684 C6H9NO
Phenylalanine Phe F 147.0684 C9H9NO
Pipecolic acid Pip — 111.0684 C6H9NO
Proline Pro P 97.0528 C5H7NO
Serine Ser S 87.0320 C3H5NO2
Tryptophan Trp W 186.0793 C11H10N2O
Tyrosine Tyr Y 163.0633 C9H9NO2
Valine Val V 99.0684 C5H9NO
a In some cases, the abbreviations commonly used for non-proteinogenic amino acids do not match the 3-letter code.
b Note, that there is no 1-letter code for some of the non-proteinogenic amino acids.
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Table 4 Non-proteinogenic amino acidsa found in peptaibiotics
Non-proteinogenic amino acid (Abbr.) Name of the peptaibiotic
α-Aminoisobutyric acid (Aib) Characteristic feature of all peptaibiotics
L-Isovaline (Iva) Bergofungins A, B and D; peptavirins A and B; clonostachin in position 7
and 10; some efrapeptins
D-Isovaline (Iva) Harzianins HC III, HC VIII, HC IX, HC XII, HC XIII, HC XV; atroviridins;
tylopeptin A; boletusin; XR586; trichokindins I–VII [91], clonostachin in
position 4 and 13, antiamoebins in different positions (except for
antiamoebin VI, which does not contain Iva)
cis-4-L-Hydroxyproline (Hyp) Bergofungins [103,104], clonostachin; XR586; zervamicins; Roseoferins H, I
and K
trans-4-L-Hydroxyproline (Hyp) Heptaibin [105], antiamoebins, emerimicins
cis-4-L-Methylproline (MePro) Most of the leucinostatins;b acremostatinsc
β-Hydroxy-L-leucine (Hyleu) Most of the leucinostatins; acremostatins
β-Alanine (β-Ala) Efrapeptins [109], leucinostatins, acremostatins, lipohexin, texenomycins
L-Pipecolic acid (Pip) Efrapeptins A–H
α-Ethyl-norvaline (Etnor) LP237 F5 and LP237 F8
2-Amino-4-methyl-6-hydroxy-8-oxo-
decanoic acid (AHMOD)
All lipoaminopeptides, exceptions are mentioned in the text (see above)
a Unless otherwise indicated amino acids possess S-configuration (L-isomers).
b The structure of a number of leucinostatins has not been completely assigned, plausible sequences were tabulated by
Isogai et al. [25].
c The optical configuration of the amino acids of the acremostatins could not be analyzed.
as well as the conjugate structure leucinostatin-
β-O-di-glucoside [54] isolated from the endophyte
Acremonium sp. Tbp-5 [55].
• five trichopolyns from Trichoderma polysporum#
(Link ex Pers.) Rifai TMI 60146 [56–58];
• two helioferins from Mycogone rosea# Link DSM
8822 [59].
• and 16 roseoferins from Mycogone rosea# Link
DSM 12973 [60]. Another nine novel roseoferins
(H1 –H4; I1,I2; K1 –K3) were obtained by replac-
ing the L-Pro moiety of the corresponding MDA-
containing roseoferins by L-Hyp via ‘precursor-
directed biosynthesis’ [61].
• and three acremostatins formed by co-cultivation
of Mycogone rosea DSM 12973 and Acremonium
sp. Tbp-5 [62].
There are five compounds that build a bridge
between peptaibols and lipoaminopeptides at
present.
Aibellin [63,64], one of these compounds, car-
ries an N-terminal Aib, which is acetylated, whereas
the C-terminus is an amino alcohol, 2-[(2-amino-3-
phenylpropyl)amino]ethanol. Lipohexin [65,66], and
texenomycins A and B [67,68], are N-terminally sub-
stituted by a 2-methyl-3-oxo-tetradecanoyl moiety
(MOTDA). The C-terminus of lipohexin representing
a partial structure of texenomycins is formed by β-
alanine. The 20meric texenomycins A and B carry an
L-arginol residue as the C-terminus. Both lipohexin
and texenomycin were co-isolated from cultures of
Acremonium (Moeszia) lindtneri DSM 11119; but
texenomycin A and its C-2-epimer texenomycin B
(which is rapidly converted into A under basic con-
ditions) by contrast, were originally claimed to be
obtained from Scleroderma texense [62]. This puff-
ball, which was recently classified as a member of
the Boletales [69–71], is occasionally infected by
species of Sepedonium (W. Gams, personal observa-
tion).
The occurrence of a free serine residue as the
C-terminus was reported for cephaibols P and Q [2].
The basic amino acids histidine and lysine as
well as the sulphur-containing amino acids cysteine
and methionine, have not been found as yet in the
peptaibiotics.
L-Serine occurs in a few peptaibols and related
structures. Examples are harzianin HC I, III, XI, XII,
and XIII [72]; trichorzin PA II, IV, V, VI, VII, VII and
XI; PAU4 and PCU4 [73,74]; trichokindins I–VII [75];
chrysospermins [32] and tylopeptins [30,31].
L-Threonine has to date only been described as a
constituent of some emerimicins and zervamicins,
and as occurring in the cephaibols P and Q [2; 76,
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77]. However, to date, L-tyrosine has been found
only in LP237 F5 [41].
The chirality of amino acids in the peptaibols
and peptaibiotics was determined to be L in
most cases. A common method for making this
determination is derivatization of amino acids in the
hydrolysate with Nα-(2,4-dinitro-5-fluoro-phenyl)-1-
L-alanine-amide (FDAA, Marfey’s reagent), followed
by HPLC separation and comparison of the retention
times with those of derivatized standard amino acids
[78]. However, classical GC/MS approaches have
also been used in amino acid analysis [37,39,72].
MASS-SPECTROMETRIC METHODS FOR
STRUCTURAL CHARACTERIZATION
Sequencing of peptaibols and peptaibiotics with a
molecular weight up to 2000 Dalton can be fur-
nished by classical (FAB-MS) and modern meth-
ods of tandem mass spectrometry (ESI-CID-MS/MS,
ESI-CID-MSn, MALDI-TOF-PSD-MS).
In the case of high-energy-ionization (FAB-MS), a
remarkable number of rather non-specific fragment
ions are observed in addition to [M + H]+, [M + Na]+
and [M + K]+. It appears important to mention that
different CID methods will generate different types of
fragments. Hence, the simultaneous use of different
MS methods is recommended.
According to the original Roepstorff nomenclature
[80] which was revised by Biemann [81], six series of
fragment ions can be generated during cleavage of a
peptide bond, corresponding to C-heteroatom- and
α-bond cleavages. The resulting positive fragment
ions are classified as a-, b-, and c-type if the
positive charge remains on the N-terminal fragment.
However, if it remains on the C-terminus, the
fragments generated are characterized as x, y and
z. Even under high energy ionization conditions, b-
type fragments are the most commonly produced
while the others are weak or even not observable.
The interpretation of spectra generated by high-
energy ionization (EI, FAB) is often hampered by
the presence of an additional series of secondary
or tertiary fragment ions, thus complicating the
subsequent structural assignment.
Soft ionization techniques such as electrospray
ionization (ESI or MALDI) will usually not generate
fragments. Such spectra almost exclusively show
pseudo-molecular ions such as [M + H]+, [M + Na]+,
[M + K]+, [2M + H]+ and [2M + Na]+. These single
ions can be activated subsequently by collision
with argon or helium gas in collision cells. Some
of the modern HR-ESI-Qq-TOF instruments use
highly purified nitrogen. In the case of FT-ICR/MS
instruments the collision gas is sometimes substi-
tuted by soft-laser pulses inducing fragmentation.
This method causes a low-energy fragmentation,
which is referred to as CID-MS/MS and CID-
MSn.
Fragments of the Bn-type- ([M − H2O]+) are
thereby produced with a bias toward the positive
ion mode, i.e the charge remains on the N-terminus
after cleavage of the peptide bond. The presence of
leucine or isoleucine will lead, for example, to a b-
type fragment of m/z 113, whereas the occurrence
of valine or isovaline in the peptide chain will be sig-
nalled by a corresponding fragment of m/z 99. Thus,
in comparison with FAB-MS, CID-MS/MS enables a
more precise assignment of fragments arising from a
defined pseudo-molecular ion. However, there is an
obvious disadvantage of ESI-CID-MS/MS of larger
peptides in comparison with FAB-MS: In most cases,
not all of the possible b-type fragments will be
visible.
The possibility of generating further generations
of daughter ions (MSn) using electric or magnetic ion
trap (IT) analysers enables both the detection and
the subsequent sequencing of positional isomers
(see below). In contrast to what occurs in linear
quadrupole analysers, but much like that seen
in ICR, the ions within an ion trap rotate for
microseconds on stable orbits in a high-frequency
field of alternating current, adjacent to a ring
electrode. By varying the amplitude of the current
a selective measurement of the mass of ions can
be achieved, which thus are forced to leave their
orbits in a stepwise manner. The real advantage
of ion trap mass spectrometers is the generation
of up to ten generations of daughter-ions. For
instance, every MS2 daughter ion generated by
collision (mostly with helium) can be fragmented
separately, thus generating MS3 grand-daughter
ions. The further fragmentation of these ions will
result in MS4 great-grand-daughter ions and so on
[82–86].
DISCUSSION
Tandem-MS methods, especially spray ionization or
MALDI coupled to quadrupole, ion trap or TOF anal-
ysers have been proven useful for assignment of
structure in studies of peptaibols and peptaibiotics.
In spite of the remarkable structural diversity of
these substances a series of general and repeating
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structural elements will often be present enabling
the identification of a given structure as a member
of the peptaibiotics.
The analysis of saturated fatty acyl moieties
occurring in lipopeptaibols and lipoaminopep-
tides often requires additional ESI-‘In-Source’-
fragmentation experiments.
1D- and 2D-NMR studies are also needed to dis-
tinguish between isoleucine or leucine as a part of
a given molecule. For fatty acid analysis, GC/MS-
, EI/MS and NMR investigations of the etheric or
CHCl3 extracts of the hydrochloric acid hydrolysate
are indispensable.
In some cases, b-type fragmentation is rather
weak. For instance, the presence of an Aib-Pro
bond often suppresses formation of bn-acylium ions.
According to Rebuffat et al. [72], this tertiary amide
bond undergoes a preferential cleavage, leading to
an N-terminal acylium ion N+, and a di-protonated
C-terminal ion. This pattern of cleavage results
in the absence of fragment ions at higher masses
and the superimposition of two independent bn-type
series at lower masses, starting from the N+ and also
from the di-protonated C-terminal ions. To overcome
this problem, the use of the so-called ‘pulsar func-
tion’ was proven to be beneficial. This function was
recently developed for ESI-QqTOF-MS/MS instru-
ments to collect, firstly, ions of a defined m/z range
or even a single mass and to subsequently release
the ‘ion package’, thus remarkably enhancing the
sensitivity of the instrument. The superiority of this
technique was recently shown for the peptaibols of
the trichofumin family [87]. Also, the presence of a
saturated N-terminal fatty acid moiety next to a pro-
line or proline-derived residue will generally induce
the formation of the corresponding a-type fragment
while suppressing the b1-fragment ion [59–62]. The
presence of a β-hydroxy amino acid within the pep-
tide chain may favour the formation of rather intense
[bn-H2O]+-ions.
No cleavage between the β-alanyl residue and the
C-terminal propane-amine moieties was observed in
the case of leucinostatins (reviewed by Isogai et al.,
[25]) and acremostatins [62]. This could be ascribed
to the presence of a non-α-peptide linkage.
Last but not least, the mass spectromet-
ric behaviour of 2-amino-4-methyl-6-hydroxy-8-
oxo-decanoic acid (AHMOD) [49,88] as a con-
stituent of leucino- and acremostatins, trichopolyns,
helioferins and roseoferins must be discussed
briefly. ESI-MS/MS and ESI-MSn of these lipoamino-
peptides are characterized by the loss of a side
chain from the AHMOD moiety (m/z 72) as a result
of an α-cleavage. This diagnostic feature leads to
the formation of a rather intense fragment ion
[M + H-C3H5O]+. Acid hydrolysis of lipoaminopep-
tides with HCl or H2SO4 and subsequent anal-
ysis of the hydrolysate by ESI-MS produces 4-
methyl-6-(2-oxobutyl)-2-piperidine carboxylic acid
(MOBPA) from AHMOD by dehydration followed
by a Michael-addition and subsequent cycliza-
tion. Thus, a characteristic fragment with m/z
214 is visible in the positive ESI mass spectrum
[52,56–58,59–62,88].
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Abstract: Trichofumins A–D were isolated from cultures of Trichoderma sp. HKI 0276 as new 11 and
13mer peptaibols. Similar to 15mer peptaibols they promote morphogenesis of the fungus Phoma destructiva
and cause hypothermia in mice as a characteristic of neuroleptic activity. Membrane measurements using
a synthetic BLM model showed that A, B, C and D increased membrane permeability for cations in a
similar manner as was shown for larger peptaibols but with comparably lower efficiency. Copyright  2003
European Peptide Society and John Wiley & Sons, Ltd.
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pigment formation; membrane activity
INTRODUCTION
Peptaibols are helical peptides forming ion-pene-
trable channels in artificial bilayer membranes [1,2].
They owe this unique property to the presence of
hydrophobic amino acids such as α-aminoisobutyric
acid (Aib), an acetylated nitrogen terminus and
an alcoholic instead of a carboxylic acid group at
the C-terminus. As an explanation for their bio-
logical activities membrane channel formation was
established for the 15–20mer peptaibols [1–6]. Pep-
taibols with >18 amino acids were subjected to
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Natural Products Research, Beutenbergstrasse 11a, D-07745 Jena,
Germany; e-mail: aberg@pmail.hki-jena.de
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Contract/grant sponsor: Deutsche Forschungsgemeinschaft Bonn;
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Contract/grant sponsor: FCI Frankfurt a.M. (Germany).
various studies of their molecular conformation, ion
channel formation and biological activities [3]. How-
ever, little information is available on the ‘smaller’
peptaibols such as 10–14mer representatives (c.f.
the trichorozins [4]).
In the course of our continuing search for new
peptaibols, Trichoderma sp. HKI 0276 was recently
disclosed as a producer of the new peptaibols
trichofumins A–D (Figure 1). The structures of A–D
were elucidated by mass spectrometry (HRESI-MS,
ESI-CID-MS/MS and ESI-QqTOF-MS/MS) as will be
shown below. Moreover, the biological activities of
A–D and their interactions of A–D with an artificial
bilayer membrane are reported.
MATERIAL AND METHODS
Compounds A–D were isolated from cultures of
Trichoderma sp. HKI 0276. The strain was cultivated
Copyright  2003 European Peptide Society and John Wiley & Sons, Ltd.
TRICHOFUMINS 811
A Acetyl-Val-Gln-Leu-Val-Aib-Pro-Leu-Leu-Aib-Pro-Leuol
B Acetyl-Val-Gln-Leu-Leu-Aib-Pro-Leu-Leu-Aib-Pro-Leuol
C Acetyl-Val-Gln-Val-Aib-Gln-Gln-Leu-Leu-Pro-Leu-Aib-Pro-Leuol
D Acetyl-Val-Gln-Leu-Aib-Gln-Gln-Leu-Leu-Pro-Leu-Aib-Pro-Leuol
Figure 1 Amino acid sequences of trichofumins A, B, C
and D.
as a surface culture (60 l) at 26 °C in 500 ml
Erlenmeyer flasks containing 100 ml malt medium
[5,6] composed as follows (g/l): malt extract 20,
glucose 10, yeast extract 1, (NH4)2SO4 5, pH 6.0.
After 20 days of cultivation at 26 °C, the culture
broth was harvested and separated by filtration.
Thereafter, the culture filtrate and the mycelium
were extracted twice with ethyl acetate. The com-
bined extracts were dried and evaporated. The
residue (3 g) was subjected to silica gel chromatog-
raphy (silica gel 60, Merck, 0.063–0.1 mm, col-
umn 600 × 40 mm, CHCl3 –MeOH, 9 : 1 v/v), and
20 ml portions were collected. Fractions contain-
ing trichofumins A–D were detected by ESI-MS.
Final purification was done by isocratic prepar-
ative HPLC (Spherisorb ODS-2, 5 µm, RP18, Pro-
mochem, 250 × 25 mm, acetonitrile H2O, 83 : 17
v/v; 12 ml/min, 210 nm).
Antimicrobial Activities
The antimicrobial activity of the new peptaibols A–D
was determined against several bacteria and fungi
by the agar plate diffusion assay [7]. The inducing
effect on pigment formation by Phoma destructiva
was investigated as reported earlier [8,10].
Assay of Hypothermia in Mice (Neuroleptic Effect)
The neuroleptic activity of the new peptaibols was
investigated according to Thompson [9,10]. Solu-
tions of peptaibols were administered intraperi-
toneally in male mice (strain NMR) obtained from the
Central Breeding Laboratory for Animals, Beuten-
berg Campus Jena, in a dosage of 20 mg/kg body
weight. The decrease of body temperature (less
2–6 °C) was recorded 30 min after administration.
The effect was in the same order of magnitude as was
described for chlorpromazine, a known neuroleptic
agent [10]. The basal body temperature was mea-
sured by a thermistor probe placed in the rectum of
mice until a stable temperature was indicated on the
thermometer. The colon temperature was recorded
0.5, 1, 3, 5, 7 and 24 h after administration of the
trichofumins A–D.
Measurements Employing Lipid Bilayer
Membranes
Planar bilayer lipid membranes (BLM) were prepared
from soya bean phosphatidylcholine (Sigma, P5638)
20 mg/ml in n-heptane [11].
The measuring glass cell (25 ml of total volume)
was equipped with a teflon cylinder (1 cm diameter),
which contained a hole of 0.5 mm diameter to
harbour the BLM. The membranes were formed by
painted method on the hole of the teflon cylinder.
Formation of the BLM was controlled by the use
of a binocular microscope. Both the measuring cell
(10 ml outside (cis)-volume) and the inner side of
Teflon cylinder (trans-volume; 1 ml) were filled with
a solution of potassium chloride ranging from 100
to 1000 mM depending on the type of experiment.
The membrane current was measured by the
voltage-clamp method [12]. The current measuring
device consisted of an operational amplifier model
Keithly.301 (USA). The amplitude current noise of
the amplifier was less than 10−13 A in the frequency
range of 0.1–20 Hz. Then 1–10 µl of the stock solu-
tions of the peptaibols (0.1–1 mg/ml in methanol)
was added into the glass chamber containing the
teflon cylinder with a bilayer membrane. The solu-
tion was mixed for 5 min by a magnetic stirrer at 500
rotations/min. The progress of the bilayer formation
and estimation of its area was monitored on the
screen of the PC by the amplitude of the membrane
capacitance currents in response to the rectangular
shape voltage pulses applied to the membrane. Mea-
surements of the membrane currents corresponding
to the applied peptaibol concentration were done
5 min after termination of the process of black mem-
brane formation marked by the constant amplitude
of the membrane capacitive current.
RESULTS AND DISCUSSION
The physicochemical properties of the new pep-
taibols, trichofumins A, B, C and D are shown
in Table 1. The structures of A–D (Figure 1)
were elucidated by HRESI-MS (Finnigan MAT
95 XL, Finnigan, Bremen, Germany; showing
for trichofumin A: m/z 1189.7918 (([M + H]+),
calcd. 1189.7929 for C59H105N12O13); trichofumin
B: m/z 1203.8096 ([M + H], calcd. 1203.8081 for
C60H107N12O13); trichofumin C: m/z 1444.9026
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 +TOF Product (1189.8): 121 MCA scans from MT20020801201150.wiff
 a=3.56723009244694890e-004, t0=2.72839201827155190e+001
Max. 892.0 counts.
100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500
m/z, amu
0
50
100
150
200
250
300
350
400
450
500
550
600
650
700
750
800
850
892
x 5.0 482.3078
409.2883
383.2271
270.1360
114.0624
369.2128324.2145 496.3105426.2792
142.0816
215.1867
256.1260
211.1378
+TOF Product (1189.8): 55 MCA scans from MT20020801191629.wiff
 a=3.56723009244694890e-004, t0=2.72839201827155190e+001 Max. 1.5e4 counts.
500 520 540 560 580 600 620 640 660 680 700 720 740 760 780 800 820 840 860 880 900 920 940
m/z, amu
0.0
1000.0
2000.0
3000.0
4000.0
5000.0
6000.0
7000.0
8000.0
9000.0
1.0e4
1.1e4
1.2e4
1.3e4
1.4e4
1.5e4
x 10.0567.3435
890.5712
581.3550
777.4699
664.3834
553.3432
 +TOF Product (1189.8): 103 MCA scans from MT20020801200149.wiff
 a=3.56723009244694890e-004, t0=2.72839201827155190e+001
Max. 2.2e4 counts.
920 940 960 980 1000 1020 1040 1060 1080 1100 1120 1140 1160 1180900 1200
m/z, amu
0.0
2000.0
4000.0
6000.0
8000.0
1.0e4
1.2e4
1.4e4
1.6e4
1.8e4
2.0e4
2.2e4
x 100.0 x 5.0975.5918
1189.7510
961.5819 1190.7442
1072.6608
904.5986
Ac-Val-Gln Leu Val
Aib Pro Leu Leu 
Aib Pro Leuol [M+H]
+
989.6134
Figure 2 Diagnostic fragment formation by trichofumin A during ESI-QqTOF-MS/MS.
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Table 1 Physico-chemical properties of trichofumins A–D
Trichofumin A B C D
Appearance White solid White solid White solid White solid
Melting point 157–160 °C 162–164 °C 167–169 °C 178–180 °C
HRESI-MS (m/z) 1189.7918 1203.8096 1444.9026 1458.9163
[M + H]+ calcd. 1189.7929 calcd. 1203.8081 calcd. 1444.9017 calcd. 1458.9174
Molecular formula C59H105N12O13 C60H107N12O13 C69H120N16O17 C70H122N16O17
[α]25D (MeOH, 3 mg/ml)
a — −1.6° −3.7° −4.2°
Rt on HPLC (min)b 15.1 15.6 14.7 14.5
a Propol polarimeter (Dr Kernchen, Seelze, Germany).
b Nucleosil 100-5, RP18, 250 × 4.6 mm, 1 ml/min, 210 nm gradient acetonitrile/H2O trifluoroacetic acid.
([M + H]+, calcd. 1444.9017 for C69H120N16O17);
and trichofumin D: m/z 1458.9163 ([M + H]+,
calcd. 1458.9174 for C70H122N16O17). The sequence
of amino acids in A–D was deduced from
ESI-CID-MS/MS (Triple Quadrupole Mass Spec-
trometer Quattro (VG Biotech, Altrincham, Eng-
land) and ESI-Qq-TOF-MS/MS (API QStar Pul-
sar, Hybrid Quadrupole-TOF mass spectrometer,
Applied Biosystems, MDS Sciex, USA) due to the
diagnostic B-type fragments arising from cleavage of
the amide bonds. An example for structure elucida-
tion of A–D is depicted in Figure 2.
Hydrolysis of A–D, derivatization of the amino
acids by Marfey’s reagent [18] and HPLC-analysis
Cyclosporin A
A
C
D
B
Figure 3 Effect of trichofumins A–D on morphogenesis
of Phoma destructiva (70 h incubation, 1 mg/ml (MeOH),
23 °C). Cyclosporin A was used as standard.
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Figure 4 Induction of hypothermia in mice by A–D (♦
control;  trichofumin A;  trichofumin B; ž trichofumin
C; ∗ trichofumin D).
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Figure 5 Trace of the membrane current in time in
presence of trichofumin A (0.3 µM). Conditions: 500 mM
KCl, membrane voltage 170 mV. Note characteristic pulse
shape of the current corresponding to the opening and
closing of the discrete ion conducting pores.
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of the derivatives showed the presence of L-valine,
L-leucine, L-glutamine, L-proline, L-leucinol and α-
aminoisobutyric acid (Aib).
Compounds A–D thus represent new members
of the ‘smaller’ peptaibols containing 11–14 amino
acids, c.f. trichorozins from Trichoderma harzianum,
trichogin-A-IV from Trichoderma longibrachiatum
and trichorovins from Trichoderma viride [4]. Tricho-
fumins A–D displayed moderate antibacterial activ-
ity against Gram-positive bacteria such as Bacillus
subtilis ATCC 6633 in a concentration of >50 µg/ml
during the agar well diffusion assay [17]. No activ-
ity was found against fungi and yeasts in the same
concentration.
Administration of A–D to surface cultures of the
phytopathogenic fungus Phoma destructiva caused
an accelerated morphogenesis of hyphae as was
indicated by earlier onset of brownish pigmentation.
The effect of A–D on this fungus depending on the
incubation time is shown in Figure 3. The pigment
formation was comparable to the standard inducer
cyclosporin A after 70 h.
Up to now little information has been available on
the biological properties of the smaller peptaibols.
Compounds A–D caused hypothermia in mice after
intraperitoneal application in the same range of
concentration and order of magnitude as the 15mer
peptaibols ampullosporin A, B and D [8]. This
effect can be taken as a measure of neuroleptic
activity [9,10]. The vital functions (shock, climbing,
refusal) were altered strongly after application of A,
B, C or D. The decrease of body temperature after
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Figure 6 Membrane conductance as a function of the peptaibol concentration: (a) for trichofumin A, (b) for trichofumin
B, (c) for trichofumin C and (d) for trichofumin D. The functions are saturated at about the same level of the membrane
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0.35 µM for trichofumin D.
Copyright  2003 European Peptide Society and John Wiley & Sons, Ltd. J. Peptide Sci. 9: 810–816 (2003)
TRICHOFUMINS 815
intraperitoneal dosage of A–D (20 mg/kg) is depicted
in Figure 4.
Compounds A–D exerted these effects on mice
and the fungus Phoma destructiva although the
sequences of amino acids are different from those
of the ampullosporins A, B and D. There are visible
variations in the activities of A, B, C and D indicating
that changes of the constituting amino acids caused
alterations of biological activity.
Trichofumins A–D were shown to interact with
artificial bilayer lipid membranes suggesting the
formation of unstable pores as was reported for other
peptaibols [13]. Figure 5 shows traces of membrane
current measured in the presence of compound A
suggesting that pores with a short life-time were
formed. Almost identical pictures were observed with
compounds B, C and D. The increase of electric
conductivity of the bilayer membrane was dependent
on the concentrations of peptaibols A, B, C or D
which were given to the cis-side of the membrane
(Figure 6).
Thereby, the 13mer peptaibols C and D displayed
membrane effects comparable to the 11mer peptai-
bols A and B. The results are compatible with the
view that even 11–13mer peptaibols are capable of
disturbing the integrity of synthetic bilayer mem-
branes by forming pores or channel-like aggregates.
However, their efficiency and channel stability is
lower than observed with the 15–20mer represen-
tatives of the peptaibol family [4,13]. No membrane
activity was observed with peptaibolin [14] as a 5mer
representative of the peptaibol structure. It can be
suggested that the capacity of channel formation
decreases in parallel with the decreasing number
of the constituting amino acids. Probably a peptide
chain of less than 10 amino acids would not enable
membrane activity.
Ampullosporins A, B and D, on the one side,
and trichofumins A–D on the other thus show
comparable biological activities and effects on
conductivity of artificial bilayer membranes. Hence,
limited permeabilization of cellular membranes
could be responsible, at least partly, for the
observed effects of 11–15mer peptaibols on fungal
morphogenesis and induction of hypothermia in
mice. It is well known that nutrient limitation in
microbes promotes their cytodifferentiation [15].
It can be suggested that effects comparable to
nutrient limitation can be caused by limited
permeabilization of the cytoplasmic membrane.
Otherwise, disturbance of ion fluxes of synaptic
cells in the presence of peptaibols could explain
the observed induction of hypothermia in mice and
neuroleptic effects in rats [16].
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Abstract: The microheterogeneous alamethicin F30 (ALM F30) isolated from the fermentation of Trichoderma viride strain NRRL
3199 was analyzed by nonaqueous capillary electrophoresis coupled to electrospray ion-trap mass spectrometry (ESI-IT-MS)
and electrospray time-of-flight mass spectrometry (ESI-TOF-MS). Tandem ESI-IT-MS was used for elucidation of the amino acid
sequence based on the fragmentation pattern of selected parent ions. The MS/MS spectra using the [M + 3H]3+ or [M + 2H]2+
ions as precursor ions displayed the respective b- and the y-type fragments resulting from cleavage of the particularly labile
Aib–Pro bond. The MS3 of these fragments generated the b acylium ion series, as well as internal fragment ion series. Eleven
amino acid sequences were identified, characterized by the exchange of Ala to Aib in position 6, Gln to Glu in positions 7 or 19 as
well as the loss of the C-terminal amino alcohol. In addition, two truncated pyroglutamyl peptaibols were found. Overall, seven
new sequences are reported compared to earlier LC–MS studies. The composition of the components was confirmed by on-line
ESI-TOF-MS detection. Mass accuracy well below 5 ppm was observed. Quantification of the individual components was achieved
by a combination of UV and TOF-MS detection. Copyright  2005 European Peptide Society and John Wiley & Sons, Ltd.
Keywords: nonaqueous capillary electrophoresis; mass spectrometry detection; peptaibiotics; polypeptide antibiotics;
peptaibols; alamethicin F30; α-aminoisobutyric acid; pyroglutamic acid
INTRODUCTION
Alamethicins are 20-residue peptaibol peptides isolated
from the culture broth of the mold Trichoderma
viride [1,2] exhibiting interesting physicochemical and
biological activities, such as the formation of voltage-
dependent ion channels in bilayer lipid membranes, as
well as antibiotic activities [3]. The voltage-dependent
ion channel formation by alamethicin can be described
by the dipole flip-flop gating model of Boheim and Jung
[4,5] based on electrical field–induced transbilayer
orientational movements of single molecules. The
conductance states of the ion conductivity pores vary
with the number of parallelly arranged α-helices.
Recently, single pore states could be stabilized by C-
terminal conjugation of alamethicin with fullerene or a
membrane-anchoring lipopeptide [6].
Peptaibols are linear peptides composed of 5–20
amino acids [7]. These compounds are exclu-
sively biosynthesized by fungicolous, plant or ento-
mopathogenic fungi, thus assuming potential impor-
tance in the parasitic life cycle of the producers [8]. The
nonribosomal biosynthesis includes nonproteinogenic
amino acids, in particular α-aminoisobutyric acid (Aib).
* Correspondence to: G. K. E. Scriba, School of Pharmacy, Department
of Pharmaceutical Chemistry, University of Jena, Philosophenweg 14,
07743 Jena, Germany; e-mail: gerhard.scriba@uni-jena.de
Aib residues are conformationally restricted and favor
the formation of 310- and α-helical structures. Peptai-
bols are amphiphilic because of the acylated, nonpolar
N-terminus and the more polar, C-terminal amino alco-
hol. The name ‘peptaibol’ reflects the characteristics of
this class of compounds being peptides containing Aib
and a C-terminal amino alcohol.
Depending on the fermentation conditions, T. viride
produces the neutral alamethicins F50 (ALM F50) or the
acidic peptaibols alamethicins F30 (ALM F30) [2]. Both
are microheterogeneous mixtures of closely related
sequential analogs that possess a phenylalaninol (Pheol
or Fol) at the C-terminus, while the N-terminus is
acetylated. ALM F50 and ALM F30 differ in the amino
acid in position 18, which is the (neutral) glutamine in
the case of ALM F50 and the (acidic) glutamate residue
in the case of ALM F30 [2,9]. The structure of ALM F30
has been confirmed by total synthesis [10].
Tandem mass spectrometry, especially electrospray
ionization (ESI) or matrix-assisted laser desorption
ionization (MALDI) coupled to quadrupole, ion-trap
(IT) or time-of-flight (TOF) mass analyzers have been
proven useful for structural studies of peptaibols [8].
The separation of the individual components of ALM
F50 and ALM F30 has been achieved by reversed-
phase high performance liquid chromotography (HPLC)
and the structure of the components was determined
Copyright  2005 European Peptide Society and John Wiley & Sons, Ltd.
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by HPLC–ESI-MSn by Bru¨ckner and coworkers [2].
The acidic ALM F30 and the neutral ALM F50
were isolated from the culture broth by XAD-2
column chromatography and separated by silica gel
chromatography. The composition of the individual
peptaibols was subsequently determined by HPLC–ESI-
MSn. According to this study, ALM F30 consists of
two major components that differ in the amino acid in
position 6 (Ala or Aib) and eight minor components.
Nonaqueous capillary electrophoresis (NACE) using
solvents such as methanol, acetonitrile or N-
methylformamide, instead of water, for the preparation
of the background electrolytes is increasingly applied
to analytical problems [11]. Important parameters such
as efficiency and selectivity can be effectively modified
when aqueous buffers are replaced by nonaqueous elec-
trolyte solutions. Organic solvents favor interactions
that are weak in aqueous media. Furthermore, the sol-
ubility and stability of many analytes and additives
are enhanced in nonaqueous solvents. Moreover, non-
aqueous solvents may be preferable for electrochemical
detection as well as for electrospray ionization mass
spectrometry (ESI-MS) detection [12].
Traditionally, peptides as hydrophilic compounds
are analyzed by capillary electrophoresis (CE) using
aqueous background electrolytes. However, beneficial
effects of organic solvents for the separation of
hydrophobic peptides in aqueous CE media have been
described. For example, an acidic aqueous buffer
containing 20% 2-propanol as organic modifier was
applied to the analysis of isomeric N-palmitoylated
bradykinin and O-palmitoylated gonadorelin as well
as (cysteinyl-4,5)-palmitoylated peptide SP-C14 [13].
Hodges and coworkers described the separation of 18-
residue α-helical amphipathic peptide diastereomers by
capillary zone electrophoresis with highly concentrated
(up to 400 mM) perfluorinated acid ion-pairing reagents
in aqueous solution [14]. The authors attributed
the successful separation to conformational changes
between the peptide diastereomers and differences in
hydrophobicity of the nonpolar face of the amphipathic
α-helices and their interactions with the hydrophobic
anionic ion-pairing reagent. On-line NACE–MS of
hydrophobic peptides gramicidin S and bacitracin has
been demonstrated [15]. The separations were achieved
in an acetonitrile/methanol-based system containing
ammonium acetate and formic acid. ESI-MS allowed
the determination of three minor components in the
case of gramicidin S and one minor component in the
case of bacitracin. The current status of CE–MS for the
analysis of proteins and peptides including NACE–MS
has been recently summarized [16].
The separation of peptaibols by CE has not
been described previously. However, because of their
lipophilic nature, NACE seems to be a suitable elec-
tromigration technique for this class of compounds.
Thus, the present study was conducted in order to
evaluate the potential of NACE coupled to MS for the
analysis of peptaibols including the determination of
their amino acid sequence. The natural ALM F30 was
selected as model peptaibols because these compounds
contain a glutamic acid residue in position 18 that can
be deprotonated for electrophoretic analysis.
MATERIALS AND METHODS
Chemicals
Methanol, acetonitrile, 2-propanol, dichloromethane (all HPLC
grade quality), ammonium acetate and silica gel 60 (mesh
size <0.063 mm) were purchased from VWR International
(Darmstadt, Germany). Ammonium formate was obtained from
Sigma-Aldrich (Steinheim, Germany). Ammonium acetate and
ammonium formate were dried overnight in a desiccator over
silica before use. ALM F30 was isolated from fermentations of
T. viride strain NRRL 3199 as described previously [2].
The peptides Pyr-Aib-Val-Aib-Gly-Leuol and Glu-Aib-Val-
Aib-Gly-Leuol were synthesized by solid-phase synthesis using
the Fmoc strategy for the assembly of the peptide on the
solid support [17,18]. The Fmoc-protected terminating amino
alcohol was directly anchored onto the 2-chlorotrityl chloride
resin. Activation of the sterically hindered Aib was achieved
using tetramethylfluoroformamidinium hexafluorophosphate
(TFFH) as coupling reagent, as described by Carpino et al.
[18]. The peptides were purified by preparative HPLC, and
their identity was confirmed by MALDI-MS.
Capillary electrophoresis
CE with UV detection was performed on a Beckman
P/ACE 5510 instrument (Beckman Coulter, Krefeld, Germany)
equipped with a diode-array detector at 25 °C using 50-µm i.d.
fused-silica capillaries (Polymicro Technologies, Phoenix, AZ,
USA) with an effective length of 50 cm and a total length of
57 cm. UV detection was carried out at 215 nm at the cathodic
end of the capillary. Sample solutions were introduced at the
anodic end by hydrodynamic injections at a pressure of 0.5 psi
for 3 s.
CE–MS experiments were performed using a Hewlett
Packard 3DCE instrument (Agilent Technologies, Waldbronn,
Germany). Separations were performed at 25 °C in 50-µm i.d.
fused-silica capillaries with a length of 57 cm by application of
a separation voltage of 30 kV (sprayer grounded). A pressure
of 50 mbar for 4 s was used for sample injection.
New capillaries were rinsed for 30 min with 0.1 M sodium
hydroxide, 5 min with water and 10 min with methanol
followed by the separation medium for 10 min. Between
analyses, the capillary was flushed with the running buffer
for 2 min. When not in use, it was washed with the respective
solvent and then stored under dry conditions.
Electrospray Ionization Mass Spectrometry
On-line coupling of the CE instrument to the mass spectrome-
ter detector was achieved with an Agilent coaxial sheath-liquid
sprayer interface (Agilent Technologies, Palo Alto, CA, USA).
The sheath liquid, 2-propanol : water (1 : 1, v/v) containing 1%
formic acid, was supplied at a flow rate of 4 µl/min by a
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syringe pump (Cole-Palmer, Vernon Hill, IL, USA). Nebulizer
gas pressure was set to 2–3 psi. All ESI-MS experiments were
carried out in positive ionization mode at 4500 V.
ESI-IT-MS measurements were performed using an ion-
trap mass spectrometer Esquire HCT (Bruker Daltonik,
Bremen, Germany). Mass spectra were acquired from m/z
200 to 1500 in the scanning mode and automatic switching
between MS and MSn . Ions were scanned at a speed of 8300
m/z per s in the MS mode in order to achieve sufficient
resolution for charge attribution of triply charged peptides.
The enhanced auto-MSn settings were optimized to get as
many MSn spectra over a selected time period as possible.
This was achieved by scanning at 26 000 m/z per s and
active exclusion after two spectra per mass in a given time
window of 0.5 min. MS2 and MS3 spectra were acquired
selecting one (MS2) or two (MS3) most abundant precursors
or by adding preferred masses in the case of follow-up
experiments.
ESI-TOF-MS measurements were performed on an orthog-
onal TOF mass spectrometer micrOTOF (Bruker Daltonik,
Bremen, Germany). The mass spectrometer operated in an
m/z range 200–1500.
Data processing was performed by DataAnalysis software
(Version 3.0; Bruker Daltonik). The peptide MS fragments are
labeled according to standard rules [19,20].
RESULTS AND DISCUSSION
NACE Separation of ALM F30
NACE separation of the microheterogeneous ALM F30
was evaluated in methanol, acetonitrile and mix-
tures of these solvents using ammonium acetate–
and ammonium formate–based electrolytes. The sol-
vents are widely used in NACE because of their
appropriate dielectric constant–to-viscosity ratio [11].
While electrolyte solutions in acetonitrile and ace-
tonitrile–methanol mixtures did not afford satisfactory
separations because of the low mobility of the ana-
lytes in these solvents, good separation selectivity was
obtained using methanol-based electrolytes. 12.5 mM
ammonium formate in methanol yielded six separated
peaks using UV detection (data not shown).
Subsequent NACE–ESI-MS was performed using
this background electrolyte and a sheath liquid
consisting of 1% formic acid in a 1 : 1 mixture
of 1-propanol and water, which provided stable
spray and protonation conditions for the peptaibols.
Figure 1 shows the base peak electropherogram of
Figure 1 Extracted ion electropherograms of NACE with full-scan ESI-IT-MS detection. (A) Base peak electropherogram.
(B–E) Mass traces of the different b13 fragments (see Table 2). (F) [M + 2H]2+ pseudomolecular ion of the Pyr-containing peptides.
Experimental conditions: capillary dimensions, 57 cm × 50 µm i.d.; running electrolyte, 12.5 mM ammonium formate in methanol;
separation voltage, 30 kV (18 µA); for ESI-MS conditions see Experimental Section. Sample concentration: 500 µg/ml in methanol.
Peak identity: numbers refer to peptide sequences shown in Table 1.
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ALM F30 (Figure 1A) as well as electropherograms
of selected mass traces of the characteristic b13
fragment ions obtained with full-scan ESI-IT-MS
(Figure 1B–E). The identification of the individual
components and the determination of their amino
acid sequences are discussed below. The extracted
ion electropherogram (EIE) of the b13 fragments
at m/z 1189.9 (Figure 1B) and 1203.8 (Figure 1D)
as well as at m/z 1190.7 (Figure 1C) and 1204.8
(Figure 1E) with mass differences of 14 Da correspond
to the exchange of Ala by Aib in the peptaibols.
Most of the respective compounds comigrated, as
the mass difference of 14 Da is apparently not
large enough to be translated into electrophoretic
separations of otherwise identical peptaibols with
molecular masses of about 1900–1950 Da. The EIE
of m/z 706 (Figure 1F) corresponds to the doubly
charged pseudomolecular [M + 2H]2+ ions of truncated
pyroglutamyl (Pyr) peptaibols.
Amino Acid Sequence Determination
Table 1 summarizes the amino acid sequences of ALM
F30 as determined by NACE–ESI-MS analysis. A dif-
ferent numbering as compared to the nomenclature
applied in Ref. 2 of the ALM F30 peptides is used for
reasons of simplicity. The mass fragments and molec-
ular ions of all components of ALM F30 determined in
this study are compiled in Table 2. The majority of the
diagnostic ions was identified via NACE–ESI-IT-MSn
in the positive ion mode from specific precursor ions
such as the triply and doubly charged pseudomolecu-
lar [M + 3H]3+ and [M + 2H]2+ ions for MS2 spectra and
from the b13 and y7 fragments, respectively, in the case
of the MS3 spectra. Figures 2 and 3 show the ESI-IT-
MS3 spectra of [Aib6] ALM F30 (3) and [desAA(1–6),Pyr7]
ALM F30 (7), respectively, as examples.
The MS spectra show the doubly and triply charged
pseudomolecular ions, [M + 2H]2+ or [M + 3H]3+, as
well as the corresponding ammonium adducts in some
cases. Moreover, b13- and y7-fragments are generated,
resulting from fragmentation of the particularly labile
Aib–Pro bond. The tertiary amide bond undergoes a
preferential cleavage, leading to an N-terminal acylium
ion (b-type fragment) and a diprotonated C-terminal ion
(y-type fragment) [21]. These characteristic fragments
were also obtained in the ESI-IT-MS full-scan mode
(without MSn ) illustrating the facile cleavage of the
Aib–Pro bond. Other peptaibols such as harzianins [21],
stilboflavins [22], trichotoxins [23] and trichofumins
[24] exhibit similar fragmentation patterns in ESI-MS.
The MS2 spectra using the [M + 3H]3+ or [M + 2H]2+ ions
as precursor ions displayed the respective b- and the
y-type fragments resulting from cleavage of the Aib–Pro
bond. The selection of the appropriate precursor ions
allowed the identification and amino acid sequence
determination also in case of comigrating substances.
In the case of the 20- and 19-residue peptaibols, the
triply charged pseudomolecular ions [M + 3H]3+ were
selected as the precursor ions for the MS2 analysis
Table 1 Sequences and relative quantities (%) of the ALM F30 peptides characterized by NACE–ESI-MS in the
microheterogeneous mixture. Exchanged amino acid positions are highlighted in bold letters. Abbreviations of the amino
acids are according to the one-letter code, Ac – acetyl, U – Aib, Pyr – pyroglutamic acid. The denotation of the ALM F30 peptides
identified by HPLC–MS [2] is listed in the third column
Nomenclature
in Ref. 2
% 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
1 ALM F50 F50/5 —a Ac U P U A U A Q U V U G L U P V U U Q Q Fol
2 [desAA(1–6),Pyr7]
ALM F50
— 0.4 Pyr U V U G L U P V U U Q Q Fol
3 [Aib6] ALM F30 F30/7 38.9 Ac U P U A U U Q U V U G L U P V U U E Q Fol
4 ALM F30 F30/3 51.0 Ac U P U A U A Q U V U G L U P V U U E Q Fol
5 [Glu19] ALM F30 — 1.4 Ac U P U A U A Q U V U G L U P V U U E E Fol
6 [Aib6,Glu19] ALM
F30
— 1.2 Ac U P U A U U Q U V U G L U P V U U E E Fol
7 [desAA(1–6),Pyr7]
ALM F30
— 2.9 Pyr U V U G L U P V U U E Q Fol
8 [desPheol] ALM
F30
— 0.6 Ac U P U A U A Q U V U G L U P V U U E Q
9 [Aib6,desPheol]
ALM F30
— 0.7 Ac U P U A U U Q U V U G L U P V U U E Q
10 [Aib6,Glu7] ALM
F30
— 1.3 Ac U P U A U U E U V U G L U P V U U E Q Fol
11 [Glu7] ALM F30 F30/6 1.7 Ac U P U A U A E U V U G L U P V U U E Q Fol
a Not quantified, because the uncharged ALM F50 comigrates with the EOF.
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Figure 2 ESI-IT-MSn (n = 1–3) of [Aib6] ALM F30 (3).
Figure 3 ESI-IT-MSn (n = 1–3) of [desAA(1–6),Pyr7] ALM F30 (7).
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(Figure 2). MS2 generated the b13 and the y7 fragment
or, in case of the desPheol ALM F30 peptides, the y6
fragment (data not shown). The b13 fragment is detected
as a doubly charged ion. The MS3 of the diprotonated
b13 fragment ([b13 + 2H]2+) generated the b2 – b10
acylium ion series, as well as the monoprotonated
internal fragments b13y10 – b13y17 (Table 2). The C-
terminal sequences of the peptides were determined
by MS3 of the y7 fragment and, in the case of the
desPheol ALM F30 peptides, of the y6 fragment. The
resulting internal ion series (y7b19 – y7b16) are formed
by the cleavage of C-terminal residues while the charge
remains at the N-terminus. Loss of water from the
y7 fragment leads to a y7 – H2O fragment ion in the
MS3 spectra. The C-terminal position of Pheol was
concluded from the mass difference of 150 + 1 Da from
diprotonated y7 and monoprotonated y7b19 fragments.
A fragmentation scheme is presented in (Figure 4)
showing the series of diagnostic ions and internal
fragments used for sequence determination of [Aib6]
ALM F30 (3).
The signals of the b2 ions were recorded at m/z
225 corresponding to the fragment Ac-Aib-Pro. The
internal fragments b13y10 (m/z 256) and y7b16 (m/z
282) correspond to the Gly-Leu-Aib and the Pro-Val-
Aib tripeptides, respectively. The sequences of these
three fragments were derived from earlier HPLC–MS
investigations of ALM F30 [2,9] assuming sequence
analogy.
The sequences of the two pyroglutamyl peptaibols
(14-residue peptides) [desAA(1–6),Pyr7] ALM F50 (2)
and [desAA(1–6),Pyr7] ALM F30 (7) were concluded from
MS3 analysis of the b7 and y7 fragments generated by
the cleavage of the Aib-Pro bond of the pseudomolecular
ion [M + 2H]2+ (Figure 3 for [desAA(1–6),Pyr7] ALM
F30). The internal fragments of b7 are the b2 − b7
acylium ion series and the monoprotonated fragments
b7y10 − b7y13 analogous to the b13 fragment of the 20-
residue ALM F30 peptaibols. The y7 fragment formed
the y7b10 − y7b13 internal fragment series. In contrast to
the 20-residue ALM F30 peptides, the sequence of the
b7y10 fragment at m/z 256 corresponding to the Gly-
Leu-Aib tripeptide could be confirmed by the b5 − b7
fragment ions.
Pandey et al. reported the formation of pyroglu-
tamyl peptide fragments in an electron-impact mass
spectrometry study of ALM F30 [9]. However, the for-
mation of pyroglutamyl peptides during the ESI pro-
cess has not been described. In order to evaluate
the fragmentation pattern of Glu versus Pyr pep-
tides, two model peptides containing reduced C-termini
with the amino acid sequences Glu-Aib-Val-Aib-Gly-
Leuol (Glu-hexapeptide) and Pyr-Aib-Val-Aib-Gly-Leuol
(Pyr-hexapeptide) were synthesized and subjected to
NACE–ESI-MS. The ESI-IT-MS3 spectra of the two
model hexapeptides displayed the respective b-type and
the y-type ion series. The [M + H]+ ions were selected as
the precursor ions, and the fragment ions are listed in
Table 3. In the spectrum of the Glu-hexapeptide, the b2,
b3 and b4 fragments were detected and also additional
signals corresponding to the loss of water from the
b2 − b4 fragments. These fragments have identical m/z
values as the b2 − b4 fragments of the Pyr-hexapeptide
so that formation of Pyr peptides in the ESI source
can be assumed. However, the Glu-hexapeptide can
be clearly distinguished by the presence of the b2 − b5
fragments 18 mass units higher than those of the Pyr-
hexapeptide. In addition, both peptides have different
electrophoretic mobilities. Thus, it can be concluded
that the truncated Pyr peptaibol components in ALM
F30 are in fact present in the investigated sample
and not an artefact generated in the ESI ion source
because the compounds did not display the respective
18-mass-units-higher fragments in the spectra. Inter-
estingly, [desAA(1–6),Pyr7] ALM F50 (2) displayed a low
anodic mobility despite the fact that this compound
should be neutral as it does not contain a charged
amino acid. Apparently, under the present NACE con-
ditions, a partial negative charge is induced. Moreover,
the anodic mobility of [desAA(1–6),Pyr7] ALM F50 (2)
Figure 4 Fragmentation scheme of [Aib6] ALM F30 (3). Fragments were generated by ESI-IT-MSn (n = 1–3).
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was confirmed by the anodic mobility of the Pyr model
hexapeptide.
The amino acid composition of the ALM F30 compo-
nents obtained by NACE–ESI-IT-MSn was confirmed by
NACE–ESI-TOF-MS analysis. Doubly or triply charged
molecular ions were the most abundant ions in the
spectra. Fragmentation was not observed (data not
shown). The high resolution of the TOF mass analyzer
allowed the analysis of the isotope pattern as shown
in Figure 5 for the [M + 3H]3+ ion of [desPheol] ALM
F30 (8) and the [M + 2H]2+ ion of [desAA(1–6),Pyr7]
ALM F30 (7) including a comparison of the experimen-
tal spectra with the simulated isotope pattern obtained
Table 3 Fragment ions, pseudomolecular ions and adducts
of pseudomolecular ions (m/z ratio) of the model hexapeptides
Glu-Aib-Val-Aib-Gly-Leuol (Glu-hexapeptide) and Pyr-Aib-Val-
Aib-Gly-Leuol (Pyr-hexapeptide)
Ion m/z
Glu-hexapeptide Pyr-hexapeptide
b2 215.1 197.1
b3 314.2 296.2
b4 399.2 381.2
b5 456.2 438.2
y2 157.1 157.1
y3 242.2 242.2
y4 341.2 341.2
y5 426.3 426.3
[b2 − H2O] 197.1 —
[b3 − H2O] 296.2 —
[b4 − H2O] 381.2 —
[M + H]+ 573.3 555.3
by the Bruker DataAnalysis software. In both exam-
ples, the measured isotope pattern was consistent with
the calculated isotope pattern, thus confirming the ele-
mental composition, i.e. the amino acid composition of
the identified components. This approach was applied
to the confirmation of the amino acid composition of
all compounds. Table 4 summarizes the experimentally
determined monoisotopic m/z values using ALM F30 as
mass calibrant compared to the respective calculated
values. With the exception of the neutral ALM F50,
mass accuracy was clearly below 5 ppm for the doubly
charged ions and below 2 ppm for the triply charged
ions. The relative inaccuracy found for ALM F50 may be
due to the fact that this compound migrates essentially
with the electroosmotic flow (EOF).
Except for the neutral components ALM F50 (1)
and [desAA(1–6),Pyr7] ALM F50 (2), the compounds
possess a Glu residue in position 18 and carry a
negative charge under the applied NACE conditions.
Not considering [desAA(1–6),Pyr7] ALM F30 (7), the
Glu18 derivatives can be divided into pairs characterized
by the exchange of Ala by Aib in position 6. This
exchange is characteristic for many peptaibol peptides
[7]. Compared to the pair of the major components ALM
F30 (4) and [Aib6] ALM F30 (3), the other pairs are
characterized by an additional carboxy group resulting
from the exchange of Gln in position 19 to Glu,
i.e. [Glu19] ALM F30 (5) and [Aib6,Glu19] ALM F30
(6), the exchange of Gln to Glu in position 7, i.e.
[Glu7] ALM F30 (11) and [Aib6,Glu7] ALM F30 (10),
or loss of the C-terminal phenylalaninol, i.e. [desPheol]
ALM F30 (8) and [Aib6,desPheol] ALM F30 (9). Except
for [Glu7] ALM F30 (11) and [Aib6,Glu7] ALM F30
(10), which are well separated, the peptaibols of the
respective pairs comigrate as the mass difference of
Figure 5 Measured (A, C) and calculated (B, D) isotope pattern of [desPheol] ALM F30 (A, B) and [desAA(1–6),Pyr7] ALM
F30 (C, D).
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Table 4 Calculated and measured m/z ratios of the pseudomolecular ions observed in ESI-TOF-MS
Molecular
formula
Monoisotopic
molecular
mass (Da)
m/z monoisotopic mass
[M + 2H]2+ m
(ppm)
[M + 3H]3+ m
(ppm)
Measured Calculated Measured Calculated
1 ALM F50 C92H151N23O24 1962.09 982.0784 982.0724 +6.1 655.0483 655.0507 −3.7
2 [des(1–6),Pyr7] ALM F50 C67H108N16O17 1408.77 705.4107 705.4112 −0.7 — — —
3 [Aib6] ALM F30 C93H152N22O25 1977.08 989.5723 989.5722 +0.1 660.0507 660.0506 +0.2
4 ALM F30 C92H150N22O25 1963.07 Calibrant 982.5644 — Calibrant 655.3787 —
5 [Glu19] ALM F30 C92H149N21O26 1964.05 983.0562 983.0564 −0.2 655.7075 655.7067 +1.2
6 [Aib6,Glu19] ALM F30 C93H151N21O26 1978.06 990.0609 990.0642 −3.3 660.3798 660.3786 +1.8
7 [des(1–6),Pyr7] ALM F30 C67H107N15O18 1409.75 705.9031 705.9032 −0.1 — — —
8 [desPheol] ALM F30 C83H139N21O25 1830.00 916.0177 916.0198 −2.3 611.0148 611.0156 −1.3
9 [Aib6,desPheol] ALM F30 C84H141N21O25 1844.01 923.0305 923.0276 +3.1 615.6873 615.6875 −0.3
10 [Aib6,Glu7] ALM F30 C93H151N21O26 1978.06 990.0634 990.0642 −0.8 660.3797 660.3786 +1.7
11 [Glu7] ALM F30 C92H149N21O26 1964.05 983.0557 983.0564 −0.7 655.7066 655.7067 −0.2
14 Da caused by the exchange of Ala versus Aib is
not sufficient to be translated into CE separations
of peptaibols with masses of approximately 1950 Da
under the experimental conditions applied.
Peptaibiotics terminating in a free amino acid or
amide instead of a C-terminal 2-amino alcohol residue
have been described previously. They comprise XR 586
(Gly at the C-terminus) [25]; trichobrachins TB I A, B, C,
and D (Gln at the C-terminus) as well as trichobrachins
II A, C, and D (Val at the C-terminus) [26]; lipohexin
(β-Ala at the C-terminus) [27,28], pseudokonin KL III
(Pro-NH2 at the C-terminus) [29] and cephaibols P and
Q (Ser at the C-terminus) [30].
N-terminal pyroglutamic acid (Pyr) containing peptai-
bols have not yet been reported. Whether [desAA(1–6),
Pyr7] ALM F50 (2) and [desAA(1–6),Pyr7] ALM F30
(7) are naturally occurring compounds or artifacts
caused by the workup or enzymatic degradation of
peptaibols in the fermentation process remains to be
answered. In order to estimate the possibility of the
formation during workup, ALM F30 was heated for
41 h at 100 °C in the crystalline state as well as in
dichloromethane/methanol (1 : 1, v/v) in the presence
of an equal amount of silica gel G 60 for 4, 8 and 24 h
at 70 °C in a closed vial simulating the chromatographic
workup [2] of the sample. The samples were analyzed
by LC–MS and CE. Neither treatment increased the
amount of the truncated pyroglutamyl peptides com-
pared to untreated samples. Thus, formation of these
peptides during workup appears to be unlikely. In addi-
tion, when specifically searching for the mass trace of
the [desAA(1–6),Pyr7] ALM F30 (7) in LC–MS, the com-
pound could also be detected in samples of ALM F30
described in Ref. 2.
To the best of our knowledge, this is the first report on
the occurrence of Pyr as a constituent of fungal peptides
in nature. Literature search did not reveal any previous
publications regarding the isolation of peptide-bound
Pyr from a fungal source. Pyr is rather widespread
as an N-terminal constituent of peptides obtained
from bacteria, plants, vertebrates and invertebrates.
For example, the enzymatic production of Pyr by
thermophilic lactic acid bacteria in Italian cheeses
has been described [31,32]. Pyr has been reported
as a constituent of antifungal peptides from the bark
of Eucommia ulmoides [33], as a constituent of an
adipokinetic hormone from the corpora cardiaca of the
butterfly Vanessa cardui (Lepidoptera, Nymphalidae)
[34], in gomesin, a defensive peptide found in the
hemocytes of the tarantula spider Acanthoscurria
gomesiana (Theraphosidae) [35], from the abdominal
ganglia of the snail Aplysia californica [36], as well as
from the hemolymph of the shrimp Penaeus vannamei
(Decapoda) [37]. The N-terminus of neurotensins from
the European green frog Rana ridibunda also contains
a Pyr [38] as does the N-terminus of bradykinin
potentiating peptides (BPPs) from the crude venom
of the viper Bothrops jararaca [39]. Biosynthetically,
Pyr peptides originate from glutaminyl peptides by
the action of pyroglutamyl cyclases. Currently, more
than 100 pyroglutamyl cyclase-type genes can be
found in genomic databases such as BLAST (Basic
Local Alignment Tool, National Center for Biotechnology
Information), including fungal sources. Thus, the
possibility of the formation of the truncated peptaibols
before extraction can also not be generally ruled out at
present. Future studies have to be performed in order
to unequivocally prove the origin of the truncated Pyr
peptaibols by T . viride.
Further confirmation of the identity of [desAA(1–6),
Pyr7] ALM F30 (7) and [desPheol] ALM F30 (8) may
be derived from the so-called sigma value that
represents a calculated parameter based on the true
isotopic pattern (TIP; Bruker Daltonik). It considers
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the mass and the relative intensities of all isotopes. For
both substances, the calculated elemental composition
based on the isotopic pattern of the [M + 2H]2+ ion
belongs to the top 10% of possible hits.
The microheterogeneous ALM F30 isolated from
a fermentation broth has previously been analyzed
by HPLC–MS and 10 components have been identi-
fied [2]. Except for one compound (peptaibol F30/6
in Ref. 2 corresponding to [Glu7] ALM F30 (11) in
this study) all components possess only one charge-
able function with Glu in position 19. Further amino
acid exchanges reported in [2] include Val to Aib or
Leu in position 9, Leu to Val in position 12 and
Aib to Val in position 17 besides the exchange of
Ala with Aib in position 6, which was also found
for the peptaibols described in the present study.
Seven of these peptaibols were not identified by
NACE–ESI-IT-MS. However, careful analysis of the ESI-
TOF-MS runs revealed that the peptaibols with the
sequences AcUPUAUAQUUUGLUPVUUEQFol (F30/1 in
Ref. 2) and AcUPUAUAQUVUGVUPVUUEQFol (F30/2
in Ref. 2) apparently comigrate with the major compo-
nents ALM F30 (4) and [Aib6] ALM F30 (3) in NACE.
Other peptaibols identified in Ref. 2 have identical
masses as the major components or masses differing
by only 14 Da. As described above, a mass difference of
14 Da between peptides of approximately 1950 Da may
not always be sufficient to be translated into a separa-
tion by CE. Thus, it appears very likely that most of the
minor peptaibol components described in Ref. 2 comi-
grate with the major components of ALM F30 in NACE.
Owing to the large excess of the major component,
it was not possible to properly select the appropriate
precursor ions for amino acid sequence elucidation of
comigrating minor components by NACE–ESI-MSn.
In contrast, the majority of minor peptaibol com-
ponents identified by NACE–MS possesses a second
carboxy function due to Gln/Glu exchange or loss of
the C-terminal Pheol. Except for [Glu7] ALM F30 (com-
ponent F30/6 in Ref. 2), these compounds were not
detected in the earlier HPLC–MS study. Apparently,
ALM F30 peptaibols possessing only one carboxy func-
tion are separated more efficiently by HPLC, while com-
ponents with two carboxy functions can be analyzed
better by NACE. This illustrates the complementarity
of both techniques due to their different separation
principles.
Quantification of ALM F30 Components
The relative amounts of the respective peptaibol
peptides in a heterogeneous mixture is required in
order to judge the relevance of structural variations of
individual peptides, in particular, when bioactivities are
discussed. In the present NACE assay, the composition
cannot be directly obtained from the electropherograms
because of the comigration of compounds. Thus, the
amount of the identified ALM F30 components in the
microheterogeneous mixture was estimated from the
NACE-UV traces at 215 nm in combination with the
NACE–ESI-TOF-MS results. The relative amount of
comigrating or incompletely separated peptides was
calculated on the basis of the corrected peak area
(peak area divided by the migration time) obtained
from the EIE of characteristic isotopic signals of
the pseudomolecular [M + 2H]2+ and [M + 3H]3+ ions,
while the absolute amount of comigrating peptides
was calculated from the corrected peak area obtained
from the NACE-UV trace. Only peptide fragments with
similar charges and masses were chosen for the relative
Figure 6 Quantification of (A) [desPheol] ALM F30 (8) and [Aib6,des Pheol], ALM F30 (9) and (B) [Glu19] ALM F30 (5), [Aib6,Glu19]
ALM F30 (6), [Glu7] ALM F30 (11) and [Aib6,Glu7] ALM F30 (10) by NACE–ESI-TOF-MS. The mass traces shown result from the
addition of the unambiguously identified isotope signals of the respective analytes.
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quantification, so that comparable ionization yields
using ESI can be assumed for the respective analytes.
Careful selection of the correct m/z values is important
because signal overlapping by ammonium adducts
of comigrating peptides occurs. Figure 6A shows the
EIE of [desPheol] ALM F30 (8) and [Aib6,desPheol]
ALM F30 (9). The integration of the peaks resulted
in a quantitative relationship of 1.00 : 1.26. The
quantification of the other comigrating substances
[Glu19] ALM F30 (5) and [Aib6,Glu19] ALM F30 (6)
as well as [Glu7] ALM F30 (11) and [Aib6,Glu7] ALM
F30 (10) based on the EIE is shown in Figure 6B.
Note that the positionally isomeric peptides 5 and
11 form identical pseudomolecular ions as do the
positionally isomeric peptides 6 and 10. The resulting
quantitative relationship for these four peptides is
1.66 : 1.36 : 1.00 : 1.34. The relative amount of the
pyroglutamyl peptides and of the pair ALM F30
(4)/[Aib6] ALM F30 (3) was calculated in a similar
manner.
The results of the quantitative analysis are listed in
Table 1. In accordance with the results obtained by
Bru¨ckner and coworkers for ALM F30 using HPLC–MS
[2], the main components ALM F30 (4) and [Aib6] ALM
F30 (3) comprise about 90% of the ALM F30 peptides.
The unusual compound [desAA(1–6),Pyr7] ALM F30 (7)
was present at a level of about 3% while all other
minor components were below 2%. The neutral ALM
F50 is transported by the EOF. The quantification of
analytes comigrating with the EOF is difficult because
of signal quenching by impurities transported by the
EOF. Therefore, ALM F50 was not quantified.
CONCLUSIONS
The components of ALM F30 isolated from fermenta-
tions of T. viride were analyzed by NACE–ESI-IT-MS
and NACE–ESI-TOF-MS. A total of 11 compounds were
identified. These are characterized by the well-known
Ala/Aib exchange in position 6 as well as additional
Gln/Glu exchanges in positions 7 or 19, as well as
the loss of the C-terminal Pheol residue. Additionally,
two truncated pyroglutamyl derivatives were detected
which have not been described for peptaibols from fun-
gal sources before.
Compared to an earlier study on ALM F30 by
HPLC–MS [2], the present results are in agreement
with regard to the structure and content of the major
components ALM F30 and [Aib6] ALM F30. However,
the discrepancy concerning the minor components is
evident. Most of the minor components described in
the HPLC study were not detected by NACE–ESI-IT-
MS. This may be explained by the fact that the mass
differences of ±14 Da between compounds in many
cases are not sufficient to translate into a separation
in CE. On the other hand, most of the compounds
found by NACE–MS were not identified by HPLC–MS.
These components are characterized by an additional
carboxy group caused by the exchange to Gln versus
Glu or loss of the C-terminal amino alcohol. Apparently,
the additional charge makes such compounds more
suitable for CE analysis while they were ‘missed’
by HPLC. This demonstrates that HPLC and CE
are complementary techniques due to the different
separation mechanisms. For complete characterization
of complex peptide mixtures, both techniques should
be applied.
Acknowledgements
We are indebted to Dr Harald Bocker (Jena) and
Prof. em. Dr Detlef Gro¨ger (Halle/Saale) for valuable
discussions on the occurrence of pyroglutamic acid in
fungal peptides and microbial sources.
REFERENCES
1. Meyer CE, Reusser F. A polypeptide antibacterial agent isolated
from Trichoderma viride. Experienta 1967; 23: 85–86.
2. Kirschbaum J, Krause C, Winzheimer RK, Bru¨ckner H. Sequences
of alamethicins F30 and F50 reconsidered and reconciled. J. Pept.
Sci. 2003; 9: 799–809.
3. Duclohier H, Wro´blewski H. Voltage-dependent pore formation and
antimicrobial activity by alamethicin and analogues. J. Membr. Biol.
2001; 184: 1–12.
4. Boheim G, Hanke W, Jung G. Alamethicin pore formation: voltage
dependent flip-flop of α-helix dipoles. Biophys. Struct. Mech. 1983;
9: 181–191.
5. Menestrina G, Voges KP, Jung G, Boheim G. Voltage-dependent
channel formation by rods of helical polypeptides. J. Membr. Biol.
1986; 93: 111–132.
6. Jung G, Redemann T, Meder S, Hirsch A, Boheim G. Template-free
self-assembling fullerene and lipopeptide conjugates of alamethicin
form voltage-dependent ion channels of remarkable stability and
activity. J. Pept. Sci. 2003; 9: 784–798.
7. Whitmore L, Chugh JK, Snook CF, Wallace BA. The peptaibol
database: a sequence and structure resource. J. Pept. Sci. 2003; 9:
663–665.
8. Degenkolb T, Berg A, Gams W, Schlegel B, Gra¨fe U. The occurence
of peptaibols and structurally related peptaibiotics in fungi and
their mass spectrometric identification via diagnostic fragment
Ions. J. Pept. Sci. 2003; 9: 666–678.
9. Pandey RC, Cook CJ, Rinehart KL. High resolution and field
desorption mass spectrometry studies and revised structures of
alamethicins I and II. J. Am. Chem. Soc. 1977; 99: 8469–8483.
10. Schmitt H, Jung G. Total synthesis of the α-helical eicosapeptide
antibiotic alamethicin. Liebigs Ann. Chem. 1985; 321–344.
11. Riekkola M-L. Recent advances in nonaqueous capillary
electrophoresis. Electrophoresis 2002; 23: 3865–3883.
12. Matysik F-M. Special aspects of detection methodology in
nonaqueous capillary electrophoresis. Electrophoresis 2002; 23:
400–407.
13. Weinmann W, Maier C, Baumeister K, Przybylski M, Parker CE,
Tomer KB. Isolation of hydrophobic lipoproteins in organic solvents
by pressure-assisted capillary electrophoresis for subsequent
mass spectrometric characterization. J. Chromatogr. 1993; 648:
251–256.
14. Popa TV, Mant CT, Chen Y, Hodges RS. Capillary zone
electrophoresis of small α-helical diastereomeric peptide pairs
Copyright  2005 European Peptide Society and John Wiley & Sons, Ltd. J. Peptide Sci. 2006; 12: 279–290
290 PSUREK ET AL.
with anionic ion-pairing reagents. J. Chromatogr. A 2004; 1043:
113–122.
15. Yang Q, Benson LM, Johnson KL, Naylor S. Analysis of lipophilic
peptides and therapeutic drugs: on-line-nonaqueous capillary
electrophoresis-mass spectrometry. J. Biochem. Biophys. Methods
1999; 38: 103–121.
16. Stutz H. Advances in the analysis of proteins and
peptides by capillary electrophoresis with matrix-assisted
laser desorption/ionization and electrospray-mass spectrometry
detection. Electrophoresis 2005; 26: 1254–1290.
17. Nguyen H-H, Imhof D, Kronen M, Schlegel B, Ha¨rtl A, Gra¨fe U,
Gera L, Reissmann S. Synthesis and biological evaluation of
analogues of the peptaibol ampullosporin A. J. Med. Chem. 2002;
45: 2781–2787.
18. Carpino LA, Beyermann M, Wenschuh H, Bienert M. Peptide
synthesis via amino acid halides. Acc. Chem. Res. 1996; 29:
268–274.
19. Roepstorff P, Fohlmann J. Proposal for a common nomenclature for
sequence ions in mass spectra of peptides. Biomed. Mass Spectrom.
1984; 11: 601.
20. Biemann K. Nomenclature for peptide fragment ions (positive ions).
Methods Enzymol. 1990; 193: 886–887.
21. Rebuffat S, Goulard C, Bodo B. Antibiotic peptides from
Trichoderma harzianum: harzianins HC, proline-rich 14-residue
peptaibols. J. Chem. Soc. Perkin Trans. 1 1995; 1849–1855.
22. Jaworski A, Bru¨ckner H. Sequences of polypeptide antibiotics
stilboflavins, natural peptaibol libraries of the mold Stilbella
flavipes. J. Pept. Sci. 2001; 7: 433–447.
23. Jaworski A, Bru¨ckner H. Detection of new sequences of
peptaibol antibiotics trichotoxins A-40 by on-line liquid
chromatography–electrospray ionization mass spectrometry. J.
Chromatogr. A 1999; 862: 179–189.
24. Berg A, Grigoriev PA, Degenkolb T, Neuhof T, Ha¨rtl A, Schlegel B,
Gra¨fe U. Isolation, structure elucidation and biological activities of
trichofumins A, B, C and D, new 11 and 13mer peptaibols from
Trichoderma sp. HKI 0276. J. Pept. Sci. 2003; 9: 810–816.
25. Sharman GJ, Try AC, Williams DH, Ainsworth AM, Beneyto R,
Gibson TM, McNicholas C, Renno DV, Robinson N, Wood KA,
Wrigley SK. Structural elucidation of XR586, a peptaibol-like
antibiotic from Acremonium persicium. Biochem. J. 1986; 320:
723–728.
26. Bru¨ckner H, Kripp M, Kieß M. Polypeptide antibiotics trichovirin
and trichobrachin: sequence determination and total synthesis.
Chem. Pept. Proteins 1993; 5/6: 357–373.
27. Heinze S, Ritzau M, Ihn W, Schlegel B, Dornberger K, Fleck WF,
Zerlin M, Christner C, Gra¨fe U, Ku¨llertz G, Fischer G. Lipohexin, a
new inhibitor of prolyl endopeptidase from Moeszia lindtneri (HKI-
0096) and Paecilomyces sp. (HKI-0055; HKI-0096). I. Screening,
isolation and structure elucidation. J. Antibiotics 1997; 50:
379–383.
28. Christner C, Zerlin M, Gra¨fe U, Heinze S, Ku¨llertz G, Fischer G.
Lipohexin, a new inhibitor of prolyl endopeptidase from Moeszia
lindtneri (HKI-0054) and Paecilomyces sp. (HKI-0055; HKI-0096). II.
Inhibition activity and specificity. J. Antibiotics 1997; 50: 384–389.
29. Rebuffat S, Goulard C, Hlimi S, Bodo B. Two unprecedented
natural Aib-peptides with the (Xaa-Yaa-Aib-Pro) motif and
an unusual C-terminus: Structures. Membrane modifying and
antibacterial properties of pseudokinins KL III and KL VI from the
fungus Trichoderma pseudokoningii. J. Pept. Sci. 2000; 6: 519–533.
30. Schiell M, Hofmann J, Kurz M, Schmidt FR, Vertesy L, Vogel M,
Wink J, Seibert G. Cephaibols, new peptaibol antibiotics with
antihelmintic properties from Acremonium tubakii DSM 12774. J.
Antibiotics 2001; 54: 220–233.
31. Mucchetti G, Locci F, Gatti M, Neviani E, Addeo F, Dossena A,
Marchelli R. Pyroglutamic acid in cheese: Presence, origin, and
correlation with ripening time of grana padano cheese. J. Dairy Sci.
2000; 83: 659–665.
32. Mucchetti G, Locci F, Massara P, Vitale R, Neviani E. Production
of pyroglutamic acid by thermophilic lactic acid bacteria in hard-
cooked mini-cheeses. J. Dairy Sci. 2002; 85: 2489–2496.
33. Huang R-H, Xiang Y, Liu X-Z, Zhang Y, Hu Z, Wang D-C. Two novel
antifungal peptides distinct with a five-disulfide motif from the bark
of Eucommia ulmoides Oliv. FEBS Lett. 2002; 521: 87–90.
34. Ko¨llisch GV, Lorenz MW, Kellner R, Verhaert PD, Hoffmann KH.
Structure elucidation and biological activity of an unusual
adipokinetic hormone from corpora cardiaca of the butterfly,
Vanessa cardui. Eur. J. Biochem. 2000; 267: 5502–5508.
35. Silva PI, Daffre S, Bulet P. Isolation and characterization of
gomesin, an 18-residue cysteine-rich defense peptide from
the spider Acanthoscurria gomesiana hemocytes with sequence
similarities to horseshoe crab antimicrobial peptides of the
tachylepsin family. J. Biol. Chem. 2000; 275: 33 464–33 470.
36. Garden RW, Moroz TP, Gleeson JM, Floyd PD, Li L, Rubakhin SS,
Sweedler J. Formation of N-pyroglutamyl peptides from N-Glu and
N-Gln precursors in Aplysia neurons. J. Neurochem. 1999; 72:
676–681.
37. Destoumieux D, Bulet P, Loew D, Dorsselaer AV, Rodriguez J,
Bache`re E. Penaeidins, a new family of antimicrobial peptides
isolated from the shrimp Penaeus vannamei (Decapoda). J. Biol.
Chem. 1997; 272: 28 398–28 406.
38. Desrues L, Tonon M-C, Leprince J, Vaudry H, Conlon JM.
Isolation, primary structure, and effects on α-melanocyte-
stimulating hormone release of frog neurotensin. Endocrinology
1998; 139: 4140–4146.
39. Ianzer D, Konno K, Marques-Porto R, Portaro FCV, Sto¨cklin R, de
Camargo ACM, Pimenta DC. Identification of five new bradykinin
potentiating peptides (BPPs) from Bothrops jararaca crude venom
by using electrospray ionization tandem mass spectrometry after a
two-step liquid chromatography. Peptides 2004; 25: 1085–1092.
Copyright  2005 European Peptide Society and John Wiley & Sons, Ltd. J. Peptide Sci. 2006; 12: 279–290
Peptaibiomics: Screening for Polypeptide Antibiotics (Peptaibiotics) from
Plant-Protective Trichoderma Species
by Thomas Degenkolba), Tom Grfenhanb)1), Albrecht Bergc), Helgard I. Nirenbergb),
Walter Gamsd), and Hans Br&ckner*a)
a) Interdisciplinary Research Center (IFZ), Department of Food Sciences,
Institute of Nutritional Science, University of Giessen, Heinrich-Buff-Ring 26–32, D-35392 Giessen
(phone: 0049-641/99-39141; fax: 0049-641/99-39149; e-mail: hans.brueckner@ernaehrung.uni-giessen.de)
b) Federal Biological Research Centre for Agriculture and Forestry (BBA), Institute for Plant Virology,
Microbiology and Biological Safety, Kçnigin-Luise-Straße 19, D-14195 Berlin
c)Max-Planck-Institute for Chemical Ecology, Department of Molecular Ecology, Hans-Knçll-Straße 8,
D-07745 Jena
d) Centraalbureau voor Schimmelcultures (CBS), Uppsalalaan 8, NL-3584 CT Utrecht
Dedicated to the memory of Prof. Dr. Udo Grfe (1941–2003).
Eight strains of Trichoderma species (T. strigosum, T. erinaceus, T. pubescens, T. stromaticum, and T.
spirale as well as T. cf. strigosum, T. cf. pubescens) were selected because of their antagonistic potential
against Eutypa dieback and Esca which are fungal diseases of grapevine trunks. These isolates were
screened for the production of a group of polypeptide antibiotics named peptaibiotics, including its
subgroups peptaibols and lipopeptaibols. Fully-grown fungal cultures on potato-dextrose agar were
extracted with CH2Cl2/MeOH, and these extracts were subjected to SPE using C18 cartridges. The
methanolic eluates were analyzed by on-line LC/ESI-MSn coupling – a method which is referred to as
FpeptaibiomicsG. New seven-, ten-, and eleven-residue lipopeptaibols, with N-terminal alkanoyl, and C-
terminal leucinol or isoleucinol residues were found and named lipostrigocins and lipopubescins.
Furthermore, new 18-residue peptaibols named trichostromaticins and 19-residue peptaibols named
trichostrigocins were discovered. One peptaibiotic carrying a free C-terminal valine (or isovaline) named
trichocompactin XII was also sequenced. These results corroborate the hypothesis that peptaibiotics
might contribute to the plant-protective action of their fungal producers. The data also point out that
comparison of peptaibiotic sequences is of limited relevance in order to establish chemotaxonomic
relationships among species of the genus Trichoderma.
1. Introduction. – Peptaibiotics are defined as linear peptide antibiotics which i)
have a molecular weight between 500 and 2,200 Dalton, ii) show a high content of a-
aminoisobutyric acid (Aib), iii) are characterized by the presence of other non-
proteinogenic amino acids and/or lipoamino acids, iv) possess an acylated N-terminus,
and v) have a C-terminal residue that, in most of them, consists of a free or MeO-
substituted 2-amino alcohol, but might also be an amine, amide, free amino acid,
piperazine-dione, or sugar alcohol [1] [2]. Since the majority of Aib-containing peptides
carries a C-terminal residue representing a 2-amino alcohol, this subgroup is referred to
as FpeptaibolsG. Very lipophilic peptaibols, the N-terminus of which is acylated by
octanoic, decanoic, or (Z)-dec-4-enoic acid, are named FlipopeptaibolsG.
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1) Present address: Agriculture and Agri-Food Canada, Biodiversity (Mycology and Botany), 960
Carling Avenue, Ottawa, Ontario, K1A 0C6, Canada.
Recently, the terms FpeptaibiomeG and FpeptaibiomicsG have been proposed [3] to
describe – in analogy to the proteome and proteomics – the approach to analyze the
entirety and dynamics of peptaibiotics produced by a fungal strain under defined
conditions. By a rapid and selective solid-phase extraction (SPE) method with SepPak'
C18 cartridges, the peptaibiotic-containing fraction was selectively absorbed, and the
eluate was subsequently analyzed by HPLC coupled to an electrospray ion-trap mass
spectrometer (ESI-MSn). The advantage of ion-trap mass spectrometers for screening
is the generation of a genealogy of the diagnostic product or daughter ions. For
instance, every MS2 product ion generated by collision with inert gases such as He and
Ar, or high-purity N2, can be fragmented separately, thus generating MS3 product ions.
The further fragmentation of these ions will result in MS4 product ions and so on [2].
Peptaibiotics show unique physico-chemical and biological activities depending on
particular structural properties. Those most intensively investigated are formation of
pores in bilayer lipid membranes as well as antibacterial, antifungal, occasionally
antiviral, insecticidal, and antiparasitic activities. Furthermore, inhibition of mitochon-
drial ATPase, uncoupling of oxidative phosphorylation, immunosuppression, and
inhibition of platelet aggregation were reported. Recently, induction of fungal
morphogenesis and neuroleptic effects have been described (for reviews, see [2] [3]).
Species of Trichoderma with teleomorphs in Hypocrea [4] have attracted much
academic and commercial interest as bioprotective agents against fungal pathogens.
The mode of action appears to be very sophisticated and complex. It depends on the
species/strain studied and may involve competition for nutrients, plant root coloniza-
tion, biofertilization, stimulation of plant resistance and defence mechanisms, rhizo-
sphere modification, and different types of mycoparasitism. The latter may involve
morphological changes such as coiling of parasite hyphae around the host and the
formation of specialized appressorium-like structures [5–10].
The species of Trichoderma are known as saprotrophs, rarely plant pathogens, or
polyphagous mycoparasites which are common in soil ecosystems. During the last
years, fungicolous fungi have attracted particular interest because of their bioactivity
against economically important fungal diseases of crop plants, which cannot effectively
be controlled by methods of classical plant protection [5].
The parallel formation and synergistic action of hydrolytic enzymes and peptai-
biotics was attributed an important role in mycoparasitism of T. harzianum on its host
Botrytis cinerea [11] [12]. Recent studies clearly indicate the importance of the
fungicolous biocontrol agent T. asperellum for induction of systemic and local
resistance of plants to a variety of plant pathogens [10] [13–15]. In addition to that,
there is molecular evidence for activity regulation and direct involvement of specific
exoenzymes [16] such as endochitinases [17], hexosaminidases [18], and aspartyl
proteases [19] during mycoparasitism. Recently, it has been demonstrated that T.
asperellum CBS 433.97 produces new and recurrent peptaibols of the trichotoxin A-50
family known for their antifungal and membrane activity [3].
More than 400 strains of 30 Trichoderma species were investigated in the course of
a project aimed at preventive plant protection and biocontrol of two fungal diseases in
viticulture: Eutypa dieback and Esca. These are latent trunk diseases that cause severe
economic losses in grapevine production [20] [21]. The in vitro bioactivity of the
Trichoderma strains against the causal agents of Eutypa dieback, Eutypa lata, and Esca
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disease, Phaeomoniella chlamydospora and Phaeoacremonium aleophilum has been
evaluated in plate assays with crude extracts. In result, some of the most active isolates
were classified as T. cf. strigosum, T. strigosum, T. erinaceus, T. cf. pubescens, T.
pubescens, T. stromaticum, and T. spirale (Table 1).
Compared to the bioactivity of isolates representing well-known biocontrol species
(e.g., T. atroviride, T. harzianum, T. koningii, and T. viride), crude extracts of the above
isolates were found to inhibit the growth of the Eutypa and Esca pathogens in vitro far
more effectively [22]. Although secondary metabolism in Trichoderma has been
studied for decades and reviewed extensively [23] [24], comparatively little is known
about bioactive metabolites produced by those Trichoderma ssp. included in the
present study.
In a recent paper, we have reported on the peptaibiome of seven plant-protective
strains belonging to the Trichoderma brevicompactum complex and described 68 new
sequences of peptaibiotics [25]. These findings demonstrate the great potential of the
peptaibiomic approach as well as the efficiency and advantages of a systematic search
for peptaibiotics in recently discovered Trichoderma species.
Some of the Trichoderma strains listed in Table 1 were also shown to produce
antimicrobially active volatiles such as a-pentylpyrones (6-PAP; 6-pentyl-2H-pyran-2-
Table 1. Trichoderma Species and Strains Included in this Study
Species Strains investigateda) Habitat Geographic origin Yieldb)
[mg]
PAPc)
produc-
tion
T. cf.
strigosum
BBA 69577¼
CBS 119777
Compost soil Berlin, Germany 8.2 d.d)
T. strigosum CBS 348.93 (ex-type) Forest soil Sengletary,
North Carolina, USA
2.5 d.
T. erinaceus DAOM 230019¼
CBS 117088 (ex-type)
Soil Coral Island
(Koh Lann), Thailand
10.5 n. t.
T. cf.
pubescens
BBA 66989¼
CBS 119776
Soil under pines (nursery) Rakownia near Posnan,
Poland
7.5 d.
T. pubescens DAOM 166162¼
CBS 345.93 (ex-type)
Forest soil Raleigh, North Carolina,
USA
3.0 g n.d.
T. stroma-
ticum
BBA 70638¼
CBS 101875¼
G.J.S. 97-183
(holotype)
FWitchesG broomG of cocoa
(Theobroma cacao)
Belem, Para´, Brazil 8.0 n.d.
BBA 70636¼
CBS 101730¼
G.J.S. 97-180
FWitchesG broomG of cocoa
(Theobroma cacao)
Belem, Para´, Brazil 21.4
T. spirale CBS 346.93 (ex-type) Soil Mekong, Thailand 1.3 n.d.
a) Abbreviations: BBA, Biologische Bundesanstalt fNr Land- und Forstwirtschaft, Braunschweig and
Berlin, Germany; CBS, Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands; DAOM,
Eastern Cereal and Oilseed Research Centre, Ottawa, Canada; G.J.S., private collection of Gary J.
Samuels; USDA-ARS, Systematic Botany and Mycology Laboratory, Beltsville, Maryland, USA. b) Dry
weight of the combined methanolic extracts obtained from 10 Petri dishes after clean-up over SepPakQ
C18 cartridges (see Exper. Part). c) PAP¼6-Pentyl-2H-pyran-2-on and related structures. d) d., detected;
n.d. not detected; n. t. , not tested.
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one and related structures [22]) the production of which is elicited in the presence of
plant-pathogenic fungi such as Rhizoctonia solani [26]. However, they were not yet
screened for the production of peptaibiotics. If peptaibiotics are, in fact, present, they
should considerably contribute to the antifungal activity of these strains, that are
already successfully used in biocontrol, or show a great potential for possible use as
biofungicides.
To characterize the FpeptaibiomeG of the Trichoderma spp. included in this study, we
have applied the rapid and selective LC-ESI-MSn technique defined as FpeptaibiomicsG
[3]. The present study was aimed at i) investigation of selected plant-protective strains
for the production of peptaibols and peptaibol-like antibiotics (peptaibiotics), ii)
sequencing of new and recurrent peptides found, and iii) testing of the hypothesis of a
possible use of the peptaibiotic patterns for chemotaxonomy.
2. Results. –General Remarks.General information such as habitat and geographic
origin of the Trichoderma biocontrol strains investigated are compiled in Table 1.
Diagnostic fragment ions m/z of peptaibiotics investigated in this study (excluding
lipopeptaibols) are listed in Table 2, and their corresponding sequences are presented
in Table 3. Diagnostic fragment ionsm/z of all lipopeptaibols are shown in Table 4, and
their sequences are listed in Table 5. Literature references may directly follow the
italicized bold species names at the beginning of every new break in theResults section.
They refer to literature providing relevant taxonomic data such as description of the ex-
type strain and its teleomorph, if known.
HPLC Elution profiles of the peptaibiotic-containing fraction from all strains are
shown in the Figure.
The HPLC/ESI-MSn-based sequencing and structural characterization of peptai-
biotics produced by T. cf. strigosum, T. strigosum, T. erinaceus, T. cf. pubescens, T.
pubescens, T. stromaticum, and T. spirale are described in the following section:
Trichoderma cf. strigosum BBA 69577. The HPLC elution profile of the strain
shown in the Figure, a, is dominated by three major peaks. According to the series of b-
type fragments generated during MSn, the two most prominent [MþH]þ ions
represent compound 1, probably tricholongin BI (m/z 1911), and compound 2,
tricholongin BII (m/z 1925). These two 19-residue peptaibols have previously been
obtained from Trichoderma longibrachiatum MNHN 3431. Both exhibit strong
membrane activity being more pronounced in the case of tricholongin BII. In contrast
to tricholongin BI, the latter carries a more hydrophobic d-Iva residue instead of Aib in
position 16 of the peptide chain [27]. A third, new compound 3, tricholongin BIII, is
characterized by the exchange of the Ser residue in position 10 against Ala ([MþH]þ
at m/z 1908) as confirmed by MSn experiments.
CID-MS analysis ofm/z 1061, 1075, 1089, and 1103 (all [MþNa]þ ) and subsequent
CID-MSn analysis of diagnostic b-type fragments (CID: 45 eV, CE: 45 eV) indicated
the presence of twelve eleven-residue lipopeptaibols, i.e., compounds 4–15. One of
them, compound 7, is probably identical with trikoningin KB I from Trichoderma
koningii strain No. 90 3589 [28], whereas compound 13 or 14 may represent trichogin
GA IV, which has also been isolated from Trichoderma longibrachiatum MNHN 3431
[29]. Comparison of sequences and retention times to those of recently reported
lipopeptaibols (see Tables 2 and 3), revealed that compounds 6–14 have been detected
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Figure. HPLC Elution Profiles. Peptaibiotic-containing fraction of (a) Trichoderma cf. strigosum BBA
69577, (b) Trichoderma strigosum CBS 348.93, (c) Trichoderma erinaceus DAOM 230019, (d)
Trichoderma cf. pubescens BBA 66989, (f) Trichoderma stromaticum BBA 70638, (g) Trichoderma
stromaticum BBA 70636, and (h) Trichoderma spirale CBS 346.93. Note that no HPLC elution profile is
available for Trichoderma pubescens CBS 345.93 (e). Annotations refer to consecutive numbering of
peptides used in the text. Numbers separated by a slash refer to co-eluting peptides.
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Figure (cont.)
in cultures of Hypocrea vinosa CBS 247.63 and Hyporea lactea CBS 853.70 [3]. In
contrast to that, compounds 4, 5, and 15 represent new sequences.
According to structural homologies, the N-terminus of compounds 4 and 5might be
protected by an a- or g-Me-branched C6 fatty acid. N-Terminal substitution of the
peptide chain with 2- or 4-Me-branched fatty acids was first described for leucino-
statins, as compiled in [30], but later defined to be a characteristic feature of all
lipoaminopeptides and structurally related peptaibiotics [2].
In addition to the eleven-residue lipopeptaibols 4–15, the strain produced six new,
truncated seven-residue lipopeptaibols, i.e., compounds 16–21, lacking the internal
pentapeptide Aib-Gly-Gly-Vxx/Lxx-Aib. The slash in the partial sequence refers to the
possible amino acid exchange of Vxx against Lxx. We suggest the name lipostrigocin
(LSG) A1–A6 for the seven-residue lipopeptaibols from T. strigosum, whereas the
eleven-residue lipopeptaibols, compounds 4–6, 8–12, and 15, are lipostrigocin B1–B9.
Trichoderma strigosum CBS 348.93 [31–33]. The main peak in the HPLC elution
profile (Fig., b) consists of at least two different ions. One of these, displaying [Mþ
Na]þ at m/z 1075 is probably identical with compound 9 by comparison of retention
time and CID-MS fragmentation. The other one, compound 22, is assumed to represent
the eleven-residue peptaibol trichobrevin B-IIIc recently described for Trichoderma cf.
brevicompactum ATCC 90237 (¼CBS 119576), IBT 40863 (¼CBS 119577), and
NRRL 3199 [25].
The two main peaks of four ions displaying [MþH]þ atm/z 1891 were analyzed by
MS2 experiments, followed by MS3 of the MS2 product ion at m/z 1150 from the [Mþ
H]þ ion, and by MS4 of m/z 780 generated from m/z 1150. CID-MS Data were used to
disclose the structure of the N-termini. The following sequence is proposed for both
compounds, 23 and 24 :
Ac-Aib-Ala-Aib-Aib-Lxx-Gln-Aib-Aib-Aib-Ser-Lxx-Aib-Pro-Vxx-Aib-Aib-Gln-
Gln-Lxxol
The N-terminal tripeptide, Ac-Aib-Ala-Aib, is very common among Trichoderma
peptaibiotics [34] [35]. The underlined partial sequence might be identical with amino
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acid positions 6–19 of compound 2, tricholongin BII. We suggest the names
Trichostrigocins (TSG)A and B for these new 19-residue peptaibols from Trichoderma
strigosum.
Trichoderma erinaceus DAOM 230019 [36]. Four pseudomolecular ions m/z 1891
were detected, as described above for Trichoderma strigosum CBS 348.93. Comparison
of CID-MS data and retention times (see Fig., c) indicated that the two predominant
[MþH]þ ions, could be identical with compounds 23 and 24.
The strain also produces a mixture of homologous lipopeptaibols. According to
CID-MS data, compound 25, displaying [MþNa]þ at m/z 1075, could be identical or
positionally isomeric with trikoningin KB II from Trichoderma koningii strain No. 90
3589 [28].
Trichoderma cf. pubescens BBA 66989. The HPLC elution profile as shown in the
Figure, d, is dominated by three peaks: the first one is at m/z 1911, whereas both the
second and third one are displayed at m/z 1925 (all [MþH]þ ). Comparison of the
CID-MS and MSn spectra with results obtained for Trichoderma cf. strigosum BBA
69577 and literature data revealed the presence of compounds 1 and 2. The third peak,
compound 26, named tricholongin BIV, is a positional isomer of compound 2, as
concluded on the basis of the CID-MS and MSn data.
The first lipopeptaibol displaying [MþNa]þ at m/z 1075 is assumed to be identical
with compound 8. Its positional isomer, compound 27, displays an exchange of Lxx3
against Vxx3, whereas Vxx7 is replaced by Lxx7. That lipopeptaibol has previously been
reported as sequence 3 fromHypocrea lacteaCBS 853.70 [3]. Compound 28, displaying
[MþNa]þ at m/z 1089, is considered to carry an N-terminal Oc-Vxx, whereas Lxx7 is
replaced by Vxx7. Its positional isomer is probably identical with compound 14. In
contrast to that, compound 29, the third positional isomer, may also carry an N-
terminal Oc-Vxx, but Lxx3 is replaced by Vxx3, whereas Lxx instead of Vxx is situated
in position 7 of the peptide chain. The lipopeptaibol displaying [MþNa]þ at m/z 1103
is supposed to be identical with compound 15. Owing to the positional isomerism with
the lipostrigocins B1–B9, compounds 4–6, 8–12, and 15, we suggest to continue that
consecutive numbering. Thus, compounds 27–29 are named lipostrigocins B10–B12.
Trichoderma pubescens CBS 345.93 [31] [32]. Three novel ten-residue lipopeptai-
bols displaying modified sequences were preparatively isolated and sequenced from the
ex-type strain of T. pubescens. The general structure of their N-terminal tetrapeptide
was elucidated as Oc-Aib-Gly-Vxx/Lxx-Aib, but the remaining sequence, except for
the C-terminal Lxxol residue, is slightly different from all other lipopeptaibols
described in this study. We propose the names linopubescin (LPB) A, B, and C for
those new compounds 30–32, respectively, from Trichoderma pubescens (Tables 4 and
5). The presence of the amino acids Gly, Aib, Vxx, Lxx and C-terminal Lxxol in the
hydrolysates was confirmed by detection of the respective [MþH]þ ions in the positive
ionization mode of the LCQ, whereas the negative ionization mode was applied to
detect the [MH] ion of the octanoic acid at m/z 143.
Trichoderma stromaticum BBA 70638 and BBA 70636 [37] [38]. The main peak of
both HPLC elution profiles shown in the Figure, f and g, respectively, displays a
protonated pseudomolecular ion m/z 1789. It is accompanied by four homologues
displaying [MþH]þ atm/z 1761, 1775, 1803, and 1817. These five 18-residue peptaibols,
compounds 33–37, represent new sequences, named trichostromaticins (TSM) A–E.
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Compounds 35 and 36 might be identical with the partial sequences 3 and 4 recently
published for T. stromaticum CBS 101875 [3]. The N-terminal sequence, Ac-Aib-Ala-
Aib-Ala-Aib-Aib-Gln-Aib-Val-Aib, comprising positions 1–10, was first reported for
the following 20-residue peptaibols, namely paracelsin C from T. reesei QM 9414 [39],
trichosporin B-IVc from T. polysporum TMI 60146 [40], trichokonin VIII from a strain
identified as T. koningii [41], and for longibrachins A III and A IV, from T.
longibrachiatum M 853431 [42]. The isobaric sequence with Iva8 instead of Val8 has
not yet been published. The C-terminal motif, Aib-Pro-Leu-Aib-Aib-Gln-Leuol,
comprising positions 12–18, has been described for the following 18-residue peptaibols,
namely trichokindins IIb, IIIa, IIIb, and VI from a strain classified as T. harzianum [43],
trichorzins HA I and HA III from T. harzianumM 903602 and M 922835 [44] [45], for
hypomurocins B II and B V from T. atroviride, formerly described as Hypocrea
muroiana IFO 31288 [46], and for trichovirins Ia, Ib, IIa, IIb, IIc, IIIa, IVa, IVb, V, and
VIb from FT. virideG NRRL 5243 [47]. The strain FT. virideG NRRL 5243 is currently
deposited as T. cf. harzianum. To date, isobaric C-terminal sequences with Ile instead of
Leu and Leuol replaced by Ileol have not been described.
In addition to these 18-residue peptaibols described above, these strains also
produced eight-residue, Ser-containing peptaibiotics. They are assumed to be identical
with the trichocompactins (TCT) V (compound 38 ; [MþH]þ at m/z 770) and VI
(compound 39 ; [MþH]þ at m/z 784) recently reported for T. cf. brevicompactum
ATCC 90237, IBT 40863, and NRRL 3199 – as concluded by comparison of the
fragmentation pattern and retention times [25]. Another new homologue, compound
40, carrying Ala6 instead of Gly6 was named TCT XII ([MþH]þ at m/z 768).
Trichoderma spirale CBS 346.93 [31–33]. The main peak in the HPLC elution
profile, shown in the Figure, h, is compound 22. It displays [MþNa]þ at m/z 1157.
Comparison of the fragmentation pattern and retention times indicated that it can be
assumed identical with eleven-residue peptaibol trichobrevin B-IIIc which has recently
described for T. cf. brevicompactum ATCC 90237, IBT 40863, and NRRL 3199 [25].
Other minor compounds withm/z 1127, 1113, and 1143 (all [MþNa]þ ) were present in
the total ion current, but their intensity was not sufficient to perform MSn experiments
in order to confirm the structures of these ions as other members of the trichobrevin B
peptaibols.
3. Discussion. – Correlation of Peptaibiotic Production and Antifungal Activity.
Peptaibols. Long-chain peptaibols are known to form voltage-gated or non-gated ion
channels in bilayer lipid membranes. The carboxyfluorescein leakage in small
unilamellar egg phosphatidylcholine vesicles with 20–30% cholesterol, induced by
tricholongins BI and BII, was demonstrated to be higher than that caused by the acidic
trichorzianine A IIIc [27]. In single-channel experiments [48], the mode of action of
trichorzianine A IIIc was shown to be consistent with the flip-flop gating model
introduced in [49]. The high structural homology of the 19-residue trichorzianine
A IIIc with the 19-residue trichologins BI, BII, and BIII (i.e., compounds 1–3), as well
as the 19-residue trichostrigocins A and B (compounds 23/24), suggests a similar mode
of membrane activity. The C-terminal fragment of the 18-residue trichostromaticins A–
E (i.e., compounds 30–35), represents a six-residue deletion sequence of that of
tricholongins BI, BII, and BIII. Obviously, it lacks one of the two Gln residues attached
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to the terminal Lxxol (compounds 1–3). Glu/Gln Residues appear to be located in the
pore lumen, which is important for conductance of the ion channel [34]. Nevertheless,
deletion of one Glu18 in a synthetic alamethicin has been demonstrated not to cause a
decrease in lifetime values of single ion channels as compared to natural alamethicin
[50]. Thus, trichostromaticins A–E may contribute to the potent bioactivity of T.
stromaticum: Hyperparasitic strains of this species, so far known only as a biologically
active cocoa endophyte, have successfully been introduced in field control of the causal
agent ofWitches< Broom Disease of cacao (Theobroma cacao) in South America. They
were shown to effectively suppress basidioma formation of the plant pathogen
Crinipellis perniciosa [37] [51].
Lipopeptaibols. The eleven-residue trichogin GA IV, the FclassicalG paradigm for
lipopeptaibols [52], was suggested to form an amphiphilic, right-handed mixed 310/a-
helical structure in methanolic solution [29]. The same behavior was reported for
trikoningins KB I and KB II [53]. Trichogin GA IVexhibits a considerable membrane-
perturbing activity which is illustrated by a two-state transition controlled by peptide
concentration: at low concentrations, the molecule is situated parallel to the membrane
surface in a Fcarpet-likeG manner with its four polar Gly residues oriented towards the
aqueous phase. Hydrophobic residues, including the N-octanoyl group as well as Leu3,7
and Ile10, face the membrane, thus stabilizing the interaction between the peptide and
the lipid bilayer. By increasing peptide concentration until membrane leakage is
observed, a cooperative transition occurs. Aggregates of trichogin GA IV are deeply
incorporated into the bilayer where they are assumed to form ion channels [54].
Chemotaxonomic Relevance of Peptaibiotics. Peptaibols. As T. stromaticum BBA
70638 and BBA 70636 were shown to produce trichocompactins, occurrence of these
peptaibiotics is also found in the T. brevicompactum complex. Furthermore, the
production of trichobrevins B by both T. strigosum (section Trichoderma, clade Viride)
and T. spirale that has tentatively been grouped into a so-called Flone lineageG of section
Pachybasium B [55] indicated a rather limited relevance of these peptaibiotics for
chemotaxonomic purposes.
Lipopeptaibols. The seven-, ten-, and eleven-residue lipopeptaibols listed in
Tables 4 and 5 were produced by Trichoderma species grouped in section Trichoderma,
H. rufa clade (T. koningii, T. strigosum, T. cf. strigosum, and T. erinaceus), and clade
Pachybasium A (T. pubescens, T. cf. pubescens). The lipopeptaibol-producing Hypo-
crea vinosa CBS 247.63 [3] is closely related to T. viride (sensu stricto), which also
belongs to theH. rufa clade (see above), whereasHypocrea citrina (syn.H. lactea) CBS
853.70 [3] belongs to a Hypocreanum subclade of section Pachybasium B. Production
of lipopeptaibols, however, has also been reported for T. longibrachiatumMNHN 3431
[29], belonging to section Longibrachiatum [56]. Obviously, biosynthesis of lip-
opeptaibol antibiotics is widespread throughout the genus Trichoderma ; but has also
been described for Tolypocladium geodes (Hypocreales ; Clavicipitaceae [57] [58]). The
genera Tolypocladium and Trichoderma are morphologically superficially similar as
illustrated by the fact that Tolypocladium inflatum, the FprincipalG source of cyclo-
sporine [59], was originally misidentified as Trichoderma polysporum [60].
4. Conclusions. – Generally, it is recommended to thoroughly identify new
peptaibiotic-producing isolates. Considering recent progress in molecular taxonomy of
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Trichoderma, a critical review and – if necessary – revision of identity of peptaibiotic-
producing strains is highly advisable:
To date, ca. 90 Trichoderma species are characterized by sequencing of ribosomal
DNA, and these data indicate that many species recognized exclusively on the basis of
morphology have probably been misidentified in the past [4] [55]. For instance, the
trichobrachin-producing T. longibrachiatum CBS 936.69 [61] is now re-classified as T.
ghanense.
Trichoderma strains that have warted conidia are traditionally identified as T. viride,
the type species of the genus. Recently, that species was subdivided into two species – T.
viride and T. asperellum – on the basis of ribosomal DNA analysis, but many more
species will have to be distinguished in this clade. Antibiotic production was exclusively
restricted to Trichoderma asperellum, while T. viride (sensu stricto) produced no
antibiotics [62] [63]. In a preceding paper, we have shown the affiliation of the
alamethicin patent strain, formerly known as FT. virideG NRRL 3199, to T. cf.
brevicompactum, and pointed out the necessity to establish a new species that is closely
related to T. brevicompactum [25]. The trichovirin-producing strain FT. virideG NRRL
5243 [47] is currently deposited as T. harzianum (sensu lato).
Like in other chemotaxonomical studies, it can be concluded that secondary
metabolites still seem to be of questionable chemotaxonomic importance. Literature
data clearly support this opinion, since fungi belonging to divergent taxonomic groups
may produce very similar sequences of peptaibiotics [31] [32].
Despite this, the patterns of peptaibiotics produced may occasionally be used as
additional markers to distinguish similar species and to supplement results of
morphological, molecular, and (bio)chemical approaches in modern taxonomy. As
species identification of Trichoderma strains was demonstrated to be possible by image
analysis of HPLC chromatograms [64], on-line coupling of HPLC and ESI-Ion-Trap-
MSn should, therefore, combine the advantages of both analytical techniques, thus
providing a more reliable structural identification of compounds produced by a certain
strain. To confirm this hypothesis, we have recently shown that the LC/MS fingerprint
of characteristic non-peptidic mycotoxins (trichothecenes [65]) and peptaibiotics (20-
residue alamethicins and eight-residue trichocompactins [25]) might be used in
addition to morphological and molecular data to separate the FBrevicompactum
complexG from other taxa of the genus Trichoderma.
Financial support by the Studienstiftung Mykologie (D-Cologne) and the Bundesprogramm
>kologischer Landbau (BLE, D-Bonn) is gratefully acknowledged.
Experimental Part
Chemicals. MeCN (Chromasolve for HPLC, far-UV; 99.9%) and CH2Cl2 (ACS reagent; 99.6%) were
obtained from Sigma-Aldrich (D-Steinheim), MeOH (99.8%, gradient grade, for HPLC) and
CF3COOH (TFA; 98.0%) were purchased from Fluka (D-Steinheim). AcOEt, Na2SO4 (all anal.
grade), and silica gel were obtained from Merck-VWR (D-Darmstadt). Bidistilled water was freshly
prepared from demineralized tap water prior to analysis using a quartz distill (Heraeus, D-
Kleinostheim).
Cultivation of Strains. Extraction of fully-grown agar-plates was performed as described in [25].
Clean-up of extracts by solid-phase extraction was performed according to [3] using SepPakQ C18
cartridges.
CHEMISTRY & BIODIVERSITY – Vol. 3 (2006) 607
Cultivation of Trichoderma pubescensCBS 345.93, and Extraction of Linopubescins A, B, and C. The
strain was cultivated as surface culture (60 l) at a temp. of 268 in 500-ml conical flasks containing 100 ml
of malt medium composed as follows (g/l): malt extract (20), glucose (10), yeast extract (1),
(NH4)2SO4 (5); pH 6.0. After 20 d of cultivation, the culture broth was harvested and separated by
filtration. Thereafter, the culture filtrate and the mycelium were extracted twice with AcOEt. The
combined extracts were dried (Na2SO4) and evaporated to dryness in vacuo. The dry residue (3 g) was
subjected to silica-gel chromatography (silica gel 60, 0.063–0.1 mm; column 60040 mm; CHCl3/
MeOH, 9 :1 (v/v)), and 20-ml fractions were collected. Linopubescin-containing samples were detected
by ESI-MS. Final purification was achieved by isocratic prep. HPLC (Spherisorb ODS-2, 5 mm, RP18,
Promochem, 25025 mm, MeCN/H2O 83 :17 (v/v); 12 ml/min, l 210 nm).
Instruments and Conditions for HPLC and Ion-Trap-ESI-LC-MS Measurements. For HPLC, a HP
1100 series instrument was used. ESI mass spectra were recorded on a LCQ instrument (Thermo
Finnigan MAT, San Jose´, CA, USA). The gradient used for HPLC and Ion-Trap-ESI-LC-MS
measurements has been described in [3]; further details concerning the anal. equipment were given in
[66].
As previously reported, a CID energy of 45 and 65 eV was applied to generate sequence-specific b-
and y-type fragments from putative [MþH]þ , [MþNa]þ , or sequence-specific fragment ions, resp.
Collision energy for MS/MS and MSn measurements was set between 25 and 65 eV, typically at 45 eV
[25].
Peptide fragment-ion series were assigned in accordance with the Roepstorff/Fohlman–Biemann
nomenclature previously used [67] [68].
Sequence Determination of Linopubescins A, B, and C. The sequence of amino acids was readily
indicated by ESI-MS/MS experiments (LCQ ion trap-instrument, Thermo Electron, D-Dreieich) due to
the diagnostic b-type cleavage of the amide bonds. The amino acid composition was confirmed by
hydrolysis. One mg of each peptide was hydrolyzed (6m HCl, 1108, 24 h) in a sealed tube under Ar
atmosphere. The residue was evaporated to dryness in vacuo and dissolved in MeOH prior to ESI
measurements in the positive mode. For isolation of the N-terminal fatty acid, the hydrolysis was
extracted twice with CHCl3. The extracts were combined, and the solvent was evaporated to dryness
under a cold stream of N2. Finally, the residue was dissolved in MeOH, and the sample was analyzed in
the negative mode of the LCQ.
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Trichoderma brevicompactum Complex: Rich Source of Novel
and Recurrent Plant-Protective Polypeptide Antibiotics
(Peptaibiotics)
THOMAS DEGENKOLB,† TOM GRA‹ FENHAN,§,# HELGARD I. NIRENBERG,§
WALTER GAMS,⊥ AND HANS BRU‹ CKNER*,†
Interdisciplinary Research Center (IFZ), Department of Food Sciences, Institute of Nutritional Science,
University of Giessen, Germany; Federal Biological Research Centre for Agriculture and Forestry
(BBA), Institute for Plant Virology, Microbiology and Biological Safety, Berlin, Germany; and
Centraalbureau voor Schimmelcultures (CBS), Utrecht, The Netherlands
Three strains of Trichoderma brevicompactum and another four that are closely related to that species
(Trichoderma cf. brevicompactum) were analyzed for the formation of polypeptide antibiotics
(peptaibiotics) by LC/ESI-MSn. These isolates were selected because of an antagonistic potential
against Eutypa dieback and Esca disease of grapevine and have not yet been investigated for the
production of peptide antibiotics. Fully grown cultures on potato dextrose agar were extracted with
CH2Cl2/MeOH, and this extract was subjected to SPE using C18 cartridges. The methanolic eluates
were analyzed by LC/ESI-MSn. All strains were found to produce membrane-active alamethicins F30.
In addition to that, novel peptaibiotics were detected, namely, 14 12-residue trichocryptins B, 12
11-residue trichocryptins A, 19 11-residue trichobrevins A and B, 6 10-residue trichoferins, and 17
8-residue trichocompactins. These compounds may partially be responsible for the plant-protective
action of the producers. Chemotaxonomic considerations also indicated the necessity to introduce
another new species that is closely related to T. brevicompactum.
KEYWORDS: Peptaibiotic; peptaibol; alamethicin; r-aminoisobutyric acid; electrospray ionization mass
spectrometry; peptide sequencing; Trichoderma; biocontrol
INTRODUCTION
More than 400 strains of 30 Trichoderma species were
investigated in the course of a project aimed at preventive plant
protection and biocontrol of two fungal diseases in organic
viticulture: Eutypa dieback and Esca. These are latent trunk
diseases that cause severe economic losses in organic grapevine
production (1, 2). The in vitro bioactivity of the Trichoderma
strains against the causal agents of Eutypa dieback, Eutypa lata,
and Esca disease, Phaeomoniella chlamydospora and Phaeo-
acremonium aleophilum, was evaluated in plate assays using
crude extracts. The most active isolates were identified either
as Trichoderma breVicompactum (sensu stricto, ss), or as
Trichoderma cf. breVicompactum (Trichoderma breVicompac-
tum, sensu lato, sl). Compared to the bioactivity of isolates
representing well-known biocontrol Trichoderma species (e.g.,
T. atroViride, T. harzianum, T. koningii, and T. Viride), crude
extracts of strains belonging to the T. breVicompactum complex
have been found to inhibit the growth of the above pathogens
in vitro far more effectively (3). Detailed information about
habitat and geographic origin of the seven isolates investigated
in this study is given in Table 1.
T. breVicompactum, an anamorphic species with a pachyba-
sium-like morphology, has been described from soil and tree
bark in North, Central, and South America and southern Asia
(4). The species was originally proposed to be phylogenetically
closely related to Hypocrea lutea (4), but also discussed to be
close to Trichoderma minutisporum/Hypocrea minutispora. As
the alignment of translation-elongation factor (TEF) sequences
turned out to be rather difficult, additional sequencing of the
second largest RNA polymerase subunit (RPB2) has been
performed. These experiments clearly indicated that the fungus
known as T. breVicompactum comprises two phylogenetically
different species that form a new lineage within the genus
Trichoderma. These findings are further supported by the results
of our work as outlined under Discussion.
Species of Trichoderma (teleomorphs in Hypocrea; 5) are
commercially used as bioprotective agents against many fungal
diseases. Most commercial preparations are formulated on the
basis of conidia, but application of biomass or chlamydospores
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has also been described. Choice of propagule for the preparation
depends on both production system and intended application
(6). The antifungal action of Trichoderma is complex. It depends
on the species/strain studied and may involve competition for
nutrients, plant root colonization, biofertilization, stimulation
of plant resistance and defense mechanisms, rhizosphere
modification, and different types of mycoparasitism. The latter
may involve morphological changes such as coiling of parasite
hyphae around the host and the formation of specialized
appressorium-like structures (7-11).
The species of Trichoderma are known as saprotrophs, rare
plant pathogens (10), or polyphagous mycoparasites, which are
common in soil ecosystems. During the recent years, fungicolous
fungi have attracted particular interest because of their bioac-
tivity against economically important fungal diseases of crop
plants, which cannot effectively be controlled by methods of
classical plant protection (12).
Secondary metabolites of Trichoderma have extensively been
reviewed (13, 14). Synergistic interactions between extracelluar
metabolites such as wall-degrading chitinases, glucanases, and
proteases, on the one hand, and antibiotics, on the other, have
clearly been demonstrated in the past. The parallel formation
of hydrolytic enzymes together with a group of membrane-active
polypeptide antibiotics, named “peptaibiotics”, and their syn-
ergistic action play an important role in mycoparasitism between
T. harzianum and its fungal hosts such as Botrytis cinerea (15,
16). The term “peptaibiotic” was introduced by Bru¨ckner et al.
(17) and reconsidered by Degenkolb et al. (18). It describes
linear peptide antibiotics that (i) range from 500 to 2200 Da in
molecular mass; (ii) show a high content of R-aminoisobutyric
acid; (iii) are characterized by the presence of other nonpro-
teinogenic amino acids and/or lipoamino acids; and (iv) possess
an acylated N terminus, whereas the C terminus may consist of
a free or methoxy-substituted 2-amino alcohol, amine, amide,
free amino acid, diketopiperazine, or sugar alcohol. “Peptaibols”
are regarded as a subgroup of the peptaibiotics, the N terminus
of which is acetylated, whereas the C terminus is reduced to a
2-amino alcohol.
Recently, the term “peptaibiomics” was proposed by Krause
et al. (19), describingsin analogy to proteomicssthe approach
to the analysis of the entirety of peptaibiotics, the so-called
“peptaibiome”, produced by a certain strain under defined
conditions.
Peptaibiotics show interesting physicochemical and biological
activities depending on particular structural properties, such as
formation of pores in bilayer lipid membranes as well as
antibacterial, antifungal, occasionally antiviral, insecticidal, and
antiparasitic activities. Inhibition of mitochondrial ATPase,
uncoupling of oxidative phosphorylation, immunosuppression,
inhibition of platelet aggregation, and induction of fungal
morphogenesis and neuroleptic effects have been reported
(summarized in refs 18 and 19).
Detailed information on structures of peptaibiotics and their
classification into subfamilies (20) can be obtained from public
Internet resources such as the “Peptaibol Database” (21). More
than 250 peptaibiotics produced by members of the genus
Trichoderma are described in the literature. Recently, a review
comprising structures and properties of 186 different peptaibi-
otics from Trichoderma has been published (14).
Screening and sequencing of peptaibiotics with a molecular
mass up to 2000 Da can be accomplished by advanced methods
of tandem mass spectrometry, especially electrospray ionization
(ESI-MS) techniques (for a review see ref 18) and completed
by GC/EI-MS and HPLC approaches (22).
As species identification of Trichoderma strains was dem-
onstrated to be possible by image analysis of HPLC chromato-
grams (23), on-line coupling of HPLC and ESI-ion-trap-MSn
should therefore combine the advantages of both analytical
techniques, thus providing a more reliable structural identifica-
tion of compounds produced by a certain strain.
To date, 88 Trichoderma species have been characterized by
sequencing of ribosomal DNA, and these data suggest that many
species recognized on the basis of morphology have probably
been misidentified in the past (5, 24). Recently, the species
Trichoderma Viride was subdivided into two speciessT. Viride
and T. asperellumson the basis of ribosomal DNA. Antibiotic
production was exclusively restricted to T. asperellum, whereas
T. Viride (ss) produced no antibiotics (25, 26).
Therefore, it may be hypothesized that the production of
peptaibiotics under standardized conditions might be used as a
chemotaxonomic marker in support of morphological, molecular,
and other (bio)chemical data for the differentiation between
species of the genus Trichoderma.
None of the strains used in this study has been screened for
peptaibol production, although six of them were previously
shown to produce trichothecene-type mycotoxins, such as
harzianum A and/or trichodermin (27). Recently, harzianum A
was also detected in cultures of NRRL 3199, which is T. cf.
breVicompactum.
The present study was aimed at (i) screening of selected plant-
protective strains for the production of peptaibols and peptaibol-
like antibiotics (peptaibiotics), (ii) sequencing of new and
recurrent peptides found, and (iii) testing the above hypothesis
concerning a possible use of the pattern of peptaibiotics for
chemotaxonomy.
EXPERIMENTAL PROCEDURES
Chemicals. Acetonitrile (MeCN; Chromasolve for HPLC, far UV,
99.9%) and dichloromethane (ACS reagent, 99.6%) were obtained from
Sigma-Aldrich (Steinheim, Germany); methanol (MeOH; 99.8%, gradi-
Table 1. Trichoderma Strains Included in This Study
straina strains investigatedb habitat geographic origin yieldc (mg)
1 CBS 109720 (ex-type) soil in sunflower field Geneva, NY 9.0
2 IBT 40840 () CBS 119570) soil Iran 21.8
3 IBT 40839 () CBS 119569) soil Qazvin, Iran 43.2
4 CBS 112445 soil Costa Rica 4.0
5 IBT 40863 () CBS 119577) soil Shar-e Kord, Chahar Mahall va Bakhtiari, Iran 14.5
6 ATCC 90237 () CBS 119576) micaceous clay from stream bed Windhoek, Namibia 2.5
7 NRRL 3199d unknown unknown 17.4
a 1-4, T. brevicompactum; 5-7, T. cf. brevicompactum. b Abbreviations: ATCC, American Type Culture Collection, Manassas, VA; CBS, Centraalbureau voor Schimmelcultures,
Utrecht, The Netherlands; DSM, Deutsche Stammsammlung von Mikroorganismen und Zellkulturen, Braunschweig, Germany; IBT, BioCentrum, DTU, Kgs. Lyngby, Denmark;
NRRL, ARS Culture Collection, Northern Regional Research Laboratory, National Center for Agricultural Utilization Research, Peoria, IL. c Dry weight of the methanolic
extracts obtained after cleanup over Sep-Pak C18 cartridges (see Experimental Procedures). d Alamethicin patent strain of Upjohn Co., Kalamazoo, MI.
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ent grade, for HPLC) and trifluoroacetic acid (TFA, 98.0%) were
purchased from Fluka (Steinheim, Germany). Toluene (SupraSolv, 99%,
for gas chromatography) was bought from VWR International (Darm-
stadt, Germany). Anhydrous KH2PO4 and Na2HPO4âH2O were from
Fluka, and methyl orange (helianthin) was from Riedel-de Hae¨n (Seelze,
Germany). Bidistilled water was freshly prepared from demineralized
tap water prior to analysis using a quartz distil (Heraeus, Kleinostheim,
Germany).
Cultivation of Strains. Cultures were grown at room temperature
(23-26 °C) under ambient daylight on Difco potato dextrose agar
(PDA, lot 4300389) obtained from Becton Dickinson (BD, Heidelberg,
Germany). The medium was prepared according to the directions of
the manufacturer and autoclaved at 121 °C for 15 min without pH
adjustment. A final pH of 5.6 ( 0.2 was measured after sterilization.
Subcultures were inoculated from PDA slants used for preservation
of strains, and a loop of conidia was streaked on 9.5 cm diameter plastic
Petri dishes containing 20 mL of PDA. Subcultures were grown for 4
days and used for inoculation of the main culture.
Extraction of Peptaibiotics. After 6 days of cultivation, fungal
cultures were extracted with a mixture of CH2Cl2/MeOH, 1:1. To
prevent any possible contamination of the extracts by plasticizers, a
ring of aluminum with a small spout on its upper margin was punched
into the agar before application of the solvent mixture. A 5 mL aliquot
of the solvent was applied onto the surface of each plate culture and
spread with a Drigalski spatula, and the extract was poured off through
the spout. This procedure was repeated twice; the combined extracts
from each agar plate were transferred into Pyrex tubes and centrifuged
at 2400g for 30 min. The supernatant was filtered and evaporated to
dryness in vacuo.
Cleanup was performed using Sep-Pak C18 cartridges (Waters Corp.,
Milford, MA) as previously described (19). Briefly, each cartridge
(dimensions: 1.5 cm  1 cm i.d.) was conditioned by successive
addition of MeOH, H2O, and H2O/MeOH, 2:1 (10 mL each). The
sample was redissolved in H2O/MeOH, 2:1, and centrifuged at 2400g
for 30 min, and the supernatant was filtered; the filtrate was applied to
the conditioned cartridge. The cartridge was rinsed with H2O and H2O/
MeOH, 2:1 (10 mL each). Finally, peptaibiotics were eluted with 10
mL of MeOH. The eluate was evaporated to dryness in vacuo. The
dry weight of the residue (see Table 1) was determined using an
analytical balance. A 10 íL aliquot of a 1% methanolic solution that
had been freshly prepared from the dried residue of the methanolic
eluate prior to analysis was used for HPLC or ion-trap ESI-LC-MS
measurements, respectively.
HPLC and Ion-Trap-ESI-LC-MS Measurements. For HPLC, a
HP 1100 series instrument was used. ESI mass spectra were recorded
on an LCQ instrument (Thermo Finnigan MAT, San Jose, CA). The
gradient used for HPLC and ion-trap-ESI-LC-MS measurements was
described previously (19); further details concerning the analytical
equipment were given in an earlier paper (28). A CID energy of 45 or
65 eV was applied to generate sequence-specific b- and y-type fragments
from putative [M + H]+, [M + Na]+, or sequence-specific fragment
ions, respectively. The collision energy for MS/MS and MSn measure-
ments was set between 25 and 65 eV, typically at 45 eV.
Fragment ion series were assigned in accordance with the Roepstorff/
Fohlman-Biemann nomenclature used previously. In cases when the
isomeric amino acids Leu/Ile or Val/Iva (Iva, isovaline) could not be
distinguished, the abbreviations Lxx and Vxx were used instead (29,
30).
RESULTS
Possible structural variations of all peptaibiotics investigated
in this study are summarized in Table 2. HPLC elution profiles
(detection wavelength ì ) 205 nm) of the peptaibiotic-
containing fraction from all strains are shown in Figures 1 and
2. In the following section, the HPLC/ESI-MSn-based sequenc-
ing and structural characterization of peptaibiotics produced by
T. breVicompactum and T. cf. breVicompactum are described.
T. breWicompactum CBS 109720. The HPLC elution profile
of this strain (Figure 1a) is dominated by four major peaks.
Furthermore, MS/MS, MSn, and CID-MS investigations and
comparison of these results with the recent literature (28) and
data obtained from experiments with authentic material from
T. Viride NRRL 3199 confirmed the structures of these
compounds as the acidic alamethicins (ALM): 1, F30/3; 2, F30/
5; 3, F30/7; and 4, F30/9. The strains of the T. breVicompactum
group were not screened for the presence of neutral alamethicins
F50 (ALM F50) in the course of this study. Analysis of that
subgroup would have required the same conditions as described
above but without TFA in the eluents. Voltage-dependent pore
formation and antimicrobial activity of alamethicins have been
reviewed (31). Alamethicins are, so far, only known from T.
Viride NRRL 3199 (28), which now can be classified as T. cf.
breVicompactum (3).
A second group of six novel eight-residue peptaibiotics from
Trichoderma breVicompactum was detected. We name these
compounds trichocompactins (TCP) 5, Ia; 6, Ib; 7, IIa; 8, IIb;
Table 2. Structural Variations of Peptaibiotics from the T. brevicompactum Complexa
residue
peptaibioticb 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
ALM F30 Ac Aib Pro Aib Ala Aib Ala Gln Aib Aib Aib Gly Vxx Aib Pro Vxx Aib Aib Glu Gln Pheol
Glu Vxx Lxx
Lxx
TCP Ac Aib Gly Ala Lxx Aib Gly Vxx Vxx
Vxx Ala Lxx
Ser
TBV Ac Aib Ala Aib Aib Aib Pro Lxx Lxx Aib Pro Alaol
Ser Vxx Vxx Aibol
Lxx Vxxol
Lxxol
TCT-A Ac Vxx Aib Pro Vxx Aib Pro Aib Aib Aib Pro Lxxol
Lxx Lxx Lxx Vxx
Lxx
TCT-B Ac Vxx Aib Pro Vxx Vxx Aib Pro Aib Aib Aib Pro Lxxol
Lxx Lxx Lxx Vxx
Lxx
TF MDA Pro AHMOD Ala Aib Aib Aib Gly Aib Aib AAE
desmethyl-
AHMOD
Vxx Vxx
Lxx
Ala
Aib
AMAE
a Exchangeable positions in a general sequence are italicized. A list of sequences of peptaibiotics detected in the individual strains is presented in the captions to
Figures 1 and 2. b ALM F30, alamethicin F30; TCP, trichocompactin; TBV, trichobrevin; TCT-A, trichocryptin A; TCT-B trichocryptin B; TF, trichoferin.
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9, IIIa; and 10, IIIb. Their fragmentation patterns and sequences
are listed in Tables 3 and 4.
The N-terminal sequence Ac-Aib-Gly-Ala-Leu-Aib was
previously described for the trichovirinsspeptaibols with a
C-terminal Gln-Leuol motif from T. Viride NRRL 5243 (30).
That strain is currently deposited as T. harzianum sl. Further-
more, valine as a C-terminal residue is known from the
trichobrachins TB IIa A and B, only, which have been isolated
from T. longibrachiatum CBS 936.69 (32), a strain now
reclassified as T. paceramosum/T. ghanense.
A third group of homologous peptaibols exhibited m/z 1210,
1224, 1238, and 1252, which were accompanied by m/z 1226,
1240, 1254, and 1268, respectively. It was demonstrated by CID-
MSn that the former series of ions represents the predominant
[M+ Na]+, whereas the latter corresponds to the [M + K]+
adduct, which is present in smaller amounts. Because the [M
+ H]+ ions of any of these compounds were never observed,
the intensive sodiated adducts had to be selected as precursors
for sequencing. Compounds 11-18 are novel 12-residue pep-
taibols from Trichoderma, which we name trichocryptins B
(TCT-B) I, II, III, and IVsowing to the cryptic behavior of
their [M + H]+ ions.
Fragmentation of [M + Na]+, as illustrated in Table 5,
exclusively generated a sodiated y-type series of daughter ions
(y2-y8), which was dominated by the corresponding series of
sodiated x-type ions, thus leading to complete suppression of
N-terminal fragments. Loss of water from the [M + Na]+ ions
indicated the presence of a C-terminal amino alcohol. The first
sequence-specific pair of fragment ions is y2/x2. The diagnostic
difference of either m/z 201 or 215 supports the presence of a
C-terminal Pro-Vxxol or Pro-Lxxol, which is followed by an
Aib residue. The extremely labile tertiary Aib-Pro bond is
preferably cleaved (33), thus explaining the absence of y1/x1
fragments. Cleavage of the Aib-Pro bond between positions 6
and 7 is the reason for the generation of an additional intensive
sodiated y-type fragment comprising amino acids 7-12 (cf.
Tables 2 and 6). Further sequence information was obtained
from CID-MS experiments: Application of a CID energy of
45 and 65 eV generated the diagnostic fragments b2-b6 and
their corresponding y-type ions. The structure of these b- and
y-type ions was confirmed by CID-MSn experiments. However,
attempts to detect the b1 fragment by CID-MSn of the ions b6
and b5 were unsuccessful. Moreover, the intensity of b2-b4 was
insufficient to perform further CID-MSn investigations. Despite
this, literature data revealed a single sequence, corresponding
only to the pair of b2/b3 ions m/z 241/338 present in compounds
12 and 14-18: the N-terminal fragment Ac-Leu-Aib-Pro has
previously been described for the cervinins I and IIs12-residue
peptaibol antibiotics from Mycogone cerVina A09-02, parasit-
izing HelVella (Paxina) acetabulum (34). Assuming structural
homology, the b2/b3 ion pair m/z 227/324 could represent Ac-
Val-Aib-Pro as an N-terminal sequence of compounds 11 and
13. The sequence Ac-Val-Aib is known from the protonophoric
bergofungin A from Emericellopsis donezkii HKI 0059 (35) as
well as from the antiprotozoic/antihelminthic antiamoebins XIII
and XIV from Stilbella fimetaria (syn. Stilbella erythrocephala)
ATCC 28144 (22). The corresponding isoforms Ac-Ile-Pro and
Ac-Iva-Pro have not been described as N termini of peptaibi-
otics, yet.
The partial sequence Pro-Aib-Leu-Aib-Pro-Leuol is known
as the C terminus of harzianins HC I, HC VI, HC XI, and HC
XIV from T. harzianum M-903614 and M-903603 (33), whereas
the other C-terminal sequences listed in Table 6 represent new
structural variations.
The strain produces a fourth group of homologous peptaibols
displaying m/z 1125 (compounds 19-21) and 1139 (compounds
22/23, all [M + Na]+). Basically, the mass spectrometric
fragmentation of these substances follows the same general
scheme described above for compounds 11-18. The CID-MS
experiments generated a series of the diagnostic fragments b2-
b5. Briefly, thespresumably invariablesVxx residue at position
4 of the peptide chain is lost, thus leading to the appearance of
novel 11-residue peptaibols, which we name trichocryptins A
(TCT-A) I and II. Fragmentation patterns and sequences of these
compounds are listed in Tables 5 and 6, respectively. Additional
homologues and positional isomers of compounds 11-23 are
Figure 1. HPLC elution profiles of the peptaibiotic-containing fraction of T. brevicompactum strains (a) CBS 109720, (b) IBT 40839, (c) IBT 40840, and
(d) CBS 112445. Annotations refer to consecutive numbering of peptides used in the text. Numbers separated by a slash refer to coeluting peptides. (a)
Alamethicins (1−4), trichocompactins (5−10), trichocryptins B (11−18), trichocryptins A (19−23); (b) alamethicins (1−4), trichocompactins (5−10), trichocryptins
A (24−30); (c) alamethicins (1−4), trichocompactins (5−10), trichocryptins A (24−30); (d) alamethicins (1−4, 31, and 32), trichocompactins (5−10),
trichocryptins A (23−28), trichocryptins B (13−18 and 33−38).
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Figure 2. HPLC elution profiles of the peptaibiotic-containing fraction of T. cf. brevicompactum strains (a) ATCC 90237, (b) NRRL 3199, and (c) IBT
40863. Annotations refer to consecutive numbering of peptides used in the text. Numbers separated by a slash refer to coeluting peptides. (a) Alamethicins
(1−4 and 63), trichocompactins (5−8, 10, and 39−43), trichocryptins B (15−18 and 33−36), trichobrevins A and B (44−62), trichoferin A (64); (b)
alamethicins (1−4), trichocompactins (70−75), trichobrevins (44−62); (c) alamethicins (1-4), trichocompactins (5−10), trichocryptins B (13−18), trichcryptins
A (22−28), trichobrevins A and B (44−62), trichoferin A (64).
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expected from the corresponding TIC traces. However, their
structures could not be determined due to their low abundance
in the mixture.
T. breWicompactum IBT 40839. Analysis of the four major
peaks displayed in the HPLC elution profile (Figure 1b) and
comparison of these data with those obtained for strain CBS
109720 confirmed the presence of compounds 1-5 and 7-10.
In contrast to what was found in strain CBS 109720, strain
IBT 40839 did not produce any of the compounds 11-23, but
a mixture of peptaibols with molecular masses m/z 1153 (24/
25), 1167 (26-28), and 1181 (29/30, all [M + Na]+), represent-
ing higher homologues of trichocryptins A I and A II.
Fragmentation and sequences of these trichocryptins A III, IV,
and V are listed in Tables 5 and 6. The C-terminal motif of
trichocryptins A IV b, IV c, V a, and V b, that is, Pro-Leu-
Leu-Aib-Pro-Leuol, has previously been described for harzianin
HK VI from T. pseudokoningii MVHC 662 (36) and the
hypomurocins A I, A II, A IV, and A Vshemolytic peptaibols
from strain IFO 31288 (37). That strain was originally described
as Hypocrea muroiana, but recently demonstrated to be Tri-
choderma atroViride/Hypocrea atroViridis by internal transcript
spacer (ITS) and elongation factor (EF) sequencing.
T. breWicompactum IBT 40840. Analysis of the four major
peaks displayed in the HPLC elution profile (Figure 1c) and
comparison of these data with those obtained for strain CBS
109720 confirmed the presence of compounds 1-9. The strain
also produces peptaibols with molecular masses m/z 1153, 1167,
and 1181 (all [M + Na]+), having the same retention time(s)
and thus supposed to be identical or positionally isomeric with
compounds 24-30 described for strain IBT 40839.
T. cf. breWicompactum CBS 112445. Analysis of the four
major peaks displayed in the HPLC elution profile (Figure 1d)
and comparison of these data with those obtained for strain CBS
109720 confirmed the presence of compounds 1-4. Additional
ALMs are present, the sequence of which could only partially
be assigned by MS/MS, which is due to their low abundance
in the mixture. For example, fragmentation of m/z 1950 [M +
H]+ at tR ) 50.4 and comparison with literature data reported
for ALMs F30 (28) indicated that alamethicin F30/2 (compound
31) could be present as a minor compound. Another novel minor
compound, 32, was detected during fragmentation of m/z 1964
([M + H]+) at tR ) 50.9. Again, assuming structure homology
with literature data deduced for the ALM F30 peptides (28),
including invariability of amino acid residues 1 and 2, the
following possible sequences are proposed for this new ALM
F30/11 as the intensity of the fragment ions obtained during
MS3 was insufficient to perform further MSn experiments.
According to structure homologies with compounds 1-4, the
variable positions 3, 5, and 8 in compound 32 consist of either
Ala or Aib, respectively, whereas positions 9-20 are invariable.
Theoretically, three positional isomers are possible. Compounds
5-10 are also presentsthe latter displaying a particularly intense
peak in that part of the HPLC elution profile. Sodiated molecular
ions m/z 1139, 1153, and 1167 were detected, which may
represent compounds 22-28 or homologues thereof.
A fourth group of peptaibols with molecular masses m/z 1224,
1238, and 1252 may consist of homologues and positional
isomers of compounds 13-18. In contrast to what has been
Table 3. Diagnostic Fragment Ions (m/z) of Trichocompactinsa
Produced by Members of the T. brevicompactum Complex
ion
5
Ia
6
Ib
7
IIa
8
IIb
9
IIIa
10
IIIb
40
IV
39
Va
41
Vb
42
VIa
43
VIb
[M + H]+ 726 726 740 740 754 754 756 770 770 784 784
[M − H2O]+ 708 708 722 722 nd 736 738 752 752 766 766
[M + Na]+ 748 748 762 762 776 776 778 792 792 806 806
b1 ndb nd nd nd nd nd nd nd nd nd nd
b2 184 nd 184 184 184 nd 184 184 184 nd 184
b3 255 269 255 255 255 nd 255 255 255 nd 255
b4 368 354 368 368 368 368 368 368 368 381 368
b5 453 439 453 453 467 467 453 453 453 467 467
b6 − H2O nd nd nd nd nd nd 522 522 522 nd nd
b6 510 496 510 510 524 524 540 540 540 nd 554
b7 − H2O nd nd nd nd nd nd 621 635 635 649 649
b7 609 609 623 623 637 637 639 653 653 667 667
a4 340 nd 340 nd 340 340 340 340 340 nd nd
y3 − H2O nd nd nd nd nd nd nd 300 nd nd nd
y3 nd nd 287 nd nd 287 nd 318 nd nd nd
y4 − H2O nd nd nd nd nd nd nd nd 385 nd nd
y4 nd nd 372 nd nd nd nd nd nd nd nd
y5 nd nd nd 485 nd nd nd 516 nd nd nd
ion
70
VII
71
VIIIa
72
VIIIb
73
IX
74
Xa
75
Xb
[M + H]+ 740 754 754 756 770 770
[M − H2O]+ 722 736 736 nd 752 752
[M + Na]+ 762 776 776 778 792 792
b1 nd nd nd nd nd nd
b2 184 184 184 184 184 184
b3 255 255 255 255 255 255
b4 368 368 368 368 368 368
b5 − H2O nd nd nd nd nd nd
b5 453 453 453 453 453 453
b6 − H2O nd nd nd 522 522 522
b6 524 524 524 nd 540 540
b7 − H2O nd nd nd 621 635 635
b7 623 637 637 nd 653 653
a4 340 nd nd 340 340 340
y3 − H2O nd nd nd nd nd 300
y3 nd 302 nd nd nd nd
y5 485 nd nd nd 516 nd
y6 nd nd nd nd nd 601
a Arabic numbers in bold refer to the consecutive numbering of peptides used
throughout the text and in Figures 1 and 2. Roman numerals followed by lower
case Arabic letters in Tables 3−8 refer to the abbreviations used for the individual
trichocompactins, trichocryptins, and trichobrevins. Capital letters in Tables 9 and
10 refer to the abbreviations used for the individual trichoferins. Capital letters for
characterization of trichoferins are introduced for conformity reasons in the
nomenclature of lipoaminopeptides. b Not detected.
Table 4. Sequences of Trichocompactins I−X Produced by Members
of the T. brevicompactum Complexa
residue
1 2 3 4 5 6 7 8 [M + H]+
5 Ia Ac Aib Gly Ala Lxx Aib Gly Vxx Vxx 726
6 Ib [269] Aib Aib Gly Lxx Vxx 726
7 IIa Ac Aib Gly Ala Lxx Aib Gly Lxx Vxx 740
8 IIb Ac Aib Gly Ala Lxx Aib Gly Lxx Vxx 740
9 IIIa Ac Aib Gly Ala Lxx Vxx Gly Lxx Vxx 754
10 IIIb Ac Aib Gly Ala Lxx Vxx Gly Lxx Vxx 754
40 IV Ac Aib Gly Ala Lxx Aib Ser Vxx Vxx 756
39 Va Ac Aib Gly Ala Lxx Aib Ser Lxx Vxx 770
41 Vb Ac Aib Gly Ala Lxx Aib Ser Lxx Vxx 770
42 VIa Ac Aib Gly Ala Lxx Aib Ser Lxx Vxx 784
43 VIb Ac Aib Gly Ala Lxx Vxx Ser Lxx Vxx 784
70 VII Ac Aib Gly Ala Lxx Aib Ala Vxx Vxx 740
71 VIIIa Ac Aib Gly Ala Lxx Aib Ala Lxx Vxx 754
72 VIIIb Ac Aib Gly Ala Lxx Aib Ala Lxx Vxx 754
73 IX Ac Aib Gly Ala Lxx Aib Ser Lxx Vxx 756
74 Xa Ac Aib Gly Ala Lxx Aib Ser Lxx Vxx 770
75 Xb Ac Aib Gly Ala Lxx Aib Ser Lxx Vxx 770
a Bold numbers in the first column refer to consecutive numbering of peptides
used throughout the text. Abbreviations of compound names used in the second
column refer to the individual compounds introduced in the text.
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Table 5. Diagnostic Fragment Ions (m/z) of Trichocryptins A and B Produced by Members of the T. brevicompactum Complexa
ion
11
B-Ia
12
B-Ib
13
B-IIa
14
B-IIb
15
B-IIIa
16
B-IIIb
17
B-IVa
18
B-IVb
33
B-Va
34
B-Vb
35
B-Vc
36
B-Vd
37
B-VIa
38
B-VIb
[M + Na]+ 1210 1210 1224 1224 1238 1238 1252 1252 1266 1266 1266 1266 1280 1280
[M + K]+ 1226 1226 1240 1240 1254 1254 1268 1268 1282 1282 1282 1282 1296 1296
[M + Na − H2O]+ 1192 1192 nd nd nd 1220 1234 1234 nd nd nd nd 1262 1262
b1 nd nd nd nd nd nd nd nd nd nd nd nd nd nd
b2 227 nd 227 241 nd 241 nd 241 241 241 241 241 241 241
b3 324 nd 324 338 338 338 nd 338 338 338 338 338 338 338
b4 423 nd 423 437 437 437 437 437 437 437 437 437 437 437
b5 522 536 522 536 536 536 550 550 550 550 536 550 550 550
b6 607 621 607 621 621 621 635 635 635 635 621 635 635 635
[Pro-Vxx + H]+ 197 nd 197 197 197 197 197 197 197 197 197 197 197 197
[Pro-Vxx-Vxx + H]+ 296 nd 296 296 296 296 nd nd nd nd 296 296 296 296
[Pro-Vxx-Lxx + H]+ nd nd nd nd nd nd 310 310 310 310 nd nd 310 310
[Pro-Vxx-Vxx-Aib + H]+ 381 nd 381 381 381 381 nd nd nd nd 381 nd nd nd
[Pro-Vxx-Lxx-Aib + H]+ nd nd nd nd nd nd 395 395 395 395 nd nd 395 nd
[Pro-Vxx-CO + H]+ 169 nd 169 169 169 169 169 169 169 169 169 169 nd nd
[Pro-Vxx-Vxx-CO + H]+ 268 nd 268 268 268 268 nd nd nd nd nd nd nd nd
[Pro-Vxx-Lxx-CO + H]+ nd nd nd nd nd nd 282 282 282 282 nd nd 282 nd
[Pro-Vxx-Vxx-Aib-CO + H]+ nd nd 353 nd nd 353 nd nd nd nd nd nd nd nd
[Pro-Vxx-Lxx-Aib-CO + H]+ nd nd nd nd nd nd nd 367 nd nd nd nd 367 nd
[Pro-Aib-Aib-Aib-Pro-Lxxol + Na]+ nd 589 nd nd nd nd nd nd nd nd nd nd nd nd
[Pro-Aib-Vxx-Aib-Pro-Lxxol + Na]+ 603 nd nd 603 nd nd nd nd nd nd nd nd nd nd
[Pro-Aib-Lxx-Aib-Pro-Lxxol + Na]+ nd nd 617 nd 617 617 617 617 nd nd nd nd nd nd
[Pro-Lxx-Lxx-Aib-Pro-Vxxol + Na]+ or
[Pro-Vxx-Lxx-Aib-Pro-Lxxol + Na]+
nd nd nd nd nd nd nd nd 631 631 nd 631 nd nd
[Pro-Lxx-Lxx-Aib-Pro-Lxxol + Na]+ nd nd nd nd nd nd nd nd nd nd 645 nd 645 645
[Pro-Aib + H]+ nd nd 183 183 nd 183 183 183 nd nd nd nd nd nd
[Pro-Aib-Lxx + H]+ nd nd 296 nd 296 296 296 296 nd nd nd nd nd nd
[Pro-Aib-Lxx-Aib + H]+ nd nd 381 nd 381 381 381 381 nd nd nd nd nd nd
(y8 + Na)+ nd nd nd nd nd 445 459 459 459 459 nd nd 459 459
(y7 + Na)+ nd nd 544 558 558 558 572 572 572 572 558 nd 572 nd
(y6 + Na)+ 629 nd 629 643 643 643 657 657 657 657 643 nd 657 nd
(y5 + Na)+ nd nd nd nd nd nd nd nd nd nd nd nd 754 nd
(y4 + Na)+ 811 825 811 825 825 825 839 839 853 867 853 867 867 867
(y3 + Na)+ 910 910 924 924 938 938 952 952 966 980 966 980 980 980
(y2 + Na)+ 995 995 1009 1009 1023 1023 1037 1037 1051 1065 1051 1065 1065 1065
(y1 + Na)+ nd nd nd nd nd nd nd nd nd nd nd nd nd nd
(x8 + Na)+ 417 nd nd nd nd 417 431 431 nd nd 431 431 431 nd
(x7 + Na)+ 516 530 516 530 530 530 544 544 544 544 530 544 544 544
(x6 + Na)+ 601 615 601 615 615 615 629 629 629 629 615 629 629 629
(x5 + Na)+ nd nd nd nd nd nd nd nd nd nd nd nd nd nd
(x4 + Na)+ 783 797 783 797 797 797 811 811 825 839 825 839 839 839
(x3 + Na)+ 882 882 896 896 910 910 924 924 938 952 938 952 952 952
(x2 + Na)+ 967 967 981 981 995 995 1009 1009 1023 1037 1023 1037 1037 1037
(x1 + Na)+ nd nd nd nd nd nd nd nd nd nd nd nd nd nd
ion
19
A-Ia
20
A-Ib
21
A-Ic
22
A-IIa
23
A-IIb
24
A-IIIa
25
A-IIIb
26
A-IVa
27
A-IVb
28
A-IVc
29
A-Va
30
A-Vb
[M + Na]+ 1125 1125 1125 1139 1139 1153 1153 1167 1167 1167 1181 1181
[M + K]+ 1141 1141 1141 1155 1155 1169 1169 1185 1185 1185 1197 1197
[M + Na − H2O]+ nd nd nd nd nd nd nd nd nd nd nd nd
b1 nd nd nd nd nd nd nd nd nd nd nd nd
b2 227 227 241 241 241 241 241 241 241 241 241 241
b3 324 324 338 338 338 338 338 338 338 338 338 338
b4 423 423 437 437 437 437 437 451 437 437 451 451
b5 508 508 522 522 522 522 522 536 522 522 536 536
[Pro-Vxx + H]+ 197 197 197 197 197 197 197 197 197 197 nd nd
[Pro-Vxx-Aib + H]+ 282 282 282 282 282 282 282 nd 282 282 nd nd
[Pro-Vxx-Vxx + H]+ nd nd nd nd nd nd nd 296 nd nd nd nd
[Pro-Vxx-Lxx + H]+ or
[Pro-Lxx-Vxx + H]+
nd nd nd nd nd nd 310 nd nd nd nd nd
[Pro-Lxx-Lxx + H]+ nd nd nd nd nd 324 nd nd 324 324 nd nd
[Pro-Lxx-Lxx-Aib + H]+ nd nd nd nd nd nd nd nd 409 409 409 nd
[Pro-Vxx-Vxx-Aib + H]+ nd nd nd nd nd nd nd 381 nd nd nd nd
[Pro-Vxx-Lxx-Aib + H]+ nd nd nd nd nd nd nd nd nd nd nd nd
[Pro-Vxx-CO + H]+ 169 169 169 169 169 169 169 169 169 169 nd nd
[Pro-Vxx-Aib-CO + H]+ 254 nd nd nd 254 254 254 nd nd nd nd nd
[Pro-Vxx-Vxx-CO + H]+ nd nd nd nd nd nd nd nd nd nd nd nd
[Pro-Vxx-Lxx-CO + H]+ nd nd nd nd nd nd 282 nd 282 282 nd nd
[Pro-Lxx + H]+ nd nd nd nd nd 211 211 nd 211 211 211 211
[Pro-Lxx-Aib + H]+ nd nd nd nd nd nd 296 nd nd nd 296 296
[Pro-Lxx-CO + H]+ nd nd nd nd nd 183 183 183 183 183 183 nd
[Pro-Lxx-Aib-CO + H]+ nd nd nd nd nd nd nd nd nd nd nd nd
[Pro-Vxx-Vxx-Aib-CO + H]+ nd nd nd nd nd nd nd nd nd nd nd nd
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described for strain CBS 109720, strain CBS 112445 did not
produce peptaibols with molecular masses m/z 1210. However,
additional higher homologues displaying m/z 1266 and 1280
(all [M + Na]+) are present. Fragmentation patterns and
sequences of these trichocryptins (33, B-Va; 34, B-Vb; 35,
B-Vc; and 36, B-Vd; as well as 37, B-VIa, and 38, B-VIb) are
listed in Tables 5 and 6. The C-terminal motif, Pro-Iva-Leu-
Aib-Pro-Leuol, is known from harzianin HB I (38) and from
Table 5 (Continued)
ion
19
A-Ia
20
A-Ib
21
A-Ic
22
A-IIa
23
A-IIb
24
A-IIIa
25
A-IIIb
26
A-IVa
27
A-IVb
28
A-IVc
29
A-Va
30
A-Vb
[Pro-Vxx-Lxx-Aib-CO + H]+ nd nd nd nd nd nd nd nd nd nd nd nd
[Pro-Aib-Aib-Aib-Pro-Lxxol + Na]+ nd nd nd nd nd nd nd nd nd nd nd nd
[Pro-Aib-Vxx-Aib-Pro-Lxxol + Na]+ nd nd 631 nd nd nd nd nd nd nd nd nd
[Pro-Aib-Lxx-Aib-Pro-Lxxol + Na]+ 617 617 nd 617 617 nd nd nd nd nd nd nd
[Pro-Lxx-Vxx-Aib-Pro-Vxxol + Na]+ nd nd nd nd nd nd nd 617 nd nd nd nd
[Pro-Lxx-Lxx-Aib-Pro-Vxxol + Na]+ or
[Pro-Vxx-Lxx-Aib-Pro-Lxxol + Na]+
nd nd nd nd nd 631 631 nd nd nd nd nd
[Pro-Lxx-Lxx-Aib-Pro-Lxxol + Na]+ nd nd nd nd nd nd nd nd 645 645 645 645
[Pro-Aib + H]+ nd nd 183 183 nd 183 183 183 nd nd nd nd
[Pro-Aib-Lxx + H]+ nd nd 296 nd 296 296 296 296 nd nd 296 296
[Pro-Aib-Lxx-Aib + H]+ nd nd 381 nd 381 381 381 381 nd nd nd nd
(y8 + Na)+ nd nd nd nd nd nd nd nd nd nd nd nd
(y7 + Na)+ nd nd nd nd 431 431 431 nd nd nd nd nd
(y6 + Na)+ 530 530 516 530 516 544 544 nd nd nd nd nd
(y5 + Na)+ nd nd nd nd nd nd nd nd nd nd nd nd
(y4 + Na)+ 712 712 726 726 726 754 754 754 nd 754 768 nd
(y3 + Na)+ 825 825 825 839 839 867 853 867 881 867 881 881
(y2 + Na)+ 910 910 910 924 924 952 938 952 966 952 966 966
(y1 + Na)+ nd nd nd nd nd nd nd nd nd nd nd nd
(x8 + Na)+ nd nd nd nd nd 403 nd nd nd 431 445 nd
(x7 + Na)+ 502 502 nd 502 nd 516 516 516 nd 516 530 530
(x6 + Na)+ nd nd nd nd nd nd nd nd nd nd nd nd
(x5 + Na)+ 684 684 698 698 698 726 726 726 740 726 740 740
(x4 + Na)+ 797 797 797 811 811 839 825 839 853 839 853 853
(x3 + Na)+ 882 882 882 896 896 924 910 924 938 924 938 938
(x2 + Na)+ nd nd nd nd nd nd nd nd nd nd nd nd
(x1 + Na)+ nd nd nd nd nd nd nd nd nd nd nd nd
a See Table 3 footnote.
Table 6. Sequences of Trichocryptins A and B Produced by Members of the T. brevicompactum Complexa
residue
A 1 2 3 4 5 6 7 8 9 10 11 [M + Na]+
19 Ia Ac Vxx Aib Pro Vxx Aib Pro Aib Lxx Aib Pro Lxxol 1125
20 Ib Ac Vxx Aib Pro Vxx Aib Pro Aib Lxx Aib Pro Lxxol 1125
21 Ic Ac Lxx Aib Pro Vxx Aib Pro Aib Vxx Aib Pro Lxxol 1125
22 IIa Ac Lxx Aib Pro Vxx Aib Pro Aib Lxx Aib Pro Lxxol 1139
23 IIb Ac Lxx Aib Pro Vxx Aib Pro Aib Lxx Aib Pro Lxxol 1139
24 IIIa Ac Lxx Aib Pro Vxx Aib Pro Lxx Lxx Aib Pro Vxxol 1153
25 IIIb Ac Lxx Aib Pro Vxx Aib Pro Lxx Vxx Aib Pro Lxxol 1153
26 IVa Ac Lxx Aib Pro Vxx Vxx Pro Lxx Vxx Aib Pro Vxxol 1167
27 IVb Ac Lxx Aib Pro Vxx Aib Pro Lxx Lxx Aib Pro Lxxol 1167
28 IVc Ac Lxx Aib Pro Vxx Aib Pro Lxx Lxx Aib Pro Lxxol 1167
29 Va Ac Lxx Aib Pro Lxx Aib Pro Lxx Lxx Aib Pro Lxxol 1181
30 Vb Ac Lxx Aib Pro Lxx Aib Pro Lxx Lxx Aib Pro Lxxol 1181
residue
B 1 2 3 4 5 6 7 8 9 10 11 12 [M + Na]+
11 Ia Ac Vxx Aib Pro Vxx Vxx Aib Pro Aib Vxx Aib Pro Lxxol 1210
12 Ib Ac Lxx Aib Pro Vxx Vxx Aib Pro Aib Aib Aib Pro Lxxol 1210
13 IIa Ac Vxx Aib Pro Vxx Vxx Aib Pro Aib Lxx Aib Pro Lxxol 1224
14 IIb Ac Lxx Aib Pro Vxx Vxx Aib Pro Aib Vxx Aib Pro Lxxol 1224
15 IIIa Ac Lxx Aib Pro Vxx Vxx Aib Pro Aib Lxx Aib Pro Lxxol 1238
16 IIIb Ac Lxx Aib Pro Vxx Vxx Aib Pro Aib Lxx Aib Pro Lxxol 1238
17 IVa Ac Lxx Aib Pro Vxx Lxx Aib Pro Aib Lxx Aib Pro Lxxol 1252
18 IVb Ac Lxx Aib Pro Vxx Lxx Aib Pro Aib Lxx Aib Pro Lxxol 1252
33 Va Ac Lxx Aib Pro Vxx Lxx Aib Pro Lxx Lxx Aib Pro Vxxol 1266
34 Vb Ac Lxx Aib Pro Vxx Lxx Aib Pro Vxx Lxx Aib Pro Lxxol 1266
35 Vc Ac Lxx Aib Pro Vxx Vxx Aib Pro Lxx Lxx Aib Pro Lxxol 1266
36 Vd Ac Lxx Aib Pro Vxx Lxx Aib Pro Lxx Lxx Aib Pro Vxxol 1266
37 VIa Ac Lxx Aib Pro Vxx Lxx Aib Pro Lxx Lxx Aib Pro Lxxol 1280
38 VIb Ac Lxx Aib Pro Vxx Lxx Aib Pro Lxx Lxx Aib Pro Lxxol 1280
a See Table 4 footnote.
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some of the previously described harzianins HC from T.
harzianum M-903603 and M-903614 (33). The C-terminal
motif, Pro-Ile-Leu-Aib-Pro-Valol, was reported for the tri-
chorozins I and II isolated from a strain of T. harzianum (39).
T. cf. breWicompactum ATCC 90237. This strain shows a
quite different and much more diverse pattern (Figure 2a)
compared to the other isolates investigated in this study: The
CID-MS and MS/MS of m/z 756, 770, and 784 (all M + H+)
revealed the presence of homologous trichocompactins, which
have been sequenced as follows below. The peak of compound
39, named TCT Va, is comparatively intense in the total ion
current (TIC), although its UV absorbance is rather low.
Compared to compounds 5-10, these pseudomolecular ions
display a mass difference of +30 Da. This fact leads to the
hypothesis that a Gly residue in the molecule might be
substituted by a Ser residue.
Serine-containing peptaibiotics often tend to display additional
b′n fragments resulting from the loss of water from the
corresponding bn fragmentssa feature that is important for the
detection of that particular amino acid in CID-MS, MS/MS,
and MSn experiments. The proposed fragmentation pattern has,
in fact, been observed, leading to the assignment of the structures
indicated in Tables 3 and 4. Assuming structural homology of
m/z 184, the N-terminal fragment of these compounds could
consist of Ac-Aib-Gly. Thus, compound 40, named TCT IV, is
a homologue of compound 5. Compounds 39 and 41 (TCT Vb)
might be interpreted as homologues of compounds 7 and 8,
whereas compounds 42 and 43 (TCT VIa and VIb) may
represent homologues of compounds 9 and 10 with Gly in
position 6 substituted by Ser. However, compounds 5-8 and
10 are also present, with 10 displaying the most abundant peak
of this part of the HPLC elution profile. Fragmentation patterns
and sequences of all trichocompactins are described in Tables
3 and 4.
Small amounts of substances with molecular masses of m/z
1238, 1252, and 1266 have also been detected, which may
represent compounds 15-18 and 33-36, whereas m/z 1210,
1224, and 1280 (all [M + Na]+) have not been observed. The
pattern of peptaibiotics with molecular masses between 1100
and 1200 Da is completely different from those of T. breVi-
compactum CBS 109720, IBT 40840, IBT 40839, and CBS
112445: T. cf. breVicompactum ATCC 90237 produced two
additional series of homologous peptaibolssthe former com-
prising m/z 1099, 1113, 1127, and 1141 and the latter, m/z 1129,
1143, and 1157. The fragmentation behavior of these ions was
very similar to that observed for trichocryptins A and B. The
molecular ions mentioned above again represented [M + Na]+
adducts. They generated a series of sodiated y-type ions
dominated by the corresponding sodiated x-type fragments, as
proven by MSn investigations. As previously observed for
trichocryptins A and B, any diagnostic N-terminal fragments
were completely suppressed in the collision chamber. However,
CID-MS revealed the ions b2-b5, but the b1 fragment could
not be detected. Despite this, a difference of m/z 199 most
probably corresponds to the N-terminal sequence Ac-Aib-Ala,
which is very common among peptaibols produced by Tricho-
derma spp. (20). For instance, an alanyl residue in position 2
has previously been described for the trichocellins from T. Viride
ATCC 20672 (40). Compounds from Trichoderma cf. breWi-
compactum displaying m/z 1099 (44-47), 1113 (48/49), 1127
(50-52), and 1141 (53/54, all [M + Na]+) contain Ala in
position 2 and were named trichobrevins A. The latter two
compounds, 53, trichobrevins A-IVa, and 54, A-IVb, as well
as compound 50, trichobrevin A-IIIa, are the most abundant
peaks in the HPLC elution profile.
In the case of m/z 1129, 1143, and 1157, the CID fragments
b2-b4 are accompanied by the corresponding bn - H2O ions.
This diagnostic phenomenon has previously been observed for
the Ser-containing trichocompactins described above. Thus, the
Ala residue in position 2 is exchanged by a seryl residue. These
compounds exhibiting [M + Na]+ ions m/z 1129 (55-57), 1143
(58/59), and 1157 (60-62) were named trichobrevins B. The
fragmentation scheme and sequences of trichobrevins A and B
are shown in Tables 7 and 8.
The C termini of trichobrevin compounds 45, A-Ib, and 47,
A-Id, consist of a Vxxol residue. Interestingly, MS/MS data
indicate that compound 46, trichobrevin A-Ic, carries a C-
terminal Aibol residue, whereas compound 44, trichobrevin
A-Ia, terminates in Alaol. However, the occurrence of Aibol
and Alaol remains tentative. Detailed investigations, preferably
on the isolated compounds, are required to unequivocally prove
the presence of these distinctive structural elements as such C
termini have not been previously reported in the literature.
Compounds 1-4 have also been detected. Partial sequences
of a minor compound m/z 1992 were determined. Diagnostic
fragments observed in the MS/MS and MSn spectra give reason
for the assumption that ALM F30/8 (compound 63, cf. ref 28)
could be present.
T. cf. breWicompactum IBT 40863. T. cf. breVicompactum
IBT 40863 (Figure 2c) produces compounds 1-4 as main
components and a number of minor ALMs, the structures of
which have not been investigated in detail. Pseudomolecular
ions m/z 1139, 1153, and 1167 could represent compounds 22-
28 or their positional isomers. Homologues displaying m/z 1125
and 1181 [M + Na]+ were not detected. Minor amounts of m/z
1224, 1238, 1252, 1266, and 1280 (all [M + Na]+) are present,
which could represent compounds 13-18 and 33-38 or
positional isomers thereof. The pattern of compounds 44-62
is supposed to be identical or very closely related to that of T.
cf. breVicompactum ATCC 90237sas deduced from the elution
order of the respective pseudomolecular ions.
T. cf. breWicompactum NRRL 3199. As previously men-
tioned, this strain is known as the “classical” source of
alamethicins (28), mostly producing compounds 1-4 (Figure
1b). Further alamethicin-like compounds are present in minor
amounts, the sequence of which could not be determined due
to their comparatively low abundance in the mixture. To date,
several hundred studies dealing with research on this particular
peptaibol have been published. Thus, alamethicin is regarded
as the most thoroughly investigated peptaibiotic. Compound 64
displays a rather low UV absorption at 205 nm, but a remarkably
good ionization in positive ESI-MS. MS/MS studies on the
pseudomolecular ion m/z 1207 revealed obvious structural
homology to helioferins (41) and roseoferins (42), nine-residue
lipoaminopeptides from the fungicolous Mycogone rosea strains
DSM 8822 and DSM 12973.
An additional diagnostic fragment, m/z 266, is found in CID-
MS spectra recorded at a CID energy of 45 and 65 eV,
respectively, as well as in MS3 spectra of the MS2 fragment
ion m/z 550. Assuming structural homology with helio- and
roseoferins, the difference of m/z 213 could correspond to an
AHMOD residue. At present, this lipoamino acid is known as
a unique constituent of most of the leucinostatins, of tri-
chopolyns, helioferins, roseoferins, and acremostatins (reviewed
in ref 18). Thus, the fragment m/z 1135 should indicate the loss
of the n-butyl side chain ([M + H - 72]+) from the AHMOD
residue by R-cleavagesa diagnostic feature observed in positive
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ES-MS of the lipoaminopeptide antibiotics mentioned above.
The C terminus of helio- and roseoferins consists of either a
2-[(2′-aminopropyl)-methylamino]-ethanol (AMAE, m/z 132)
or a 2-(2′-aminopropyl)amino-ethanol (AAE, m/z 118) residue.
Furthermore, the presence of a C-terminal AMAE is indicated
by the loss of C3H9NO from the pseudomolecular ion. Conse-
quently, [M + H - 75]+ should be formedsa fragment that is
present at m/z 1132. Moreover, m/z 1189 indicates the loss of
water from [M + H]+sa typical feature of C-terminal (amino)
alcohols. CID-MS/MS investigations on m/z 266 revealed its
corresponding a-type fragment m/z 238. Further diagnostic
fragments were not observed, due to the comparatively low
Table 7. Diagnostic Fragment Ions (m/z) of Trichobrevins A and B Produced by Members of the T. brevicompactum Complexa
ion
44
A-Ia
45
A-Ib
46
A-Ic
47
A-Id
48
A-IIa
49
A-IIb
50
A-IIIa
51
A-IIIb
52
A-IIIc
53
A-IVa
54
A-IVb
[M + Na]+ 1099 1099 1099 1099 1113 1113 1127 1127 1127 1141 1141
[M + K]+ 1115 1115 1115 1115 1129 1129 1143 1143 1143 1157 1157
[M + H]+ nd nd nd nd nd nd nd nd nd nd nd
[M + Na − H2O]+ 1081 1081 1081 1081 1095 1095 1109 1109 1109 1123 1123
b1 nd nd nd nd nd nd nd nd nd nd nd
b2 199 nd nd nd 199 199 199 199 199 199 199
b3 298 nd nd 284 298 284 298 298 298 298 298
b4 411 nd nd 383 397 383 411 397 397 411 411
b5 496 468 nd 468 482 468 496 482 482 496 496
[Pro-Lxx-Lxx-Aib-Pro-Alaol + Na]+ 603 nd nd nd nd nd nd nd nd nd nd
[Pro-Lxx-Lxx-Aib-Pro-Aibol + Na]+ nd nd 617 nd nd nd nd nd nd nd nd
[Pro-Lxx-Lxx-Aib-Pro-Vxxol + Na]+ or
[Pro-Vxx-Lxx-Aib-Pro-Lxxol + Na]+
nd 631 nd 631 631 nd 631 nd nd nd nd
[Pro-Lxx-Lxx-Aib-Pro-Lxxol + Na]+ nd nd nd nd nd 645 nd 645 645 645 645
(y7 + Na)+ nd nd nd 405 419 nd 433 418 418 433 433
(y6 + Na)+ nd nd nd 490 504 nd 518 504 504 518 nd
(y5 + Na)+ nd nd nd nd nd nd nd nd nd nd nd
(y4 + Na)+ 728 nd nd 700 714 700 728 714 714 728 728
(y3 + Na)+ 841 nd 827 813 827 813 841 827 827 841 841
(y2 + Na)+ 926 nd nd 898 912 898 926 912 912 926 926
(y1 + Na)+ nd nd nd nd nd nd nd nd nd nd nd
(x7 + Na)+ nd nd nd 377 nd 377 405 nd nd 405 405
(x6 + Na)+ 490 462 476 462 476 462 490 476 476 490 490
(x5 + Na)+ nd nd nd nd nd nd nd nd nd nd nd
(x4 + Na)+ 700 672 686 672 686 672 700 686 686 700 700
(x3 + Na)+ 813 785 799 785 799 785 813 799 799 813 813
(x2 + Na)+ 898 870 884 870 884 870 898 884 884 898 898
(x1 + Na)+ nd nd nd nd nd nd nd nd nd nd nd
ion
55
B-Ia
56
B-Ib
57
B-Ic
58
B-IIa
59
B-IIb
60
B-IIIa
61
B-IIIb
62
B-IIIc
[M + Na]+ 1129 1129 1129 1143 1143 1157 1157 1157
[M + K]+ 1145 1145 1145 1159 1159 1173 1173 1173
[M + H]+ nd nd nd nd nd nd nd nd
[M + Na − H2O]+ 1111 1111 1111 1125 1125 1139 1139 1139
b1 nd nd nd nd nd nd nd nd
b2 − H2O 197 nd 197 197 197 197 197 197
b2 nd nd 215 215 215 215 215 215
b3 − H2O 296 nd 296 296 296 296 296 296
b3 314 nd 314 314 314 314 314 314
b4 − H2O 409 nd nd 409 395 409 409 409
b4 427 399 413 427 413 427 427 427
b5 − H2O nd nd nd 494 nd nd nd 494
b5 512 484 498 512 498 512 512 512
[Pro-Lxx-Lxx-Aib-Pro-Aibol + Na]+ 617 nd nd nd nd nd nd nd
[Pro-Lxx-Lxx-Aib-Pro-Vxxol + Na]+ or
[Pro-Vxx-Lxx-Aib-Pro-Lxxol + Na]+
nd nd 631 631 nd nd nd nd
[Pro-Lxx-Lxx-Aib-Pro-Lxxol + Na]+ nd 645 nd nd 645 645 645 645
(y7 + Na)+ nd nd nd nd nd nd 449 nd
(y6 + Na)+ nd 506 520 nd nd 534 534 nd
(y5 + Na)+ nd nd nd nd nd nd nd nd
(y4 + Na)+ 744 716 730 744 730 744 744 744
(y3 + Na)+ 857 829 843 857 843 857 857 857
(y2 + Na)+ 942 914 928 942 928 942 942 942
(y1 + Na)+ nd nd nd nd nd nd nd nd
(x7 + Na)+ nd nd nd 431 nd 421 421 421
(x6 + Na)+ 506 nd 492 516 492 nd 506 nd
(x5 + Na)+ nd nd nd nd nd nd nd nd
(x4 + Na)+ 716 688 702 716 702 716 716 716
(x3 + Na)+ 829 801 815 829 815 829 829 829
(x2 + Na)+ 914 886 900 914 900 914 914 914
(x1 + Na)+ nd nd nd nd nd nd nd nd
a See Table 3 footnote.
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abundance of m/z 266, which was not sufficient to perform
further CID-MSn experiments. Considering the obvious struc-
tural homologies with helio- and roseoferins, the ion m/z 266
could consist of a Pro linked to an R-methyldecanoic acid
residue. Positional isomers or higher homologues of compound
64 have not been detected. However, homologues displaying a
mass difference of -14 Da (m/z 1193, [M + H]+) are present.
The C-terminal AMAE residue of compound 64 is replaced by
AAE in compound 65sas previously described as a structural
variation of helio- and roseoferins (40, 41). The Lxx residue in
position 6 of compound 64 is exchanged by Vxx in compound
66, which carries a C-terminal AMAE residue. The presence
of m/z 1118 indicates a C-terminal AMAE residue for compound
67. Interestingly, MS3 of the MS2 ions m/z 536 and 621 proved
that m/z 465 and 266 are formed. Isomerism is therefore located
in the lipoamino acid residue, as also observed for compound
68. Assuming structural homology with the previously described
compounds 64-66, sequences containing a novel desmethyl-
AHMOD residue (m/z 199) are proposed for compounds 67 and
68. The Ala residue in position 7 of compound 64 is exchanged
by Gly in compound 69, which carries AHMOD in position 3
and a C-terminal AMAE residue. Compounds with a strongly
basic secondary or tertiary amine such as AAE or AMAE,
respectively, which is bound to a lipophilic backbone, give a
positive reaction in the two-phase vertical stacking assay (43).
This diagnostic feature, which has previously been described
for helio- and roseoferins (41, 42), was also observed for extracts
from T. cf. breVicompactum NRRL 3199. The positive reaction
of helioferin in the two-phase vertical stacking assay is
correlated with a strong ionophoric activity of this antibiotic
(44). Therefore, these seven novel compounds from Tricho-
derma cf. breVicompactum NRRL 3199, which promote the
transfer of water-soluble helianthin to a toluene layer, were
named trichoferins (TFR) A-F. Their fragmentation patterns
and structures are illustrated in Tables 9 and 10. T. cf.
breVicompactum strains ATCC 90237 and IBT 40863 also
produced compound 64, trichoferin A, as proven by MS/MS
and CID-MS experiments. Minor amounts of an ion m/z 1207
that could be identical with compound 64 were also found in
T. breVicompactum CBS 109720, whereas only trace amounts
of m/z 1207 are present in T. breVicompactum CBS 112445,
IBT 40840, and IBT 40839. It should be mentioned that
compounds 65-69 (trichoferins B-F) have been detected only
in T. cf. breVicompactum NRRL 3199.
Furthermore, the strain produces novel sequences of trichoc-
ompactins VII, VIIIa, and VIIIb with Gly in position 6 replaced
by Ala (compounds 70-72). In addition to that, three serine-
containing trichocompactins IX, Xa, and Xb were detected
(compounds 73-75). Interestingly, compounds 5-10 could not
be found. Fragmentations and sequences of all trichocompactins
described in this study are listed in Tables 2 and 3. Compounds
44-62 were detected again and their structures proven by CID-
MS and MSn experiments. In contrast to what was found for T.
cf. breVicompactum ATCC 90237 and IBT 40863, compounds
61 and 62 were the most prominent ions besides the compounds
1-4.
Table 8. Sequences of Trichobrevins A and B Produced by Members of the T. brevicompactum Complexa
residue
1 2 3 4 5 6 7 8 9 10 11 [M + Na]+
44 A-Ia Ac Aib Ala Vxx Lxx Aib Pro Lxx Lxx Aib Pro Alaol 1099
45 A-Ib Ac Aib Ala Aib Vxx Aib Pro Lxx Lxx Aib Pro Vxxol 1099
46 A-Ic Ac Aib Ala Vxx Vxx Aib Pro Lxx Lxx Aib Pro Aibol 1099
47 A-Id Ac Aib Ala Aib Vxx Aib Pro Lxx Lxx Aib Pro Vxxol 1099
48 A-IIa Ac Aib Ala Vxx Vxx Aib Pro Lxx Lxx Aib Pro Vxxol 1113
49 A-IIb Ac Aib Ala Aib Vxx Aib Pro Lxx Lxx Aib Pro Lxxol 1113
50 A-IIIa Ac Aib Ala Vxx Lxx Aib Pro Lxx Lxx Aib Pro Vxxol 1127
51 A-IIIb Ac Aib Ala Vxx Vxx Aib Pro Lxx Lxx Aib Pro Lxxol 1127
52 A-IIIc Ac Aib Ala Vxx Vxx Aib Pro Lxx Lxx Aib Pro Lxxol 1127
53 A-IVa Ac Aib Ala Vxx Lxx Aib Pro Lxx Lxx Aib Pro Lxxol 1141
54 A-IVb Ac Aib Ala Vxx Lxx Aib Pro Lxx Lxx Aib Pro Lxxol 1141
55 B-Ia Ac Aib Ser Vxx Lxx Aib Pro Lxx Lxx Aib Pro Aibol 1129
56 B-Ib Ac Aib Ser Vxx Aib Aib Pro Lxx Lxx Aib Pro Lxxol 1129
57 B-Ic Ac Aib Ser Vxx Vxx Aib Pro Lxx Lxx Aib Pro Vxxol 1129
58 B-IIa Ac Aib Ser Vxx Vxx Aib Pro Lxx Lxx Aib Pro Lxxol 1143
59 B-IIb Ac Aib Ser Vxx Lxx Aib Pro Lxx Lxx Aib Pro Vxxol 1143
60 B-IIIa Ac Aib Ser Vxx Lxx Aib Pro Lxx Lxx Aib Pro Lxxol 1157
61 B-IIIb Ac Aib Ser Vxx Lxx Aib Pro Lxx Lxx Aib Pro Lxxol 1157
62 B-IIIc Ac Aib Ser Vxx Lxx Aib Pro Lxx Lxx Aib Pro Lxxol 1157
a See Table 4 footnote.
Table 9. Diagnostic Fragment Ions (m/z) of Trichoferins Produced by
Members of the T. brevicompactum Complexa
ion
64
A
65
B
66
C
67
D
68
E
69
F
[M + H]+ 1207 1193 1193 1193 1193 1193
[M + Na]+ 1229 1215 1215 1215 1215 1215
[M − H2O]+ 1189 1175 1175 1175 nd nd
[M − C4H7O]+ 1135 1120 1120 1120 1120 1120
[M − C3H8NO]+ 1132 nd 1060 1060 1118 nd
[M − C2H6NO]+ nd 1132 nd nd nd nd
b1 nd nd nd nd nd nd
b2 266 266 266 266 266 266
b3 − CO nd nd nd nd 419 nd
b3 − H2O nd nd nd nd 447 nd
b3 479 479 479 465 465 nd
b4 − H2O nd nd nd nd 518 nd
b4 550 550 550 536 536 550
b5 - CO nd nd nd nd 593 nd
b5 − H2O nd nd nd nd 603 nd
b5 635 635 635 621 621 635
b6 720 720 720 706 706 720
b7 833 833 819 805 819 833
b8 904 904 890 890 890 890
b9 989 989 975 975 975 975
b10 1074 1074 1060 1060 1060 1060
a2 238 238 238 238 238 238
a See Table 3 footnote.
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DISCUSSION
Screening of recently described species of Trichoderma
greatly enhances the possibility to find new peptaibiotics.
Remarkably, 69 of the 75 peptides (93%) analyzed in this study
represent new sequences. The strains produced 14 12-residue
trichocryptins B, 12 11-residue trichocryptins A, 19 11-residue
trichobrevins A and B, 6 10-residue trichoferins, and 17
8-residue trichocompactins. The number of new compounds
described in this study clearly illustrates the impressive potential
of a peptaibiomic approach.
Obviously, there are structural homologies of the new 11-
and 12-residue compounds with previously reported peptaibi-
otics, such as harzianins (33, 36, 38), antiamoebins (22),
hypomurocins (37), and bergofungins (35). Thus, comparable
biological activities could be expected, although the decrease
in chain length may lead to a reduction in efficacy.
As alamethicins are present in every strain investigated, they
should considerably contribute to the biological activity against
the causal agents of Eutypa dieback and Esca disease of
grapevine. The exceptional antimicrobial activity of alamethicins
can be explained by the dipole flip-flop gating model of Boheim
and Jung (45). Alamethicins, as long-chain, 20-residue peptai-
bols, may form larger and more stable pores than shorter chain
peptaibiotics, thus remarkably lowering the minimal inhibitory
concentration (MIC) to microorganisms (for a review see ref
31).
Structural homologies of trichoferins with the protonophoric
roseo- and helioferins and the positive reaction of trichoferin-
containing extracts in the two-phase vertical stacking assay
indicate an ionophoric activity that may amplify the biocontrol
potential of the trichoferin-producing strains. However, the
importance of trichocompactins for the bioactivity of the
producing strains remains doubtful.
Generally, a decrease in chain length is correlated with a loss
of bioactivity as exemplified in the case of the 19-residue
chrysospermins (46) and the 5-residue peptaibolin (47) from
Sepedonium chrysospermum (teleomorph: Hypomyces chry-
sospermus). Chrysospermins may form nongated membrane
channels (48), thus exhibiting strong antimicrobial activity
against Gram-positive bacteria, yeasts, and fungi. They also
accelerate cytodifferentiation of the coelomycete Phoma de-
structiVa and cause neuroleptic activity in mice (49). For
peptaibolin, however, no significant bioactivities have been
reported.
Notably, the distribution of peptaibiotics among taxonomic
groups/species clusters of Trichoderma is currently under
investigation in order to explain and correlate their antagonistic
properties (50).
According to our data, the alamethicins are restricted to the
T. breVicompactum group, being the most abundant peptaibiotic
metabolites of T. breVicompactum (ss).
When grown on PDA at 25 °C, T. breVicompactum also
biosynthesized diterpene mycotoxins of the trichothecene
group: strains CBS 109720, IBT 40839, and IBT 40840
produced trichodermin, whereas harzianum A was detected in
strain CBS 112445 as well. However, phylogenetic analyses
suggested the classification of all of these strains as T.
breVicompactum (ss). In contrast, T. cf. breVicompactum ATCC
90237, IBT 40863, and NRRL 3199 mainly biosynthesized
harzianum A. Notably, 17 strains belonging to the T. breVi-
compactum complex consistently produced trichothecenes on
all media tested. In contrast to that, formation of trichothecenes
has not been observed for any other of the more than 250
Trichoderma strains screened (3, 27).
This leads to the conclusion that the pattern of characteristic
nonpeptidic mycotoxins (trichothecenes) and peptaibiotics (alame-
thicins and trichocompactins) might be used in addition to
morphological and molecular data to separate the breVicom-
pactum complex from other taxa of the genus Trichoderma.
Morphological, molecular, and chemical data of strain NRRL
3199 support its affiliation with T. cf. breVicompactum rather
than T. Viride (3). Taken together, the differential patterns of
alamethicin production as well as the production of two different
trichothecene-type mycotoxins clearly support DNA sequencing
results. Both molecular and chemotaxonomic approaches clearly
indicate the existence of two phylogenetic species within what
has been called T. breVicompactum, so far. Both trichocryptins
and trichobrevins are more widespread in the genus Tricho-
derma, illustrating the limitations of chemotaxonomic conclu-
sions focused exclusively on the pattern of peptaibiotics.
Nevertheless, the taxonomy of T. breVicompactum remains a
rather complex topic and is the subject of an ongoing study.
Summarizing the sequences presented in this paper, it can
be concluded that peptaibiotics still seem to be of questionable
chemotaxonomic importance. Literature data clearly support this
opinion, because fungi belonging to divergent taxonomic groups
may produce closely related sequences of peptaibiotics.
The biosynthesis of lipoaminopeptides, for example, has been
described for strains of the fungicolous species Paecilomyces
lilacinus and Paecilomyces marquandii, but was also observed
in cultures of Trichoderma polysporum isolated from infested
fruit bodies of Lentinula edodes and in the mycoparasite M.
rosea (reviewed in ref 18).
To continue, 16-residue peptaibols, antiamoebins, were
obtained from Emericellopsis synnematicola, Emericellopsis
poonensis, Verticillium epiphytum (syn. Cephalosporium pim-
prina), and Stilbella fimetaria CBS 548.84 and ATCC 28144
(syn. Stilbella erythrocephala), but have also been isolated from
Clonostachys rosea f. catenulata (syn. Gliocladium catenulatum)
CBS 511.66 (21, 22).
Consequently, the formation of peptaibiotics should rather
be defined as an adaptation to highly specialized modes of life
of the producers, mostly being facultative or obligate plant
Table 10. Sequences of Trichoferins Produced by Members of the T. brevicompactum Complexa,b
residue
1 2 3 4 5 6 7 8 9 10 [M + H]+
64 A MDA Pro AHMOD Ala Aib Aib Lxx Ala Aib Aib AMAE 1207
65 B MDA Pro AHMOD Ala Aib Aib Lxx Ala Aib Aib AAE 1193
66 C MDA Pro AHMOD Ala Aib Aib Vxx Ala Aib Aib AMAE 1193
67 D MDA Pro desmethyl-AHMOD Ala Aib Vxx Aib Aib Aib Aib AMAE 1193
68 E MDA Pro desmethyl-AHMOD Ala Aib Aib Lxx Ala Aib Aib AMAE 1193
69 F MDA Pro AHMOD Ala Aib Aib Lxx Gly Aib Aib AMAE 1193
a See Table 4 footnote. b Abbreviations: MDA, 2-methyldecanoic acid; AHMOD, 2-amino-4-methyl-6-hydroxy-8-oxodecanoic acid.
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pathogens or fungicolous fungi occupying some particular
ecological niches.
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New Sequences, Constituents, and Producers of Peptaibiotics: An
Updated Review
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To date, 18 genera of imperfect and ascomycetous fungi have been recognized to produce ca. 700
individual sequences of peptaibiotics. These are linear polypeptide antibiotics which i) have a molecular
weight between 500 and 2,200 Dalton, thus containing 5–21 residues; ii) show a high content of a-
aminoisobutyric acid; iii) are characterized by the presence of other nonproteinogenic amino acids and/
or lipoamino acids; iv) possess an acylated N-terminus, and v) have a C-terminal residue that, in most of
them, consists of a free or acetylated amide-bonded 1,2-amino alcohol, but might also be an amine,
amide, free amino acid, 2,5-dioxopiperazine, or sugar alcohol. From April 2003 until present, ca. 300 new
individual sequences of peptaibiotics have been published in the literature, but most of them have not yet
been included in databases. To summarize these new sequences and novel constituents, as well as to
introduce fungal species hitherto unknown as producers of peptaibiotics, the relevant literature is
reviewed. Furthermore, ecophysiological and taxonomic aspects of the producing fungi are discussed.
1. Introduction. – Peptaibiotics constitute a constantly growing family of peptide
antibiotics of fungal origin. The term >peptaibiotics? was introduced in [1] and
reconsidered in [2]. Peptaibiotics are defined as linear peptide antibiotics which i) have
a molecular weight between 500 and 2,200 Dalton, thus containing 5–21 residues; ii)
show a high content of a-aminoisobutyric acid (Aib); iii) are characterized by the
presence of other nonproteinogenic amino acids and/or lipoamino acids; iv) possess an
acylated N-terminus, and v) have a C-terminal residue that, in most of them, consists of
a free or acetylated amide-bonded 1,2-amino alcohol, but might also be an amine,
amide, free amino acid, 2,5-dioxopiperazine, or sugar alcohol. Since the majority of
Aib-containing peptides carries a C-terminal residue representing a 1,2-amino
alcohol, this subgroup is referred to as peptaibols. Very lipophilic peptaibols, the N-
terminus of which is acylated by octanoic, decanoic, or cis-dec-4-enoic acid, are named
lipopeptaibols [2] [3]. In the third subfamily of lipoaminopeptides (also reported as
aminolipopeptides), the N-terminus is substituted by unbranched, a- or g-methyl-
branched, saturated, or unsaturated C4–C15 fatty acids. An l-proline-, trans-4-hydroxy-
l-proline, or cis-4-methyl-l-proline residue is found in position 1 of the peptide chain,
and, in most cases, it is followed by a lipoamino acid residue in position 2. To our
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present knowledge, this compound, 2-amino-6-hydroxy-4-methyl-8-oxo-decanoic acid
(AHMOD), has only been recorded from this subfamily. A fourth subfamily comprises
all other peptaibiotics that cannot be classified in any of the other three preceding
subfamilies. A review introducing nine subfamilies according to structural homologies
of peptaibiotics has been published [4].
Usually, peptaibiotics are classified according to their main chain length, as long-
chain (17–21 residues), medium-chain (11–16), and short-chain (5–10) sequences.
Although not yet reported in literature, the detection of very short chain (< 5)
peptaibiotics that may represent drastically truncated sequences is basically possible.
Notably, sequences comprising more than 21 amino acids have not been reported yet.
The number of Aib residues found may range from one as in some of the
trichocompactins [5] or two as in the five-residue peptaibolin [6] up to nine in some
of the 20-residue stilboflavins [7], or even ten in the 21-residue peptaibiotic SCH
643432 [8]. Trichobrachins TB III A and TB III B are peptides, the N-termini of which
have not been assigned yet [9]. Nonribosomal peptide synthetases from Trichoderma
virens [10] and Sepedonium ampullosporum [11] have recently been characterized.
Peptaibiotics show interesting physicochemical and biological activities depending
on particular structural properties, such as formation of pores in bilayer lipid
membranes as well as antibacterial, antifungal, occasionally antiviral, and antiparasitic
activities. Inhibition of mitochondrial ATPase, uncoupling of oxidative phosphoryla-
tion, immunosuppression, inhibition of platelet aggregation, induction of fungal
morphogenesis, and neuroleptic effects have been reported and reviewed in [2].
From April 2003 until present, ca. 300 new individual sequences of peptaibiotics
were published in the literature, but most of them have not yet been included in
databases such as the >Peptaibol Database? [12]. To summarize these new sequences
and novel constituents, as well as to introduce fungal species hitherto unknown as
producers of peptaibiotics, the relevant literature is reviewed. Furthermore, ecophy-
siological and taxonomic aspects of the producing fungi are discussed.
2. New Sequences, Constituents, and Producers of Peptaibiotics: General Remarks.
– The first three paragraphs, i.e., 2.1–2.3, of this section comprise these new
peptaibiotics that have been isolated from their fungal producers as pure individual
substances, or mixtures of homologues and/or positional isomers in preparative
amounts. In contrast, those new peptaibiotics that have been exclusively discovered and
sequenced by a so-called >peptaibiomic? approach [5] [13] [14] will be introduced
separately in 2.4 of this section. Representative sequences of new peptaibiotics are
listed in the Table, whereas uncommon and new constituents of peptaibiotics are
illustrated in the Figure.
2.1. Peptaibols. Alamethicin. The 20-residue alamethicins (ALM) can be considered
as the most thoroughly investigated peptaibol antibiotics. The first report on the
isolation and partial structural characterization of a polypeptide antibiotic (Upjohn
Company, Kalamazoo; U-22,324) from the culture broth of the fungal strain NRRL
3199, having originally been misidentified as Trichoderma viride, was published almost
40 years ago [15]. The taxonomy of ALM-producing Trichoderma species has recently
been revised. All strains investigated were assigned to belong to the so-called T.
brevicompactum complex [5]. An investigation by TLC on silica H (i.e., acidic silica
CHEMISTRY & BIODIVERSITY – Vol. 4 (2007) 1053
gel) of theUpjohnALM revealed that this material was composed of two major groups
named, according to Rf 100 values: ALM F30 (ca. 85%), ALM F50 (ca. 12%), and a
minor component ALM F20 (2%). However, minor or trace components of ALMs,
numbered accordingly F40, F60, and F70, were also detected by TLC [16]. In 1984, a
sequence of the acidic ALM F30 and a sequence of the neutral ALM F50 were
published [17]. The former was recognized to carry a Glu-Gln residue in positions 18
and 19, which is exchanged byGln-Gln in the latter. In 2003, the sequences of ALMF30
and ALM F50 were thoroughly reconsidered and reconciled [18].
HPLC Separation of ALM F30 using an acidic gradient revealed ten individual
sequences of ALM F30/1–10. Basically, the same gradient was used to separate ALM
F50 but omitting the addition of TFA (CF3COOH) to the eluents. As a result, 13
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Figure. Selected uncommon constituents of peptaibiotics
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individual peptides, ALM F50/2, 3a–3c, 4a, 4b, 5, 6a, 6b, 7, and 8a–8c, could be
sequenced.
Recently, the same material used in [18] was further analyzed by nonaqueous
capillary electrophoresis/mass spectrometry (NACE/MS): eleven amino acid sequen-
ces were identified, characterized by the exchange of Ala to Aib in position 6, Gln to
Glu in position 7 or 19. To continue, two novel ALM were detected, which are
characterized by the loss of the C-terminal Pheol residue, thus terminating in Gln.
Notably, two truncated 14-residue sequences carrying an N-terminal pyroglutamyl
group (commonly abbreviated as Glp, pGlu, or Pyr) were found. Overall, seven new
minor sequences are reported compared to [18]. To the best of our knowledge, this is
the first report on the occurrence of Glp as a constituent of fungal peptides in nature.
Literature search did not reveal any previous publication regarding the isolation of
peptide-bound Glp from a fungal source. To exclude the artificial formation of the Glp-
peptaibols during workup or long-term storage, degradation studies were performed.
Although neither treatment increased the amount of the truncated Glp peptides
compared to untreated samples, further studies have to be performed in order to
unequivocally prove the origin of the truncated Glp peptaibols [19].
Suzukacillin. Suzukacillin (SZ) was isolated from the culture broth of Trichoderma
viride strain 63C-I and separated by TLC into two fractions, suzukacillins A (Rf 0.18)
and B (Rf 0.70) [20] [21]. Using the material provided by Dr. T. Ooka, the major
fraction, SZ-A, was further characterized and a preliminary sequence published [22].
Although it appeared to be uniform in TLC, SZ-A could be further separated by
HPLC, yielding 13 individual peaks. Nevertheless, two of them, SZ-A10 and -11, still
represented a microheterogeneous mixture. Thus, 15 individual 20-residue peptaibols,
SZ-A1–A9, -A10a/b, -A11a/b, and SZ-A12–A13, were shown to be present in total.
Despite the microheterogeneity, complete sequences of all SZ-A peptaibols and
chirality of the individual amino acids have been determined by HPLC/MSn and GC/
EI-MS approaches [23]. In this context, the previously established presence of d-Iva
[24] was confirmed.
Trichobrachin. Trichobrachin (TB) has been isolated from Trichoderma longi-
brachiatum CBS 936.69 – a strain that is now reclassified as Trichoderma ghanense.
Three major groups designated TB I, TB II, and TB III could be separated and isolated
by preparative TLC on silica gel [9]. Recently, the formation of peptaibiotics by
Trichoderma parceramosum (ghanense) CBS 936.69 was thoroughly reinvestigated
[25]. The trichobrachin mixture comprises ten 19-residue peptides with free C-terminal
Gln residues (TB I peptides), two 18-residue peptides with free C-terminal Gln
residues (TB II 1 and TB II 2), seven 20-residue peptides with C-terminal amide-
bonded Pheol (TB II 3–10), and thirty-four eleven-residue peptides with either C-
terminal Leuol, Ileol, or Valol (TB III 1–34). TLC Analysis of the dynamics of TB
formation and degradation unequivocally demonstrated that those two 18-residue TB I
and TB II peptides with a free carboxy terminus resulted from enzymatic C-terminal
degradation of 20-residue TB II peptides.
Antiamoebin. The 16-residue peptaibols antiamoebins (AAM) I–XVI, known for
their antihelminthic and antiprotozoal activities had previously been reported from
cultures of Emericellopsis synnematicola, Emericellopsis poonensis, and Verticillium
epiphytum (syn. Cephalosporium pimprina), but have also been isolated from
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Clonostachys rosea f. catenulata (syn. Gliocladium catenulatum) CBS 511.66, as well as
Stilbella fimetaria (syn. Stilbella erythrocephala) CBS 548.84 and ATCC 28144 [26].
Notably, most of the above producers of AAM are fungicolous or coprophilous fungi.
Fruiting bodies of mushrooms and toadstools, but also dung, are generally regarded
as highly competitive substrates. In an impressive study [27], it has unequivocally
been proven that antiamoebins were responsible for antibiosis in colonized herbivore
dung.
Four strains of Stilbella fimetaria (syn. S. erythrocephala) were isolated from dung of
wild rabbits (D 99026, D 01024, and D 03001) or of the tortoise Testudo hermanni (D
03012). Furthermore, dung pellets naturally colonized by S. fimetaria, were collected in
the field, lyophilized, and extracted. The same was carried out with pre-sterilized dung
that has been artificially inoculated with the four strains mentioned above. As
expected, AAM could be detected in all liquid cultures. To continue, the total AAM
concentration – both in wild and artificially inoculated dungs – was 126–624 mg/g fresh
weight, with minimum inhibitory concentrations against most other coprophilous fungi
being at or below 100 mg/ml. It should be pointed out that this is the first report
describing the detection and isolation of peptaibiotics from natural substrates. The
diterpene antibiotic myrocin B, not previously described from S. fimetaria, was also
produced, but only at low, nonfungicidal levels (5.3 mg/g). As no other antifungal
substances could be detected, a decisive role of the broad-spectrum antimycotic AAM
during colonization of dung was proposed.
Cervinins I and II. The genusMycogone exclusively comprises fungicolous fungi.M.
perniciosa and M. rosea are known as devastating, nonspecific parasites of agarics.
These two species have been reported to cause economically relevant losses in
commercial mushroom growing [28].M. rosea is known as the producer of nine-residue
lipoaminopeptides: strain DSM 8822 was reported as the producer of helioferins A and
B [29], whereas strain DSM 12973 produced both helioferins and the closely related
roseoferins A–G [30]. Other species ofMycogone infect a rather narrow range of host
fungi: M. calospora, for instance, exclusively parasitizes coral fungi of the genus
Ramaria (Gomphales, Ramariaceae), whereasMycogone cervina has been reported on
the Glazed Cup, Mycolachnea hemisphaerica (Pezizales, Pyronemataceae), and on
false morels (Pezizales, Helvellaceae) so far [31].
Recently, M. cervina strain A09–02 was isolated as a parasite of the Vinegar Cup
Helvella (Paxina) acetabulum and shown to produce two twelve-residue peptaibol
antibiotics both exhibiting Ac-Leu as a new N-terminal motif [32]. Moreover, Leuol is
found as the C-terminal residue of cervinin I. Notably, no attempts were made to
determine the configuration of the amino acids. Cervinin II, however, has the same
sequence of amino acids, but its C-terminal Leuol residue is acetylated [32]. As no
comments were made with respect to the origin of the latter C-terminus it cannot be
completely excluded that cervinin I could have been partly acetylated during workup,
thus generating cervinin II. Furthermore, the authors stated that peptaibols exclusively
contain l-amino acids. The latter assertion is not acceptable because a number of well-
known counter-examples concerning the occurrence of d-Iva in peptaibiotics has been
published and discussed in [2]. To the best of our knowledge, this is the first report on
the isolation and structure elucidation of secondary metabolites from M. cervina.
Surprisingly, no lipoaminopeptides have yet been recorded for that species.
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2.2. Lipoaminopeptides. Culicinin. Four ten-residue lipoaminopeptides, culicinins
A–D, were recently characterized from an Australian isolate of Culicinomyces
clavisporus (Hypocreales, Clavicipitaceae). Strain LL-12I252 was isolated from larvae
of the biting midge Forcipomyia marksae (Diptera, Ceratopogonidae). Culicinins
exhibit a number of common structural features: their N-terminal Pro residue is
protected by butanoic acid (BTA). In 2-position, 2-amino-6-hydroxy-4-methyl-8-
oxodecanoic acid (AHMOD) is found. Another lipoamino acid, 2-amino-4-methyl-
decanoic acid (AMD), is situated in position 5, while b-alanine (3-aminopropanoic
acid: APA) is located in position 9 of the peptide chain. The C-terminus is substituted
by 2-(2’-aminopropyl)aminoethanol (AAE), here referred to as APAE [33]. The
lipoamino acid AHMOD is present in position 2 of almost all lipoaminopeptides, being
the characteristic structural element of this subgroup of the peptaibiotics. C-Terminal
AAE has previously been described for trichopolyns, helio- and roseoferins (as
reviewed in [2]). Notably, BTA and AMD have been detected in peptaibiotics for the
first time, thus representing novel structural elements. Selective inhibitory activity
against PTEN-negative MDA468 tumor cells has been observed.
2.3.Other Peptaibiotics. SCH 466457 and SCH 466456. Two antifungal peptaibiotics
carrying an N-terminal 2-methyl-3-oxotetradecanoyl (MOTDA) residue were isolated
from a taxonomically unidentified fungus [34]. The first compound, SCH 466457,
represents a 17-residue peptaibiotic which terminates in free Ala. The second
compound, SCH 466456, exhibits the same amino acid sequence in positions 1–16,
and another Ala residue follows in position 17. Notably, a free Aib residue is found in
the C-terminal position 18. To the best of our knowledge, this is the first report in
literature describing the occurrence of free Aib residue as the C-terminal constituent of
a peptaibiotic. Both compounds were active against Candida ssp., Aspergillus ssp., and
Trichophyton dermatophytes.
SCH 643432. Two antifungal 21-residue peptaibiotics, the N-termini of which are
also blocked by a MOTDA residue, were isolated from Paecilomyces variotii SCF 1559
[8]. They exhibit some structural homology with the 21-residue texenomycins A and B
[35], as well as the six-residue lipohexin which represents a deletion sequence of the
texenomycins. However, the configuration of the amino acids has not been determined.
Both peptaibiotics are produced by Acremonium lindtneri (syn. Moeszia lindtneri,
teleomorph: Hypomyces chrysostomus) DSM 11119, Mariannaea elegans CBS 120677
(i265), and M. elegans CBS 120687 (i910), the latter two strains originally being
misidentified as Paecilomyces sp. [36]. As in the case of lipohexin, the C-terminus of
SCH 643432-(1) is composed of free alanine or b-alanine, respectively. The primary
structure of the isobaric compound SCH 643432-(2) has not yet been published. There
are some examples of peptaibols, the C-terminus of which are composed of a free
amino acid: Gly is known as a constituent XR586 from Acremonium persicinum
X21488 [37], from both integramides A and B, and from two neoefrapeptins (see
below). Ser has been described for cephaibols P and Q fromAcremonium tubakiiDSM
12774 [38], Val is known from the trichobrachins TB IIa A and B [9], and Gln has
recently been detected in two minor compounds of alamethicin ([19], see above).
Furthermore, the presence of Vxx has recently been reported for trichocompactins I–
XII from Trichoderma brevicompactum and T. cf. brevicompactum [4] as well as T.
stromaticum [14].
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Efrapeptins/Elvapeptins. The 16-residue efrapeptins (EFR) [39] have been isolated
from Tolypocladium inflatum (syn. T. niveum, teleomorph: Cordyceps subsessilis :
[40]). The material referred to as tolypin by Matha et al. [41] mainly consists of
efrapeptin F. The potent antifungal and insecticidal activity of these peptaibiotics is best
explained by inhibition of mitochondrial ATPase [42]. In 1982, a partial sequence of
efrapeptin D, the major compound, was published [43]. However, the structure of the
C-terminus was not elucidated until 1991, when efrapeptins C, D, E, F, G, and H were
shown to be blocked by N-peptido-1-isobutyl-2-(2,3,4,6,7,8-hexahydro-1-pyrrolo[1,2-
a]pyrimidinio)ethylamine [39], subsequently abbreviated as PIHPPE. Furthermore,
production of efrapeptins has been demonstrated for Tolypocladium geodes [44] and
the two entomopathogenic species T. parasiticum [45] and T. cylindrosporum, as well as
for T. nubicola and T. tundrense [46]. It was suggested to use the pattern of efrapeptins
as a chemotaxonomic marker to distinguish between morphologically similar species of
Tolypocladium. However, efrapeptin production seems to be not only species-, but
strain-specific. The remarkable antifungal and insecticidal activity of the efrapeptins
may contribute to the ecophysiology of their fungal producers as their in vivo formation
has also been demonstrated [45]. Further minor compounds designated efrapeptins A,
H, and I have been reported, but no attempts were made to elucidate their structures [47].
Recently, two highly methylated linear peptides, as well as efrapeptin G, were
isolated from the marine fungus, strain 021172cKZ, associated with the sponge
Teichaxinella sp. (Halichondria, Axinellidae). The taxonomy of the producer remains,
however, confusing: it was identified as Leucosphaerina indica (Hypocreales,
Sordariomycetes, Ascomycota) via molecular methods, but classified as an atypical
Acremonium sp. through morphology-based examination [48].
To clarify the biosynthetic relationship between efra- and elvapeptins (ELV) that
have been obtained as co-metabolites from Tolypocladium inflatum IMI 202309 [49], a
study was conducted which demonstrated the in vitro conversion of elvapeptins to
efrapeptins by oxidative cyclization with CuCl/pyridine. From this observation, the
authors concluded that elvapeptins may contain a C-terminal spermidine residue that
might also be converted to the amine residue of efrapeptins in vivo [50].
Acretocin. Another group of peptaibiotics, acretocin (ACR), that is very closely
related to the efrapeptins has been detected inAcremonium croticinigenum CBS 217.70
– a species that is known as a facultative parasite of a number of polypores (¼bracket
fungi) and agarics. Unlike efrapeptins which carry l-Iva ((S)-Iva), the presence of d-
Iva ((R)-Iva) has been established for acretocins. Remarkably, acretocins I–VI differ
from the efrapeptins C–G by a mass difference of 2 Da, an observation that led to the
assumption that an a,b-didehydro amino acid, presumably a,b-didehydro-a-amino-
butanoic acid, might be present [51]. Although a,b-didehydro amino acids have not yet
been reported as constituents of peptaibiotics, they are frequently found in peptide
antibiotics from Gram-positive bacteria. The most well-known examples are lanti-
biotics, such as gallidermin which is produced by the Gram-positive bacterium
Staphylococcus gallinarum (F16/P57) TJ 3928 [52]. Apart from those antibiotics, the
presence of a,b-didehydro-a-aminobutanoic acid has recently been established for
hassallidin A [53] and B [54] – two glycosylated cyclo-lipopeptides from the epiphytic
cyanobacterium Hassallia sp. (Nostocales, Microchaetaceae). Comparing the sequen-
ces of the neoefrapeptins [55], the presence of 1-aminocyclopropane-1-carboxylic acid
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(Ac3c) in acretocins instead of an a,b-didehydro amino acid was established recently by
us (to be published).
Neoefrapeptins. Recently, ten 16-residue and two 13-residue neoefrapeptins A–N
with insecticidal activity [55] were isolated from Geotrichum candidum SID 22780
(Saccharomycetales, Endomycetaceae; teleomorph:Galactomyces candidus). Notably,
strains of G. candidum are of relevance in smear-ripened cheeses. It should be pointed
out that this is the first report in the literature regarding the isolation and structural
elucidation of a peptaibiotic from a yeast-like fungus. A nonribosomal peptide
synthetase (NRPS) has recently been assigned as the key enzyme for production of the
cyclohexapeptide siderophore ferrichrome by the fission yeast Schizosaccharomyces
pombe [56]. Thus, the detection of further peptaibiotics from yeast-like organisms
could be postulated.
Neoefrapeptins revealed a number of uncommon structural elements that are newly
described for peptaibiotics: Ac3c (abbreviated as Acc in the Table and in [55]) and
(2S,3S)-3-methylproline (cis-l-3-MePro) were identified. Configuration analysis of the
16-residue neoefrapeptins revealed l-Iva15. Except for the Aib-containing neoefra-
peptins D and N, Iva is present in position 4. Some of the neoefrapeptins also contain
Iva5 and Iva10. If present in position 4 and/or 5, the Iva residue was assigned the d-
configuration, whereas the Iva residues in positions 10 and 15 were shown to possess the
l-configuration. The l-configuration was assigned to all pipecolic acid (Pip) residues
found in neoefrapeptins.
Cicadapeptins. Some species of Cordyceps (Hypocreales, Clavicipitaceae) are
widely used in traditional Chinese medicine. Structures of known bioactive secondary
metabolites and their pharmacological effects have thoroughly been reviewed [57].
The genus contains mostly entomopathogenic (C. sinensis, C.militaris, C. pruinosa) and
fungicolous fungi (C. ophioglossoides, a parasite of underground deer truffles,
Elaphomyces spp.). Recently, two eight-residue peptaibiotics, cicadapeptins I and II,
were isolated from Cordyceps heteropoda ARSEF#1880, a parasite of the Australian
cicadaCicadetta puer (Homoptera, Cicadaceae). The N-terminus of these peptaibiotics
is blocked by a decanoic acid residue, and the C-terminus is amidated by 1,2-diamino-4-
methylpentane (DMAP) [58]. Decanoic acid as N-terminal substituent of peptaibiotics
has previously described for the lipopeptaibol LP237/F 7 [59] obtained from the soil-
borne Tolypocladium geodes LP237, whereas 1,2-diamino-4-methylpentane represents
a new structural element of peptaibiotics. Another distinguishing feature is the
presence of two consecutive trans-l-4-Hyp residues. Notably, such Hyp-Hyp motif has
been described for the first time to occur in peptaibiotics.
Integramides. Two novel inhibitors of HIV-1 integrase, the 16-residue integramides
A and B, were isolated from extracts of Dendrodochium sp. MF 6888 [60]. The
taxonomic position of the anamorphic fungal genus is yet unclear but some
representatives seem to belong to the family Bionectriaceae of the order Hypocreales.
Remarkably, integramides contain an acetylated N-terminal d-Iva and a total of five
(A) or six (B) d- or l-Iva residues. Among the natural peptaibiotics, integramides are
those containing the largest proportion of Iva described to date. Free Gly is found at the
C-terminus of both peptaibiotics.
2.4. Peptaibiomics – A Novel Methodical Approach in the Search for Peptaibiotics.
Recently, the technical term >peptaibiomics? was proposed, describing, in analogy to
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proteomics, the approach to analyze the entirety of peptaibiotics, the so-called
>peptaibiome?, produced by a certain strain under defined conditions. An advanced,
rapid, and selective method was introduced that comprises solid-phase extraction
(SPE) of peptaibiotics on C18-cartridges followed by on-line reversed-phase (RP)
HPLC coupled to an ion trap electrospray tandem mass spectrometer (ES-MS). The
presence of peptaibiotics is indicated by the characteristic mass differences of m/z 85.1
Da, representing Aib residues which can be observed in the b-series of acylium
fragment ions resulting from ESI-MS. This method was used to analyze the
peptaibiome of recently described species ofHypocrea and Trichoderma. Peptaibiotics
produced by the following strains were partially sequenced and compared to published
sequences:Hypocrea muroianaMUCL 28442,H. nigricansMUCL 28439,H. gelatinosa
CBS 724.87, H. dichromospora CBS 337.69, H. vinosa CBS 247.63, H. semiorbis CBS
244.63, andH. citrina (syn.H. lactea) CBS 853.70; Trichoderma asperellum CBS 433.97,
T. aggressivum f. europaeum CBS 100526, T. inhamatum CBS 345.96, and T.
stromaticum CBS 101875 [13].
Three strains of Trichoderma brevicompactum (CBS 109720, CBS 119569, CBS
119570) and another four which are closely related to that species (Trichoderma cf.
brevicompactum CBS 112445, CBS 119576, CBS 119577, and NRRL 3199) were
analyzed for the formation of peptaibiotics. These isolates were selected because of an
antagonistic potential against Eutypa dieback and Esca, fungal diseases of grapevine
(Vitis vinifera) trunks, that have not yet been investigated for the production of peptide
antibiotics. All strains were found to produce membrane-active alamethicins F 30 (see
above). In addition to that, novel peptaibols were detected, namely fourteen twelve-
residue trichocryptins B, twelve eleven-residue trichocryptins A, nineteen eleven-
residue trichobrevins A and B, six ten-residue lipoaminopeptides – trichoferins, and
seventeen eight-residue trichocompactins, the latter terminating in free Vxx [5]. Taken
together, the differential patterns of alamethicin production as well as the production
of different trichothecene-type mycotoxins clearly support DNA-sequencing results.
Both molecular and chemotaxonomic approaches indicate the existence of two species
within what has been called Trichoderma brevicompactum. The taxonomy of
Trichoderma brevicompactum is the subject of an ongoing study because the species,
as presently circumscribed, is still heterogeneous.
The same approach has been applied to another eight grapevine-protective strains
of Trichoderma species (T. strigosum, T. erinaceus, T. pubescens, T. stromaticum, and T.
spirale as well as T. cf. strigosum, T. cf. pubescens): new seven-, ten-, and eleven-residue
lipopeptaibols, with N-terminal alkanoyl, and C-terminal Leuol or Ileol residues were
found, and named lipostrigocins and lipopubescins. Furthermore, new 18-residue
peptaibols named trichostromaticins, and 19-residue peptaibols, named trichostrigo-
cins, were discovered. One peptaibiotic carrying a free C-terminal Vxx, named
trichocompactin XII, was also sequenced. In summary, these compounds may partially
be responsible for plant-protective action of the producers [5] [14].
3. Discussion. – The number of peptaibiotics published in the literature remarkably
increased during the last three years. A first major reason explaining this phenomenon
is that the analytical equipment used for screening and structural elucidation of peptide
antibiotics is becoming more and more sophisticated [61]. New analytical approaches,
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as illustrated by the method of peptaibiomics, target-oriented selection, and optimi-
zation of separation techniques, as well as the use of state-of-the-art methods in mass
spectrometry, enable the detection of homologues and positional isomers, even if
present in trace amounts. In principle, only one fully-grown Petri dish or slope is
required for a first routine analysis of the peptaibiome of a fungal culture. In this
context, it should be clearly pointed out again that Iva is frequently found as d- or l-
isomer in peptaibiotics [2]. To continue, both enantiomers of Iva can be present in the
same peptaibiotic, as was reported for neoefrapeptins and integramides (see above) as
well as for the 15-residue peptaibol clonostachin: the latter contains d-Iva in positions 4
and 13, whereas l-Iva is found in positions 7 and 10 [62]. On total hydrolysis, an
apparently racemic mixture (RS)-dl-Iva is released. Separation of dl-Iva and dl-Pip,
analyzed as N-trifluoroacyl amino acid propyl esters on Chirasil-l-ValTM (N-propionyl-
l-valine-tert-butylamide polysiloxane), is not always satisfactory, as it depends both on
the age and quality of the capillary columns provided by various manufacturers.
However, Iva enantiomers can be resolved on Chirasil-l-ValTM after conversion intoN-
acetylisovaline propyl esters [63]. Instead of Chirasil-l-ValTM, a LipodexTM E column,
representing a functionalized g-cyclodextrine, can be used providing excellent
resolution of Iva and Pro enantiomers [64]. Notably, all eight stereoisomers of 3-
and 4-Hyp can be resolved on Chirasil-l-ValTM [65]. Alternatively, pre-column
derivatization with the chiral Na-(5-fluoro-2,4-dinitrophenyl)-l-alanine amide
(FDAA; Marfey?s reagent), and subsequent HPLC or HPLC/ESI-MS analysis of the
resulting diastereoisomers is recommended [66]: by this method, dl-Iva and dl-Pip are
very well resolved. Last but not least, methanolysis of peptaibiotics, followed by
trifluoroacetylation and analysis of the resulting dipeptides by GC/EI-MS, has been
introduced as a method to solve the problem to assign the positions of isobaric amino
acids Val/Iva and Leu/Ile, respectively [26]. Recent advances in quantitation of dl-
amino acids are summarized in [67].
Second, screening of fungi from highly competitive habitats such as fungicolous,
coprophilous, and entomopathogenic species remarkably enhances the probability to
find new sequences of peptaibiotics. For instance, trichostromaticins A–E [14] may
contribute to the potent bioactivity of Trichoderma stromaticum [68] (teleomorph:
Hypocrea stromatica [69]). Hyperparasitic strains of this species that is known as a
biologically active cacao endophyte have successfully been introduced in field control
of the causal agent of Witches? Broom Disease of cacao (Theobroma cacao) in South
America. They were shown to effectively suppress basidioma formation of the plant
pathogen Crinipellis perniciosa (Tricholomataceae, Agaricales) [68] [70]. High selec-
tion pressure in such environment favors strains capable of producing secondary
metabolites with interesting biological activities that may effectively eliminate
competitors. Owing to their exceptional membrane-penetrating action as exemplified
in [71–74], peptaibiotics may play a decisive role in natural habitat as clearly
demonstrated [27]. This observation supports the hypothesis of a parallel formation of
hydrolytic enzymes and peptaibiotics, as their synergistic action was attributed an
important role in mycoparasitism between T. harzianum and its fungal hosts such as
Botrytis cinerea [75] [76]. Depending on the Trichoderma strain/species studied, other
antibiotic metabolites such as a-pentyl pyrones (6-PAP: 6-pentyl-2H-pyran-2-one and
related structures [77]), as well as trichothecenes [78], may play an important role.
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It can be hypothesized that the number of peptaibiotics described in the near future
will increase considerably. For instance, the genus Trichoderma (with teleomorphs in
Hypocrea [79]) is generally regarded as the richest source of peptaibiotic-producing
species [80]. At the beginning of 2005, it was shown to comprise 88 species [81]. Two
new species, for example, have been reported as endophytes of cocoa [82]. In April
2006, more than 100 Trichoderma species could be distinguished by molecular methods
[83]. Many more – detected in sapwood of trunks of Theobroma spp., Cola spp., Fagus
sylvatica (beech), Scalesia pedunculata (Daisy tree, Asteraceae), and in the woody
liana Ancistroderma korupensis – have recently been described [84] [85]. To continue,
two new species of Hypocrea, H. voglmayrii [86] and H. cristalligena [87], have also
been published.
Modern methods of molecular taxonomy have already led to significant changes in
fungal systematics. The contribution of chemotaxonomy to this process is yet unclear
but should not be overestimated. Nevertheless, the differential patterns of alamethicin
production, as well as the production of different trichothecene-type mycotoxins,
clearly supported necessary subdivision that is evident from the DNA-sequencing
results in the Trichoderma brevicompactum complex. Both molecular and chemo-
taxonomic approaches indicate the existence of two species within what has been called
Trichoderma brevicompactum.
With the exception of neoefrapeptins (see above), peptaibiotics have only been
reported and sequenced in three families, Hypocreaceae, Clavicipitaceae, and
Bionectriaceae of the order Hypocreales. Publications regarding the isolation of
peptaibiotics from basidiomycetes should be considered very critically as outlined in
[2]. In some cases, an infection of an asco- or basidiomycete?s fruiting-body with
mycoparasites might not be visible to the naked eye. For that reason, it cannot be
excluded that younger stages of infection have accidentally not been recognized
macroscopically, thus leading to extraction of infested material. This was first pointed
out in [88]. The authors isolated chrysospermins A–D from the new Vietnamese
species Xerocomus langbianensis (Boletaceae, Boletales) [89]. In contrast, in
[35] [90] [91], the production of the respective peptaibiotics texenomycin, boletusin,
and tylopeptin were attributed to the extracted fruiting bodies of the Potato Earthball
Scleroderma texense (syn. Scleroderma bovista, Sclerodermataceae, Boletales), Boletus
sp., and the Bitter Bolete Tylopilus neofelleus (Boletaceae, Boletales). It is likely that
an unrecognized infection of X. langbianensis with Sepedonium sp. was the reason for
detection of the four chrysospermins [88]. It should be considered that chrysospermins
have originally been described from S. chrysospermum [92], a widespread parasite of
the order Boletales [31].
To date, 18 genera of imperfect and ascomycetous fungi have been recognized to
produce ca. 700 sequences of peptaibiotics. Most of the structures reviewed here and in
[2] were isolated from the genera Trichoderma and its Hypocrea teleomorphs, from
Acremonium, Tolypocladium, Paecilomyces, Emericellopsis, and Sepedonium. Less
commonly reported producers were found in Verticimonosporium, Stilbella,Mycogone,
Mariannaea, Myrothecium, Clonostachys, Culicinomyces, Cordyceps, Geotrichum, and
Dendrodochium. Regardless of a number of attempts undertaken to validate the
previously reported detection of Aib in hydrolyzed extracts of Penicillium roquefortii
[93] and P. nalgiovense [94], both species could not be confirmed as producers of
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peptaibiotics. Nevertheless, the abundance of data fully confirm our predictions
expressed almost two decades ago [93] [94].
By GC-FID and GC/EI-MS approaches, Aib, and pure enantiomers or mixtures of
d- and l-Iva were found to occur in HCl hydrolysates of organic extracts of a number of
ascomycetes. This comprises the following strains [95]: Lecythophora mutabilis CBS
303.62, Nectriopsis candicans CBS 627.72 (Bionectriaceae, Hypocreales), Clonostachys
candelabrum (syn. Sesquicillium candelabrum) CBS 205.69 (Bionectriaceae, Hypo-
creales), Bionectria pityrodes CBS 322.78 (syn. Nectria pityrodes, Bionectriaceae,
Hypocreales),Niesslia aemula CBS 556.75, N. exigua CBS 152.68, N. exilis CBS 560.74,
as well as Niesslia sp., strains CBS 236.74 and CBS 477.74 (Niessliaceae, Hypocreales),
and the related anamorphs Monocillum mucidum CBS 306.70 and M. nordinii CBS
101.63 (Niessliaceae, Hypocreales),Wardomyces columbinus CBS 233.66,W. humicola
CBS 368.62, and W. inflatus CBS 367.62 (Microascaceae, Microascales). From these
observations, the formation of peptides containing these nonproteinogenic a-alkyl
amino acids can be concluded. Consequently, those strains should be regarded as
particularly promising sources for future screening approaches. To continue, free Aib
and enantiomeric mixtures of d- and l-Iva have actually been detected to occur in
aqueous extracts of cultures of Nectria cinnabarina (Nectriaceae, Hypocreales) and a
number ofHypomyces sp. (personal observation). To understand the importance of the
latter finding, additional investigations would be required.
Generally, formation of peptaibiotics should rather be discussed as an adaptation to
highly specialized life styles of the producers occasionally being marine symbionts
[48] [96], but mostly facultative or obligate plant pathogens, fungicolous or entomo-
pathogenic fungi occupying some particular ecological niches.
Overall, fungal biodiversity creates differences in chemical structures that may
exhibit new bioactivities, thus leading to the development of new drugs for use in
human and veterinary medicine, and in agriculture and forestry.
We are grateful to Prof. Dr.W. Gams for valuable comments on taxonomic aspects of the manuscript
and thank Dr. A. W. A. M. de Cock (Centraalbureau voor Schimmelcultures [CBS], NL-Utrecht) for
recent re-identification and subsequent correction of the taxonomy of the texenomycin/lipohexin-
producing strains i265 and i910 as Mariannaea elegans.
Note added in Proof. Four nine-residue peptaibiotics, MS-681a, b, c, and d, which act as inhibitors of
myrosin light chain kinase, were isolated fromMyrothecium sp. KY6568 [97]. Notably, the configuration
of the Iva8 and the Iva2 residue was shown to be >l?, whereas Iva5 was assigned the >d?-configuration. The
C-terminus of all four homologues is protected by the same polyamine, (2’RS)-N1-(2-amino-3-
phenylpropyl)spermidine, being another novel constituent of peptaibiotics. [98]. Two 20-residue
peptaibiotics, septocylindrin A and B, have been isolated from the fungus LL-Z1518 [99]. Amino acid
residues 1–19 and configurations of the amino acids are identical with those reported for alamethicin
F30/3 of alamethicin F50/5, respectively.
Septocylindrins differ from alamethicins only in the structure of the C-terminal alcohol, which is 2-
(2-amino-3-phenylpropylamino)ethanol (Phaol). Such C-terminus has only been described for aibellin, a
20-residue peptaibiotic from Verticimonosporium ellipticum D1528 before [100]. However, the
identification of the producer as Septocylindrium sp. is questionable as the authors did not provide
taxonomic data to verify its identity [101].
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Fungi of the genus Trichodermawith teleomorphs inHypocrea are abundant producers of a group of
amphiphilic, non-ribosomal peptide antibiotics, which are rich in the non-proteinogenic amino acid Aib
(a-aminoisobutyric acid). They are referred to as peptaibiotics, or peptaibols, if a 1,2-amino alcohol is
present at the C-terminus. Trichoderma/Hypocrea, like other ascomycetous fungi, also produce
hydrophobins, a class of small, cysteine-rich proteins. Advanced soft ionization mass spectrometric
techniques such as LC-CID-MS, LC-ESI-MSn, and IC-MALDI-TOF-MS enabled the high-throughput
analysis, simultaneous detection and sequence determination of peptaibiotics and hydrophobins from
minute quantities of fungal materials. Some Trichoderma species have been recognized to produce
peptaibiotics as well as simple mycotoxins of the trichothecene group. The combination of sequence data
of both groups of peptides with the pattern of low-molecular-weight secondary metabolites, including
trichothecene-type mycotoxins, independently confirmed the results of morphological, molecular, and
phylogenetic analyses. This approach established a new lineage in Trichoderma/Hypocrea, the
Brevicompactum clade, comprising four new and one redescribed species. Notably, commercial
preparations of single or mixed cultures of Trichoderma species, in particular T. harzianum, and T.
koningii, are registered as biocontrol agents for soil and plant pathogens. In this context, it is emphasized
that the four mycotoxin-producing species of the recently established Brevicompactum clade (T.
brevicompactum, T. arundinaceum, T. turrialbense, andT. protrudens) are not closely related to any of the
Trichoderma species currently used as biocontrol agents. Furthermore, possible health concerns about
release of peptaibiotics in the biosphere are discussed with respect to their bioactivities and their use as
drugs in human and veterinary medicine. Finally, future prospects regarding novel bioactivities and
further research needs, including interdisciplinary taxonomic approaches, are outlined.
Peptaibiotics. – Peptaibiotics/peptaibols constitute a constantly growing family of
peptide antibiotics [1–3]. Currently, more than 700 individual sequences of peptai-
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biotics, produced by members of 18 fungal genera, are reported in the literature. Of
these ca. 20 genera, Trichoderma and Hypocrea are the most abundant sources of
peptaibiotics with approximately half of the known peptaibiotics originating from those
two genera [4]. Trichoderma is the asexual form of, and is phylogenetically
indistinguishable from, Hypocrea. Thus, in this review we refer to a single genus,
Trichoderma/Hypocrea. Most of the peptaibiotic-producing species formerly included
in Gliocladium have been reclassified in Trichoderma [5]. A continuous problem has
been the high rate of reports of biological activities of Trichoderma/Hypocrea based on
misidentified species [6]. However, positive identification can be achieved by DNA
sequencing which is currently accepted as the state-of-the-art approach in fungal
taxonomy. Complete or partial sequences of peptaibiotics have been reported from ca.
25 Trichoderma/Hypocrea species [7–9], the identity of which has been verified by
DNA sequencing. An additional 15 positively identified species are known to produce
peptaibiotics [10] by an Lintact cell matrix assisted laser desorption/ionization-time of
flight mass spectrometryM (IC-MALDI-TOF-MS) approach [11]. In a pilot study of ca.
60 species, we found that ca. 75% of these strains produced peptaibiotics on the
medium tested. While ca. 400 species of Hypocrea have been described over the past
175 years, few of them have been seen since they were first described, and even fewer
have been linked to Trichoderma stages. On the other hand, only few species of
Trichoderma were described prior to the mid 1990s, when molecular techniques were
routinely applied in taxonomy. The consequence is that Trichoderma stands as one of
the few species-rich genera of microfungi for which all known species have been
cultured, and for which sequences of two or more genomes have been deposited in
GenBank. The web site of the International Commission for Taxonomy of Fungi,
Trichoderma and Hypocrea subcommittee (http://www.isth.info/biodiversity/in-
dex.php), currently provides DNA sequences for 104 species of Trichoderma/
Hypocrea, but several new species are in the process of being described. So, while
only approximately half of the known Trichoderma/Hypocrea species have been
investigated for the production of peptaibiotics, the full diversity of the genus has only
begun to be revealed. The certain discovery and characterization of new Trichoderma/
Hypocrea species in previously unexplored regions, for instance Asia [12], and in
ecological niches, such as woody tissues of trees [13–15], will lead certainly to the
discovery of new producers, novel constituents, and eventually uncommon building
schemes of peptaibiotics.
A multiphasic, interdisciplinary approach to taxonomy has always been most
convenient to discern species boundaries and the relationships among species.
Taxonomy was initially strictly based on morphology of the sexual or asexual morph,
which ever was in the hand of the taxonomist and depended upon the interests of the
taxonomist. By the mid 19th century, it was known that ascomycetes such as Hypocrea
had asexual morphs that were classified in different genera, but rather few taxonomists
viewed the organism as a whole. Over the last 30 years of the 20th century, a greater
emphasis was placed on amalgamating anamorph and teleomorph taxonomy. This
amalgamation not only provided information about the respective morphs, but also,
because artificial cultures were involved, taxonomic characters could be drawn from
the Petri dish. Over time, there have been attempts to use metabolites and physiology in
taxonomy of ascomycetes, such as carbon uptake [16], but interspecific variation in
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these characters has limited their use in taxonomy. A major difficulty in evaluating the
taxonomic utility of metabolic or other physiological characters is the high degree of
misidentifications in the literature, as was mentioned above. The mid 1990s brought
molecular phylogenetics together with a surge in descriptions or redescriptions of
Trichoderma species. The DNA sequencing provided a precision in species identi-
fication and species boundaries that was lacking in purely morphological taxonomy.
Thus, the newly described species were scrutinized through the lens of DNA
sequencing, as have been all of the roughly 130 species known today. Prior to 2000,
peptaibiotics were attributed to four LcommonM species, T. viride, T. koningii, T.
harzianum, and T. longibrachiatum. However, the identity of those cultures is in doubt,
or has already been shown to be incorrect. Certainly, we cannot be criticized, as it has
only been in the last few years that sufficient sequences of correctly identified
Trichoderma species have been generally available through the ISTH web site and
GenBank [17]. Nevertheless, statements about Trichoderma species must always be
accepted with great caution unless the authors of those reports describe how their
cultures were identified.
Peptaibiotics such as alamethicins are considered for treatment of plant diseases
because of their effect on the walls of pathogens [18] [19]. They may also have a role to
play in taxonomy and species identification. Peptaibiomics [7–9] and IC-MALDI-
TOF-MS [3] [10] [11] have considerably increased the screening efficiency for peptai-
biotics but also contributed to progress in chemotaxonomy of Trichoderma/Hypocrea.
Recently, peptaibiotics have even been isolated from natural habitats, such as dung of
rabbits and from the tortoise Testudo hermanni [20]; and they were also considered as
stable markers for the presence of fungi in the marine environment [21]. Briefly, linear
peptaibiotics are polypeptide antibiotics which i) have a molecular weight between 500
and 2,200 Da, thus containing 5–21 residues; ii) show a high content of a-amino-
isobutyric acid (Aib); iii) are characterized by the presence of other non-proteinogenic
amino acids and/or lipoamino acids; iv) possess an acylated N-terminus, and v) have a
C-terminal residue that, in most of them, consists of a free or acetylated amide-bonded
1,2-amino alcohol, but might also be an amine, amide, free amino acid, 2,5-
dioxopiperazine, or sugar alcohol [4]. Many different peptaibiotics may be produced
by a single strain of Trichoderma/Hypocrea. Peptaibiomics is the characterization of the
entirety of peptaibiotics produced by a fungal strain under defined culture conditions. It
also may include the time-dependent dynamics of biosynthesis and degradation of
peptaibiotics [22]. An LC/MS-based peptaibiomics approach is based on the
generation of so-called Lin-source fragmentsM by Lcollision-induced decompositionM
mass spectrometry (CID-MS) to the skimmer region of an ESI mass spectrometer.
Varying voltages are applied to the skimmer, thus providing the possibility of clearly
differentiating various types of ions. The CID-MS technique provides a possibility to
partially sequence peptaibiotics. The most diagnostic difference to screen for is D (m/z)
85, which indicates the presence of the a-aminoisobutyric (Aib) residue being unique
to all peptaibiotics. Another diagnostic difference is D (m/z) 99, indicative for a Vxx
residue (i.e., isomeric valine or isovaline). In this context, it should be pointed out again
that non-proteinogenic Iva is frequently found as d- or l-isomer in peptaibiotics,
whereas all other chiral constituents known so far have been reported to possess l-
configuration. In some cases, both enantiomers of Iva are present in the same
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peptaibiotic [4]. Complete sequencing is achieved by a combination of data from CID-
MS, MS/MS, QTOF MS, and MSn (in the case of ion-trap instruments). These data are
generally needed to be combined with HPLC elution profiles, the so-called fingerprints
of the samples [4] [8] [9].
Intact cell MALDI-TOF mass spectrometry (ICMS) permits detection of
biomolecules in unfractionated biomass down to the attomolar level. Microcolonies
of cyanobacteria of 50 to 100 cells have been characterized at the clonal level,
differentiating strains by their peptide metabolite inventory [23–25]. We thus could
expect to analyze much larger fungal cells down to the single-cell level. Analysis of
bacteria at the intact-cell level by ICMS is now well-established, and generally
detection of a set of ribosomal proteins as most abundant compounds permits identifica-
tion at or below the species level at a comparable sensitivity as PCR techniques [26–
29], while additional protein markers permit, e.g., the differentiation of drug-resistant
strains [30–33]. The standard ICMS sample-preparation process suspending cells in a
solvent mixture disintegrates bacterial membranes releasing intracellular proteins.
With fungal cells, however, solvent-soluble components of the cell wall as hydrophobins
or excreted metabolites are detected [3] [10] [11] [34] [35]. Although the metabolite
inventory is essential for strain characterization, this information alone is generally
insufficient for the identification of microbial species and strains. Peptaibol formation
has been comparatively analyzed in 32 strains of 29 species of Trichoderma/Hypocrea
concluding that there is no strict correlation of phylogeny with the types and sequences
of the peptaibols produced, but that the production of some groups of peptaibols
appears to be found only in some clades or sections of the genus [10]. It is clear from
this and another analysis including mycotoxins [36] that relevant phylogenetic
information could only be drawn from the respective biosynthetic genes.
Most peptaibols range in size between 1000 and 2000 Da, and are thus easily
detected without interference from low-mass metabolite signals or matrix signals. In
this region, monoisotopic masses are recorded, and peptide family patterns are visible.
Peptaibol production on solid media starts at the onset of sporulation, as has been
shown for H. atroviridis [35]. In recent studies, more than 40 strains of 32 species of
Trichoderma/Hypocrea have been investigated for the production of 10- to 20-residue
peptaibiotics. One study defined 26 groups of characteristic mass peaks, and assigned
half of these to known peptaibiotics [10]. This overview identified species with yet
undescribed compounds. The purpose of the study has been to search for correlations of
peptaibol type production with phylogenetically ascertained species descriptions.
Taken together with all available data on peptaibiotics in Trichoderma/Hypocrea, the
complexity of relations between phylogeny and peptaibol synthetases becomes
obvious. Certain peptaibols are found throughout all sections and clades, while others
are restricted to particular sections. As orthologous peptide synthetase domains and
modules are found, and also obvious extensive regional similarities exist, possible
relationships would best be analyzed at the peptide synthetase gene level.
ICMS Peptaibol patterns obviously need further analysis of molecular ions to
clearly identify the sequences of the respective compounds. With the current MALDI-
TOF-MS approach, the presence of these metabolites can be detected extremely
rapidly from small amounts of mycelia/spores, thus also facilitating extended
expression studies.
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HPLC-MS combined with ESI, atmospheric-pressure chemical ionization (APCI),
or other atmospheric-ionization techniques as well as UV/VIS diode array detection
revolutionized the process of assaying for uncommon mycotoxins. These can be further
characterized by high-resolution MS from TOF, and now also with Orbi-Trap
instruments, for quickly determining the elementary composition of a given metabolite,
which can be identified in databases such as Antibase, comprising 33,557 records in the
2007 version [37]. This is especially true for UV/VIS-active compounds where the UV/
VIS data and original strain information can be used for validation [38]. For trace
analysis, HPLC-MS/MS on triple quadrupole instruments is state-of-the art, because
both the sensitivity (down to low fg levels) and specificity are excellent.
Hydrophobins. – Hydrophobins range in size from ca. 75 up to 400 amino acid
residues containing eight positionally conserved cysteine residues forming character-
istic disulfide bonds, and are divided into two classes with respect to their hydropathy
profiles and cystein spacings. Hydrophobins have been considered as suitable
phylogenetic markers for several reasons. Fungi contain a set of hydrophobin genes,
generally with a developmentally regulated expression reflecting life conditions and
interactions. Overproduction of a hydrophobin during endophytic interaction of T.
asperellum and cucumber roots has recently been demonstrated [39]. The hydro-
phobins HFB1 and HFB2 have diverse functions in development of H. jecorina [40],
including surface hydrophobicity, formation of aerial mycelia, and spore properties.
Genome sequencing of H. jecorina/T. reesei revealed the presence of six hydro-
phobin genes, and for H. atroviridis/T. atroviride and T. virens, ten hydrophobin genes
have been annotated so far, respectively [10] [41] [42]. These hydrophobic peptides can
be selectively dissolved and are thus excellent biomarkers for MALDI-TOF-MS
[3] [10] [11]. Extending genomic information, hydrophobin patterns are diverse due to
posttranslational processing, as shown in the pioneering work on H. jecorina [43–45].
Processing involves the respective signal sequences for excreted proteins, but also
defined N- and C-terminal cleavage sites [10] [11]. Due to their fairly small size,
sequence information of the hydrophobins can be obtained by mass spectrometry, and
the respective genes are accessible by standard PCR methods. It has been noted that
the variability of hydrophobin genes is fairly significant and exceeds similarities of
other biomarkers proposed, e.g., ubiquitins. In addition, variation of the number of
hydrophobin genes provides additional information to housekeeping gene structures.
Gain and loss of hydrophobin genes may also play a key role in speciation.
ICMS Patterns of the strain H. jecorina (syn. T. reesei) QM9414 have been
correlated with the respective hydrophobin composition of HFB1 and HFB2 through
analysis of knock out mutants [10]. Unexpectedly, two other strains, CPK 618 and CPK
665, showed differing mass peaks, which have been tentatively assigned to the
expression of either HFB3 and HFB4 or differing processing of HFB1. Vegetative and
sporulating mycelia differed as expected in their hydrophobin patterns. In the same
study, 29 species of Trichoderma/Hypocrea have been compared, and unique patterns
have been detected. In case of H. atroviridis/T. atroviride P1, mass peaks could be
correlated with sporulation related hydrophobin SRH1, as also for T. longibrachiatum
HFB3. As the results indicate proteolytic processing beyond signal peptide cleavage,
further work is needed to ascertain cleavage sites and proteases involved.
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We successfully linked morphological, molecular taxonomic, and phylogenetic
approaches, and IC-MALDI-TOF MS, peptaibiomics, and LC/HR-ESI-MS mycotoxin
screening of Trichoderma/Hypocrea to redescribe a new lineage in Trichoderma/
Hypocrea, the Brevicompactum clade. This clade included, in addition to T.
brevicompactum, four new species in the T. brevicompactum complex, and an
additional new Hypocrea species [36]. This approach clearly supported our previous
hypothesis that more than one species was involved when T. brevicompactum has
originally been described. Combination of classical morphological mycology with DNA
sequencing and profiling of mycotoxins and other small metabolites, hydrophobins, and
peptaibioitics clearly delimited four new species fromwithin the original morphological
construct of T. brevicompactum [46]. In summary, the combination of these methods
provides information about metabolites that can be used to identify species and strains.
New Bioactivities. – Sophisticated approaches are urgently required to detect novel
or previously unrecognized biological activities of peptaibiotics. Hosotani et al. [1]
reported on the inhibition of amyloid b-peptide formation in primary guinea pig
cerebral cortex neuron cell cultures by a 14-residue peptaibol, SPF-5506-A. It is known
that increased accumulation of amyloid b-peptides plays a decisive role in the
pathogenesis of neurodegenerative dementia such as AlzheimerMs disease. Produced by
Trichoderma sp. SPF-5506, peptaibol SPF-5506-A can be considered as a positional
isomer of the 14-residue harzianin HC [47]. Thus, it can be hypothesized that harzianins
and structurally related peptaibols might display similar bioactivity.
Biocontrol Agents. – In the past decade, peptaibiotics and the fungi producing them
have gained much interest as a possible alternative to xenobiotics such as synthetic
pesticides in agriculture and forestry. Recently, it has been demonstrated that five new
18-residue peptaibols, trichostromaticins A–E, produced by Trichoderma stromaticum
[48] (teleomorph: Hypocrea stromatica [49]), strains CBS 101875 and CBS 101730,
may contribute to the potent bioactivity of these two strains [9]. This species, which is
known only as a mycoparasite of the cacao (Theobroma cacao) WitchesM Broom
disease pathogen Moniliophthora perniciosa [48], formerly Crinipellis perniciosa [50],
has successfully been introduced into field control of the disease in South America. The
main effect is the suppression of basidioma formation by the pathogen [51]. These two
strains of T. stromaticum and another seven strains of T. cf. strigosum, T. strigosum, T.
erinaceus, T. cf. pubescens, T. pubescens, and T. spirale were highly active against the
causal agents of Eutypa dieback, Eutypa lata, and Esca disease, Phaeomoniella
chlamydospora, and Phaeoacremonium aleophilum. These are latent trunk diseases
that cause severe economic losses in viticulture [52]. Notably, all of the eight
Trichoderma strains produced peptaibiotics that may contribute to their potent
bioactivity against the above grapevine pathogens [9].
Strains originally identified as T. harzianum and T. koningii are currently used in
commercial biological control agents (BCAs) in Europe and North America. Our own,
preliminary studies on five BCAs available on the German market most likely indicate
that the bioactivity of these commercial products can clearly be attributed to the
presence of peptaibiotics. Taxonomy of the Trichoderma strains in these BCAs is
currently under revision [53].
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Mycotoxin Production. – Concerns have been expressed about potential toxicity of
peptaibols/peptaibiotics in biological control, a fear that is reinforced by names such as
LtrichotoxinM. Clearly, a biological control agent that enters the food chain should not
produce toxins. Species identified as biological control agents, including T. harzianum
and T. viride, are reported to produce trichothecene toxins. However, they have been
reidentified as T. brevicompactum and T. arundinaceum, closely related species, both of
which belong to the T. brevicompactum complex that was mentioned above. This
lineage is distant from any biological control species. Only T. brevicompactum and
three closely related species within the T. brevicompactum complex [8] [36] have been
proven to produce trichothecene-type mycotoxins (trichodermin, harzianum A), and
neither in [54], nor in [9] were trichothecenes reported in any species outside of the T.
brevicompactum complex.
Note, that the 11- and 14-residue peptaibols harzianins HB [55] and HC [47] must
not be confused with the non-peptidic, trichothecene-type mycotoxins harzianum A
[54] [56] [57] and harzianum B [58]. Studies reporting other types of trichothecenes
than the one with only a OH group in the 4- and perhaps 15-position are probably
wrong, as these other types, e.g., from Fusarium, are biosynthesised via trichotriol,
rather than trichodermol [59], as is probably the case in Stachybotrys, Myrothecium,
Memnoniella, and Podostroma (¼Hypocrea) [54] [59] [60], all of which are members
of the Hypocreales along with Trichoderma/Hypocrea. Gliotoxin is produced by
Trichoderma virens, which is commonly reported in the literature asGliocladium virens
[61].
Toxicity of Peptaibiotics. – Recently, it has been reported [62] [63] that the 20-
residue peptaibols alamethicin and paracelsin, the 16-residue antiamoebin, and other
11-residue trichobrachins [2] [64] were highly toxic in three in vitro invertebrate models,
viz. Crassostrea gigas, Artemia salina, and Daphnia magna. An alternative explanation
of the toxicity reported in [62] and [63] might be that the batch of the alamethicin
standard used (Sigma-Aldrich, product number A-4665) may have been contaminated
with the trichothecene mycotoxin harzianum A that is produced by the strain of
Trichoderma cf. brevicompactum used for alamethicin fermentations [8]. In our own
work, we have found that this particular Sigma alamethicin contains harzianum A; and
this group of trichothecene toxins is highly toxic to Artemia salina [36].
In contrast, oral administration of antiamoebin [65] [66], trichotoxin A [67],
aibellin [68] [69], ampullosporin [70], and trichofumin [71] to rodents and ruminants
revealed a very low toxicity. This was explained by the almost complete resistance of
peptaibiotics towards any kind of proteolytic cleavage with the result that their high
molecular weight prevented them from passing through the intestinal cell. The
microheterogeneous mixtures of antiamoebin or aibellin were administered in huge
amounts to cows or goats, respectively. The idea behind these experiments was to
inhibit protozoa and other microbial competitors in order to increase cellulose
digestibility by rumen bacteria. Antiamoebin was also tested for antiprotozoal and
anthelminthic activities in man and against Trypanosoma evansii in laboratory animals.
While its LD50 value was very high: 155–165 mg/kg body weight/animal, only 10 mg/kg
killed the pathogen [65], a concentration far below the level that would affect the test
animal.
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Trichotoxin and alamethicin have been reported to cause haemolysis of eryth-
rocytes [72]. This action, however, is common for many amphiphilic detergent-like
molecules, including soaps and saponins, and requires direct contact with cell
membranes. Analogously, the reported uncoupling of oxidative phosphorylation in
mitochondria caused, for instance, by efrapeptins [73] requires direct interaction under
experimental conditions.
From an application point of view, the potential LtoxicM effect of peptaibiotics
appears to be more theoretical than real, perhaps no more than that of common
amphiphilic detergents, and well below the threshold of human consequence. On the
other hand, the reported synergistic effects of peptaibiotics and cellulases by strains of
Trichoderma and Hypocrea, and the antibiotic activities of peptaibiotics which are of
interest for plant protection [18] [19] enhance their potential for biological control
application.
Conclusions. – The introduction of novel methodical approaches during the past
two years such as peptaibiomics and IC-MALDI-TOF-MS have remarkably enhanced
screening efficiency for peptaibiotics and has extended their application to chemo-
taxonomic questions. More than half of the currently known sequences of peptaibiotics
were determined, between 2002 and 2007, mostly by HPLC-MS approaches. Likewise,
HPLC-MS has revolutionized mycotoxin analysis in the past decade, not only lowering
detection limits but also with the introduction of high-resolutionMS screening, and fast
identification/dereplication of mycotoxins without reference standards are now
possible. Novel test assays have been used to detect new or previously unrecognized
bioactivities of peptaibiotics such as neuroleptic [70], anti-HIV integrase I [74], and
anti-Alzheimer [1] effects. Combined use of molecular biology, direct-infusion MS,
HPLC-MS, and MALDI-TOF-MS has also been proven to be beneficial for character-
ization of new fungal species [36] [38] [75].
Certainly, trichothecene-producing strains of Trichoderma and Hypocrea must not
be introduced into biological control of fungal pathogens in the field or greenhouse.
Thanks to a growing phylogenetic understanding of Trichoderma/Hypocrea, we are
able to predict biological properties of species, and avoid those that are related to
known toxigenic species. Mycotoxin-free Trichoderma species such T. stromaticum that
can be regarded as safe are already in use for crop protection [51].
Financial support by the Studienstiftung Mykologie (D-Cologne) and the Erwin-Stein-Stiftung
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Note Added in Proof. Recently, a new subfamily of natural peptaibiotics, named cyclopeptaibiotics,
was introduced, currently comprising seven 4-membered and two 7-membered cyclic peptides, which
contain at least one Aib or Iva residue [76].
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Abstract The Brevicompactum clade is recognized as a
separate lineage in Trichoderma/Hypocrea. This includes T.
brevicompactum and the new species T. arundinaceum, T.
turrialbense, T. protrudens and Hypocrea rodmanii. The
closest relative of the Brevicompactum clade is the Lutea
clade. With the exception of H. rodmanii, all members of
this clade produce the simple trichothecene-type toxins
harzianum A or trichodermin. All members of the clade
produce peptaibiotics, including alamethicins. Strains pre-
viously reported as T. harzianum (ATCC 90237), T. viride
(NRRL 3199) or Hypocrea sp. (F000527, CBS 113214) to
produce trichothecenes are reidentified as T. arundinaceum.
The Brevicompactum clade is not closely related to species
that have biological application.
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Introduction
Visible phenotype, including microscopic and colony
characters, has come to occupy a role subsidiary to
molecular phylogenetics in Trichoderma and its
corresponding teleomorph, Hypocrea. For example, T.
viride is the most commonly reported species in the genus,
but many, or most, of those reports are likely to have been
based on misidentifications because it is now known that T.
viride has a limited distribution in the northern hemisphere
while the morphologically very similar T. viridescens is
widely distributed at temperate latitudes (Jaklitsch et al.
2006). Similarly, T. harzianum also ranks among the most
commonly reported species, on the basis of its morphology,
but gradually this morphological concept is being refined.
Thus, the cause of green mould disease of commercial
mushrooms was originally identified as T. harzianum but is
now known to be T. aggressivum (Samuels et al. 2002).
While the physical differences between T. viride and T.
viridescens and between T. harzianum and T. aggressivum
are small but consistent, it was only through phylogenetic
analysis that the respective pairs were seen to represent
distinct species.
Trichoderma brevicompactum could be mistaken for T.
harzianum on the basis of considerable shared micro-
morphology, but phylogenetic analysis shows them to be
only distantly related (Kraus et al. 2004). Moreover, when it
was originally described (Kraus et al. 2004), a combined
ITS-tef1 phylogram indicated two, highly supported, sister
groups within T. brevicompactum. The two well-supported
sister clades at least indicated distinct phylogenetic if not
taxonomic species.
In their study of mycotoxin production in Trichoderma,
Nielsen et al. (2005) found that the ex-type and other
cultures of T. brevicompactum produced the simple tricho-
thecene-type mycotoxin trichodermin, while isolates in the
sister lineage to the ex-type produced harziaum A.
Trichodermin is the first trichothecene for which the
structure was fully elucidated; it was produced by a culture
identified as T. viride LEO ND 8 (Godtfredsen and
Vangedal 1964, 1965). That culture was reidentified by
Nielsen et al. (2005) as T. brevicompactum. Harzianum A
was isolated from a culture identified as T. harzianum
(ATCC 90237, Corley et al. 1994) and later reidentified by
Nielsen et al. (2005) as T. brevicompactum, although in the
sister lineage mentioned above. Because the patterns of
toxin production by isolates coincided with the phyloge-
netic lineages observed in the protologue of T. brevicom-
pactum, Nielsen et al. (2005) suggested the existence of
two phylogenetic species within the morphological species
T. brevicompactum. However, the trichothecene results
were ambiguous in that one of the cultures (CBS 112445)
identified by Kraus et al. (2004) as being in the T.
brevicompactum-type group produced harzianum A, not
trichodermin. This culture was separated from the type
group in a parsimony tree, but with only modest bootstrap
support (69%) (Kraus et al. 2004).
Nielsen et al. (2005) demonstrated the production of
alamethicins in extracts of T. brevicompactum. Alamethi-
cins are a group of 20-residue polypeptides belonging to the
so-called peptaibiotics. Almost 850 individual sequences of
linear and 9 of cyclic peptaibiotics are reported to be
produced by members of approximately 20 fungal genera.
Peptaibiotics are defined as linear or cyclic polypeptide
antibiotics which (1) have a molecular weight between 500
and 2,200 Dalton, thus containing 4–21 residues; (2) show
a high content of α-aminoisobutyric acid (Aib); (3) are
characterized by the presence of other non-proteinogenic
amino acids such as isovaline (Iva) and/or lipoamino acids;
(4) possess an acylated N-terminus, and (5), in the case of
the linear compounds, have a C-terminal residue that in
most of them consists of a free or acetylated amide-bonded
1,2-amino alcohol, but might also be an amine, amide, free
amino acid, 2,5-dioxopiperazine, or sugar alcohol. The
majority of linear Aib-containing peptides carries a C-
terminal residue representing a 2-amino alcohol, and this
subgroup is therefore referred to as peptaibols. Notably, half
of the known peptaibiotics are produced by strains and
species of the genus Hypocrea/Trichoderma (Degenkolb et
al. 2003, 2006a, 2007, 2008a, b; Krause et al. 2006).
Peptaibiotics were proposed to contribute to the disruption
of the cell walls of fungal pathogens owing to their
amphiphilicity and membrane activity (Lorito et al. 1996).
Gräfenhan (2006, see also Degenkolb et al. 2006a) reported
that cultures of T. brevicompactum had unusually high
antagonistic activity against the causal agents of two
grapevine diseases, Eutypa dieback (Eutypa lata) and Esca
disease (Phaeomoniella chlamydospora, Phaeoacremonium
aleophilum) when compared to other Trichoderma species
so far used in biological control (T. atroviride, T.
harzianum, T. koningii, and T. viride). In an effort to
understand the in vitro antagonistic activity against the
grape pathogens and, at the same time, to explore for any
link between production of peptaibiotics and phylogeny
within what they termed ‘the T. brevicompactum complex,’
Degenkolb et al. (2006a) documented the production of
peptaibiotics in T. brevicompactum. They also showed that
the alamethicin F30 patent strain NRRL 3199, originally
identified as T. viride (Coats et al. 1974; Brückner and Jung
1980; Kirschbaum et al. 2003; Psurek et al. 2006),
belonged to the sister clade of the ex-type strain of T.
brevicompactum. Degenkolb et al. (2006a) found that in
general the patterns of peptaibiotics produced in Tricho-
derma/Hypocrea are species-specific. The isolates in the
type-group of T. brevicompactum did not produce tricho-
brevins while those belonging to its sister clade, including
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NRRL 3199, did. Like other members of this clade, NRRL
3199 produced harzianum A. The peptaibiotics of CBS
112445, which was weakly linked to the type group of T.
brevicompactum (Kraus et al. 2004), were more comparable
to those of the type group than to those of the sister group.
Since the appearance of the publications cited above, we
have found additional cultures of the morphological species
T. brevicompactum. DNA sequence analysis showed that
these cultures fall into the respective phylogenetic lineages
that were seen in the protologue. In the course of our
monographic studies of Trichoderma and Hypocrea we
have found additional cultures of Trichoderma/Hypocrea
that are closely related to T. brevicompactum s. lat. but that
form independent lineages. In the present work, we re-
examine the phylogenetic lineages within the morpholog-
ical species T. brevicompactum and the phylogenetic
relationships of T. brevicompactum and its closest relatives.
We continue an examination of the secondary metabolites
produced by members of this clade with descriptions of the
peptaibiotics, hydrophobins, and small metabolites like
trichothecenes, and the significance of these metabolites
to taxonomy.
Materials and methods
Chemicals used
Solvents were HPLC grade and all other chemicals
analytical grade unless otherwise stated. Water was 18.2
MΩ cm-1 purified.
Morphological analyses
The isolates studied are listed in Table 1. Most were
obtained from the indicated culture collections. The strain
CBS 121320 was isolated as an endophyte from sapwood
of a cacao tree (Theobroma cacao) following the protocol
described by Evans et al. (2003). Cultures of Hypocrea
rodmanii were obtained by isolating single ascospores from
freshly collected specimens on cornmeal-dextrose agar
(CMD; cornmeal agar Difco + 2% dextrose).
Material to be used for microscopic measurements was
first immersed in 3% KOH. Herbarium specimens of
Hypocrea collections were rehydrated briefly in 3% KOH.
Sections were made with an IEC-CTF microtome cryostat
(International Equipment, Needham Heights, Mass.). Mea-
surements and observations of sectioned perithecia were
carried out in lactic acid preparations. Measurements of
microscopic characters of the anamorph and teleomorph
were made from 3% KOH, which was replaced with
distilled water, following the protocol of Samuels et al.
(2002). Microscopic characters of conidiophores and
conidia were taken from CMD or SNA (synthetic low
nutrient agar; Nirenberg 1976) within approximately 7
days, mostly using intermittent light (12 h cool white
fluorescent lamps, 12 h darkness). Presence of chlamydo-
spores was determined by examining the underside of
colonies after 7–10 days on CMD with the 40× objective.
Where possible, 30 units of each character were measured,
using Scion Image for Windows™ (www.scioncorp.com).
Observations were made with differential interference
contrast (DIC), phase contrast (PC), and bright field (BF)
microscopy. Helicon Focus™ version 4.21.5 Pro(MP)
(Helicon Soft, http://HeliconFocus.com) was used to
produce some composite images (e.g. Figs. 7o, 8b, 9i and
12c). Color standards are from Kornerup and Wanscher
(1978) and are cited as “K&W.”
Growth rates were determined on potato-dextrose agar
(PDA, Becton, Dickenson, Sparks, Md.) and SNA follow-
ing Samuels et al. (2002, 2006).
Statistical analysis
For each strain, descriptive statistics (minimum, mean,
median, maximum, standard deviation and 95% confidence
intervals of the mean) were computed for the morpholog-
ical data. These are summarized in Table 8 (see later).
Metabolite data were coded using categorical scales.
Multidimensional scaling (MDS) was performed using
standardized data matrices that included either the morpho-
logical data, expressed as means for each strain, or the
metabolite data, or both. The characters used in the analysis
are shown in Tables 7 and 8 (see later). Computation of
descriptive statistics was performed using Systat 11 (Systat
Software, San José, Calif.). Only strains for which no data
were missing were included in the analysis. The MDS had
exploratory character only and was aimed at detecting
grouping of strains according to the variables measured.
The ALSCAL procedure implemented in SPSS 16 (SPSS,
Chicago, Ill.) was used for the MDS analysis.
Phylogenetic analysis
The extraction of genomic DNAwas performed as reported
previously (Dodd et al. 2002). Sixty-six cultures of diverse
Trichoderma species were used in the phylogenetic analysis
(Table 2).
The gene regions studied were RNA polymerase II
subunit (rpb2), translation elongation factor 1α (tef1) and
internal transcribed spacers ITS (ITS1, 5.8S, and ITS2) of
the nrDNA gene repeat. The primers for rbp2 amplification
were fRPB2-and fRPB2-7cR (Liu et al. 1999). Primers for
Tef1 amplification were Ef728F (Carbone and Kohn 1999)
and Tef1R (Samuels et al. 2002). The primers for ITS
amplification were ITS5 and ITS4 (White et al. 1990).
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Table 2 Isolates and GenBank accession numbers
Isolate Species tef1 rpb2 ITS
CBS 119573 T. arundinaceum EU338280 EU338308 AY154943
NRRL 3199 T. arundinaceum EU338279 EU338307 EU330932
CBS 121153 T. arundinaceum EU338278 EU338306 EU330931
CBS 119577 T. arundinaceum EU338277 EU338305 AY154921
CBS 119578 T. arundinaceum EU338276 EU338304 AY154921
CBS 119575 T T. arundinaceum EU338275 EU338303 AY154921
CBS 119574 T. arundinaceum EU338274 EU338302 AY154921
ATCC 90237 T. arundinaceum EU338291 EU338326 DQ080074
CBS 1132314 T. arundinaceum EU596602 EU596603
CBS 109720 T T. brevicompactum EU338299 EU338317 AY324173/AY324183
CBS 112443 T. brevicompactum EU338281 EU338319 AY324174/AY324183
CBS 121154 T. brevicompactum EU338283 EU338310 EU338330
CBS 119570 T. brevicompactum EU338298 EU338316 AY154920
CBS 119569 T. brevicompactum EU338297 EU338315 AY154920
CBS 112444 T. brevicompactum EU338296 EU338314 AY324173/AY324183
CBS 119572 T. brevicompactum EU338295 EU338313 EU330937
G.J.S. 04–380 = MA 4103 T. brevicompactum EU338292 EU338309 EU330935
IBT 40841 T. brevicompactum EU338294 EU338312 AY154920
CBS 119571 T. brevicompactum EU338293 EU338311 AY154920
CBS 112446 T. brevicompactum EU338273 EU338301 AY324173/AY324183
CBS 112447 T. brevicompactum EU338300 EU338318 EU330942
CBS 114249 H. candida AY737742 AY391899 AY737757
CBS 114232 H. catoptron AY737726 AY391900 AY737766
CBS 114245 H. ceracea AY937437 AF545508 EU330953
CBS 114576 H. ceramica AY737738 AF545510 AY737764
G.J.S. 90–97 = IMI 352471 H. cf. rufa VE DQ307530 EU341808 DQ315449
G.J.S. 98-1 H. chlorospora AY737737 AY391906 AY737762
G.J.S. 94-67 H. chromosperma AY737728 AY391912 AY737774
G.J.S. 97-237 H. cinnamomea AY737732 AY391920 AY737759
DAOM 139758 H. citrinoviride EU338334 EU338338 EU330960
P.C. 21 H. costaricensis AY737741 AY391921 AY737754
CBS 111146 H. cremea AY737736 AF545511 AY737760
CBS 111148 H. cuneispora AY737727 AF545512 AY737763
CBS 119053 H. dingleyae AF348117 EU341803 DQ313151
CBS 119089 H. dorotheae DQ307536 EU248602 DQ313144
CBS 111147 H. estonica AY737733 AF545514 AY737767
G.J.S. 02-78 H. intricata EU248630 EU241505 EU264002
G.J.S. 90-22 = IMI 393966 H. lixii AF443933 AY391925 AF443915
CBS 102037 H. lutea AY737731 AY489662 AY737773
CBS 114236 H. melanomagna AY737751 AY391926 AY737770
CBS 114330 H. nigrovirens AY737744 AF545518 AY737777
CBS 115283 H. pezizoides AY937438 EU248608 DQ000632
CBS 114071 H. phyllostachydis AY737745 AF545513 EU330959
CBS 814.68 H. pilulifera AY737747 AF545519 Z48813
CBS 121320 = DIS 119fT T. protrudens EU338289 EU338322 EU330946
HY 8 H. psychrophila AY737752 AF545520 EU330957
G.J.S. 89–120 H. rodmanii EU338285 EU338323 EU330947
CBS 120895 H. rodmanii EU338286 EU338324 EU330948
CBS 109719 H. rodmanii EU338290 EU338325 EU330949
DAOM 167636 H. semiorbis AY737750 AF545522 AY737758
CBS 112888 H. stilbohypoxyli AY376062 EU341805 AY380915
CBS 114248 H. straminea AY737746 AY391945 AY737765
G.J.S. 85–228 H. sulawesensis AY737730 AY391954 AY737753
CBS 111145 H. surrotunda AY737734 AF545540 AY737769
CBS 114234 H. thailandica AY737748 AY391957 AY737772
CBS 114237 H. thelephoricola AY737735 AY391958 AY737776
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PCR amplifications were performed in a solution that
contained: 2.5µl of 10X PCR Buffer (New England Biolab,
Ipswich, Mass.) with MgCl2 to a final concentration of 1.5
mM, 0.2 mM dNTPs, 0.2 µM of forward and reverse
primers, 1.25 units of Taq Polymerase (New England
Biolab), and 10–50 ng of genomic DNA and double-
distilled water for a total volume to 25µl per reaction. The
reactions were placed in a PTC-200 MJ Research thermo-
cycler (Waltham, Mass.) using a touchdown program (Don
et al. 1991). The touchdown PCR was initiated with a
2-min denaturation at 94°C followed by an initial 15 cycles
of PCR amplification. The annealing temperature in the
first amplification cycle was 65°C, which was reduced 1°C
per cycle over the next 15 cycles. An additional 35 cycles
were performed, each consisting of 30-s denaturation at
94°C, 30-s annealing at 48°C and 1-min extension at 72°C
concluding with 10-min extension at 72°C. The resulting
products were purified with ExoSAP-it kit (USB, Cleve-
land, Ohio) using the manufacturer’s protocol. The purified
amplicons were sequenced directly using the BigDye
Terminator v3.1 chemistry in a 16 capillary automated
DNA sequencer (ABI 3100; Applied Biosystems, Foster
City, Calif.). For each locus, both strands were sequenced
using the primers used in producing the amplicons. In the
case of rpb2, two additional internal primers RPB-432F (5’-
ATGATCAACAGAGGYATGGA) and RPB-450R (5′-
TCCATRCCTCTGTTTGATCAT) were used in sequencing
reactions. Sequences were edited and assembled using
Sequencher 4.1 (Gene Codes, Madison, Wis.). Clustal X
1.81 (Thompson et al. 1997) was used to align the
sequences; the alignment was adjusted manually with
McClade version 3.06 software (Maddison and Maddison
2005).
Sequence analyses To determine the phylogenetic position
of the Brevicompactum clade, the sequence alignment of
the three gene sections for 66 isolates of Trichoderma
species (Table 2) was analysed with maximum parsimony
(MP), neighbour-joining (NJ) and Bayesian inference (BI).
The MP analysis was carried out with PAUP* version b10
(Swofford 2002) using a heuristic search, with a starting
tree obtained via 1000 random stepwise addition sequences,
tree-bisection-reconnection as the branch-swapping algo-
rithm, and MULTREES on. PAUP* was also used to
Table 2 (continued)
Isolate Species tef1 rpb2 ITS
CBS 112445 T. turrialbense EU338284 EU338321 AY324173/AY324183
BBA 72294 T. turrialbense EU338282 EU338320 EU330944
G.J.S. 99–130 H. victoriensis EU338331 EU338336 EU330952
PC 278 H. virescentiflava AY737749 AY391059 AY737768
DAOM 100525 T. aggressivum AF348095 AF545541 AF057600
G.J.S. 90–7 T. asperellum EU338333 EU338337 EU330956
CBS 142.95 T. atroviride AF456891 EU341801 AF456917
DAOM 167161 T. fertile AY750881 AF545546 DQ083018
DAOM 167652 T. flavofuscum AY750891 AF545547 EU330955
DAOM 167057 T. hamatum AY750893 AF545548 Z48816
CBS 988.97 T. koningii DQ289007 EU248600 DQ323409
DAOM 222105 T. koningiopsis AY376042 EU341810 AY380901
DAOM 166989 T. longibrachiatum EU338335 EU338339 EU330961
DAOM 167069 T. minutisporum AY750883 EU341809 DQ083015
DAOM 167085 T. oblongisporum AY750884 AY545551 DQ083020
DAOM 166162 T. pubescens AY750887 AF545552 DQ083016
G.J.S. 03–74 T. scalesiae DQ841726 EU252007 DQ841742
DAOM 183974 T. spirale AY750890 AF545553 DQ083014
DAOM 166121 T. erinaceus DQ109547 EU248604 DQ109534
DAOM 166121 T. strigosum AF487668 AF545556 AF487657
G.J.S. 00–108 T. stromaticum AY937436 EU341807 DQ083013
DAOM 178713A T. tomentosum AY750882 AF545557 DQ085432
G.J.S. 01–287 T. virens AY750894 EU341804 DQ083023
CBS 101526 T. viride AY376053 EU248599 X93979
CBS 438.95 T. viride DQ307522 EU341806 DQ315438
CBS 333.72 T. viridescens DQ307523 EU341802 DQ315441
G.J.S. 74–83 H. lutea EU338287 EU338327 EU330950
G.J.S. 85–26 H. lutea EU338288 EU338328 EU330951
DIS 219C Trichoderma sp. EU338332 EU338329 EU330954
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construct NJ trees, with a distance set to Kimura 2-
parameter model. Bootstrap values for MP and NJ trees
were calculated from 1,000 replicates. Two members of
Trichoderma sect. Longibrachiatum were used as outgroup
species. GenBank accession numbers are given in Table 2.
MrBayes 3.0 b4 (Huelsenbeck 2000; Huelsenbeck et al.
2001) was used to reconstruct phylogenetic trees based on
the Bayesian approach (Mau et al. 1999; Rannala and Yang
1996). The Bayesian analysis used a different model of
evolution for each of the three loci (ITS, tef1, rpb2). The
models of DNA substitution for rpb2 and tef1 were deter-
mined previously (Chaverri and Samuels 2003; Chaverri et
al. 2005) with Modeltest 3.6 (Posada and Crandall 1998).
The parameters estimated for ITS by Modeltest were:
general time reversible (GTR + I + G, nst = 6) model with
gamma distributions and invariable sites; base frequencies =
0.2082, 0.3400, 0.2485; rates (Rmat) = 1.7117, 2.4357,
2.0885, 0.6750, 4.7081; gamma shape = 0.7900; proportion
invariable sites (pinvar) = 0.6037. Four chains and
5,000,000 Markov chain-Monte Carlo generations were
run, and the current tree was saved to a file every 100
generations. Stability of likelihood scores was confirmed
with the software TRACER version 1.2.1 (Rambaut and
Drummond 2004), which traces the parameter against the
generation number. Once stability was reached both in
terms of likelihood scores and parameter estimation, the
first 5,000 trees were discarded (as burn-in).
Topological incongruence for the trees based on indi-
vidual genes was examined with a reciprocal 70% bootstrap
(BP) or a 95% posterior probability (PP) threshold (Mason-
Gamer and Kellogg 1996; Reeb et al. 2004) to determine
whether the sequences from the three genes should be
combined in a single analysis. Bootstrap values were
generated with neighbour joining (NJ) with 1,000 replicates
and a maximum likelihood distance. Posterior probabilities
were calculated with Bayesian analysis in MrBayes. A
conflict was assumed to be significant if two relationships
for the same taxa, one being monophyletic and the other
non-monophyletic, both with BP = 70% and PP = 95%,
were observed on each ITS, tef1 and rpb2 majority-rule
consensus trees. The three partitions could be combined if
no significant conflicts were detected.
The culture G.J.S. 85-26 (H. lutea) was used as an
outgroup because this species was shown to be the closest
to the Brevicompactum clade.
Secondary metabolites
Peptaibiotics: HPLC-ESI-Ion-Trap-Mass spectroscopy
Cultivation of strains All subcultures and main cultures
used for peptaibiomics were grown at room temperature
(23–26°C) under ambient daylight on PDA (Difco, Becton
Dickinson, Heidelberg, Germany). Peptaibiotics studied are
listed in Tables 1, 3, 4, 5, 6 and 7.
Subcultures were grown on PDA for 4 days and used for
inoculation of the main culture.
Extraction After 6 days cultivation, fungal cultures were
extracted with a mixture of 1:1 (v/v) CH2Cl2:MeOH,
evaporated in vacuo, and cleaned over Sep-Pak C18
cartridges as described by Krause et al. (2006).
HPLC-UV-ESI-Ion-Trap- MS measurements
Analyses were performed on an Agilent 1100 HPLC
equipped with Kromasil KR100 column, (150 mm × 4.6
mm i. d., 3.5 µm) held at 35°C. The UV detector was set at
205 nm (Krause et al. 2006; Degenkolb et al. 2006a, b).
Online HPLC/ESI-MS was performed on a LCQ ion
trap MS (Thermo Finnigan MAT, San José, Calif.) using
Excalibur v.1.2 software. Sequence analysis was carried
out in the positive ESI mode in centroid mode with an
accuracy of ± m/z 0.5. A collision induced dissociation
(CID) energy of 0% was used for scanning molecular
masses ([M+H]+/[M+Na]+) and fragments resulting from
cleavage of the extremely labile Aib-Pro bond. CID
energies of 45% and 65% were used for generating series
of characteristic “in-source”-fragment ions. The collision
energy for MSn experiments was set between 25 and 65 V,
depending on the precursor ion, typically at 45 V.
Fragment ion series were assigned in accordance with
the previously used nomenclature. In cases where the
isomeric amino acids Leu/Ile or Val/Iva (Iva, isovaline)
could not be distinguished, the abbreviations Lxx and Vxx
were used instead (Krause et al. 2006; Degenkolb et al.
2006a, b).
Detection of DL-Alaol by GC/MS measurements For GC/
MS measurements, a GC-A17 coupled to a QP-5000
MS (Shimadzu, Kyoto) was used. The instrument was
equipped with a Chirasil-L-Val (i.e., N-propionyl-L-valine-
tert-butylamide polysiloxane) capillary column, 25 m ×
0.25 mm i.d. (Varian-Chrompack, Darmstadt). Helium was
used as the carrier gas. EI mass spectra were recorded at
70 eV. A subfraction of 1 mg of the methanolic extract, also
used for HPLC and LC/MS measurements, was dried under
a cold stream of N2 and hydrolyzed in a ReactiVial with
6 N HCl at 110°C for 18 h. The chirality of Alaol was
determined after derivatization of the dried hydrolysate
with N-pentafluoropropionic anhydride (PFPAA) by GC/
MS in SIM mode at m/z 190−191. N-pentafluoropropionyl
derivatives of L-Alaol and DL-Alaol were used as standard
samples (Küsters and Portmann 1994). The following
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Table 3 Peptaibiotic patterns of strains from the Trichoderma brevicompactum complex (excluding Hypocra rodmanii)
Species Strain Peptaibiotics: molecular weight
ALM TCP TCT-A TCT-B TBV TFR
Trichoderma
brevicompactum
CBS 109720 =
IBT 40866 =
DAOM 231232
(ex-type)
1964 [1]a 1,978
[2, 3], 1992 [4]
726 [5, 6];
740 [7, 8];
754 [9, 10]
1125 [19, 20, 21];
1139 [22, 23]
1210 [11, 12];
1224 [13, 14];
1238 [15, 16];
1252 [17, 18]
n.d. n.d.
CBS 119569 =
IBT 40839
1964 [1], 1,978
[2, 3], 1992 [4]
726 [5]; 740
[7, 8] 754
[9, 10]
1153 [24, 25];
1167 [26, 27,
28]; 1181
[29, 30]
n.d. n.d. n.d.
CBS 119570 =
IBT 40840
1964 [1], 1,978 [2,
3], 1992 [4]
726 [5]; 740
[7, 8]; 754
[9, 10]
1153 [24, 25];
1167 [26, 27,
28]; 1181
[29, 30]
n.d. n.d. n.d.
CBS 112444 =
IBT 40861
1964 [1], 1,978
[2, 3], 1992 [4]
740 [7, 8];
754 [9, 10]
1111 [80, 81];
1125 [20, 21];
1139 [23]; 1153
[82]
1210 [11]; 1,224
[13, 14]; 1238
[16, 83, 84, 85];
1252 [17, 18]
n.d. 1207 [64]
CBS 112446 =
IBT 40862
1963 [76], 1964
[1], 1977 [77],
1978 [2, 3],
1992 [4]
740 [7, 8];
754 [9, 10]
1111 [80, 81];
1125 [20, 21];
1139 [23]
1210 [11]; 1224
[13, 14]; 1238
[16, 83, 84, 85];
1252 [17, 18]
n.d. 1207 [64];
1193 [66, 67,
68]
CBS 112447 1963 [76], 1964
[1], 1977 [77],
1978 [2, 3],
1992 [4]
740 [7, 8];
754 [9, 10]
1111 [80, 81];
1125 [20, 21];
1139 [23]; 1153
[25]
1210 [11]; 1224
[13, 14]; 1238
[16, 83, 84, 85];
1252 [17, 18]
n.d. 1207 [64],
1193 [66, 67,
68]
CBS 121154 =
G.J.S. 05–355
1963 [76]; 1977
[77]; 1977 [78];
1991 [79]; 1950
[31]; 1964 [1],
1978 [2, 3],
1992 [4]
726 [5]; 740
[7, 8]; 754
[9, 10]
1125 [86, 87, 88,
89]; 1139 [90];
1153 [91]
n.d. 1127 [52]; 1141
[53, 54]; 1157
[61, 62] (in trace
amounts)
1207 [64];
1193
[66, 68]
Trichoderma
turrialbense
CBS 112445 =
IBT 40868
(ex-type)
1950 [31]; 1964
[1], 1978 [2, 3],
1992 [4]
726 [5, 6];
740 [7, 8];
754 [9, 10]
1139 [22, 23];
1153 [24, 25];
1167 [26, 27, 28]
1224 [13, 14];
1238 [15, 16];
1252 [17, 18];
1266 [33, 34,
35, 36]; 1280
[37, 38]
n.d. n.d.
CBS 122554 =
BBA 72294
1963 [76]; 1977
[77]; 1977 [78];
1991 [79]; 1964
[1], 1978 [2, 3],
1992 [4]
740 [7, 8];
754 [9, 10]
1097 [92]; 1111
[93]; 1125 [94]
1196 [95]; 1210
[96, 97]; 1224
[98, 99, 100,
101]; 1238
[102, 103]
1127 [52]; 1,141
[53]; 1157 [62]
1207 [64]
Trichoderma
arundinaceum
CBS 119575 =
IBT 40842 = G.
J.S. 05–180
(ex-type)
1963 [76]; 1977
[77]; 1977 [78];
1991 [79]; 1964
[1], 1978 [2, 3],
1992 [4]
740 [7, 8];
776 [9, 10];
770 [39]
n.d. n.d. 1127 [50-52];
1143 [58, 59];
1141 [53, 54];
1157 [60, 61, 62]
1207 [64]
CBS 119576 =
ATCC 90237 =
IBT 9471
1964 [1], 1978
[2, 3], 1992 [4,
63]
726 [5, 6];
740 [7, 8];
756 [10];
770 [39, 41];
784 [42, 43]
n.d. 1238 [15, 16];
1252 [17, 18];
1266 [33–36] (in
trace amounts)
1099 [44–47];
1113 [48, 49];
1127 [50–52];
1141 [53, 54];
1129 [55–57];
1143 [58, 59];
1157 [60–62]
1207 [64]
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modified temperature program was used for GC separation:
injector and interface temperature, 250°C each; initial
temperature, 65°C, 4 min hold; 3°C/min until reaching
100°C, 3.5 min hold; 40°C/min until reaching 190°C, 5 min
hold. The pressure program was as follows: initial pressure
3.2 kPa, 4 min hold; 0.2 kPa/ min until reaching 7 kPa,
3 min hold. The split ratio was set 30:1.
Peptaibiotics: MALDI-TOF analysis
Growth conditions Cultures were routinely grown at 25°C
on malt extract (Oxoid, Wesel, Germany) agar plates and
prepared on day 6 in the sporulation phase. Peptaibiotics
from MALDI-TOF MS analysis are summarized in Table 1.
Extraction and preparation of mycelium for MALDI-TOF
analysis A few µg of mycelium were directly spotted onto
target wells of a 100-position sample plate and immediately
mixed with 1 µl of matrix solution [10 mg/ml dihydroxy-
benzoic acid (DHB, from Anagnostec, Golm, Germany) in
acetonitrile ⁄ methanol ⁄ water (1: 1:1, v/v) and 0.3%
trifluoroacetic acid]. The sample matrix mixture was
allowed to air-dry prior to analysis.
MS analysis by MALDI-TOF MS
Low-molecular mass peptides were measured on a VOYAG-
ER DE-PRO - time of flight mass spectrometer from Applied
Biosystems using a nitrogen laser beam (λ = 337 nm), with the
MS in the delayed extraction mode, allowing the determina-
tion of monoisotopic mass values. A low mass gate of 800 Da
improved the measurement by filtering out the most intensive
matrix ions. The mass spectrometer was used in the positive
ion detection and reflector mode.
Table 3 (continued)
Species Strain Peptaibiotics: molecular weight
ALM TCP TCT-A TCT-B TBV TFR
NRRL 3199 1964 [1], 1978
[2, 3], 1992 [4]
740 [70]; 754
[71, 72]; 756
[73]; 770
[74, 75]
n.d. n.d. 1099 [44–47];
1113 [48, 49];
1127 [50–52];
1141 [53, 54];
1129 [55–57];
1143 [58, 59];
1157 [60–62]
1207 [64];
1193 [66–69]
CBS 119577 =
IBT 40863
1964 [1], 1978
[2, 3], 1992 [4]
726 [5, 6];
740 [7, 8];
754 [9, 10]
n.d. n.d. 1099 [44–47];
1113 [48, 49];
1127 [50–52];
1141 [53, 54];
1129 [55–57];
1143 [58, 59];
1157 [60–62]
1207 [64]
CBS 121153 =
G.J.S. 90–2
1963 [76]; 1977
[77]; 1977 [78];
1991 [79]; 1964
[1], 1978 [2, 3],
1992 [4]
754 [10]; 770
[39, 41]
n.d. n.d. 1113 [48, 49];
1127 [52]; 1141
[53, 54]; 1129
[57]; 1143 [58,
59]; 1157
[60–62]
1207 [64]
Trichoderma
protrudens
CBS 121320 =
DIS 119f
(ex-type)
1963 [76]; 1977
[77]; 1977 [78];
1991 [79]; 1964
[1], 1978 [2, 3],
1992 [4]
754 [10]; 770
[39, 41]
n.d. n.d. 1113 [48, 49];
1127 [52]; 1141
[53, 54]; 1129
[57]; 1143 [58,
59]; 1157 [60,
61, 62]; 1171
[104–106]
1207 [64];
1193 [65, 66,
68]
a Consecutive numbering for recurrent sequences from [1]–[75] is adopted from Degenkolb et al. (2006a); new compounds are listed in ascending
order from [76] on. Numbers in bold indicate major compounds in the HPLC elution profiles produced by an individual strain
ALM F30/F50 Alamethicin F30/F50, TCP trichocompactin, TBV trichobrevin A and B, TCT-A trichocryptin A, TCT-B trichocryptin B, TFR
trichoferin, n.d. not detected. For ALMs, TCPs, and TFRs, the predominant [M+H]+ ions are listed; for TCTs and TBVs, the predominant
[M+Na]+ ions
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Characterization by MALDI-TOF MS analysis was
performed on the same MALDI instrument in linear
delayed extraction mode using an acceleration voltage of
20 kV and a low mass gate of 1,500 Da. Spectra for
individual specimens were compiled, averaging results
from at least 100 shots taken across the width of the
specimen for m/z 2,000–20,000.
Mycotoxin and secondary metabolite profiling
Cultivation and extraction Liquid cultivations were per-
formed in 25-ml Blue cap bottles containing 4 ml potato-
dextrose broth (Difco) for 10 days in darkness. Cultures
were extracted over night using 15 ml ethyl acetate, which
was then evaporated in vacuo and redissolved in 500μl
acetonitrile /water (2:1, v/v) and filtered through a 0.45-μm
PTFE syringe filter (Nielsen et al. 2005). Plate cultures
were grown on oatmeal agar and PDA (Difco) for 10 days
in darkness at 25°C, and a 0.6-cm2 agar culture was cut out
and transferred to a 2-ml vial along with the 10-cm2 culture
mat which was scraped off using a scalpel. The sample was
ultrasonicated with 0.75 ml acetonitrile for 1 h, and filtered
through a 0.45-μm PTFE syringe filter.
HPLC-DAD-ESI-TOF-MS Analysis was performed on an
Agilent 1100 system equipped with a photo diode array
detector (DAD), and a Luna C18 II column (Phenomenex,
Torrance, Calif.) and coupled to a LCT orthogonal time-
of-flight MS (Waters-Micromass, Manchester, UK), with a
Z-spray ESI source and a LockSpray probe (Nielsen et al.
2005).
Samples were analyzed in positive ESI+ and ESI- using a
water-acetonitrile gradient system starting from either 5%
acetonitrile, which was increased linearly to 100% in 23 min
holding for 5 min, or 15% acetonitrile, which was in-
creased linearly to 100% in 20 min holding for 5 min
(Nielsen et al. 2005). In both ESI+ and ESI- two scan
functions (1 s each) were used: the first with a potential
Table 4 Sequences of new 11- and 12-residue peptaibiotics of different strains from the Trichoderma brevicompactum complex (excluding
Hypocrea rodmanii)
Peptaibiotica Molecular weight
([M+Na]+)
Residue
1 2 3 4 5 6 7 8 9 10 11 12
TCT-A_VIa [80] 1111 Ac Vxx Aib Pro Vxx Aib Pro Aib Vxx Aib Pro Lxxol
TCT-A_VIb [81] 1111 Ac Lxx Aib Pro Vxx Aib Pro Aib Aib Aib Pro Lxxol
TCT-A_IIIc [82] 1153 Ac Lxx Aib Pro Lxx Aib Pro Lxx Aib Aib Pro Lxxol
TCT-B_IIIc [83] 1238 Ac Lxx Aib Pro Vxx Vxx Aib Pro Aib Lxx Aib Pro Lxxol
TCT-B_IIId [84] 1238 Ac Vxx Aib Pro Vxx Lxx Aib Pro Aib Lxx Aib Pro Lxxol
TCT-B_IIIe [85] 1238 Ac Lxx Aib Pro Vxx Lxx Aib Pro Aib Vxx Aib Pro Lxxol
TCT-A_Ic [86] 1125 Ac Vxx Aib Pro Lxx Aib Pro Lxx Aib Aib Pro Vxxol
TCT-A_Id [87] 1125 Ac Lxx Aib Pro Lxx Aib Pro Lxx Aib Aib Pro Aibol
TCT-A_Ie [88] 1125 Ac Vxx Aib Pro Lxx Aib Pro Lxx Aib Aib Pro Vxxol
TCT-A_1f [89] 1125 Ac Lxx Aib Pro Lxx Aib Pro Vxx Aib Aib Pro Vxxol
TCT-A_IIc [90] 1139 Ac Lxx Aib Pro Lxx Aib Pro Lxx Aib Aib Pro Vxxol
TCT-A_IIIc [91] 1153 Ac Lxx Aib Pro Lxx Aib Pro Lxx Aib Aib Pro Lxxol
TCT-C_Ia [92] 1097 Ac Vxx Aib Pro Vxx Aib Pro Lxx Vxx Aib Pro Alaol
TCT-C_IIa [93] 1111 Ac Vxx Aib Pro Vxx Aib Pro Lxx Lxx Aib Pro Alaol
TCT-C_IIIa [94] 1125 Ac Lxx Aib Pro Vxx Aib Pro Lxx Lxx Aib Pro Alaol
TCT-D_Ia [95] 1196 Ac Vxx Aib Pro Vxx Vxx Aib Pro Lxx Vxx Aib Pro Alaol
TCT-D_IIa [96] 1210 Ac Vxx Aib Pro Vxx Vxx Aib Pro Lxx Lxx Aib Pro Alaol
TCT-D_IIb [97] 1210 Ac Lxx Aib Pro Vxx Vxx Aib Pro Lxx Vxx Aib Pro Alaol
TCT-D_IIIa [98] 1224 Ac Lxx Aib Pro Vxx Vxx Aib Pro Lxx Lxx Aib Pro Alaol
TCT-D_IIIb [99] 1224 Ac Vxx Aib Pro Vxx Lxx Aib Pro Lxx Lxx Aib Pro Alaol
TCT-D_IIIc [100] 1224 Ac Lxx Aib Pro Vxx Vxx Aib Pro Lxx Lxx Aib Pro Alaol
TCT-D_IIId [101] 1224 Ac Lxx Aib Pro Vxx Vxx Aib Pro Lxx Lxx Aib Pro Alaol
TCT-D_IVa [102] 1238 Ac Lxx Aib Pro Vxx Lxx Aib Pro Lxx Lxx Aib Pro Alaol
TCT-D_IVb [103] 1238 Ac Lxx Aib Pro Vxx Lxx Aib Pro Lxx Lxx Aib Pro Alaol
TBV-B_IVa [104] 1171 Ac Aib Ser Lxx Lxx Aib Pro Lxx Lxx Aib Pro Lxxol
TBV-B_IVb [105] 1171 Ac Aib Ser Lxx Lxx Aib Pro Lxx Lxx Aib Pro Lxxol
TBV-B_IVc [106] 1171 Ac Aib Ser Lxx Lxx Aib Pro Lxx Lxx Aib Pro Lxxol
a The N-terminal sequences AcVxx-Aib and AcLxx-Aib were tentatively assigned from sequence homologies with those trichocryptins/
trichobrevins previously reported by Degenkolb et al (2006a)
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difference of 14 V between the skimmers scanning m/z 100
to 900, the second with 40 V between the skimmers
scanning m/z 100–2,200.
Data analysis was performed as described previously
(Nielsen et al. 2005). Unknown peaks were matched against
an internal reference standard database (~730 compounds)
as well as the 33,557 compounds in Antibase 2007 (Laatsch
2007).
Results
For ease of discussion, the new names that will be
introduced below are used in this and the "Discussion"
sections.
Phylogeny
To position T. brevicompactum and its relatives within
Trichoderma, we sequenced parts of three genes tef1, rpb2,
and ITS (Fig. 1). The alignment of three loci included a
total of 2,369 characters in the analyses (848 for rpb2, 837
for tef1, 684 for ITS), including insertions and deletions.
Ambiguously-aligned regions were manually excluded
from the analyses (356 characters). In the maximum
parsimony analyses, the consistency and homoplasy indices
for the combined dataset were, respectively, 0.333 and
0.667. Of the included characters, rpb2 provided the most
parsimony informative characters (34%), followed by ITS
(20.8%), and tef1 (19.4%); tef1 provided the least informa-
tive characters, in part because most of the ambiguously-
aligned characters were in the large intron of tef1.
The reciprocal 70% BP and 95% PP thresholds for
individual loci show that the topologies of the three genes
are congruent (results not shown) and therefore the
partitions were combined in a single tree (Fig. 1). Figure 1
represents a Bayesian phylogram with the best log
likelihood (LnL = −22,426.97). Bootstrap results from the
MP and NJ analyses are indicated in Fig. 2 but trees are not
shown. The results of all BI, MP, and NJ analyses show
high BP and PP values for the clade that includes T.
brevicompactum, T. protrudens, T. turrialbense, T. arundi-
naceum, and H. rodmanii, hereafter the Brevicompactum
clade. These five species received high bootstrap support in
parsimony analysis and high posterior probabilities in
Bayesian analysis.
Results of the phylogenetic analyses reveal high BP and
PP for previously described clades/lineages (Kindermann et
al. 1998; Chaverri and Samuels 2003; Samuels 2006;
International Subcommission on Trichoderma and Hypo-
crea Taxonomy: http://www.isth.info/biodiversity/index.
php). The Brevicompactum clade is distinct from other
known lineages and thus represents a separate lineageTa
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Table 7 Peptaibiotics, mycotoxins and hydrophobins
Number Pseudomolecular ion ([M+H]+or [M+Na]+) of peptaibiotics and
hydrophobinsa
I. ALAMETHECINS (ALM)
1 1964
2 1978
3 1978
4 1992
31 1950
76 1963
77 1977
78 1977
79 1991
II. TRICHOCOMPACTIN (TCP)
5 726
6 726
7 740
8 740
9 754
10 754
40 756
39 770
41 770
42 784
43 784
70 740
71 754
72 754
73 756
74 770
75 770
III. TRI0CHOCRYPTIN-A (TCT-A)
19 1125
20 1125
21 1125
22 1139
23 1139
24 1153
25 1153
26 1167
27 1167
28 1167
29 1181
30 1181
80 1111
81 1111
82 1153
86 1125
87 1125
88 1125
89 1125
90 1139
91 1153
IV. TRI0CHOCRYPTIN-B (TCT-B)
11 1210
12 1210
13 1224
14 1224
Table 7 (continued)
Number Pseudomolecular ion ([M+H]+or [M+Na]+) of peptaibiotics and
hydrophobinsa
15 1238
16 1238
17 1252
18 1252
33 1266
34 1266
35 1266
36 1266
83 1238
84 1238
85 1238
V. TRICHOCRYPTIN-C (11-residue peptaibols with C-terminal Alaol)
(TCT-C)
92 1097
93 1111
94 1125
VI. TRICHOCRYPTIN-D (12-residue peptaibols with C-terminal Alaol)
TCT-D
95 1196
96 1210
97 1210
98 1224
99 1224
100 1224
101 1224
102 1238
103 1238
VII. TRICHOBREVIN (TBV)
44 1099
45 1099
46 1099
47 1099
48 1113
49 1113
50 1127
51 1127
52 1127
53 1141
54 1141
55 1129
56 1129
57 1129
58 1143
59 1143
60 1157
61 1157
62 1157
104 1171
105 1171
106 1171
VIII. TRICHOFERIN (TFR)
64 1207
65 1193
66 1193
67 1193
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within Trichoderma/Hypocrea, as was suggested by Kraus
et al. (2004) for the single species T. brevicompactum.
Because of low bootstrap support (Fig. 1), the Brevicom-
pactum clade is in an unresolved polytomy with H. victoriensis
and the Viride, Minutisporum, Megalocitrina, and Lutea
Clades. However, based on branch length the closest relative
to the Brevicompactum clade is the Lutea clade (Fig. 1).
For convenience, we included only representative cultures
of members of the Brevicompactum clade in Fig. 1. In order
to clarify the interrelationships of members of the Brevi-
compactum clade, we analyzed all 28 isolates that we know
belong in that clade in our subsequent analyses (Fig. 2a−d)
(the 29th, CBS 113214, was received too late to include in
the phylogenetic analysis). We adopted the phylogenetic
species recognition of Dettman et al. (2003). Briefly a clade
is recognized as an independent evolutionary lineage if it
satisfies either of two criteria: (1) genealogical concordance:
the clade is present in the majority of the single-locus trees; or
(2) genealogical nonconcordance: the clade is well supported
in at least one single-locus tree and is not contradicted in any
other single-locus tree at the same level of support. We
sequenced three unlinked loci: tef1 (Fig. 2b), rpb2 (Fig. 2c),
and ITS (Fig. 2c). The properties of the data set for each
gene and the combined multi locus sequence (MLS; Fig. 2a)
are given in Table 2. In this second analysis, the sequences
varied strikingly in their variability; tef1 had the highest
number of parsimony informative characters (144 out of 596
or 24%) followed by rpb2 (14.6%) and ITS (2.2%).
Figure 2a represents a Bayesian inference majority-rule
consensus tree based on MLS. This tree shows a strongly
supported Brevicompactum clade (9) that is divided into two
sister subclades: Hypocrea rodmanii (7) and the Brevicom-
pactum complex (8), each of which was highly supported in
the combined data set and in the individual gene trees based
on tef1 and rpb2 (Fig. 2b,c). The T. brevicompactum complex
was divided further into a polytomy comprising three main
clades: 1 (T. brevicompactum, T. turrialbense), 2 (T. arundi-
naceum), and the single culture CBS 121320 (T. protrudens).
Subclades 1 and 2 were also highly supported in the individual
gene trees (Fig. 2b,c). The T. brevicompactum clade (3) again
showed two supported subclades (4, 5); the ex-type culture of
T. brevicompactum (CBS 109720) is in subclade 4. Subclade
4 did not have support in the rbp2 tree (Fig. 2c) but subclade
5 received strong support in both of the individual gene trees
(Fig. 2b,c). The two members of subclade 5 (CBS 112446,
CBS 112447) differed by only one allele despite their widely
divergent geographic origins (India and Mexico). There was
no support for taxonomic separation of clade 3 from
morphology, secondary metabolites or biogeography.
The two isolates of node 6 (T. turrialbense) originated
from the same area in Costa Rica. This clade is highly
supported in MLS, tef1 and rpb2. Despite a strong sister
relationship with T. brevicompactum s. str. (clade 1), it
differs from T. brevicompactum in producing harzianum A
and in subtle morphological characters (Table 8).
The other large clade (clade 2, T. arundinaceum)
consisted of 8 isolates. This clade had high support in the
MLS, tef1 and rpb2 trees. Despite their diverse geographic
origins, their sequences were highly homogenous. Such a
high homogeneity among isolates of one species having
such diverse origin is uncommon in Trichoderma.
Trichoderma protrudens, which was found as an
endophyte in sapwood of Theobroma cacao in India, had
strong sister relationship to clades 1 and 2 in MLS (Fig. 2a)
and the single gene trees (Fig. 2b,c). The ITS sequence for
this isolate differed from T. brevicompactum and T.
turrialbense by a 1-bp insertion.
The three isolates of Hypocrea rodmanii (clade 7) were
collected in the Mid Atlantic states (Maryland and Virginia)
Table 7 (continued)
Number Pseudomolecular ion ([M+H]+or [M+Na]+) of peptaibiotics and
hydrophobinsa
68 1193
69 1193
IX. HYPOCOMPACTIN (HPC)
107 738
108 752
109 766
110 780
111 714
112 728
X. HYPORODICIN (HRC)
113 1437
114 1451
115 1465
116 1380
117 1394
XI. TRICHOKONIN ((TKO)
118 1866
119 1880
HYDROPHOBIN BIOMARKERS (HPH)
300 6658
301 6879
302 6943
303 7118
304 7289
305 7319
306 8755
307 9499
308 9567
TRICHOTHECENES
400 Trichodermin TDERMIN)
401 Harzianum A (HARZ_A)
Consecutive numbering from 1 to 75 according to Degenkolb et al. 2006a
a For details, see text
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H. ceramica G.J.S. 88-70
H. estonica G.J.S. 96-129
H. chromosperma G.J.S. 94-67
H. gelatinosa G.J.S. 88-17
H. nigrovirens G.J.S. 99-64
H. catoptron G.J.S. 02-76
H. ceracea  G.J.S. 95-159
T. tomentosum DAOM 178713a
H. cinnamomea G.J.S. 97-237
H. straminea G.J.S. 02-84
Trichoderma sp. DIS 219c
H. lixii G.J.S. 90-22
T. aggressivum CBS 100525
T. virens DAOM 167652
T. virens G.J.S. 01-287
T. stromaticum G.J.S. 00-108
T. protrudens DIS 119f
T. arundinaceum ATCC 90237
T. arundinaceum CBS 119577
T. turrialbae CBS 112445
T. brevicompactum CBS 112446a
T. brevicompactum CBS112447
T. brevicompactum G.J.S. 04-381
H. rodmanii CBS 109719
H. rodmanii CBS 120895
H. dingleyae G.J.S. 99-105
H. intricata G.J.S. 02-78
H. dorotheae G.J.S. 99-202
T. koningiopsis DAOM 222105
T. koningii G.J.S. 90-18
T. virideVE G.J.S. 90-97
H. stilbohypoxyli G.J.S. 96-32
H. rufa CBS 101526
T. scalesiae G.J.S. 03-74
T. atroviride CBS 14295
T. viridescens CBS 33372
T. viridescens CBS 43895
T. erinacium DIS 7
T. strigosum DAOM 166121
T. asperellum G.J.S. 907
T. hamatum DAOM 167057
T. pubescens DAOM 166162
H. pezizoides G.J.S. 01-257
H. pilulifera CBS 81468
T. minutisporum DAOM 167069
H. psychrophila Hy8
H. lutea G.J.S. 89-129
H. melanomagna G.J.S. 99-153
H. victoriensis G.J.S. 99-130
H. semiorbis DAOM 167636
T. oblongisporum DAOM 167085
T. fertile DAOM 167161
H. candida P.C. 59
H. chlorospora G.J.S. 98-1
H. cremea G.J.S. 91-125
H. surrotunda G.J.S. 88-73
H. thelephoricola G.J.S. 95-135
H. costaricensis P.C. 21
H. thailandica G.J.S. 97-61
H. virescentiflava P.C. 278
H. cuneispora G.J.S. 91-93
T. spirale DAOM 183974
H. phyllostachydis G.J.S. 92-123
H. sulawesensis G.J.S. 85-228
T. longibrachiatum DAOM 139758
T. longibrachiatum DAOM 166989
50 changes
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
HARZIANUM CLADE
BREVICOMPACTUM CLADE
VIRIDE CLADE
MINUTISPORUM CLADE
LUTEA CLADE
SEMIORBIS CLADE
CHLOROSPORA CLADE
LONGIBRACHIATUM CLADE (outgroup)
CERAMICA CLADE
VIRENS
STRICTIPILE CLADE
MEGALOCITRINA CLADE
STROMATICUM CLADE
Fig. 1 Bayesian phylogram of combined ITS, tef1, and rpb2 sequence
data. The tree presented had the best log likelihood (LnL=−22,426.97)
in the Bayesian analysis. Thick black lines represent nodes with
posterior probability >90%, and Parsimony and Neighbour-Joining
bootstraps >70%. Thick gray lines represent nodes with posterior
probability >90%, Neighbor-Joining bootstrap >70%, and Parsimony
bootstrap <70%. Nodes with asterisks (*) represent clades with
posterior probabilities >90%. Clade/lineage names based in part on:
Samuels 2006; Chaverri and Samuels 2003; and ISTH (http://www.
isth.info/biodiversity/index.php)
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ATCC 90237
CBS 119574
CBS 119575
CBS 119578
CBS 119577
CBS 121153
NRRL 3199
CBS 119573
CBS 119571
MA 4103
IBT 40841
CBS 119572
CBS 112444
CBS 119569
CBS 119570
CBS 109720
CBS 121154
CBS 112447
CBS 112446
CBS 112443
BBA 72294
CBS 112445
DIS 119F
G.J.S. 89-120
CBS 120895
CBS 109719
G.J.S. 74-83
G.J.S. 85-26
MLS
*
*
2
4
5
6
1
3
7
8
9
T. arundinaceum
T. brevicompactum
T. turrialbense
T.protrudens
BREVICOMPACTUM
COMPLEX
H. rodmanii
H. lutea
H.lutea
BREVICOMPACTUM
CLADE
CBS 112446 
CBS 112447
CBS 119571
MA 4103
IBT 40841
CBS 119572
CBS 112444
CBS 119569
CBS 119570
CBS 109720
CBS 121154
CBS 112443
BBA 72294
CBS 112445
DIS 119F
ATCC 90237 
CBS 119574
CBS 119575
CBS 119578
CBS 119577
CBS 121153
NRRL 3199
CBS 119573
G.J.S. 89-120
CBS 120895
CBS 109719
G.J.S. 74-83
G.J.S. 85-26
tef1
*
T. protrudens
T. turrialbense
T. arundinaceum
H.rodmanii
T. brevicompactum
H.lutea
H.lutea
CBS 119572
CBS 119571
MA 4103
CBS 109720
IBT 40841
CBS 119569
CBS 119570
CBS 112444
CBS 121154
CBS 112447
CBS 112446
CBS 112443
BBA 72294
CBS 112445
CBS 119577
CBS 121153
ATCC90237
NRRL 3199
CBS 119573
CBS 119575
CBS 119574
CBS 119578
DIS 119F
G.J.S. 89-120
CBS 120895
CBS 109719
G.J.S. 74-83
G.J.S. 85-26
rpb2
H. rodmanii
T. arundinaceum
T. protrudens
T. turrialbense
T. brevicompactum
H.lutea
H. lutea
CBC 112446
CBS 112447
ATCC 90237
CBS 119574
CBS 119575
CBS 119578
CBS 119577
CBS 121153
NRRL 3199
CBS 119573
CBS 119571
CBS 112444
MA 4103
CBS 109720
IBT 40841
CBS 119572
CBS 112443
CBS 119569
CBS 121154
CBS 119570
BBA 72294
CBS 112445
DIS 119F
G.J.S. 89-120
CBS 120895
CBS 109719
G.J.S. 74-83
G.J.S. 85-26
100
100
99
96
ITS
H. rodmanii
BREVICOMPACTUM
COMPLEX
T. arundinaceum
BREVICOMPACTUM
CLADE
H.lutea
H.lutea
a b
d
c
Fig. 2 Majority-rule (50%) consensus tree resulting from Bayesian
analysis of a combined 3-gene, b tef1, c rpb2 and d ITS dataset.
Branches with thick black lines represent clades with posterior
probability (PP) ≥ 0.95 and bootstrap Maximum parsimony (BS-MP)
and Bootstrap Neighbour-Joining (BS-NJ) values ≥ 70%. Thick gray
lines represent clades with PP ≥ 0.95 and BS-MP or BS-NJ or both
< 70%. Asterisks (*) represent clades with PP ≥0.90. Numbers on
nodes correspond with node numbers used in the text
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Table 8 Continuous characters of morphology and colony
Taxa
Character Trichoderma
arundinaceum
Trichoderma
brevicompactum
Trichoderma
protrudens
Hypocrea
rodmanii
Trichoderma
turrialbense
Dominant distribution Cosmopolitan,
temperate
and tropical
Cosmopolitan,
temperate
and tropical
India: Kerala USA: MD, VA Costa Rica
Conidia length (μm) (2.2)2.7–3.5(5.0) (2.2)2.7–3.0(3.7) (2.5)2.7–3.2(3.5) (1.7)2.0–2.5(2.7) (2.2)2.5–3.0(3.2)
95% CI 3.1–3.2 2.9–3.0 2.9–3.0 2.2–2.3 2.7–2.8
n=270 n=330. n=30 n=60
Width (μm) (1.7)2.5–3.0(3.5) (2.0)2.2–2.7(3.0) (2.2)2.5–2.7(3.0) (1.7)2.0–2.2(2.5) (2.0)2.2–2.7(3.0)
95% CI 2.6–2.7 2.5–2.6 2.5–2.7 2.0–2.1 2.5–2.6
n =270 n=330 n=30 n=60 n=60
L/W (0.9−)1.0−1.4(−1.7) (0.9)1.1–1.3(1.4) (1.0)1.0–1.3(1.5) (0.9)1.0–1.2(1.4) (0.8)1.0–1.1(1.5)
95% CI 1.16–1.20 1.16–1.19 1.1–1.2 1.07–1.12 1.06–1.10
n = 270 n=330 n=30 n=60 n=60
Phialides length (μm) (3.7)4.5–7.0(12.7) (3.7)4.7–6.7(15.0) (4.0)5.5–9.0(12.0) (3.0)4.0–5.5(7.0) (3.7)4.5–6.7(12.0)
95% CI 5.5–5.7 5.6–5.9 6.7–8.0 4.5–4.9 5.3–5.9
n=270 n=330 n=30 n=60 n=60
Max. width (μm) (2.0)3.0–4.0(4.5) (2.5)3.0–3.7(4.5) (2.2)2.5–3.0(3.2) (2.5)2.7–3.2(3.7) (2.5)2.7–3.7(4.2)
95% CI 3.4–3.5 3.3–3.4 2.7–3.0 2.9–3.1 3.1–3.3
n=270 n=330 n=30 n=60 n=60
Base (μm) (1.2)2.0–3.0(3.7) (1.3)2.0–2.7(3.7) (1.5)1.7–2.7(3.2) (1.0)1.5–2.2(2.5) (1.5)2.0–2.7(3.7)
95% CI 2.5–2.6 2.4–2.5 2.1–2.3 1.7–2.0 2.3–2.5
n=270 n=330 n=60 n=30 n=60
Length/width (1.1)1.2–2.2(5.2) (1.1)1.3–2.2(5.1) (1.4)1.8–3.4(5.0) (1.0)1.3–1.7(2.4) (1.2)1.3–2.3(4.3)
95% CI 1.6–1.8 1.7–1.8 2.4–2.9 1.5–1.7 1.7–1.9
n=270 n=330 n=30 n=60 n=60
Width of supporting cell (μm) (2.0)3.0–4.2(6.0) (1.7)2.7–4.0(5.7) (2.2)2.5–3.0(3.2) (2.2)3.0–4.0(4.5) (2.0)2.5–3.5(4.2)
95% CI 3.5–3.6 3.3–3.5 2.6–2.8 3.3–3.5 3.0–3.3
n=270 n=330 n=30 n=60 n=60
Ratio phialide length/width of
supporting cell
(0.8)1.1–2.3(6.5) (1.0)1.3–2.3(4.8) (1.5)2.0–3.5(6.5) (0.8)1.1–1.7(2.5) (0.9)1,2–2.6(6.0)
95% CI 1.6–1.7 1.7–1.8 2.5−3.0 1.4–1.5 1.7–2.1
n=270 n=330 n=30 n=60 n=60
Ratio phialide width/width of
supporting cell
(0.5)0.8–1.2(1.6) (0.6)0.8–1.2(1.7) (0.7)0.9–1.3(1.4) (0.6)0.7–1.1(1.4) (0.6)0.9–1.3(1.8)
95% CI 0.97–1.01 1.0–1.1 1.0–1.1 0.9–1.0 1.0–1.1
n=270 n=330 n=30 n - 60 n=60
Colony radius PDA 72 H (mm)
15°C Range 2–6 0–6 1–3 3–7 0–5
Mean 5 2 6 3
SD 1 2 2 2
n 7 11 1 2 2
CI 4–5 2–3 5–8 1–5
20°C Range 9–37 14–39 17–28 29–33 21–36
Mean 32 30 31 25
SD 7 7 2 6
n 7 11 2 2
CI 29–35 27–33 20–36 29–32
25°C Range 32–48 30–50 30–38 31–40 35–45
Mean 41 42 35 40
SD 4 5 4 4
n 7 11 1 2 2
CI 39–45 40–44 32–39 40–44
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and formed a highly supported clade (7) in MLS, tef1 and
rpb2 that was sister to the Brevicompactum complex. In the
ITS tree (Fig. 2d), this clade received strong support in
Bayesian analysis, but its bootstrap support was low (Fig. 2d).
In brief, phylogenetically, T. brevicompactum (Fig. 2a,
clade 3), T. arundinaceum (Fig. 2a, clade 2), T. turrialbense
(Fig. 2a, clade 6), T. protrudens (Fig. 2a) and H. rodmanii
(Fig. 2a, clade 7) have support in the majority (2/3) of the
three individual gene trees and thus meet the genealogical
concordance criteria of Dettman et al. (2003) for recogniz-
ing species. Trichoderma protrudens was consistently
independent of all other lineages in all of the analyses.
ITS sequences were able to discriminate unequivocally H.
rodmanii and T. arundinaceum; but T. brevicompactum, T.
turrialbense, and T. protrudens were indistinguishable by
ITS. The present work confirms the reidentification as T.
Table 8 (continued)
Taxa
Character Trichoderma
arundinaceum
Trichoderma
brevicompactum
Trichoderma
protrudens
Hypocrea
rodmanii
Trichoderma
turrialbense
Dominant distribution Cosmopolitan,
temperate
and tropical
Cosmopolitan,
temperate
and tropical
India: Kerala USA: MD, VA Costa Rica
30°C Range 40–69 36–60 52–58 35–42 44–63
Mean 54 52 37 56
SD 7 6 3 7
n 7 11 1 2 2
CI 51–57 50–54 36–42 50–54
37°C Range 0–18 0–30 23−45 0 3–38
Mean 8 7 11
SD 7 10 15
n 7 11 1 2 2
CI 6–12 4–10 4–10
Colony radius SNA 72 H (mm)
15°C Range 1–8 0–5 5–7 2–4 2–5
Mean 4 1.5 3 2
SD 2 2 1 1.5
n 7 11 1 2 3
CI –5 1–2 2–4 13–21
20°C Range 0–39 12–34 19–29 10–19 21–38
Mean 30 24 17 26
SD 5 5 4 7
n 7 11 1 2 2
CI 27–32 22–26 20–35
CI
25°C Range 32–48 19–48 30–41 13–28 38–50
Mean 41 35 22 44
SD 4 11 5 4
n 7 1 1 2 2
CI 39–43 33–37 16–27 40–48
30°C Range 40–55 20–56 39–47 7–26 54–59
Mean 47 41 19 56
SD 5 9 7 2
n 7 11 1 2 2
45–50 38–45 11–26 54–59
37°C Range 0–22 0–25 16–27 0 1–45
Mean 7 5 14
SD 5 7 19
n 7 11 1 2 2
CI 5–9 2–7 0–25
Temperature of first appearance of green conidia on PDA grown in intermittent light
20−25°C 25(−30)°C 30°C 20−25°C 20−25°C
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arundinaceum of three Trichoderma/Hypocrea strains that
have been reported in the peptaibiotic or mycotoxin
literature. Culture NRRL 3199 is cited as T. viride in U.S.
Patent 3833723 (Coats et al. 1974) for production of
alamethicin and has become the standard source for
alamethicins (e.g., Kirschbaum et al. 2003). Culture ATCC
90237 was reported in the literature, as T. harzianum, as the
original source of harzianum A (Corley et al. 1994). Culture
CBS 113214, a soil isolate, was reported by Lee et al.
(2005, as F000527) as a likely new Hypocrea sp. that
produces harzianum A.
Peptaibiotics
Peptaibiotics: HPLC-ESI-Ion-Trap-MS
General Remarks The patterns of peptaibiotics produced
by T. brevicompactum CBS 109720, CBS 119569, CBS
119570, T. arundinaceum CBS 119576, CBS 119577,
NRRL 3199 and T. turrialbense CBS 112445 (as T. cf.
brevicompactum) were investigated earlier (Degenkolb et
al. 2006a). To maintain conformity and to prevent confu-
sion about the identity of recurrent sequences mentioned
throughout the text and in tables, we adopt the consecutive
numbering of peptaibiotics from 1 to 75 previously
introduced by Degenkolb et al. (2006a). Consequently,
numbering of additional, mostly new sequences proceeds
consecutively from substance 76–119. The peptaibiotics
pattern of the above seven strains is shown in Table 3. New
sequences of peptaibiotics detected in the Trichoderma
strains (excluding T./H. rodmanii) are listed in Table 4,
sequences of peptaibiotics from T./H. rodmanii in Table 5,
and general sequences (“building schemes”) of peptai-
biotics found in the Brevicompactum clade are listed in
Table 6. All strains of T. brevicompactum, T. arundina-
ceum, T. turrialbense, and T. protrudens listed in Table 1
produced a number of 20-residue peptaibols, alamethicins
(ALMs), as major components. The alamethicins, which are
the most thoroughly investigated peptaibols, were recently
reviewed (Leitgeb et al. 2007).
Peptaibiomics of Trichoderma brevicompactum Some in-
traspecific variation among the ALM profiles was ob-
served. ALMs F30 [1–4] were produced by four strains,
whereas the remaining three strains produced a mixture of
the acidic ALMs F30 and the neutral ALMs F50/5, F50/6a,
F50/7, and F50/8b [76–79]. It appears, however, that in
cases where both subgroups of ALMs were produced,
ALMs F30 dominated over ALMs F50. These results
confirm the observation of Kirschbaum et al. (2003) who
described a time-dependent formation of ALM subgroups
by T. arundinaceum NRRL 3199. The latter produced the
neutral ALM F50 (Gln18-Gln19) at the beginning of the
fermentation; after about 5 d the ALM F50 concentration
decreased whereas the concentration of the acidic ALM
F30 (Glu18-Gln19) increased.
The second most abundant group were the 11-residue
trichocryptins A [19–30, 80, 81, 86–91]. They represent
deletion sequences of the 12-residue trichocryptins B [11–
18, 83–85], lacking the amino acid residue in position 5,
which is either Lxx or Vxx. Again, there is intraspecific
variation in the pattern of trichocryptins produced. The
trichocryptins A are found in every investigated strain but
chain length varied, depending on the amino acids in the
exchange position 1, 4, 7, and 8. The trichocryptins B
display the same building scheme as trichcryptins A but
carry an additional Vxx residue in position 4. Variable
amino acids are therefore located in position 1, 5, 8, and 9.
Trichoferins (TFR) are a group of minor, 10-residue
lipoaminopeptides produced by four of the seven strains.
The major component, TFR A [64], is produced by each of
the four trichoferin-positive strains, but there is some
intraspecific variation in the pattern of the four minor
homologues, TFR C-E [66–68]. Notably, trace amounts of
trichobrevins [52–54, 61, 62] were found in CBS 121154
but not in any of the other six strains. The pattern of
peptaibiotics produced by that strain is less complex than in
any other T. brevicompactum strain investigated.
Peptaibiomics of Trichoderma turrialbense Trichoderma
turrialbense is distinguished from T. brevicompactum
mainly by the production of different trichothecenes as
pointed out above. Like T. brevicompactum, T. turrialbense
produces ALMs F30 [1–4] as the major group of peptai-
biotics, although larger amounts of ALMs F50 [76–79] are
also present in CBS 122554 but not in CBS 112445.
Trichocryptins A [23–28] and B [13–18, 33–38] were
found in CBS 112445, being the only strain to produce
major amounts of trichocryptins B, which display [M+Na]+
ions at m/z 1266 [33–36] and 1280 [37, 38]. In contrast, T.
turrialbense CBS 122554 produced four 11-residue tricho-
cryptins C [92–95] and eight 12-residue trichocryptins D
[96–103], the former representing deletion sequences of the
latter. As shown in Table 6, both of these novel subgroups
exhibit high structural homology with trichocryptins A and
B, but they carry an L-alaninol (Alaol) residue at their C-
terminus. This is the first report to unambiguously prove
the presence of L-Alaol as a C-terminal constituent of
peptaibiotics. Small amounts of trichobrevins A [52, 53]
and B [62] and trichoferin A [64] were also detected in
strain CBS 122554. From its pattern of peptaibiotics, the
new species T. turrialbense is intermediate between T.
brevicompactum and T. arundinaceum.
Peptaibiomics of Trichoderma arundinaceum This includes
strain NRRL 3199, a patent strain originally reported as “T.
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viride” and generally considered to be the classical
commercial source of ALMs (Kirschbaum et al. 2003;
Leitgeb et al. 2007). The 12-residue trichobrevins (TBV,
44–62) were recognized as the second most abundant group
of peptaibiotics of T. arundinaceum. Depending on the
strain investigated, TBV B-IIIb [61] and B-IIIc [62], or A-
IVa [53] and A-IV-B [54] were observed as the predomi-
nant compounds. Thus, the common presence of both
alamethicins and trichobrevins as the two major groups of
peptaibiotics was recognized as the most important feature
distinguishing T. brevicompactum/T. turrialbense from T.
arundinaceum/T. protrudens. Trace amounts of trichocryp-
tins B were also detected in strain CBS 119576.
Peptaibiomics of Trichoderma protrudens The pattern of
peptaibiotics produced by CBS 121320 is quantitatively
identical to that of all five strains of T. arundinaceum
studied. CBS 121320 produced three new, positionally
isomeric minor compounds, the 11-residue trichobrevins B-
IVa [104–106], in small, but in somewhat larger amounts
than in T. arundinaceum, enabling us to sequence them.
Additional minor components, such as 7-residue tricho-
compactins III b (10), Va (39), and Vb (41), as well as four
10-residue lipoaminopeptides, trichoferins A (64), B (65),
C (66), and E (68), were found.
Peptaibiomics of Hypocrea rodmanii Hypocrea rodmanii
did not produce any of the peptaibiotics typical of the
Trichoderma species treated above. The most conspicuous
difference is the absence of alamethicins F30/F50, trichoc-
ryptins, trichobrevins, and trichoferins, which were the
distinctive peptaibiotics of T. brevicompactum, T. arundi-
naceum, T. turrialbense and T. protrudens.
Both investigated strains of Hypocrea rodmanii pro-
duced six new 7-residue lipopeptaibols, named hypocom-
pactins (HCP) I-VI [107–112]. Four of them, HCPs I-IV
[107–110], exhibit homology with four 7-residue lipostrigo-
cins A1-A4 from T. cf. strigosum CBS 119777 (Degenkolb
et al. 2006b) and the 7-residue trichocompactins produced by
T. brevicompactum, T. turrialbense, T. arundinaceum, and T.
protrudens. We assume that the N-terminal Gly of hypo-
compactins I-IV has been blocked by a C8 mono-unsaturat-
ed, branched or non-branched fatty acid, probably
n-octenoyl. This is based on LC/high-resolution CID-MS
data (K.F. Nielsen and T. Degenkolb, unpublished data) and
structural homologies with the lipostrigocins, trichogin GA
IV from T. longibrachiatum M 3431 (Auvin-Guette et al.
1992), and trikoningin KB I from T. koningii 903589
(Auvin-Guette et al. 1993), all carrying an N-terminal
n-octanoyl-Aib residue. This assumption is further sup-
ported by the presence of a cis-4-decenoyl residue bound
to Gly in the trichodecenins I and II. The producer of the
latter two lipopeptaibols was reported as T. viride (Fujita et
al. 1994), but neither details of taxonomic identification
nor a strain accession number were given. Hypocompac-
tins V and VI [111, 112] could only be sequenced partially
because of the very low intensities of the N-terminal b-type
fragment ions. The hypothesis of N-terminal n-octenoyl-
Gly in HCP I-IV leads to the hypothesis that n-octanoyl-
Gly (Oc-Gly) might be present in the all TCPs, as
supported by LC/high-resolution CID-MS data (K.F.
Nielsen and T. Degenkolb, unpublished data).
Hypocrea rodmanii CBS 120895 and CBS 109719
produced compounds [113–117] representing five new 14-
residue peptaibols, hyporodicins (HRC) A–E. All of them
carry the C-terminal octapeptide Vxx-Aib-Pro-Aib-Lxx-
Aib-Pro-Lxxol. This C-terminus has also been identified in
some of the trichobrevins and trichocryptins; and it was
first reported for the 14-residue harzianins HC-I and HC-VI
from T. harzianum, strains M-90361 and M-903603, with
Vxx = Val and Lxx = Leu (Rebuffat et al. 1995). The close
relationship of the hyporodicins [113–117], with harzianins
HC is further supported by the structure of the N-terminal
pentapeptide Ac-Aib-Gln-Lxx-Aib-Pro found in [113–115]:
the same sequence with Lxx = Leu has been reported
previously for harzianins HC-X, HC-XIII, and HC-XV
(Rebuffat et al. 1995).
Two 19-residue peptaibols, the compounds [118] and
[119], were produced. Compound [118] exhibited the same
fragmentation pattern as trichokonin V (TKO-V) from a
fungicolous strain of T. koningii that was isolated from a
fruiting body of Ganoderma lucidum (Huang et al. 1995).
Consequently, it could be identical with trichokonin V, or
represent a positional isomer. The second trichokonin-like
homologue carries a Vxx residue instead of Aib in position
16 of the peptide chain. Thus, compound [119] might
represent a deletion sequence of trichokonin VII (Huang et
al. 1995), as it lacks the Ala residue of the former in
position 6. Peptaibols with the same C-terminal sequences
were described from T. koningii LCP984209 (Landreau et
al. 2002), a marine strain that was isolated as a contaminant
from the cockle Cerastoderma edule (Sallenave et al.
1999).
Typing of strains by intact cell MALDI-TOF mass
spectrometry (ICMS) and hydrophobins
Sporulating mycelium of strains grown on PDA was
subjected on day 6 to intact cell mass spectrometry (ICMS).
Patterns in the high mass metabolite range of 1,000 to
2,000 Da and in the low mass proteome region of 4,000 to
12,000 Da were recorded (Tables 1 and 7). The low mass
protein region provides molecular ions of hydrophobins,
small hydrophobic proteins that are excreted and proteolyt-
ically processed. Each spectrum consisted of 3–11 masses
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of different intensities, and the mass data were analysed by
UPGMA cluster analysis (Pearson Correlation, not shown).
The data are grouped into 3 main clusters, Trichoderma/
Hypocrea rodmanii (CBS 120895), T.arundinaceum/T.
protrudens (NRRL 3199, CBS 119575, CBS 119576/CBS
121320), and T. turrialbense (CBS 122554). A total of 58
different masses were observed. None of the masses
recorded for H. rodmanii and T. protrudens (CBS 121320)
were shared by other strains. This supports the conclusion that
these isolates represent individual species. T. arundinaceum
and T. protrudens have been grouped by UPGMA cluster
analysis or use of the commercial program SARAMIS in
one cluster, since the 4 dominant masses and their spacings
are fairly similar (CBS 121320 with dominating peaks at
m/z 5566, 7188/7249 and 9623, T. arundinaceum with
corresponding masses of m/z 5605, 7172/7222 and 9650).
All T. arundinaceum strains share the masses m/z 5603,
8648 and 9652, which were not detected in any other
strains. These masses can be considered as biomarkers for
this species.
More complex is the situation in the T. brevicompactum/
T. turrialbense cluster. Some of the masses are found in
both subclusters, as reflected by the cluster analysis.
Inspection of the mass spectra, however, reveals that two
of the dominating masses, respectively, in each subcluster
are not shared by the other (m/z 7092 and 9552 in T.
turrialbense, m/z 6946 and 9572 in T. brevicompactum),
while two significant masses of the Brevicompactum
subcluster are shared as minor peaks in the Turrialbense
subcluster (m/z 7112, and 8753), and one significant peak
(m/z 9307) of the Turrialbense subcluster is shared by the
Brevicompactum subcluster. Both subclusters share addi-
tional minor peaks (m/z 7293 and 8815). Analysis of the
spectra with the program SARAMIS (Anagnostec) devel-
oped for ICMS identification of microbes locates the
Turrialbense subcluster within a Brevicompactum cluster.
The data suggest that certain hydrophobins may be shared
in both subclusters, while others are not. Because hydro-
phobins are small proteins directly encoded by DNA,
identical proteins indicate largely identical gene sequences.
Mass data alone do not permit recognition of a species, as
we cannot deduce any information on the respective genetic
background. Only sequence information on the respective
hydrophobins will permit a clear evaluation (Fig. 3).
Mycotoxin and secondary metabolite profilies
Two trichothecene mycotoxins were detected by LC-HRMS
in members of the Brevicompactum complex (Table 1),
trichodermin and harzianum A. The latter compound was
produced by all members of T. turrialbense, T. protrudens,
and T. arundinaceum, whereas T. brevicompactum pro-
duced trichodermin as previously described (Nielsen et al.
2005). Production of these were 30–100 times higher on
PDA than oatmeal agar (OAT).
Besides tricothecenes, several isocoumarins (polyketi-
des) including diaportinol and diaportinic acid (matching
authentic reference standards) were detected in shake
cultures of T. turrialbense, T. protrudens, T. arundinaceum,
and T. brevicompactum.
Trichoderma arundinaceum and T. protrudens produced
large amounts of an undescribed compound (no likely
matches in Antibase 2007), with a [M-H]- ion of m/z
535.1627 and UV max of 200 nm. As this compound did
not ionize in ESI+, it cannot be assigned as a peptide.
Notably, it was also observed in T. brevicompactum but in
100- to 1,000-fold lower amounts.
All species except H. rodmanii produced a unique
metabolite with an assumed elementary composition of
C10H16O4 ([M-H]
- m/z 199.0967 calculated 199.0872 Da,
deviation −1.7 ppm) and UV-max 214 nm (no likely matches
in Antibase 2007), in ESI- it displayed a significant loss of
CO2 and showed a [M-2H + Na]
- ion strongly indicating
that the molecule contained a carboxylic acid moiety.
Neither trichothecenes nor isocoumarins were detected
in H. rodmanii (CBS 120895 and CBS 109719), and the
only metabolites detected in ESI+, ESI-, and UV/VIS were
the peptides, which are discussed under Peptaibiomics.
Putative pathways of trichothecene biosynthesis are
shown in Fig. 4.
Biogeography
Isolates of T. brevicompactum and T. arundinaceum are
sympatric and probably cosmopolitan. The two known
cultures of T. turrialbense were collected in Costa Rica, and
the only known culture of T. protrudens was isolated as an
endophyte of the trunk of one Theobroma cacao tree in
India. Hypocrea rodmanii originates from the Mid Atlantic
region of the eastern U.S.A. (Maryland, Virginia).
Multidimensional Scaling (MDS)
MDS, a parameter-free data reduction procedure, was
performed to detect any grouping of the strains that could
be determined by the values of the variables used. Three
different analyses were run (Fig. 6).
The first included only morphological data and is
presented in Fig. 6a. The stress of the final configuration
is 0.1818, which indicates only a moderate fit of the data to
the model. While the Brevicompactum and Arundinaceum
clades cannot be distinguished based on available morpho-
logical and cultural characters, CBS 109719 and CBS
120895 (H. rodmanii) form a distinct group, and also CBS
121320 (T. protrudens) is clearly distinguishable from all
other strains.
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The two other analyses were carried out on a subset of
cultures for which all metabolite data were available.
When the combined morphological and metabolite
characters are used (Fig. 6b), the stress of the final
configuration is 0.134 and the MDS performed on the
metabolite data alone (Fig. 6c) yields a stress of 0.144, both
values slightly better than that obtained with the morpho-
logical data alone, but still indicating only a moderate fit of
the data to the model. The results of both analyses are very
similar and thus confirm the modest contribution of
morphological data to the separation of the clades. The
scatterplot produced by the MDS with both morphological
and metabolite data (Fig. 6b) reveals that isolates tend to
group together according to their taxonomy. The major
groups (H. rodmanii, T. brevicompactum, T. arundinaceum,
and T. protrudens) are confirmed, although the separation is
not complete. Hypocrea rodmanii is separated from all
other strains and Trichoderma protrudens clusters closer to
T. arundinaceum, thus reinforcing its phylogenetic similar-
ity of the two species. The two T. turrialbense cultures, on
the other hand, are widely separated from each other and
cluster with T. brevicompactum and T. arundinaceum. The
difference between the two strains of T. turrialbense may be
explained by differences in trichocryptins C and D. The
isolate CBS 121154, T. brevicompactum from Cameroon,
occupies an intermediate position between T. arundina-
ceum, T. brevicompactum, and isolate CBS 122554 of T.
turrialbense because of its production of trichobrevins [61]
and [62], and trichocompactins [86–91].
Species delimitation
The cultures of H. rodmanii were derived from isolated
single ascospores. Two cultures (CBS 120897, CBS
122581) were not included in the phylogenetic analysis
but are undoubtedly representative of this species. Macro-
10400 12000
0
10
20
30
40
50
60
70
80
90
100
965
5
560
6
725
8
267 719
8
482
4
978
5
750
9
6 6 8
4000 5600 7200 8800
Mass (m/z)
8945.3
%
 In
te
ns
ity
72
34
96
55
56
06
72
58
56
34
86
52
71
98
92
82
40
12
48
24
97
85
75
09
43
27
62
74
66
08
89
39
11
66
4
55
88
50
40
52
32
4000 5600 7200 8800 10400 12000
Mass (m/z)
21E+4
0
10
20
30
40
50
60
70
80
90
100
%
 In
te
ns
ity
56
01
72
16
96
49
71
67
56
29
86
45
71
20
54
90 73
24
43
23
94
43
48
25
89
30
55
83
77
71
11
65
4
53
21
72
72
64
46
75
14
4000 5600 7200 8800 10400 12000
Mass (m/z)
1.3E+4
0
10
20
30
40
50
60
70
80
90
100
%
 In
te
ns
ity
56
00
96
48
54
88 71
39
71
65
56
28
86
44
73
21
94
44
48
21
41
94
77
14
55
83
71
20
46
32
52
85
97
82
40
02
89
28
67
15
61
01
92
39
43
85
64
05
CBS 119576 =
ATCC 90237 =
IBT 9471
T. arundinaceum
G.J.S. 05-180 =
CBS 119575 =
IBT 40842
T. arundinaceum
NRRL 3199
T. arundinaceum
Fig. 3 Intact cell MALDI-TOF
mass spectra showing the fin-
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or triplicate spectra is shown
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and microanatomy of stromata (Figs. 7j-o and 11a-e) are
unremarkable in the genus. Ascospores are typical of
Hypocrea in being hyaline and finely spinulose; the part-
ascospores are dimorphic (Fig. 11h, i). There is very little of
the stroma morphology or anatomy to distinguish it from
other species that have luteous stromata, such as H. lutea,
which has hyaline ascospores, or H. straminea (Chaverri
and Samuels 2003), a species that has green ascospores. It
is the anamorph that distinguishes this species. Tele-
omorphs are not known for other members of the
Brevicompactum clade.
Two apomorphies combine to characterize the Brevi-
compactum clade: subglobose conidia and the formation of
long white, unbranched or little to frequently branched,
conidiophores that project conspicuously from the surface
of the pustule (Figs. 8b, 10b, 12c and 13b). These may be
sterile over a considerable part of their length but bear one
to a few phialides at the tip (e.g., Figs. 8c, 9b, c and 13c).
Conidia arise from near their base in a more or less slimy
mass; thus, pustules of conidia often appear papillate or
lanose. Typical pustules on SNA and CMD are very
compact and hemispherical, and free conidiophores within
the pustule are not visible when viewed with a stereo
microscope. On CMD there is a tendency for pustules to be
more extensive, flat and more loosely organized. The
papillate aspect is slightly less well developed in T.
turrialbense. The original description of T. brevicompactum
(Kraus et al. 2004) described the long extensions as
developing in old cultures, but in our experience they are
conspicuous elements from an early stage on SNA and
CMD. There is a tendency for the projecting conidiophores
of T. brevicompactum, T. turrialbense and T. protrudens to
be more branched than in T. arundinaceum.
In addition to conidiophores with long extensions, all of
the species discussed here produce completely fertile conid-
iophores that do not have long extensions (e.g., Figs. 8j, 9g
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and 10h). These conidiophores resemble T. harzianum
(Bissett 1991).
Hypocrea rodmanii is separated from the Brevicompac-
tum complex by its slower rate of growth, smaller conidia
and phialides, the production of trichokonins, hyporodicins,
and hypocompactins. Unlike all members of the Brevicom-
pactum clade, it does not produce alamethicins or tricho-
thecene-type toxins. The small green, globose conidia
combine with projecting, partially sterile conidiophores to
distinguish this species from all known Hypocrea and
Trichoderma species.
Members of the Brevicompactum complex are not easily
separated on the basis of phenotype (Fig. 6; continuous
characters are summarized in Table 8).
Trichoderma protrudens is distinguished by its longer
phialides, its high growth rate at 37°C, production of
harzianum A, and its unique pattern of hydrophobins.
Trichoderma turrialbense is very closely related to T.
brevicompactum; we distinguish these species mainly on
the basis of production of trichodermin by T. brevicompac-
tum and harzianum A by T. turrialbense. Trichoderma
arundinaceum is distinguished from T. brevicompactum by
the production of harzianum A and by the lack of a
synanamorph in CMD cultures of the former (see below).
Overall, the phialides of T. protrudens are longer and
narrower than in all other species treated, with a conse-
quently larger L/W ratio. The cells that produce phialides
are narrowest in T. protrudens, 2.5–3.0 µm, as compared to
3–4 µm in the other species. The phialides of H. rodmanii
are shortest.
No microscopic characters reliably and practically separate
T. brevicompactum, T. turrialbense and T. arundinaceum.
Small, but consistent differences in conidial sizes, especially
when seen at the 95% confidence intervals and growth rates
can be seen in Table 8 and Fig. 5. There is a very slight
tendency for conidia of T. arundinaceum to be longer and
wider than in the other species. Trichoderma arundinaceum
and T. brevicompactum have a larger l/w ratio while the
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l/w ratio of conidia of H. rodmanii and T. turrialbense is
smaller; the l/w ratio of conidia of T. prodrudens is
intermediate between the two groups (Fig. 5). Trichoderma
turrialbense differs from both T. brevicompactum and T.
arundinaceum in having a slightly faster rate of growth at 25
and 30°C on SNA. The formation of, especially, different
peptaibiotics in the respective species (trichocryptins in T.
brevicompactum/T. turrialbense vs trichobrevins in T. arun-
dinaceum/T. protrudens), supports a distinction between T.
brevicompactum and T. arundinaceum.
Chemotaxonomic data separate three clusters, T. protru-
dens (a), T. arundinaceum (b) and T. brevicompactum (c1)/
T. turrialbense (c2) due to the presence of one unique non-
ribosomal peptide synthtase (NRPS) gene for trichoferin,
and high-level expression of trichobrevins. All three groups
may produce alamethicins. Trichocryptins A are character-
istic for (c1). Major amounts of trichobrevins are found
only in (a) and (b), whereas CBS 112154 is the only isolate
in (c) to produce traces of trichobrevins. Trichocryptins B
are found in (c) only. The structural data of the compounds
does not reflect their phylogenetic difference. A comparison
of a single domain of all respective alamethicin synthetases
would provide this information.
It is thus not possible to clearly differentiate clusters T.
protrudens from T. arundinaceum, or T. turrialbense from
T. brevicompactum by their metabolite profiles, as there is
just a single compound, either harzianum A or an unknown
peptaibol besides 4 or 5 others, and it might well be that,
e.g., new strains of T. protrudens producing trichodermin
will be discovered. On the other hand, it is very clearly
possible to separate T. protrudens/T. arundinaceum (a, b)
from T. brevicompactum/T. turrialbense (c) due to different
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pattern of trichobrevins (low concentration in c) and
trichocryptins B (high concentration in c, trace amounts in
T. arundinaceum CBS 119576).
The pattern of peptaibiotics of the two strains of T.
turrialbense is similar but not identical. Both strains produce
alamethicins as the major group of peptaibiotics. Trichobre-
vins are present in only small amounts, if at all, a fact that
clearly distinguishes these two strains from T. arundinaceum.
The major difference between CBS 112445 and CBS 122554
is the presence of 11- and 12-residue trichocryptins C and D
in the latter. Trichocryptins C and D terminate in L-alaninol
(Alaol), whereas we find Vxxol or Lxxol in trichocryptins A
and B. So far, CBS 122554 is the only strain in which we
have unambiguously found C-terminal Alaol and also the first
report of Alaol as a C-terminal constituent of peptaibiotics.
We did not find Alaol at the C-terminus of CBS 112445
trichocryptins. However, that difference is more interesting
from a biochemical point of view. The building scheme of all
trichcryptins A, B, C, and D is the same, and differences may
be explained by positional isomerism.
Discussion
Analyses of partial sequences of rpb2 indicate that
Trichoderma brevicompactum represents a separate lineage
in Trichoderma/Hypocrea, which we refer to here as the
Brevicompactum clade. Kraus et al. (2004) suggested the
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phylogenetic distinctiveness of the single species, T.
brevicompactum. As can be seen from Fig. 1, the Lutea
clade is the closest relative of the Brevicompactum clade
when branch lengths are considered; this confirms the
findings of Kraus et al. (2004).
Additional collections emphasize the two lineages that
were seen in the original description of T. brevicompactum
(Kraus et al. 2004). However, increased sampling has added
one new Hypocrea, an endophyte in a trunk of cacao in
India, and additional Trichoderma cultures from diverse
geographic sources. The combination of sequences of tef1,
rbp2 and ITS with phenotype data derived from micromor-
phology, colony morphology and secondary metabolites
has led us to recognize five species, of which four are new.
Members of the Brevicompactum clade are notable for their
subglobose conidia. The only three other species that have
smooth, subglobose conidia are T. harzianum and T.
aggressivum (Harzianum clade) and T. atroviride (Viride
clade); these species are not closely related to each other or
to T. brevicompactum.
The pattern of peptaibiotics produced by H. rodmanii
does not identify it as a close relative of T. brevicompactum
(see Fig. 6c), and it does not produce the trichothecenes or
other metabolites that are unique to the Brevicompactum
complex. Thus, the apparent relationship of H. rodmanii to
other members of the clade could be a sampling artefact.
With the discovery of additional taxa, the relationship
between H. rodmanii and members of the Brevicompactum
compex may change.
Kraus et al. (2004) cannot be criticized for having
recognized only one species. Although they found that T.
brevicompactum could be distinguished from H. lutea, T.
virens and T. harzianum on the basis of carbohydrate
utilization, they found virtually no difference among their
isolates of T. brevicompactum. Our own examination of the
morphological and cultural characters of an expanded panel
of isolates and analysis using multidimensional scaling
revealed only subtle differences. However, the anomalous
production of trichothecene-type toxins among the cultures
identified by Kraus et al. (2004) as T. brevicompactum led
us to search for additional phenotypic data from metabolites
(peptaibiotics) and physical phenotype.
As studies of species rich genera such as Trichoderma
expand and include increasing numbers of cultures, more
phylogenetic diversity is revealed than can be accounted for
by phenotype. In the current work, very small differences in
characters such as rate of growth or length/width ratio of
conidia are apomorphic for species and combine with
metabolic characters in defining species. However ‘small’
these differences are, they are representative of the species
diversity and are taxonomically significant, a point that was
made by Hawksworth (2001) with regard to the true
diversity of species of fungi.
Although no teleomorph has been discovered for any of
the members of the Brevicompactum clade, except for H.
rodmanii, the moderate diversity among isolates of T.
brevicompactum suggest recombination. Part of the diver-
sity of T. brevicompactum may be due to geographic
diversity, as exemplified by CBS 121154 (Cameroon) and
CBS 112443 (Papua New Guinea), whereas the remaining
cultures are from more or less contiguous continental areas
where one might expect genetic interchange. In contrast, T.
arundinaceum is noteworthy for its apparent lack of
phylogenetic diversity despite having essentially the same
geographic distribution as most of the T. brevicompactum
cultures, which suggests that T. arundinaceum is clonal.
Despite strong morphological similarity and overlapping
ranges, the phylogenetic analysis indicates considerable
phylogenetic distance with no genetic interchange between
the two species.
Kraus et al. (2004) were surprised that T. brevicompac-
tum could be closely related to H. lutea because of the
conspicuous differences in the respective conidiophores,
‘pachybasium-like’ in T. brevicompactum and ‘gliocladium-
like’ in H. lutea and its sister species, H. melanomagna.
However, the morphology of the gliocladium-like ana-
morphs of H. lutea (Gliocladium viride), and H. melano-
magna is so unusual in the genus as to give no clues about
the relationships of these species (see Domsch et al. 2007).
No anamorph in Hypocrea and no species of Trichoderma
is strictly similar to G. viride in anything other than wet,
green pigment and phylogeny. However, gliocladium- or
verticillium-like anamorphs occur in unrelated positions of
Trichoderma either as the primary anamorphs (T. virens, H.
gelatinosa, T. crassum, H. nigrovirens) or as synanamorphs
of more typical Trichoderma species that produce primary
conidia in pustules (Chaverri and Samuels 2003). Kraus et
al. (2004) did not describe gliocladium- or verticillium-like
Fig. 5 95% confidence intervals of conidium length/width ratios
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Fig. 6 Results of multidimen-
sional scaling. a Morphological
characters alone. b Combined
morphological and metabolic
characters. c Metabolic
characters alone. The following
strains lacked metabolic data
and thus were excluded from B
and C: G.J.S. 05–182, G.J.S.
05–183, G.J.S. 05–184, CBS
112443, G.J.S. 05–178, G.J.S.
05–174, G.J.S. 04–380, G.J.S.
05–176. ♦=T. arundinaceum,
▲=T. brevicompactum,✚ =T.
protrusum, ●=H. rodmanii, ■=
T. turrialbense
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conidiophores for T. brevicompactum, but the formation of
these conidiophores may depend upon the medium that is
used. We did not observe them on PDA and only rarely on
SNA whereas on CMD the synanamorph is abundantly
formed in all but T. arundinaceum. Possibly in H. lutea and
T. virens, where the primary conidiophore is gliocladium-
like, the ‘true’ Trichoderma morph has been lost leaving
only the synanamorph.
The culture CBS 121320, T. protrudens, an endophyte
from the trunk of a cacao (Theobroma cacao) tree, occupied
a unique lineage within the Brevicompactum complex in the
phylogenetic analysis (Figs. 1 and 2a–c). In other cases,
endophytic Trichoderma species are represented by single
cultures that occupy unique lineages, sometimes basal to
more complex species (e.g., DIS 328gi, G.J.S. 04–40 basal
to T. viride; Jaklitsch et al. 2006; Hanada et al. 2008) or in
the case of T. koningiopsis endophytic isolates formed
solitary internal lineages or endophyte-pure internal lineages
(Samuels et al. 2006). The endophytic habit seems to have
limited the ability of the strains living within plant tissue to
exchange genetic material with ‘freeliving’ strains. Perhaps
living as an endophyte has compromised their ability to
survive in what could be a much more demanding
environment outside of the host plant.
The Brevicompactum clade is characterized by the
production of simple trichothecene-type mycotoxins. With
the exception of H. rodmanii, all members of the clade
produce either trichodermin or harzianum A. Various
species of Trichoderma are reported to produce trichothe-
cenes (Nielsen et al. 2005). Corley et al. (1994) character-
ized harzianum A from a culture that was identified as T.
harzianum ATCC 90237, which we have re-identified here
as T. arundinaceum. Lee et al. (2005) reported production of
harzianum A by a strain (F000527 = CBS 113214) isolated
directly from a soil sample collected in Daejeon, Korea, and
identified by DNA sequences as a Hypocrea sp. Recently, a
new trichothecene homologue, harzianum B, was isolated
from the same strain (Jin et al. 2007). We received this strain
too late to include in our phylogenetic analysis, but we have
identified it also as T. arundinaceum. The culture NRRL
3199, a patent strain of unknown provenance identified as T.
viride, was also shown to produce harzianum A and was
re-identified here as T. arundinaceum.
A few studies have claimed production of simple
trichothecene-type toxins by species of Trichoderma
(Adams and Hanson 1972; Bamburg and Strong 1969;
Watts et al. 1988; Cvetnić and Pepelnjak 1997; see also
Sivasithamparam and Ghisalberti 1998 for a review), but in
most of the studies, nonspecific analytical methods such as
TLC and HPLC were used and no details of taxonomic
identification were given. Of these reports, we have only
been able to examine the T. polysporum strain (IMI 40624)
reported by Adams and Hanson (1972). Although we can
confirm that it is correctly identified, it did not produce
trichothecenes on any of the numerous media that we
tested. In contrast to these simple trichothecenes, macro-
cyclic trichothecenes have been reported from a rare,
deadly poisonous, East Asian species, Podostroma cornu-
damae (Saikawa et al. 2001). However, we cannot confirm
the identity of the specimen used by these authors as
apparently neither a voucher specimen nor culture were
deposited. The Japanese cultures, NBRC 9005 (P. cornu-
damae) and NBRC 9523 (P. giganteum), both of unknown
provenances, produce macrocyclic trichothecenes (K.F.
Nielsen, unpublished data). The respective ITS and tef1 of
these two cultures are identical, suggesting that there has
been contamination of one culture by the other. The
sequences place the cultures in the Viride clade (Fig. 1)
(K.F. Nielsen and G.J. Samuels, unpublished data). We
cannot confirm the production of simple, non-macrocyclic
trichothecene mycotoxins, including T-2, by any species of
Trichoderma/Hypocrea outside of the Brevicompactum
clade, and the phylogenetic results presented here show that
this clade is phylogenetically distant from any species that
are used in biological control. In a survey of Trichoderma
species from all known clades, we have not encountered
macrocyclic trichothecenes using a LC-MS approach (K.F.
Nielsen, unpublished data.). Despite the production of
alamethicins by members of the T. brevicompactum clade
(Degenkolb et al. 2006a), which could enhance their abilities
as biocontrol agents (Corley et al. 1994), the production of
trichothecene-type toxins could limit their practical applica-
tion in integrated crop management schemes.
Recently, Favilla et al. (2006) and Poirier et al. (2007)
claimed that the 20-residue peptaibols alamethicin and
paracelsin, the 16-residue antiamoebin and other 11-residue
trichobrachins (Mohamed-Benkada et al. 2006; Ruiz et al.
2007) were highly toxic in three in vitro invertebrate
models, viz. Crassostrea gigas, Artemia salina and Daph-
nia magna. An alternative explanation of the toxicitiy
reported by Favilla et al. (2006) and Poirier et al. (2007) is
that the batch of the alamethicin standard that they used
(Sigma-Aldrich; product number A-4665) was contaminat-
ed with the trichothecene harzianum A. In our own work,
we have found that this particular Sigma alamethicin
contains harzianum A; and this group of trichothecene-type
toxins is highly toxic to Artemia salina (K.F. Nielsen,
unpublished results). Notably, it took 40 years to recognize
that Trichoderma “viride” NRRL 3199, which now has
been re-identified here as T. arundinaceum, also produces
harzianum A. Thus, alamethicin samples and standards
tested in toxicity assays prior to 2005 could very likely have
given false positive results based upon contamination of
the samples by trichothecene-type mycotoxins (Degenkolb
et al. 2008a). There are no good GLP studies of the toxicity
of trichodermin and harzianum A. Trichodermin inhibits the
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chain elongation of protein synthesis by binding to the
peptidyltransferase (Gilly et al. 1985), whereas the much
more potent T-2 toxin from Fusarium inhibits initiation of
protein synthesis (Liao et al. 1976). There are contradictory
results regarding the toxicity of harzianum A: Corley et al.
(1994) observed no cytotoxicity in hamster kidney cells
whereas Lee et al. (2005) reported this simple trichothecene
to be highly toxic to several cell lines.
Harzianum A is especially interesting when considered
in light of production of the highly toxic (>10 times more
than T-2 toxin) macrocyclic trichothecenes by other
hypocrealean fungi, including Stachybotrys, Myrothecium,
and Podostroma cornu-damae (syn. Hypocrea cornu-
damae) noted above (Saikawa et al. 2001). Harzianum A
may be a missing link between the simple (trichodermin, T-
2 toxin, etc.) and macrocyclic trichothecenes: the missing
hydroxyl group on the 15-carbon atom in harzianum A
would provide the possibility of attaching an additional
octa-(2Z,4E,6E)-trienedioic acid (or a related compound) on
the C-15. The two arms can then condense to a form a
macrocyclic ring (Fig. 4).
Production of isocoumarins by all strains of the
Brevicompactum clade, except H. rodmanii, (including
diaportinol and diaportinic acid) is interesting because this
requires the expression of genes for polyketides. However,
production of these metabolites is not restricted to the
Brevicompactum complex as it is detected throughout
Trichoderma (K.F. Nielsen, unpublished data) as well as
in, e.g., Penicillium nalgiovense. Quantitatively, isocoumar-
ins seem to vary considerably from time to time during
long-term growth, especially in potato-dextrose broth.
Peptaibiotics are characteristic linear or cyclie α-
aminoisobutyrate-containing peptides that are produced
mainly by species of Trichoderma/Hypocrea (for a review,
see Degenkolb et al. 2003, 2007, 2008a, b). The Brevi-
compactum clade is a rich source of new peptaibiotics.
Degenkolb et al. (2006a) discovered that 69 of the 75
peptaibiotics produced by species that we describe here as
T. brevicompactum, T. arundinaceum and T. turrialbense
were new to science. All peptaibiotics consecutively
assigned as compounds [80]–[117] in this study also
represent new compounds. All members of the Brevicom-
pactum complex produced the 7-residue trichocompactins
(TCP) or 7-residue hypocompactins (HCP). Similar 7- or 8-
residue peptaibiotics, mostly lipopeptaibols, were also
found in T. aggressivum f. europaeum CBS 100526, H.
dichromospora CBS 337.69 (Krause et al. 2006), and T. cf.
strigosum (Degenkolb et al. 2006b); they represent deletion
sequences of 10-, 11- or, 12-residue lipopeptaibols. This
subgroup of peptaibiotics is biosynthesized by species from
different sections and clades of Trichoderma; thus its
chemotaxonomic relevance is low (Degenkolb et al.
2006b).
Alamethicins and alamethicin-like peptaibols are not
restricted to the Brevicompactum complex. They have
been found throughout Trichoderma, with very similar
atroviridins (Oh et al. 2002) and polysporins (New et al.
1996). The respective synthetases can be classified by
specificities of their adenylate domains in positions 6, 9,
12, 17 and 20. Most analyses have been carried out with T.
arundinaceum NRRL 3199, and the alamethicins of the
F30/50 type (Kirschbaum et al. 2003) have previously
been found in strains CBS 109720, IBT 40839, IBT
40840, CBS 112445, ATCC 90237, and IBT 40863
(Degenkolb et al. 2006a). These represent a special type
of synthetase with module 6 preferring Ala against Aib,
module 9 strictly Val, module 12 strictly Leu, module
17 preferring Aib against Vxx, and module 20 strictly
Pheol.
Hydrophobins are small hydrophobic proteins presum-
ably ubiquitous in filamentous fungi. They are usually
secreted and processed, being components of the outer
surfaces of walls of hyphae and conidia. Besides their
roles in cell wall structure they may mediate interactions
between the fungus and the environment such as surface
recognition during pathogenic interaction with plants,
insects or other fungi, but also in symbiosis. A hydro-
phobin gene found in a biocontrol strain of T. asperellum
(T203, Viride clade) enabled the root attachment and
colonization that are steps in initiation of a resistance
reaction in host the plant to a parasite (Viterbo and Chet
2006). The size of hydrophobins ranges from approximate-
ly 75 to 400 amino acid residues containing eight
positionally conserved cysteine residues; they can be
divided into two classes according to their hydropathy
profiles and spacing between the conserved cysteins
(Linder et al. 2005). The number of hydrophobin genes
detected in fungal genomes may exceed 10, and expression
varies with physiological conditions. We here investigated
sporulating mycelium under conditions previously applied
for class II hydrophobins (Neuhof et al. 2007a). The unique
hydrophobin patterns of H. rodmanii, T. protrudens and T.
arundinaceum identify these as discrete species, while T.
brevicompactum and T. turrialbense show partially over-
lapping sets of protein masses. For a review of Class II
hydrophobin gene families in Trichoderma, see Kubicek et
al. (2008).
In a recent intact cell mass spectroscopy (ICMS) study
of 32 strains of 29 different species of Trichoderma/
Hypocrea, hydrophobin patterns specific both at the species
and isolate (subspecies) level were observed (Neuhof et al.
2007b). Two to four marker masses of hydrophobins were
evaluated for each species. In 21 cases, single masses are
shared within experimental errors by two species. A
comparison of H. atroviridis/T. atroviride mycelium and
conidia showed two identical masses. An evaluation of 3
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strains ofH. jecorina/T. reesei revealed three identical masses
in one case besides three differing masses, and five differing
masses in another case. These differing masses have been
attributed in two cases to different post-translational process-
ing of the hydrophobins Hfb1 and Hfb2.
In the case of T. brevicompactum and T. turrialbense, the
two dominating mass peaks differ, supporting individual
species. However, two significant masses of the Brevicom-
pactum group and one mass of the Turrialbense group have
also been detected as minor mass peaks in each group
respectively. Two additional minor mass peaks are shared
as well. These apparent similarities need to be resolved at
the sequence level.
Taxonomy
For continuous characters, see Table 8.
1. Trichoderma arundinaceum Zafari, Gräf. & Samuels,
sp. nov. Figures 7a–c and 8.
Trichodermati brevicompacto G. F. Kraus, C. P.
Kubicek & W. Gams simile sed harzianum A produens
et in agaro dicto SNA magis celeriter crescens. Conidia
subglobosa vel ovoidea, (2.2−)2.7–3.5(−5.0) × (1.7−)2.5–
3.0(−3.5) µm.
Teleomorph None known.
Characteristics in culture Optimum temperature for growth
on PDA and SNA 30°C. Barely growing at 37°C on PDA
or SNA. Colonies grown on PDA sometimes sporulating at
37°C in intermittent light after 72–96 h. On PDA after 5
days at 25°C under intermittent producing conidia in 3 or 4
conspicuous concentric rings, colony margin deeply scal-
loped. Conidia on PDA yellowish green (K&W 28–30 D-F
8). No pigment diffusing through the agar; no distinctive
odour. Colonies grown on SNA in intermittent light
forming conidia within 72 (96) h at (25) 30°C. On SNA
after 1 week under intermittent light conidia forming
abundantly around the colony margin in a broad band,
most typically as a continuous lawn, sometimes as discrete,
1.5 mm diam, flat pustules, yellow rarely noted in devel-
oping conidia, conidia similar in color to conidia formed on
PDA and CMD. Colonies grown on CMD at 25°C under
light (12 h cool white fluorescent/12 h darkness) >9 cm
diam within one week, conidia green, forming in pustules
mainly around the colony margin and to a lesser extent in
concentric rings behind the colony margin, similar to the
pustules formed on SNA. Pustules formed on CMD and
SNA flat, ca. 1 mm diam, remaining discrete or becoming
confluent, dense, spiky or papillate from projecting,
terminally fertile conidiophores and wet masses of conidia
at the base of the projecting conidiophores. Conidiophores
on CMD and SNA comprising a broad, more or less
conspicuous central axis with lateral and often terminal
fertile branches; fertile primary branches profuse, separated
by short internodes, typically paired, arising at or near right
angles with respect to the main axis, typically increasing in
length with distance from the tip; primary branches
typically more than 2 cells in length; secondary branches
arising at right angles from primary branches, often
comprising a single, broad cell; phialides arising in clusters
of 3–5 at tips of primary and secondary branches; often a
single branch of a conidiophore extending beyond the
surface of the pustule, branched or unbranched, straight,
smooth, septate, bearing a verticil of a few lageniform
phialides at the tip. Phialides slightly enlarged in the middle
and lageniform when arising on widely spaced fertile
branches or shorter and wider, ampulliform, when arising
from crowded fertile branches. Conidia subglobose to
ovoidal, (2.2−)2.7–3.5(−5.0) × (1.7−)2.5–3.0(−3.5) µm,
smooth, green. Synanamorph not observed on CMD.
Chlamydospores not observed on CMD after 1 week at
25°C, intermittent light.
Etymology From Latin ‘arundo,’ a reed or cane or
anything made of a reed or cane such as a fishing rod, in
reference to the long conidiophores that project from the
pustules.
Habitat Soil.
Known distribution Iran, Namibia, United States (Miss.).
Holotype Iran: Hamadan, from soil (BPI 878405 ex CBS
119575; ex-type culture CBS 119575).
Additional cultures see Table 1.
2. Trichoderma brevicompactum G.F. Kraus, C.P. Kubicek
& W. Gams, Mycologia 96: 1063. 2004. Figures 7d–f
and 9
Telemorph None known.
Characteristics in culture Optimum temperature for growth
on PDA and SNA 30°C. Slowly growing at 37°C,
sometimes sporulating on PDA and SNA after 96 h at
37°C. On PDA after 1 week at 25°C under intermittent light
producing conidia in several closely spaced, broad, con-
centric rings; colony margin entire. Conidia on PDA
yellowish green (K&W 28–30 D-F 8). No pigment
diffusing through the agar; no distinctive odor. Colonies
grown on SNA in intermittent light forming conidia within
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72–96 h at (25) 30°C. On SNA after 1 week under
intermittent light conidia forming abundantly around the
colony margin and in obscure concentric rings between the
margin and the inoculum, rings formed of confluent pustules,
complete or broken, conidia at first yellow then similar in
color to conidia formed on PDA and CMD grown on SNA in
intermittent light forming conidia within 72–96 h at (25)
30°C. On SNA after 1 week under intermittent light conidia
forming mainly around the colony margin and to a lesser
extent in concentric rings behind the colony margin, similar to
the pustules formed on SNA. Pustules formed on CMD and
SNA flat, to 2 mm diam, remaining discrete or becoming
confluent, tending to be loosely organized, conidial masses
appearing to be moist; numerous conspicuous white, usually
Fig. 7 a–i Cultures of Tricho-
derma species and Hypocrea
rodmanii on PDA 96 h, inter-
mittent light, in 9-cm-diam Petri
dishes. a–c T. arundinaceum. a
ATCC 90237. b NRRL 3199. c
CBS 119578. d–f T. brevicom-
pactum. d CBS 112444. e G.J.S.
04–380. f IBT 40841. g T.
protrudens. CBS 121320. h T.
turrialbense CBS 112445. i H.
rodmanii CBS 120895. j–o H.
rodmanii, immature (j) and ma-
ture (k–o) stromata. j, k from
CBS 122581; l from CBS
120897; m from G.J.S. 91–90; n
from CBS 122582; o from CBS
1208979. Scale bars: j, k, l,
o=0.5 mm; m, n=1 mm
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branched, terminally fertile conidiophores protruding from
easch pustule. Conidiophores on CMD and SNA comprising a
more or less distinct, broad central axis with fertile branches;
fertile branches profuse, separated by short internodes,
typically paired, arising at or near right angles with respect
to the main axis, typically increasing in length with distance
from the tip; primary branches often comprising a single,
broad cell producing phialides in a dense terminal cluster, or
primary branches multicellular and narrower, producing
phialides at the tip and rebranching to produce secondary
branches terminating in phialides; often a single branch of a
conidiophore extending beyond the surface of the pustule,
straight, septate, smooth, unbranched or sparingly branched
with long internodes between branches, each branch termi-
nating in a verticil of 1–3 phialides or the terminal phialides
held in an appressed penicillus of 3–5 on a broad cell.
Fig. 8 Trichoderma arundina-
ceum. a, b Pustules. Protruding
conidiophores seen in b. a on
SNA, b on CMD. c–j Conidio-
phores. c, e, f, g, j from SNA; d,
h, i from CMD. k Conidia, from
SNA. c = CBS 121153, d =
CBS 119573, e, f, j, k = CBS
119575, i = ATCC 90237. Scale
bars: a = 1 mm, b=250 μm,
c–k=10 μm
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Phialides slightly enlarged in the middle and lageniform when
arising on widely spaced fertile branches; shorter and wider,
ampulliform, when arising from crowded fertile branches.
Conidia subglobose, (2.2−)2.7–3.0(−3.7) × (2.0−)2.2–2.7
(−3.0) µm smooth, yellowish green in mass. Synanamorph
forming on CMD, verticillium- or gliocladium-like, single
conidiophores arising from agar surface and the scant aerial
hyphae, conidia held in wet, green heads. Chlamydospores
produced only in few cultures on CMD after 1 week at 25°C
under intermittent light, terminal, subglobose, (5.7) 8.0–11.0
(13.5) × (5.0) 6.5–9.2 (10.2) μm.
Habitat Soil.
Known distribution St. Vincent and the Grenadines, Carib-
bean Region (Union Island), India, Iran, Papua-New
Fig. 9 Trichoderma brevicom-
pactum. a Pustule on SNA. b–g
Conidiophores taken from
pustules. b, d from SNA: c, e-g
from CMD. h. Conidia from
SNA. i-l. Synanamorph on
CMD. a, e from G.J.S. 04–380,
b from CBS 109720, c from
CBS 119570; d from CBS
119572, f from CBS 119569, g,
j, k from CBS 112446, h from
CBS 121154, i from CBS
112443, l from CBS 112447.
Scale bars: a=0.5 mm, b–h, k,
l=10 um; i=1 mm, j=150 μm
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Guinea, Peru, United States (N.Y., Wis.), México, Costa
Rica, Iran, Colombia. Probably cosmopolitan.
Holotype UNITED STATES, New York, Geneva, New
York State Agricultural Experimental Station, isolated from
soil in a sunflower field, 20 June 2000, S. Petzolt & G.E.
Harman (DAOM 231232! Ex-type culture CBS 109720).
Additional cultures examined See Table 1.
3. Trichoderma protrudens Samuels & Chaverri, sp. nov.
Figures 7g and 10.
Trichodermati arundinaceo Zafari, Gräfenhan &
Samuels simile sed phialides longiores et angustiores et
in agaro dicto PDA temperatura 37°C magis celeriter
crescens. Conidia subglobosa vel ovoidea, (2.5−)2.7–3.2
(−3.5) × (2.2−)2.5–2.7(−3.0) µm.
Teleomorph None known.
Characteristics in culture Optimum temperature for growth
on PDA and SNA 30°C; some growth visible at 35°C after
72 h on PDA and SNA. Colonies grown on PDA in
intermittent light forming conidia within 72 h at 30°C, on
Fig. 10 Trichoderma protru-
dens. a, b Pustules. Protruding
conidiophores seen in b. a, b
from SNA. c–h Conidiophores.
c from CMD; d, e, f from SNA;
g, h from CMD. i Conidia, from
CMD. j, k Synanamorph on
CMD. All from CBS 121320.
Scale bars: a=1 mm,
b=150 μm, c–k=10 μm
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SNA within 96 h at 30°C; sporulating after 72 h in
intermittent light on PDA, not sporulating on SNA at
37°C. On PDA after 1 week at 25°C under intermittent light
producing conidia in 2 or 3 rather conspicuous concentric
rings of coalescing, flat pustules; colony margin scalloped.
Conidia on PDA grayish green to dark green (K&W 27
C-F 7). No pigment diffusing through the agar; no
distinctive odor. On SNA and CMD after 1 week under
intermittent light conidia forming abundantly in the aerial
mycelium around the margin of the colony and in discrete,
1–2 mm diam, pustules; pustules more abundant on SNA
than on CMD, pustules on SNA formed behind the margin,
on CMD in a marginal band; conidia yellowish green
(K&W 29 F 8). Pustules on CMD and SNA pulvinate to
hemispherical, very compact, conidial masses appearing to
be moist; conspicuous long, white, terminally fertile
conidiophores arising from each pustule. Conidiophores
on CMD and SNA comprising a rather distinct, broad
central axis with lateral and often terminal fertile branches;
fertile branches profuse, separated by short internodes,
typically paired, arising at or near right angles with respect
to the main axis, typically increasing in length with distance
from the tip; primary branches often comprising a single,
broad, cell producing phialides in a dense terminal cluster,
or primary branches multicellular and narrower, producing
phialides at the tip and rebranching to produce secondary
branches with another cluster of phialides; often a single
branch of a conidiophore extending beyond the surface of
the pustule, straight, septate, smooth, unbranched or
sparingly branched, with long internodes between branches,
each branch terminating in a verticil of a few phialides.
Phialides slightly enlarged in the middle and lageniform
when arising on widely spaced fertile branches or shorter
and wider, ampulliform, when arising from crowded fertile
branches. Synanamorph abundant in the aerial mycelium,
verticillium-like, conidia held in wet, green heads. Conidia
subglobose to ovoidal, (2.5−)2.7–3.2(−3.5) × (2.2−)2.5–2.7
(−3.0) µm, smooth, deep green in mass. Chlamydospores
not observed.
Etymology ‘protrudens’ refers to the protruding conidio-
phores that arise from pustules.
Habitat Isolated as an endophyte from trunk of Theobroma
cacao.
Known distribution India (Kerala), known only from the
type collection.
Holotype INDIA, Kerala, Kannara, Plantation Crops Re-
search Institute, isolated from trunk of 8–10-m-tall tree of
Theobroma cacao, 5 Nov 1999, H. C. Evans CBS 121320
(BPI 878378; ex-type culture CBS 121320).
4. Hypocrea rodmanii Samuels & Chaverri, sp. nov.
Figures 7j–o, 11 and 12
Stromata lutea, KOH-, 2–3 × 1–2 mm. Ascosporae
hyalinae, spinulosae. Pars distalis ascosporarum subglobosa
vel globosa, (3.0−)3.2−4.0(−4.5) × (2.7−)3.2–3.7(−4.2) µm;
pars proximalis cuneiformis vel oblonga, (3.0−)4.5−4.5
(−7.0) × (2.2−)2.7−3.2(−3.7) µm. Anamorphosis T. brevicom-
pacto G. F. Kraus, C. P. Kubicek & W. Gams similis. Conidia
subglobosa, (1.7−)2.0–2.5(−2.7) × (2.0−)2.2–2.7(−3.0) µm.
Stromata superficial, sometimes forming below bark, at
first semi-effused, light yellow (K&W 4A4-6) with darker
ostiola and a white margin, becoming pulvinate, 2–3 × 1–2
mm, ca. 1.5 mm high, darker yellow (4B7–8, 5B6–7), not
reacting to KOH, broadly attached with edges slightly free,
surface plane, perithecial elevations not evident, ostiola
appearing as darker, viscid dots. Cells of the stroma surface
in face view angular, ca. 4.5 × 3.7 μm, thin-walled. Surface
region of stroma 15–20 μm wide, not pigmented, cells in
section textura epidermoidea, 2.5–4.5 × 2.5–3.0 μm, walls
slightly thickened. Tissue below stroma surface region of
intertwined, ca. 2.5 μm wide, thin-walled hyphae. Perithe-
cia elliptic in section, 215–270 μm tall, 150–250 μm diam,
ostiolar canal 60–70 μm long (n = 3), perithecial apex not
protruding through the stroma surface, cells not distinct
from cells of the surrounding stroma surface. Tissue below
perithecia textura epidermoidea, 8–24 × 6–10 μm, thin-
walled. Asci cylindrical, (60) 70–87 (110) × (3.0) 4.0–5.5
(6.5) μm, apex with a shallow ring, 8-spored. Part-ascospores
hyaline, finely spinulose, dimorphic; distal part-ascospores
subglobose to globose, (3.0) 3.2–4.0 (4.5) × (2.7) 3.2–3.7
(4.2) μm; proximal part-ascospores wedge-shaped to oblong,
(3.0) 4.5–4.5 (7.0) × (2.2) 2.7–3.2 (3.7) μm.
Characteristics in culture and anamorph Optimum temper-
ature for growth on PDA 25–30°C and on SNA 20–30°C,
not growing at 37°C. Colonies grown on PDA in
intermittent light forming conidia within 48 h at 30°C;
after 4 days in intermittent light conidial production in 3 or
4 conspicuous, narrow concentric rings of densely aggre-
gated conidia. Conidia on PDA grayish green (K&W 27–
28B-C4-6). No pigment diffusing through the agar; no
distinctive odor. Conidia not forming on SNA within one
week in intermittent light. Colonies grown on CMD at 25°C
intermittent light >9 cm diam within one week, conidia
forming in a broad ring around the margin in confluent
grayish green, cottony pustules; long, sterile hairs arising
from the pustules, sometimes hairs producing one phialide at
the tip. Conidiophores on CMD comprising a ca. 5-μm-wide
main axis from which fertile branches arise near the base; the
terminal part of the conidiophore (to 100 μm) septate,
straight, thin-walled; apex blunt, sterile or bearing a single,
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terminal phialide. Branches arising at right angles to the
main axis at or near 90°, often consisting of one or a few
broad cells, or branches longer and of narrower cells; fertile
branches often paired, mostly progressively longer with
distance from the tip, often rebranching to produce second-
ary branches; secondary branches typically comprising a
single, broad cell with a terminal cluster of phialides.
Conidiophores often lacking a sterile elongation, internodes
between secondary branches short and phialides densely
disposed on short secondary branches. Phialides held in
divergent heads of 3–5, ampulliform. Conidia subglobose,
(1.7−)2.0–2.5(−2.7) × (2.0−)2.2–2.7(−3.0) µm, smooth,
grayish green in mass. Synanamorph not observed. Chla-
mydospores not observed after 1 week on CMD under
intermittent light.
Etymology Hypocrea rodmanii is named in honour of Dr.
James E. Rodman, U.S. National Science Foundation, in
Fig. 11 Hypocrea rodmanii,
teleomorph. a Longitudinal
section through a stroma.
b Median longitudinal section
through two perithecia. c Cells
of the stroma surface in face
view. d Median longitudinal
section through a perithecium
showing details of the stroma
surface and ostiolar region.
e Cells of the stroma below
perithecia. f Young asci showing
croziers (arrows) and develop-
ing ascospores. g, h Asci.
Apical rings visible in g.
i Discharged ascospores. a, b,
d, e, i from G.J.S. 91–90; f, g
from G.J.S. 91–89; c, h from
G.J.S. 91–88. Scale bars: a,
b=100 μm; c–f, g-i=10 μm
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recognition of vision and tenacity in developing the NSF
program Partnerships Enhancing Expertise in Taxonomy
(PEET), which supported the authors of this species as,
respectively, mentor and student.
Habitat On decorticated, rotten wood, often below flaking
bark.
Known distribution United States (Maryland, Virginia).
Holotype UNITED STATES, Virginia, Giles County, Cas-
cades Recreation Site, 4 mi N of Pembroke, along Little Stony
Creek, 37°02′N, 80°35′W, elev. 838m, 18 Sep 1991, on branch-
lets,G.J. Samuels, C.T. Rogerson, S.M. Huhndorf, S. Rehner
& M. Williams (BPI 1112859, ex-type culture CBS 120895).
Fig. 12 Hypocrea rodmanii,
Trichoderma anamorph. a–c
Pustules from CMD. d–k
Conidiophores, detail of
phialides shown in k. d, e, g–k
from CMD, f from SNA. l
Conidia, from CMD. a, c, f from
G.J.S. 91–89; b, d, g, j from
G.J.S. 91–88; e, h, i, k,
l from G.J.S. 91–91. Scale
bars: a, b=1 μm, c=150 μm,
d−l=10 μm
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Additional specimens examined Three specimens with the
same collecting data as the holotype (G.J.S. 91-90 = BPI
1112861; BPI 1112862, culture G.J.S. 91-91 = CBS
109719; BPI 1112860, culture G.J.S. 91-89 = CBS
120897; BPI 1112861). Maryland, Garrett County, 5 mi
N of Barton, Little Savage River Ravine, on decorticated
wood, 23 Sep 1989, G.J. Samuels (89–120), C.T. Roger-
son, W.R. Buck, R.C. Harris (NY = CBS 122582); same
collecting data, G.J. Samuels (89–116) (NY = CBS
122581).
Comments The form and pigmentation of the stroma of H.
rodmanii suggest H. lutea, but the anamorph readily
distinguishes this species from other known species.
Fig. 13 Trichoderma turrial-
bense. a, b Pustules, protruding
conidiophores visible in b. a
from CMD, b from SNA. c–g
Conidiophores. c, d, e, f from
SNA; g from CMD. h Conidia
from SNA. i–l Synanamorph on
CMD. Details of phialides seen
in l. m Chlamydospores from
CMD. a c, d, f, k, l = GJS
07–74, b, e, g, h, j, m =
CBS 112445. Scale bars: a,
b=0.5 mm, c−m=10 μm
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5. Trichoderma turrialbense Samuels, Degenkolb, K.F.
Nielsen & Gräf. sp. nov. Figures 7h and 13.
Trichodermati brevicompacto G. F. Kraus, C. P.
Kubicek & W. Gams simile sed harzianum A produens.
Conidia subglobosa, (2.2−)2.5–3.0(−3.2) × (2.0−)2.2–2.7
(−3.0) µm.
Teleomorph None known.
Characteristics in culture Optimum temperature for growth
on PDA and SNA 30°C; very little growth at 37°C after 72
h. On PDA forming conidia under intermittent light within
72 h at 30°C, sometimes also sporulating on PDA at 37°C
in intermittent light after 96 h. On PDA at 25°C after 5 days
under intermittent light producing conidia in broad concen-
tric rings, the oldest conidia in the center and the youngest
at the edge of the colony; colony margin even. Conidia on
PDA yellowish green (K&W 28–30 D-E 8). No pigment
diffusing through the agar; no distinctive odor. Colonies
grown on SNA under intermittent light forming conidia
only sporadically after 72 h at 30°C. On CMD and SNA
after 1 week at 25°C under 12 h cool white fluorescent
light/12 h darkness conidia forming abundantly around the
colony periphery in more or less conspicuous, compact flat
pustules 0.5–1 mm diam, yellow green (‘deep green,’
K&W 29 E-F 8). Pustules compact or loosely arranged,
conidiophores more or less extensively branched, often
with long internodes between branches, with a conspicuous
main axis; often producing one or a few divergent phialides
from the tip; branches arising at right angles to the main
axis, short, progressively longer with distance from the tip.
Secondary branches arising at right angles from the primary
branches, typically unicellular, each terminating in 2−5
divergent or convergent (gliocladium-like) phialides. Phia-
lides ampulliform, shorter and broader when crowded.
Conidia subglobose, (2.2−)2.5–3.0(−3.2) × (2.0−)2.2–2.7
(−3.0) µm, smooth, green, appearing to be held in globose
wet heads. On CMD and SNA conidiophores of synana-
morph arising from surface of agar and from aerial
mycelium in abundance, 70–180 μm long, 5–14 μm wide
at the base, lateral branches arising at an angle of < 90°
with respect to the main axis, terminating in an appressed
head of phialides or lower branches producing secondary
branches with an appressed head of 2–5 phialides. Phialides
ampulliform, 6–7 µm long, 3.0–3.5 μm wide at the widest
point, collarette often flared. Chlamydospores not observed
on CMD.
Etymology ‘turrialbense’ refers to the town of Turrialba,
Costa Rica, the only place where this species is known to
occur.
Holotype Costa Rica, Turrialba, La Montaña, isolated from
soil in a maize field, date not known, S. Danielsen 017,
comm. M. Lübeck (BPI 878379, ex-type culture CBS
112445).
Additonal culture examined Costa Rica, Turrialba, isolated
from banana roots, date unknown, A. zum Felde S14
comm. R. Sikora (BPI 878380; live culture BBA 72294=
CBS 122554).
Comments The culture CBS 112445 was included in the
original description of T. brevicompactum, where it was
reported under the number ‘4105.’ The main distinction
between T. turrialbense and T. brevicompactum is that the
main toxin of the former is harzianum A whereas the main
toxin of the latter is trichodermin. As can be seen from
Table 8, there are slight differences in conidial length,
length/width of conidia, width of phialides and cells from
which phialides arise. The peptaibiotics pattern of T.
turrialbense is similar to that of T. brevicompactum.
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Linearity is not considered a prerequisite anymore, and extension of the current definition of
7peptaibiotics8 to cyclic, Aib-containing peptides is proposed. Sequences and bioactivities, together with
ecophysiological importance of cyclopeptaibiotics and related cyclic tetrapeptides, and their fungal-
taxonomic relationships, are discussed.
Introduction. – Peptaibiotics constitute a constantly growing family of peptide
antibiotics [1–3]. Currently, more than 800 individual sequences of peptaibiotics,
produced by members of ca. 20 fungal genera, are reported in the literature.
Peptaibiotics are defined as linear polypeptide antibiotics which i) have a molecular
weight between 500 and 2,200 Dalton, thus containing 5–21 amino acid residues; ii)
show a high content of a-aminoisobutyric acid (Aib); iii) are characterized by the
presence of other non-proteinogenic amino acids and/or lipoamino acids; iv) possess an
acylated N-terminus, and v) have a C-terminal residue that, in most of them, consists of
a free or acetylated amide-bonded 1,2-amino alcohol, but might also be an amine,
amide, free amino acid, 2,5-dioxopiperazine, or sugar alcohol. The majority of Aib-
containing peptides carries a C-terminal residue representing a 2-amino alcohol, and
this subgroup is, therefore, referred to as peptaibols. In strongly lipophilic peptaibols,
the N-terminus is acylated by octanoic, decanoic, or (Z)-dec-4-enoic acid, and these are
named lipopeptaibols [4]. In the third subfamily of lipoaminopeptides (also named
aminolipopeptides) the N-terminus is substituted by unbranched, a- or g-methyl
branched, saturated or unsaturated C4–C15 fatty acids. An l-proline-, trans-4-hydroxy-
l-proline, or cis-4-methyl-l-proline residue is found in position 1 of the peptide chain,
and, in most cases, it is followed by a lipoamino acid residue in position 2. To our
present knowledge, the compound, 2-amino-6-hydroxy-4-methyl-8-oxodecanoic acid
(AHMOD), has only been recorded from this subfamily. A fourth subfamily comprises
all other peptaibiotics that cannot be classified in any of the other three preceding
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subfamilies [1]. A review introducing nine subfamilies according to structural
homologies of peptaibiotics has been published [5], but these need to be revised and
updated, because more than half of the currently known sequences of peptaibiotics
have been discovered since then [2] [3] [6].
Peptaibiotics are usually classified according to their main chain length, as long-
chain (17–21 residues), medium-chain (11–16 residues), and short-chain (5–10
residues) sequences. Although not yet reported in literature, Brckner and co-workers
[1] claimed the detection of very short chain (< 5 residues) peptaibiotics that may
represent drastically truncated sequences.
Cyclopeptaibiotics – A New Subfamily of Peptaibiotics. – We do not consider
linearity as a necessary prerequisite anymore and propose to extend the above
definition of 7peptaibiotics8 to encompass also cyclic, Aib-containing peptides.
Currently, this small subgroup comprises seven cyclic tetrapeptides all of them
displaying the same building scheme (Fig. 1).
Sequences and bioactivities, ecophysiological and taxonomic importance of cyclo-
peptaibiotics and related cyclic peptides will be discussed below. Finally, this review is
aimed at linking the remarkable chemical and biological properties of linear and cyclic
Aib-containing peptides.
Chlamydocin. – Originally isolated from the soil fungus Diheterospora [7] (now
Pochonia) chlamydosporia (Clavicipitaceae, Hypocreales; teleomorph Metacordyceps
(syn. Cordyceps) chlamydosporia [8]) S 3440, chlamydocin (1) is regarded as the
classical paradigm of a 7cyclopeptaibiotic8. The chlamydocin-producing species is
known as an egg parasite of cyst nematodes such asHeterodera schachtii in beet or root-
knot nematodes of the genusMeloidogyne. As this fungus is still found to be genetically
heterogeneous [8], some biochemical heterogeneity can be expected that might entail
the production of structurally variable, microheterogeneous mixtures of cyclic peptides
by different strains. To the best of our knowledge, chlamydocin (1) is the first example
of a cyclic, Aib-containing peptide reported in literature. Chlamydocin (1) was
sequenced after trifluoroacetolysis and subsequent Edman degradation; the config-
uration of the amino acids was determined by treatment of the HCl hydrolysate with l-
and d-amino acid oxidase. Notably, its proline residue was assigned the d-config-
uration. In this context, it should be pointed out again that isovaline (Iva) is frequently
reported as d- or l-isomer in peptaibiotics, whereas all other chiral a-amino acids of
linear peptaibiotics known so far have been reported to possess l-configuration. Both
enantiomers of Iva may even be present in the same peptaibiotic [1].
The uncommon lipoamino acid of chlamydocin (1) was assigned as l-2-amino-9,10-
epoxy-8-oxodecanoic acid (Aoe). A minor component, 2, carrying l-2-amino-9,10-
epoxy-8-hydroxydecanoic acid (Ahe) was also detected instead of Aoe in the crude
extract of Pochonia chlamydosporia S 3440 [7].
Based on structural homology, it was demonstrated that chlamydocin (1) displayed
unspecific phytotoxic bioactivity [9], which is in agreement with its cytostatic activity in
rodents [10]. Stereoselective total syntheses of chlamydocin (1) and dihydrochlamy-
docin have been reported [11].
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Chlamydocin Analogue from Verticillium coccosporum. – Twenty years after the
first report on chlamydocin (1) had been published, a second cyclopeptaibiotic, 3, was
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Fig. 1. Structures of cyclotetrapeptaibiotics
isolated from a strain of 7Verticillium coccosporum8 (without accession number)
obtained from the USDA-ARS collection of entomopathogenic fungi [12]. This isolate
might be identical with Pochonia suchlasporia var. catenata CBS 789.85 – a strain that
has originally been deposited as Verticillium coccosporum, subsequently preserved as
Verticillium suchlasporium var. catenatum, and finally included in Pochonia [8]. The
species Pochonia suchlasporia var. catenata is known as an egg parasite of the cereal
cyst nematode Heterodera avenae and the Gypsy moth Lymantria dispar. The
lipoamino acid of this analogue was assigned l-(9S)-2-amino-9-hydroxy-8-oxo-
decanoic acid (Aoh). The analogue showed high phytotoxic activity against common
Duckweed, Lemna minor [12].
Diheteropeptin. – In 1997, the isolation of diheteropeptin (4) from a Diheterospora
sp. was reported [13]. The producing fungus was subsequently identified as
Diheterospora chlamydosporia Q 58044 [14], thus representing the same species as
the chlamydocin producer S 3440. Diheteropeptin (4) is distinguished from the above
chlamydocin homologues by the presence of a (2S,8R,9R)-2-amino-8,9-dihydroxyde-
canoic acid (Add) residue [15]. The peptide inhibited histone deacetylase and
mimicked transforming growth factor-b (TGF-b)-like activity in mink epithelial lung
(Mv1Lu) cells. It is known that TGF-b protects neuronal cells from damage caused by
brain ischemia injury and Alzheimer8s disease. Thus, chlamydocin analogues were
discussed as potential candidates for treatment of neuronal disorders [13] [14]. An
asymmetric total synthesis of diheteropeptin (4) has been elaborated [16].
Chlamydocin and Analogues from Peniophora cf. nuda. – Chlamydocin (1) and two
new analogues, 5 and 6, were recently isolated from a culture of Peniophora cf. nuda
(Peniophoraceae, Russulales). The isolate was obtained from a soil sample collected in
Tottori Prefecture, Japan [17]. The species is widely distributed and commonly
associated with white rot of dead branches of woody angiosperms [18].
Electron microscopy revealed a dolipore-parenthesome septum, and sequencing of
its 18S rRNA gene identified the fungus to be closely related to Peniophora nuda [17].
Notably, this is the first unequivocal report confirming the isolation of an Aib-
containing peptide from a basidiomycete. Such a result is of chemotaxonomic
importance, as all previous reports claiming the isolation of peptaibiotics from
basidiomycetes [19–21] should be considered ambiguous, as they might have involved a
mycoparasite of ascomycete affinity [1] [22–24]. Most peptaibiotics reported to date
were isolated from two families of the order Hypocreales – Hypocreaceae and
Clavicipitaceae (sensu lato). Other Hypocrealean families have been positively
screened for the presence of Aib and/or Iva, as recently reviewed [1], but, to the
best of our knowledge, no basidiomycete taxa.
Two lipoamino acids, 2-amino-8-oxodecanoic acid (Aod) and its AcO derivative
were found in the new chlamydocin analogues. Chlamydocin (1) and its two new
analogues exhibited plant growth-retarding activity towards rice seedlings (Oryza
sativa cv. 7Koshihikari8), a feature that is discussed to reduce lodging, permit higher
nitrogen application rates, and increase yields. Plant growth-retarding activity was
shown to be caused by decrease of the endogenous level of gibberellins (gibberellic acid
1 (GA1)), along with a simultaneous increase of abscisic acid (ABA). Regulation of
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these two plant hormones was postulated to be caused by inhibition of histone
deacetylases (HDACs) that may differentially affect biosynthesis of GA1 and ABA
[25]. Similar plant growth retardation has previously reported for the HC-toxin (12 ; see
the Table and Fig. 3) from Cochliobolus carbonum, the causing agent of Leaf Spot of
Maize [26].
FR235222 – The First Iva-Containing Cyclotetrapeptaibiotic. – Isovaline (Iva)
which is generally considered as the CH2 homologue of Aib, has been reported from a
number of linear peptaibiotics [1]. Notably, structure elucidation of the cyclotetrapep-
tide FR235222 (7), isolated from a culture of Acremonium sp. No. 27082 [27], revealed
the presence of one l-Iva residue. The structure of FR235222 (7) as shown in Fig. 1 was
assigned cyclo(-(2S,9R)-2-amino-9-hydroxy-8-oxodecanoic acid-trans-4-d-MePro-l-
Phe-l-Iva-) [28]. The producer was isolated from a soil sample in Aktia City, Japan,
identified as Acremonium cf. murorum by its morphological characteristics, and finally
deposited as Acremonium sp. FERRM BP-6539. The peptide displayed potent and
selective inhibition of T-cell proliferation and lymphokine production. Furthermore, it
exhibited potent inhibition of HDAC [29]. Total synthesis [30] [31], NMR solution
structure, and a binding model have recently been published [31].
Further Aib-Containing Cyclic Heptapeptides: Scytalidamides A and B. – Two
cyclic heptapeptides (Fig. 2), scytalidamides A (8) and B (9) were reported from
Scytalidium sp. CNC-310 [32]. The genus Scytalidium, however, is considered very
heterogeneous with teleomorphs belonging to different ascomycetous genera.
The fungus was isolated from the surface of a sample of the green algaHalimeda sp.
collected from a patch reef at a depth of 15 m from the northern end of Long Island,
Bahamas. Thus, discovery of scytalidamides further extends the sources of Aib-
containing cyclic peptides to marine habitats although the genus Scytalidium is
generally known to be associated with terrestrial plants. Scytalidamides A and B (8 and
9, resp.) displayed moderate in vitro cytotoxicity towards HCT-116 human adenocar-
cinoma.
Fig. 2. Structures of cycloheptapeptaibiotics, scytalidamides A (8) and B (9)
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Both scytalidamides contain one Aib residue but display a building scheme
different from the cyclopeptaibiotics and cyclic tetrapeptides mentioned above. The
presence of further non-proteinogenic amino acids, however, supports a non-ribosomal
biosynthesis: scytalidamide A (8) was assigned as cyclo(-l-Phe-l-N-MePhe-l-Phe-Aib-
l-N-MeLeu-l-Pro-l-Leu-) and scytalidamide B (9) as cyclo(-l-Phe-l-N-MePhe-l-Phe-
Aib-l-N-MeLeu-(2S,3S)-3-MePro-l-Leu-). For configuration analysis of the amino
acids in the HCl hydrolysate, an advanced LC/MS method based on derivatization with
l- or d-1-fluoro-2,4-dinitrophenyl-5-l-leucinamide (l-FDLA or d-FDLA, a modified
Marfey8s reagent) [33] was used. Preparative amounts of (2S,3S)-3-methylproline
(MePro) were isolated and further characterized by NMR, HRFAB-MS, and LC/MS of
its l- and d-FDLA derivatives. Total synthesis of scytalidamide A (8) has been
reported in [34].
Aib-Free Cyclic Tetrapeptides. – A number of cyclic tetrapeptides lacking the Aib
residue have been described. These Aib-free cyclic tetrapeptides containing d-Pro, d-
pipecolic acid (Pip), and d-O-methyltyrosine (d-OMe-Tyr) are listed in the Table. The
structures of the apicidins are shown in Fig. 4, those of the azumamides and
microsporins are illustrated in Fig. 5, and those of the remaining Aib-free cyclic
tetrapeptides are depicted in Fig. 3.
Notably, their producers are often known from highly competitive or specialized
habitats. The producer of the phytotoxic peptides Cyl-1 (10) and Cyl-2 (11),
Cylindrocladium scoparium [35], teleomorph Calonectria morganii [36], acts as a
plant pathogen infecting a wide range of crop and ornamental plants [18] [37], and the
HC-toxin (12)-producing Cochliobolus carbonum is known as the causal agent of leaf
spot of maize [9] [41]. The two apicidin-producing Fusarium isolates were reported as
endophytes from acacia and White Mangroves, respectively [46] [49].
The configuration of the Phe residue of WF-3161 (13) was originally reported to be
l [42], but subsequently corrected to d by 2D-NMR, and treatment of the HCl
hydrolysate with d- and l-amino acid oxidase [43]. Finally, its total synthesis was
described in [52].
Treatment with amino acid oxidase was also applied to the HCl hydrolysate of HC-
toxin (12) [9] as well as Cyl-1 (10) [35], and Cyl-2 (11) [38], respectively.
For configuration analysis of the amino acids in the HCl hydrolysates of trapoxin A
and B (14 and 15, resp.), HPLC on a chiral Crown Pak CR phase was used [44].
Crystalline trapoxin A (14) was investigated by X-ray-analysis [45]. Total synthesis of
trapoxin B (15) and analogues has been reported in [53].
The configuration of the amino acids in the apicidins, 16–22, was determined by
2D-NMR and amino acid oxidase [46] [47].
The importance of d-amino acids has recently been compiled, including protocols
for their analysis [54].
Can a Sponge Produce Cyclic Tetrapeptides? – Five cyclic tetrapeptides,
azumamides A–E (23–27, resp.), were recently isolated from a frozen 2.2-kg sample
of the marine sponge Mycale izuensis. They were shown to contain unusual lipoamino
acids, namely (2S,3R)-3-amino-2-methylnon-5-enedioic acid 9-amide (Amnaa), or
(2S,3R)-3-amino-2-methylnon-5-endioic acid (Amnda). Depending on the isomer,
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amino acid analysis revealed the presence of d-Val, d-Ala, d-Phe, and d-Tyr (Fig. 5).
For amino acid analysis, Marfey8s reagent was used [50]. However, production of
azumamides by a sponge, as reported, is highly questionable. Contrary to what has been
stated in [50], we rather tend to assign the biosynthesis to a sponge-associated fungus
whose presence has not been recognized in the material extracted.
This hypothesis is further supported by the recently reported isolation of
microsporins A and B (28 and 29, resp.). These cyclic tetrapeptides were isolated
from Microsporum cf. gypseum CNL-692. The fungus was found to be associated with
the marine bryozoan Bugula sp. collected from the U.S. Virgin Islands [51]. The
keratinophilic genus Microsporum (with teleomorphs in Nannizzia) has a worldwide
distribution. Some species are known as geophilic saprotrophs, whereas others are
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Fig. 3. Structures of other, Aib-free cyclic tetrapeptides
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Fig. 4. Structures of apicidins
Fig. 5. Structures of azumamides A–E (23–27, resp.) , and microsporins A and B (28 and 29, resp.)
dermatophytes pathogenic to mammals, including humans [55]. Usually, they cause a
single inflammatory skin or scalp lesion; invaded hairs show an ectothrix infection [56].
The sequences of microsporin A (28) was established as cyclo(-Aod-d-Pip-Phe-
Ala-) and cyclo(-Ahd-d-Pip-Phe-Ala-), respectively. The structure of microsporin A
(28) was further confirmed by solid-phase synthesis. Notably, the unusual lipoamino
acid of microsporin B (29), (2S)-2-amino-8-hydroxydecanoic acid (Ahd), has not been
described for cyclic tetrapeptides or cyclopeptaibiotics before. The configuration of the
amino acids in the HCl hydrolysate was determined after derivatization with Marfey8s
reagent and subsequent HPLC analysis of the diastereoisomers. Microsporins A and B
(28 and 29, resp.) are potent inhibitors of histone deacetylase and showed cytotoxic
activity against human colon adenocarcinoma (HCT-116) and other cancer cell lines
[51].
Facts and Hypotheses on Structure–Activity Relationships. – Notably, all cyclic
tetrapeptides reviewed here display the same building scheme. An uncommon,
branched or unbranched lipoamino acid is linked to a Pro or Pip residue, respectively.
Two additional amino acids are required to form a four-membered ring (Figs. 1–5).
Most of the cyclic tetrapeptides contain one d-amino acid residue, which is likely to
confer increased resistance to the ring system against proteolytic cleavage. This
resistance is further increased by the presence of one Aib residue in the cyclopeptai-
biotics. The occurrence of lipoamino and d-amino acids strongly suggests a non-
ribosomal peptide biosynthesis as it is known from linear peptaibiotics [57] [58] and
larger cyclic peptides of fungal origin such as the l-a-aminobutyric acid (Abu)-
containing cyclosporins from Tolypocladium inflatum [59] [60].
The potent antiprotozoal activity of apicidins 16–22, was demonstrated to be
caused by inhibition of parasite histone deacylase [46–48]. The antitumor effects of
WF-3161 (13) [42] and trapoxins [44] may be explained by irreversible inhibition of
histone deacetylase 1 [61]. Contrary to what is known from linear peptaibiotics [1] [23],
ionophoric activities of cyclic tetrapeptides and cyclopeptaibiotics have not yet been
reported in literature. The lumen formed by such a four-membered ring system is too
small to act as a channel. Currently, the potent bioactivities of these peptides are best
explained by the inhibition of histone deacetylases [61].
Synthetic, Non-Natural Aib-Containing Cyclic Peptides. – Although this review is
focussed on naturally occurring cyclic peptides, it is worth mentioning that several non-
natural cyclic hexa-, hepta-, and octapeptides containing a number of sterically
constrained Aib-residues have been prepared by solution-phase synthesis. Crystal
structures of some of them have been determined by X-ray-analysis [62–66].
Neither synthetic Aib-containing analogues of natural astins representing anti-
tumor cyclic pentapeptides [67] and macrocyclic analogues of linear natural peptides
such as neuropeptide Y (NPY) [68], nor the vast number of Aib-containing cyclic
peptides filed in the patent literature, are treated in this review. We propose that use of
the term 7cyclopeptaibiotics8 should be restricted to biologically active, native peptides.
Future Prospects. – Structural diversity of cyclic tetrapeptides and cyclopeptai-
biotics is expected to increase in the future. Recently, microheterogeneity has been
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impressively demonstrated for apicidins [46] and azumamides [50]. Therefore, a similar
structural diversity, as it is already known from linear peptaibiotics [69–71], can be
postulated for cyclic tetrapeptides and cyclopeptaibiotics. Considering structural
homologies known from linear peptaibiotics, it is not excluded that, for instance, HC-
toxins containing Aib or Vxx (Val, and d- or l-Iva) instead of Ala will be detected.
Such result would confirm previous observations for trichobrachins TB III A and TB
III B: These are hexapeptides, the N-terminus of which has not been assigned yet.
Remarkably, Aib could not be determined in those peptides [71] [72].
The method of peptaibiomics [73] which has been successfully applied to screen
peptaibiotics of Trichoderma sp. and its Hypocrea teleomorphs [3] [74] [75] is also
recommended as a pivotal tool for screening cyclic tetrapeptides and cyclopeptai-
biotics. Formation of such cyclic tetrapeptides and cyclopeptaibiotics might be
interpreted as an adaptation to the highly specialized life style of the producers as
plant pathogens, egg pathogens of nematodes or insects, or as plant endophytes.
Therefore, screening of fungi from such ecological niches should considerably
contribute to the diversification of cyclic tetrapeptide and cyclopeptaibiotic structures.
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Fungi are generally regarded as a literally infinite resource of bioactive secondary metabolites
displaying remarkable structural diversity. Research on a particular group of linear and cyclic peptide
antibiotics comprehensively named peptaibiotics – as result of the abundance of the non-proteinogenic
Ca-dialkylated a-amino acids a-aminoisobutyric acid (Aib) and isovaline (Iva) – has been started 50
years ago. These peptides have gained constantly increasing interest because of their unique bioactivities
and conformations. This review, reflecting the history of peptaibiotic research from 1958 to 2008, is
focussed on introducing both the structural diversity and natural microheterogeneity of the peptaibiotics,
as well as the biodiversity of their fungal producers. Recently introduced state-of-the-art methods for
rapid screening and sequencing of peptaibiotics, such as peptaibiomics and intact-cell MALDI-TOFmass
spectrometry, are discussed. Finally, future prospects in peptaibiotic research are presented. Owing to the
ubiquity and biodiversity of the fungal producers in the biosphere, the discovery of a myriad of
peptaibiotics within the next decade is predicted.
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1. Introduction. – Fungi are generally regarded as a literally infinite resource of
bioactive secondary metabolites displaying remarkable structural diversity. Peptide
antibiotics constitute a considerable part of these metabolites. During the past two
decades, a constantly growing group of peptide antibiotics, the peptaibiotics, has started
to regain particular interest because of their unique bioactivities and conformations [1].
Peptaibiotics are defined as linear or cyclic polypeptide antibiotics which i) have a
molecular weight between 500 and 2,200 Da, thus containing 4–21 residues; ii) show a
high content of the marker a-aminoisobutyric acid (Aib); iii) are characterized by the
presence of other non-proteinogenic amino acids and/or lipoamino acids; iv) possess an
acylated N-terminus, and v) in the case of linear peptides, have a C-terminal residue
that, in most of them, consists of a free or acetylated amide-bonded 2-amino alcohol.
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The C-terminus might also be an amine, amide, free amino acid, 2,5-dioxopiperazine, or
sugar alcohol. The majority of Aib-containing peptides carries a C-terminal residue
representing a 2-amino alcohol, and this subgroup is, therefore, referred to as
peptaibols [2] [3]. In strongly lipophilic peptaibols, the N-terminus is acylated by
octanoic, decanoic, or cis-dec-4-enoic acid, and these are named lipopeptaibols [4]. In
the third subfamily of lipoaminopeptides (also named aminolipopeptides), the N-
terminus is substituted by unbranched, a- or g-methyl-branched, saturated or
unsaturated C4–C15 fatty acids. An l-proline-, trans-4-hydroxy-l-proline, or cis-4-
methyl-l-proline residue is found in position 1 of the peptide chain, and, in most cases,
it is followed by a lipoamino acid residue in position 2. To our present knowledge, this
compound, 2-amino-6-hydroxy-4-methyl-8-oxodecanoic acid (AHMOD), has only
been detected in this subfamily. A fourth subfamily comprises all other linear
peptaibiotics that cannot be classified in any of the other three preceding subfamilies
[2]. Recently, a fifth subfamily has been introduced. Not considering linearity as a
necessary prerequisite anymore, extension of the above definition of GpeptaibioticsH to
encompass also cyclic, Aib- or Iva-containing peptides of natural origin was proposed
[3].
A review introducing nine subfamilies according to structural homologies of
peptaibiotics has been published in 2001 [5], but these need to be revised and updated
[6], because more than half of the currently known sequences of peptaibiotics have
been discovered since then, including more than 200 found in our group [7–12].
Peptaibiotics are usually classified according to their main chain length as long-chain
(17–21 residues), medium-chain (11–16 residues), and short-chain (5–10 residues)
sequences. Although not yet reported in literature, Degenkolb et al. [2] claimed the
detection of very short chain (< 5 residues) peptaibiotics that may represent drastically
truncated sequences.
2. 1958–2008: Fifty Years of Peptaibiotic Research. – 2.1.Discovery of the First Aib-
Containing Peptide Antibiotic, ICI 13959. The first report on the isolation of peptide-
bound Aib from a fungal source was already published in 1958 [13], when an HCl
hydrolysate of the non-crystalline peptide antibiotic ICI 13959 was investigated by
ascending two-dimensional paper chromatography and elementary analysis of the
resulting ninhydrin-positive spots. This antibiotic, produced by a taxonomically
unidentified strain of the genus Paecilomyces, has shown remarkably high activity
against Trypanosoma congolense infections in mice. Five ninhydrin-positive spots, A–
E, were analyzed as Leu, Aib, g-methylproline (g-MePro), b-hydroxyleucine (b-
Hyleu), and b-alanine (b-Ala), respectively. Furthermore, Gbasic substancesH were
produced during hydrolysis the structures of which have not been elucidated [13].
Subsequently, spot D was further characterized as l-threo-b-hydroxyleucine [14],
whereas spot C was determined as cis-4-methyl-l-proline [15]. Taken together, these
results strongly suggest that antibiotic ICI 13959 might have consisted of a mixture of
homologous leucinostatins. These lipoaminopeptides were subsequently isolated from
Paecilomyces lilacinusA-267 [16–20], No. 1907 [21], P168 [22–25], and other strains of
this species, as well as from P. marquandii 699/ISS [26–31]. To the best of our
knowledge, neither reports to complete the structural elucidation of ICI 13959, nor
bioactivity data were subsequently published.
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2.2. The First Two Decades of Peptaibol Research. The history of research on
peptaibiotics dates back to 1966, when suzukacillin (SZ), a mixture of two TLC-
separable components, SZ-A and SZ-B, from Trichoderma viride 63 C-I, was obtained
in crystalline form [32]. The unknown amino acid detected in the HCl hydrolysate was
subsequently isolated and identified as Aib [33]. In 1967, the first report on the Aib-
containing antibiotic U-22324 from Trichoderma viride NRRL 3199 was published
[34]. This polypeptide antibiotic, later renamed alamethicin (ALM), is generally
regarded as the most thoroughly investigated peptaibiotic, thus often serving as the
classical paradigm of a peptaibol [8] [10] [12] [35] [36]. The antiprotozoal activity of
antiamoebin (AAM) was published later the same year [37]. In 1968, its action on
rumen microorganisms [38], polypeptidic nature, including the presence of non-
proteinogenic amino acids such as Aib and Hyp [39] [40], were recognized as well as
the presence of an amino alcohol, determined as l-2-amino-3-phenylpropan-1-ol (l-
phenylalaninol, Pheol) [41]. After the breaking publication byMueller and Rudin, who
reported on the induction of action potentials in experimental bilayer lipid membranes
(BLMs) and cationic conductance induced by ALM [42], the interest in similar
membrane-active peptide antibiotics increased remarkably – both SZ [43] [44] and
TXT A-40 [45] [46] were subsequently reported to display similar channel-forming
activity. Furthermore, the haemolytic activity of SZ, ALM, and TXT-A40 were
published [47]. Non-targeted antimicrobial screening approaches led to the isolation of
the following peptide antibiotics, which subsequently could be demonstrated to belong
to the family of peptaibiotics:
 Stilbellin from a coprophilous (deer dung) isolate of Stilbella sp. [48], which later
deceased;
 Trichotoxin A (TXT A) from GTrichoderma virideH NRRL 5242 and Trichotoxin B
(TXT B) from GTrichoderma virideH NRRL 5243, two secondary invaders of maize
cultures infested with Helminthosporium maydis (¼Bipolaris maydis, teleomorph
Cochliobolus heterostrophus) race T, the causal agent of Southern Leaf Spot of
Maize [49];
 Emerimicins I– IV from Emericellopsis microspora 333 [50];
 Zervamicins I and II from Emericellopsis salmosynnemata 336 [51];
 Samarosporin from a mycelial culture of the ascomycete GSamarospora sp.H FERM-P
224 (F-7762) [52] that ceased the production of the antibiotic and is no longer
deposited.
2.3.Mass Spectrometry Becomes a Decisive Tool in Peptaibol Research. During the
first decade of research in this field, structure elucidation of peptaibols was remarkably
hampered by the presence of an acylated N-terminus and a C-terminus that represents
a 2-amino alcohol. Owing to the negative ninhydrin reaction, a cyclic structure was
originally proposed for ALM [34], AAM [40], and TXT-A [49]. Linearity of ALM,
including the presence of an acetylated N-terminus, Ac-Aib, was first recognized by
NMR [53]. However, the correct, C-terminal position of the phenylalaninol (Pheol)
residue in AAM, ALM, and emerimicins III and IV was assigned by a combination of a
cation-exchange technique and field-desorption high-resolution mass spectrometry
(FD-HR-MS), gas chromatography/high-resolution electron impact mass spectrome-
try (GC/HR-EI-MS), and gas chromatography/field ionization mass spectrometry
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(GC/FI-MS), which also confirmed the presence of an N-terminal Ac-Aib residue [54–
57]. Notably, Pandey et al. were the first to define a new family of peptide antibioitics,
the so-called peptaibophols, as peptide antibiotics, which contain the marker amino
acid Aib and a C-terminal phenylalaninol (Pheol) residue [55]. Subsequently,
combinations of FD-MS, GC/EI-MS, and CI-MS analyses of trifluoroacetylated and
esterified partial hydrolyzates, as well as reduced and trimethylsilylated peptide
fragments were introduced. These approaches proved to be a pivotal tool accelerating
the sequence determination, as exemplified for TXT-A40 [58] – one of the two TLC-
separable fractions of trichotoxin, TXT-A40 and TXT-A50. The importance of a chiral
GC/MS approach could subsequently been demonstrated when hydrolysates of AAM,
emerimicin IV, SZ, and TXT-A40 were shown to also contain d-Iva [59]. GC/MS
Analysis of its methyl ester was also used to unambiguously establish the presence of
AcAib in ALM F30, ALM F50, TXT-A40, TXT-A50, and SZ-A after selective
trifluoroacetolytic scission of the above peptide antibiotics [60].
Since additional 2-alcohols such as valinol (Valol) in TXT-A40 [58] and leucinol
(Leuol) in hypelcin from Hypocrea peltata [61] were detected as C-terminal
constituents, the above definition of peptaibophols needed to be revised and updated.
To appropriately characterize this family of peptide antibiotics, the technical term
peptaibol was – independently from each other – proposed by Benedetti et al. [62], and
by Brckner and Graf [63] for those peptide antibiotics, which contain the marker
amino acid Aib and a C-terminal amino alcohol (Xol) residue.
The introduction of fast atom bombardment mass spectrometry (FAB-MS) is to be
considered as a further milestone for peptide sequencing [64] [65]. FAB-MS
impressively demonstrated the sequence identity of leucinostatin A [20], which is
present as a constituent of the following antibiotics: A-267 [16], No. 1907 [21], P168
[22–25], and CC-1014 [66]. A multiple analytical approach combining HPLC, gas–
liquid chromatography (GLC), FD-MS, and FAB-MS was used to confirm the identity
of stilbellin and samarosporin with emerimicin IV [67]. Similar approaches, including
selective in situ hydrolysis, were subsequently used to characterize the microheteroge-
neous mixtures of zervamicin [64], paracelsin (PC), TXT-A40, and TXT-A50 as well as
gliodeliquescin [58] [68–71].
By the middle of the 1980s, it was generally recognized that most of the hitherto
known peptaibol antibiotics and related, Aib-containing structures such as trichopolyns
[72] [73], efrapeptins [74], elvapeptins [75], and hypelcins [76] [77] represent micro-
heterogeneous mixtures.
Although of microcrystalline structure, these Aib-containing peptide antibiotics
still consist of a more or less complex mixture of homologous and positionally isomeric
components. Microheterogeneity was postulated to originate from non-ribosomal
peptide biosynthesis as indicated by the presence of non-proteinogenic amino acids
[78] such as Aib, d-Iva, b-Ala, Hyp, Hyleu, MePro, as well as lipoamino acids such as
AHMOD [17], C-terminal amino alcohols or amines. Non-ribosomal biosynthesis of
ALM was already established in 1967, as the addition of cycloheximide to a growing
culture of Trichoderma viride NRRL 3199 was found to block ribosomal peptide
synthesis, but it did not interfere with the biosynthesis of ALM [78]. Moreover, the in
vitro synthesis of ALM was not influenced by puromycin or RNase and found to be
thiotemplate-associated [79].
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In 1985, high-pressure liquid chromatography/fast-atom-bombardment mass spec-
trometry (HPLC/FAB-MS) with jet sprayer and moving belt interface was introduced.
The idea behind this was to first separate the amphiphilic and thermally labile peptide
antibiotics, including peptaibols, on C18 columns, which are subsequently sequenced by
FAB-MS. [80]. The LC/MS interface was subsequently improved replacing the jet
sprayer by a frit. HPLC/Frit-FAB-MS confirmed the identity of leucinostatin A
[16] [19] [20] with antibiotic No. 1907 [21], P168 [22–25], and CC-1014 [66].
Furthermore, it revealed the structures of four new minor components of the
leucinostatin family [81]. Finally, HPLC/Frit-FAB-MS was used to separate and
sequence the microheterogeneous P168 mixture, which consisted of at least 20
homologous and positionally isomeric leucinostatins [25].
2.3.1. New MS-Based Screening Approaches in Peptaibol Research. The Aib-
containing peptide antibiotics treated above were randomly discovered in bioactivity-
guided screenings. By 1987, ca. 60 individual sequences of peptaibols and related Aib-
containing linear peptides have been described in literature. Notably, all of them were
isolated from hypocrealean fungi, belonging to different genera of the family
Hypocreaceae (Trichoderma/Hypocrea, Gliocladium, Emericellopsis, Stilbella, and
Paecilomyces) or Clavicipitaceae (Tolypocladium). As half of the sequences known at
that time were produced by members of Trichoderma (and its Hypocrea anamorphs),
this genus was the first one to be systematically screened for new peptaibol producers.
Crude organic extracts of fungal cultures were hydrolyzed; the free amino acids
were converted into the corresponding pentafluoropropionyl-1-propyl esters; and the
sample was subsequently analyzed for the presence of the PFP-Aib-1-propyl ester by
GC-FID. Because a huge number of new Aib-positive species and strains of
Trichoderma has been detected [82] [83], this method was subsequently broadened,
and both GC-FID and GC/MS were used for screening of Stilbella, Emericellopsis,
Gliocladium, Trichoderma, and Hypocrea [84–86]. For resolution of dl-Iva on
ChirasilValTM, conversion into N-acetyl-isovaline-1-propyl esters was found to be
superior [87]. HPLC Analysis after precolumn derivatization of the total hydrolysate
with o-phthaldialdehyde-3-mercaptopropionic acid (OPA/MPA) was introduced at the
same time [85]; and subsequently different chiral variations of MarfeyHs reagent were
used for HPLC analysis of amino acids [88–90]. Regardless of a number of subsequent
attempts undertaken to validate the previously reported detection of Aib in hydrolyzed
extracts ofMetarhizium anisopliae [91], Penicillium roquefortii [84], and P. nalgiovense
[85], those three species could not be confirmed as producers of peptaibiotics.
Furthermore, our isolate of M. anisopliae CBS 597.80 deceased; and this strain is no
longer deposited in the culture collection of CBS. Thus, the isolation of metanincin [91]
could not be reproduced. Notably, none of the subsequently examined strains and
species of Metarhizium produced Aib-containing peptides. Therefore, taxonomic
identity of M. anisopliae CBS 597.80 either had to be doubted, or that culture was
contaminated by Trichoderma sp. The latter assumption was supported by the fact that
ca. 1.4 g (!) of a peptaibol mixture, structurally related to the paracelsins, was isolated
from a submerged fermentation of the fungus. Despite these three
counter-examples, it should be emphasized here that most of the fungal strains and
species we have reported positive for Aib and/or dl-Iva [92] [93] were unambiguously
confirmed as producers of peptaibiotics. Subsequent attempts undertaken by us or
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other groups led to the isolation and complete chemical characterization of these
compounds.
From the middle of the 1980s on, a huge number of fungal strains and species were
systematically screened for the production of Aib-containing polypeptide antibiotics.
Research was mainly focused on previously uninvestigated species of Trichoderma and
its Hypocrea teleomorphs, which proved to be the richest sources of peptaibols and
related Aib-peptides: In 1985, trichorzianine AIIIc was isolated from Trichoderma
harzianum ATCC 20672 [94] – a strain from which another eight neutral 19-residue
trichorzianins A [95] and seven acidic 19-residue trichorzianins B [96] could
subsequently be obtained. Fujita et al. were the first to demonstrate that T. polysporum
TMI 60146 produced a mixture of different subfamilies of Aib-containing polypeptide
antibiotics [97]. In addition to the previously described ten-residue lipoaminopeptides
trichopolyns I and II, eleven 20-residue peptaibols, named trichosporins B, were
isolated [98] [99]. The same phenomenon was reported for T. longibrachiatumMNHN
3431: this strain produced a mixture of two 20-residue peptaibols tricholongins B [100],
and the eleven-residue trichogin A IV. The latter was shown to carry an N-terminal
octanoyl (Oc) instead of an acetyl (Ac) residue. Thus, trichogin A IV was the first
representative of a new subfamily of the peptaibiotics, named lipopeptaibols, as they
carry an N-terminal acyl instead of an Ac residue [101]. Further eleven-residue
lipopeptaibols, trikoningin KB I and KB II, and the 19-residue peptaibol trikoningin
KAV were isolated from T. koningii MNHN 903589 [102].
In view of the constantly growing structural diversity of Aib-containing polypeptide
antibiotics, Brckner et al. introduced the technical term peptaibiotic [103] [104] to
encompass all Aib-containing polypeptide antibiotics that did not match the classical
definition of a peptaibol anymore [62] [63].
Four neutral 20-residue peptaibols were isolated from T. saturnisporum MNHN
903578 [105]. Ca. 31 trichobrachins of different building scheme and chain length were
reported from T. longibrachiatum CBS 936.69, and another seven 14-residue
trichovirins from T. viride NRRL 5243 [106]. Seven of the eleven trichokindins, Iva-
containing 18-residue peptaibols from T. harzianum, were shown to carry the rare C-
terminal isoleucinol (Ileol) residue [107]. The same strain was subsequently shown to
produce four eleven-residue trichorozins [108]. Trichodecenins I and II, two seven-
residue lipoeptaibols with an N-terminal (Z)-dec-4-enoyl group [109], 24 eleven-
residue trichorovins [110], eight 20-residue trichocellins A, and two 20-residue
trichocellins B [111] were reported from a strain of T. viride. Harzianins HC, a mixture
of eleven 14-residue peptaibols, was reported from strains of T. harzianum, viz. M-
903614 and M-903603 [112]. The latter also produced the six 18-residue trichorzins HA
[113] [114] and the eleven-residue harzianin HB I [115]. Further peptaibols isolated
from T. harzianum include three 18-residue trichorzins MA from strain M-922835
[113] [114]. Furthermore, paracelsin E was obtained from T. saturnisporum CBS 330.70
[116]. Besides the eleven-residue peptaibol harzianin HK VI [117], two additional
peptaibiotics with modified C-termini were isolated from T. pseudokoningii MVHC
662: the ten-residue pseudokonin KL III terminating in prolinamide (Pro-NH2), and
the nine-residue pseudokonin KLVI carrying an unusual 2,5-diketopiperazine, namely
cyclo-Aib-l-prolinal. Notably, harzianin HK VI, and pseudokonins KL III and KLVI
display the same sequence of the N-terminal heptapeptide [118]. Nine 20-residue
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hypelcins A [119] and five 20-residue hypelcins B [120] some of which carry the rare C-
terminal Ileol residue were isolated from the ascomycete Hypocrea peltata.
The search for novel sources of peptaibiotics also comprised previously uninves-
tigated genera and species of fungi such as:
 Tolypocladium inflatum (syn. T. niveum) and T. geodes, producing six insecticidal 16-
residue efrapeptins C–H that carry an unusual C-terminal amine, N-peptido-1-
isobutyl-2-(2,3,4,6,7,8-hexahydro-1-pyrrolo[1,2-a]pyrimidinio)ethylamine (PIHPPE)
[121–124], and
 the ascomycetous Verticimonosporium ellipticum D 1528, the producer of aibellin, a
20-residue peptaibiotic carrying a diamino alcohol residue, 2-[(2-amino-3-phenyl-
propyl)amino]ethanol [125].
2.3.2. Electrospray Ionization MS (ESI-MS) Revolutionizes the Research on
Peptaibiotics. Spray ionization (SI) techniques, such as electrospray ionization (ESI)
and atmospheric pressure chemical ionization (APCI), introduced at the beginning of
the 1990s, revolutionized the search for peptaibiotics. Contrary to the classical
ionization techniques mentioned above, these GsoftH ionization techniques usually do
not generate intense fragment ions but mostly pseudomolecular ions such as [MþH]þ ,
[MþNa]þ , [MþK]þ , [2MþH]þ , and [2MþNa]þ , or [MH] in the negative-ion
mode, thus facilitating the recognition of the molecular weight and significantly
reducing sample requirement. In most cases, sequence information is not obtained until
collision-induced dissociation (CID) is performed in the skimmer region of the MS, or,
more specifically, single precursor ions are selected and subsequently fragmented by
collision with Ar, He, or ultrapure N2, thus generating product ions in the collision cell
– a technique, which is referred to as MS/MS or MS2 [126] [127].
Within three years, triple-quadrupole MS/MS impressively revealed its superiority
for sequencing of peptaibiotics: for instance, a fungicolous strain of Trichoderma
koningii, isolated from the bracket fungusGanoderma lucidum, which has been used in
Traditional Chinese Medicine for more than 4,000 years, was shown to produce nine 20-
residue trichokonins and one 19-residue trichkonin [128–130]. The polysporins A–D,
four alamethicin-like 20-residue peptaibols, were isolated from a strain reported as T.
polysporum [131].
Notably, further mycoparasitic fungi outside Trichoderma/Hypocrea were success-
fully screened for the presence of peptaibiotics: Mycogone rosea DSM 8822, the
producer of two nine-residue lipoaminopeptides, helioferin A and B [132]; Sepedonium
chrysospermum DSM 7444 (teleomorph Hypomyces chrysospermus, syn. Apiocrea
chrysosperma), biosynthesizing four 19-residue chrysospermins A–D [133]; Sepedo-
nium ampullosporum DSM 10602, source of the neuroleptic 15-residue ampullosporin
A [134], and further seven minor components, ampullosporins B–E4 [135]. This strain
also produced the five-residue peptaibolin, the shortest peptaibol reported in literature
to date [136].
2.4. Towards Structural Diversification: from 1996 to 2008. 2.4.1.New Peptaibols and
Lipopeptaibols from Soil Fungi. In 1996, three novel eleven-residue lipopeptaibols,
LP237-F5, -F7, and -F8, were obtained from Tolypocladium geodes LP237, a soil fungus
collected in the Pennine Mountains (UK). The N-terminus of LP237-F5 and -F8 is
protected by an octanoyl residue, whereas LP237-F7 carries an decanoyl residue, thus
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being the first lipopeptaibol to display this particular structural element. Another
unique feature of LP237-F5 and -F8 is the presence of one a-ethylnorvaline (EtNor)
residue, the methylene homologue of isovaline [137] [138]. Four 15-residue bergofun-
gins A [139] and B–D [140] were isolated from Emericellopsis donezkiiHKI 0059. The
17-residue peptaibiotic XR586 obtained from the tropical soil fungus Acremonium
persicinum X21488 was shown to terminate in Gly [141].
2.4.2. New Peptaibiotics with Unusual N- and C-Termini. In 1997, a peptaibiotic
displaying a mannitol residue as a unique C-terminal substituent was isolated from the
soil fungus Clonostachys sp. F5898: the 15-residue clonostachin is the only peptaibiotic
described in literature so far the C-terminus of which is esterified to the carboxy group
of the penultimate Ile residue [142]. Six eleven-residue hypomurocins A and another
six 18-residue hypomurocins B were isolated from strain IFO 31288 [143]. This strain
has originally been misidentified as Hypocrea muroiana but was recently proven to be
Trichoderma atroviride [10].
The same year, two 21-residue peptaibiotics, texenomycins A and B, were claimed
to be isolated from the basidiomycete Scleroderma texenseDSM 10601 (syn. S. bovista).
The N-terminal Pro residue of the texenomycins is protected by a b-keto-2-
methyltetradecanoyl (MOTDA) residue, whereas arginol (Argol) is found as a so far
unique C-terminal constituent [144]. However, ecophysiological and chemotaxonomic
considerations rather suggest an unrecognized infection of the investigated strain by a
mycoparasite of basidiomycete affiliation that could be attributed as the producer of
these peptaibiotics [2] [122]. Lipohexin, an inhibitor of prolyl endopeptidase,
representing a six-residue N-terminal deletion sequence of texenomycin, was isolated
from three fungal strains, originally identified as Moeszia lindtneri HKI-0054, and two
Paecilomyces sp., HKI-0055 and HKI-0096 [145] [146]. The former strain was
subsequently reclassified as Acremonium lindtnerei DSM 11119 (teleomorph Hypo-
myces chrysostomus), and the latter two were recently reidentified as Mariannaea
elegans CBS 120677 and CBS 120687 [2].
Four nine-residue peptaibiotics, MS-681a, b, c, and d, which act as inhibitors of
myrosin light chain kinase, were isolated fromMyrothecium sp. KY6568 [147]. Notably,
the configuration of the Iva8 and the Iva2 residues was shown to be l, whereas Iva5 was
assigned the d-configuration. The C-terminus of all four homologues is protected by
the same polyamine, (2’RS)-N1-(2-amino-3-phenylpropyl)spermidine, another novel
constituent of peptaibiotics [148].
The same year, a commercial sample of paracelsin from T. reesei QM 9414 was
reinvestigated by high-energy CID tandem mass spectrometry, which led to the
detection of four minor homologues, viz. PC-F, -G, -H-, and -I [149].
2.4.3. Discovery of New, Iva-Rich Peptaibols. In 1998, the sequences of the new
minor components of paracelsin could independently be confirmed by HPLC coupled
to an ESI-ion-trap MS [150]. Further diversification of the trichorzianine A mixture
was also achieved by high-energy CID tandem mass spectrometry, leading to the
detection of five new sequences in addition to the nine previously reported [151].
Moreover, seven Iva-rich 18-residue peptaibols, trichorzins PA, were isolated from
T. harzianumM-902608 [152]. When the latter strain was grown on Aib-supplemented
medium, two new compounds, trichorzin PAU4 and harzianin PCU4, were obtained in
addition to the seven trichorzins PA mentioned above. Fermentation of T. longi-
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brachiatum M-853431 on a synthetic medium led to the production of four 20-residue
neutral longibrachins A I–IVand two acidic longibrachins B II and III. Growth of that
strain on Aib-supplemented medium resulted in the simplification of the peptaibol
mixture produced [153] [154].
2.4.4. From Friend or Foe, Host or Mycoparasite? – The Origin of New Peptaibiotics
Found in Fruiting Bodies of Basidiomycetes. In 1999, the isolation of the 19-residue
boletusin [155] and the 15-residue tylopeptin [156] from fruiting bodies of basidio-
myces, viz. Boletus sp. and Tylopilus neofelleus, was reported. However, the isolation of
a peptaibiotic from a fruiting body of a member of the Boletales should be regarded as
highly ambiguous.
Boletaceous fungi are known to be preferentially parasitized by members of the
genus Sepedonium (with teleomorphs in Hypomyces). It should be emphasized again
that the peptaibiotics produced by this genus exhibit a remarkably high structural
homology with boletusin or tylopeptin. This phenomenon was extensively discussed by
Degenkolb et al. [2] [127]. Finally,Neuhof et al. [157] demonstrated that the fungicolous
Sepedonium chalcipori, which exclusively parasitizes the Peppery Bolete Chalciporus
piperatus, produced tylopeptins A and B in solid-state fermentation. These authors
suggested that tylopeptins, as reported by Lee et al. [156], were in fact produced by an
ascomycetous mycoparasite. Thus, the conclusions by Kiet et al. could be corroborated
who attributed the detection of chrysospermins A–D in fruiting bodies of the new
Vietnamese species Xerocomus langbiannensis to an unrecognized infection of this
bolete by Sepedonium sp. [158].
A reinvestigation of the trichopolyn mixture produced by the fungicolous isolate T.
polysporum TMI 60146 revealed the presence of three minor components, trichopolyns
III–V in addition to the previously reported trichopolyns I and II. Notably, the N-
terminal Pro residue of trichopolyn V carries a novel N-terminal substituent, 3-
hydroxy-2-methyldecanoic acid (HMDA) [159].
Trichoderma viride NRRL 5243, currently deposited as T. cf. harzianum [10], has
been reported in 1972 as the producer of trichotoxin B [49]. This strain was
reinvestigated, ESI-ion trap MSn being the method of choice for sequencing of
homologous and positionally isomeric peptaibiotics. Even chromatographically insep-
arable peptides can be sequenced by the generation of different generations of product
ions [126] [127]. Trichotoxin B had been renamed to trichovirin in the meantime and
found to consist of the groups trichovirins I and II [106]. The latter were shown to be a
microheterogeneous mixture of twelve 18-residue peptaibols [160].
Trichotoxin A-40 produced by Trichoderma viride NRRL 5242, now reidentified as
T. asperellum [161] [162], was shown to consist of six homologous and positionally
isomeric 18-residue peptaibols [163].
2.4.5. New Producers of Antiamoebins and of Lipoaminopeptides. In 2000,
antiamoebin mixtures obtained from different fungi and from two commercial
preparations of AAM were reinvestigated by LC/ESI-ion-trap MSn and dipeptide
analysis by GC/MS. Finally, this approach disclosed the impressive microheterogeneity
of AAM, leading to the introduction of 14 new sequences. The following strains were
confirmed as producers of AAM: Stilbella erythrocephala (syn. S. fimetaria) ATCC
28144, S. fimetaria CBS 548.84, Gliocladium catenulatum (syn. Clonostachys rosea f.
catenulata) CBS 511.66, Emericellopsis synnematicola CBS 176.60, and E. salmosyn-
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nemata CBS 382.62 [164]. Notably, Lehr et al. were – six years later – first to
unequivocally prove that antiamoebins were responsible for antibiosis in colonized
herbivore dung [165]. Four strains of Stilbella fimetaria (syn. S. erythrocephala) were
isolated from dung of wild rabbits (D99026, D01024, and D03001) or of the tortoise
Testudo hermanni (D03012). Furthermore, dung pellets naturally colonized by S.
fimetaria were collected in the field, lyophilized, and extracted. The same was carried
out with presterilized dung that has been artificially inoculated with the four strains
mentioned above. As expected, AAM could be detected in all liquid cultures. To
continue, the total AAM concentration – both in wild and artificially inoculated dung –
was 126–624 mg/g fresh weight, with minimum inhibitory concentrations against most
other coprophilous fungi being at or below 100 mg/ml. It should be pointed out that this
is the first report describing the detection and isolation of peptaibiotics from natural
substrates. The diterpene antibiotic myrocin B, not previously described from S.
fimetaria, was also produced, but only at low, nonfungicidal levels (5.3 mg/g). As no
other antifungal substances could be detected, a decisive role of the broad-spectrum
antimycotic AAM during colonization of dung was proposed [165]. The 15-residue
heptaibin was also isolated from Emericellopsis sp. BAUA8289, a strain colonizing the
roots of a rice plant [166]. Heptaibin, displaying seven Aib-residues, is considered one
of the Aib-richest peptaibols reported to date.
An ESI-ion-trap MSn approach was shown to be decisive for sequencing of the
roseoferin complex, a mixture of at least 16 homologous and positionally isomeric nine-
residue lipoaminopeptides produced by Mycogone rosea DSM 12973. [167]. The
liopaminopeptides of the helioferin/roseoferin complex are characterized by the
presence of an N-terminal Pro residue that is protected by a-Me-branched fatty acids –
either 2-methyloctanoic (MOA), or 2-methyldecanoic acid (MDA). A secondary or
tertiary amine, either 2-(2’-aminopropyl)-aminoethanol (AAE), or 2-(2’-aminoprop-
yl)-N-(methylamino)-ethanol (AMAE) is found at the C-terminus.
Further peptaibols reported in 2000 comprise two antiviral 19-residue peptaivirins
A and B from an unidentified fungal strain KGT142 [168] and three atroviridins A–C,
20-residue peptaibols, from Trichoderma atroviride [169].
2.4.6. Microheterogeneous Stilboflavins, Antihelmintic Cephaibols, Antimycoplas-
mic Longibrachins, and a Peptaibiotic Terminating in Free Aib. In 2001, three
microheterogeneous groups of peptaibols, stilboflavins A–C, were isolated from the
soil fungus Stilbella flavipes CBS 146.81. Stilboflavin A consists of seven acidic
(Glu18Gln19) 20-residue peptaibols terminating in Valol or Leuol. Stilboflavin B,
however, is a complex of ten neutral (Gln18Gln19) 20-residue peptaibols, eight of them
displaying a C-terminal Valol or Leuol residue. Notably, two of them carry the rare Ileol
terminus [170].
Cephaibols, two groups of antihelminthic 16- or 17-residue peptaibiotics, were
isolated from Acremonium tubakii DSM 12774 and shown to be highly active against
ectoparasites. The 16-residue cephaibols A, A2, B, C, D, and E represent peptaibols
with a C-terminal Pheol residue, whereas cephaibols P and Q are peptaibiotics carrying
a Phe16 and terminating in a free Ser17 residue. Notably, cephabols E and D were shown
to be identical with antiamoebins III and VI, respectively [171].
Two antimycoplasmic 20-residue peptaibols, longribrachin LGB II and LGB III,
were isolated from Trichoderma longibrachiatum LCP-853431 [172].
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Two antifungal peptaibiotics, SCH 466457 and SCH 466456, carrying an N-terminal
2-methyl-3-oxotetradecanoyl (MOTDA) residue were isolated from a taxonomically
unidentified fungus. The first compound, SCH 466457, represents a 17-residue
peptaibiotic, which terminates in free Ala. The second compound, SCH 466456,
exhibits the same amino acid sequence in positions 1–16, and another Ala residue
follows in position 17. Notably, a free Aib residue is found in the C-terminal position 18.
Both compounds were active against Candida ssp., Aspergillus ssp., and Trichophyton
dermatophytes [173]. To the best of our knowledge, this is the first report describing the
occurrence of a free Aib residue as the C-terminal constituent of a peptaibiotic.
2.4.7. Integramides, d- and l-Iva-Containing Inhibitors of HIV Integrase I.
Diversification of the Lipoaminopeptide Pattern by Cofermentation of Two Producers.
In 2002, two novel inhibitors of HIV-1 integrase, the 16-residue integramides A and B,
were isolated from extracts of the fungus Dendrodochium sp. MF6888. Remarkably,
integramides contain an acetylated N-terminal d-Iva and a total of five (A), or six (B)
d- or l-Iva residues. Recently, the complete chiral sequence of integramide A has
definitely been assigned [174]. Among the natural peptaibiotics, integramides are those
that contain the largest proportion of Iva described to date. Free Gly is found at the C-
terminus of both peptaibiotics [174].
Four 18-residue neotroviridins A, B, C, and D, and three atroviridins A, B, and C
were isolated from T. atroviride F80317 [175] [176].
Trichoaureocin, a microheterogeneous mixture of nine 20-residue peptaibols, was
isolated from T. aureoviride IMI 91968. This strain has been isolated from bark of Fagus
sylvatica and was recently reclassified as T. citrinoviride [6]. Notably, the very rare Ac-
Ala is found as the N-terminal constituent of trichoaureocin 1a [177].
Further structural diversification of peptaibiotic pattern was achieved by co-
cultivation of two lipoaminopeptide-producing strains. The roseoferin producer
Mycogone rosea DSM 12973 [161] and the leucinostatin-producing endophyte Acre-
monium sp. Tbp-5 [178] were grown in dual cultures. Notably, neither glucosylation of
leucinostatin [178], nor glucosylation of roseoferin was observed. However, the
(4S,2E)-4-methylhex-2-enoyl (MeHA) residue protecting the N-terminus of leucino-
statins A, B, and K was substituted by the 2-methyldecanoyl (MDA) residue that is
found as an N-terminal substituent of the roseoferins, thus leading to three novel ten-
residue lipoaminopeptides, acremostatins A, B, and C [179].
2.4.8. Sequences of Alamethicins Reconsidered and New Peptaibiotics from
Paecilomyces. In 2003, the sequences of ALM F30 and ALM F50 were thoroughly
reconsidered and reconciled [8]: HPLC separation of ALM F30 using an acidic
gradient revealed ten individual sequences of ALM F30/1–10. Basically, the same
gradient was used to separate ALM F50 but omitting the addition of TFA to the
eluents. As a result, 13 individual peptides, ALM F50/2, 3a–3c, 4a, 4b, 5, 6a, 6b, 7, and
8a–8c could be sequenced.
Recently, the same material used by Kirschbaum et al. [8] was further analyzed by
nonaqueous capillary electrophoresis/mass spectrometry (NACE/MS): eleven amino
acid sequences were identified, and characterized by the exchange of Ala to Aib in
position 6, Gln to Glu in position 7 or 19. To continue, two novel ALM were detected,
which were characterized by the loss of the C-terminal Pheol residue, thus terminating
in Gln. Notably, two truncated 14-residue sequences carrying an N-terminal pyroglu-
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tamyl group (commonly abbreviated as Glp, pGlu, or Pyr) were found. Overall, seven
new sequences are reported compared to [8]. To the best of our knowledge, this is the
first report on the occurrence of Glp as a constituent of fungal peptides in nature.
Literature search did not reveal any previous publications regarding the isolation of
peptide-bound Glp from a fungal source. To exclude the artificial formation of the Glp-
peptaibols during workup or long-term storage, degradation studies were performed.
Although neither treatment increased the amount of the truncated Glp peptides
compared to untreated samples, further studies have to be performed in order to
unequivocally prove the origin of the truncated Glp peptaibols [36].
Furthermore, two eleven-residue trichofumins A and B, as well as two 13-residue
trichofumins C and D were obtained from Trichoderma sp. HKI 276, displaying
neuroleptic activity in rodents [180].
Two antifungal 21-residue peptaibiotics, the N-terminus of which are also blocked
by a MOTDA residue, were isolated from Paecilomyces variotii SCF 1559 [181]. They
exhibit some structural homology with the 21-residue texenomycins A and B [144], as
well as the six-residue lipohexin, which represents a deletion sequence of the
texenomycins [145]. However, the configuration of the amino acids has not been
determined.
2.4.9. Cervinins, New Sequences from Mycogone cervina, a Mycoparasite on
Helvellaeae. In 2004, Mycogone cervina A09–02 was isolated as a parasite of the
Vinegar Cup Helvella (Paxina) acetabulum and shown to produce two twelve-residue
peptaibol antibiotics both exhibiting Ac-Leu as a new N-terminal motif. Leuol is found
as the C-terminal residue of cervinin I. Cervinin II, however, has the same sequence of
amino acids, but its C-terminal Leuol residue is acetylated [182]. As no comments were
made with respect to the origin of the latter C-terminus, it cannot be completely
excluded that cervinin I could have been partly acetylated during the process of
workup, thus generating cervinin II. Surprisingly, no attempts were made to determine
the configuration of the amino acids. We also have to comment on the authorsH
statement that peptaibols exclusively contain l-amino acids. The latter assertion is not
acceptable, because a number of well-known counter-examples concerning the
occurrence of d-Iva in peptaibiotics has been published and discussed in [2] and
[127]. To the best of our knowledge, this is the first report on the isolation and structure
elucidation of secondary metabolites from M. cervina. Surprisingly, no lipoaminopep-
tides have yet been recorded for that species [2] [186].
2.4.10. Cicadapeptins, New Peptaibiotics from an Entomopathogenic Fungus. In
2005, two eight-residue peptaibiotics, cicadapeptins I and II, were isolated from
Cordyceps heteropodaARSEF#1880, a parasite of the Australian cicadaCicadetta puer.
The N-terminus of these peptaibiotics is blocked by an decanoic acid residue, and the
C-terminus is amidated by 1,2-diamino-4-methylpentane (DMAP) [183].
2.4.11. Sequences of Suzukacillins A Reconsidered. Neoefrapeptins and Acretocins –
the First Two Groups of Peptaibiotics Containing the Rare 1-Aminocyclopropane-1-
carboxylic Acid (Acc). In 2006, the microheterogeneous mixture of suzukacillin A
could be further separated by HPLC, yielding 13 individual peaks. Nevertheless, two of
them, SZ-A10 and -A11, still represented a microheterogeneous mixture. Thus, 15
individual 20-residue peptaibols, SZ-A1–A9, -A10a/b, -A11a/b, and SZ-A12 and -A13,
were shown to be present in total. Despite the microheterogeneity, complete sequences
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of all SZ-A peptaibols and configuration of the individual amino acids have been
determined by HPLC/MSn and GC/EI-MS approaches [9]. In this context, the
previously established presence of d-Iva [59] was confirmed. However, both l-Val/d-
Iva and l-Leu/l-Ile were detected in HCl hydrolysates of SZ-A by chiral GC/MS, thus
increasing the previously established sequence combinations for the main C-terminal
heptapeptides of SZ-A [184]. However, it appears as if the suzukacillin-producing
strain is no longer deposited, – neither in industrial, nor in public culture collections.
Ten 16-residue and two 13-residue neoefrapeptins A–N with insecticidal activity
[185] were isolated from Geotrichum candidum SID 22780. It should be pointed out
that this is the first report regarding the isolation and structure elucidation of a
peptaibiotic from a yeast-like fungus. Neoefrapeptins revealed two uncommon
structural elements that are newly described for peptaibiotics: 1-aminocyclopropane-
1-carboxylic acid (commonly abbreviated as Acc) and (2S,3S)-3-methylproline (cis-3-l-
MePro) were identified. Configuration analysis of the 16-residue neoefrapeptins
revealed l-Iva15. Except for the Aib-containing neoefrapeptins D and N, Iva is present
in position 4. Some of the neoefrapeptins also contain Iva5 and Iva10. If present in
position 4 and/or 5, the Iva residue was assigned the d-configuration, whereas the Iva
residues in positions 10 and 15 were shown to possess the l-configuration. The l-
configuration was assigned to all pipecolic acid (Pip) residues found in neoefrapeptins.
Notably, papainic cleavage and ESI-MS of the enzymatically generated fragments were
applied as a novel approach for sequence determination.
Another group of peptaibiotics, acretocin (ACR) [186], that is very closely related
to the efrapeptins (including tolypin) [186] has been detected in Acremonium
crotocinigenum CBS 217.70 – a species that is known as a facultative parasite of a
number of polypores (¼ bracket fungi) and agarics. Unlike efrapeptins which carry l-
Iva (S-Iva), the presence of d-Iva (R-Iva) has been established for acretocins.
Remarkably, acretocins I–VI differ from the efrapeptins C–G by a mass difference of
2 Da, indicating the presence of an amino acid residue of m/z 83 [186]. Such an
observation led to the assumption that acretocins could also contain an Acc9 residue.
This hypothesis was subsequently confirmed by GC/MS analysis of the hydrolyzed
acretocin mixture, comparing retention time and fragmentation behavior with those of
a standard sample of TFA-Acc-isopropyl ester [2].
Four ten-residue lipoaminopeptides, culicinins A–D, were characterized from an
Australian isolate of Culicinomyces clavisporus (Hypocreales, Clavicipitaceae). Strain
LL-12I252 was isolated from larvae of the biting midge Forcipomyia marksae (Diptera,
Ceratopogonidae). Culicinins exhibit a number of common structural features: their N-
terminal Pro residue is protected by butanoic acid (BTA). In 2-position, 2-amino-6-
hydroxy-4-methyl-8-oxodecanoic acid (AHMOD) is found. Another lipoamino acid, 2-
amino-4-methyldecanoic acid (AMD), is situated in position 5, while b-alanine (3-
aminopropionic acid; APA) is located in position 9 of the peptide chain. The C-
terminus is substituted by 2-(2’-aminopropyl)-aminoethanol (AAE), here referred to
as APAE. The lipoamino acid AHMOD is present in position 2 of almost all
lipoaminopeptides, being the characteristic structural element of this subgroup of the
peptaibiotics. C-Terminal APAE has previously been described for trichopolyns,
helioferins, and roseoferins. Notably, BTA and AMD have been detected in peptai-
biotics for the first time, thus representing novel structural elements. Selective
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inhibitory activity against PTEN-negative MDA468 tumor cells has been observed
[187]. Furthermore, eight new eleven-residue peptaibols, trichobrachins A I–IVand B
I–IV, as well as one trichorovin [110] were reported from T. longibrachiatumMMS 151,
a marine strain that has been isolated from the cockle Mytilus edulis [188].
2.4.12.New Sequences and Bioactivities: Inhibition of Amyloid b-Peptide Formation
by Peptaibols. In 2007, T. longibrachiatumMMS 151 was reinvestigated by LC/MS, and
a total of 30 eleven-residue trichobrachins A and C were sequenced, 21 of which were
regarded as new [189].
Notably,Hosotani et al. [190] demonstrated that sophisticated approaches may lead
to the detection of novel or previously unrecognized biological activities of peptai-
biotics. These authors reported on the inhibition of amyloid b-peptide formation in
primary guinea pig cerebral cortex neuron cell cultures by a 14-residue peptaibol, SPF-
5506-A. It is known that increased accumulation of amyloid b-peptides plays a decisive
role in the pathogenesis of neurodegenerative dementia such as AlzheimerHs disease.
Produced by Trichoderma sp. SPF-5506, peptaibol SPF-5506-A4 can be considered
as a positional isomer of the 14-residue harzianin HC [112]. Thus, it can be
hypothesized that harzianins and structurally related peptaibols might display similar
bioactivities.
Two 20-residue peptaibiotics, septocylindrins A and B, have been isolated from the
fungus LL-Z1518 [191]. Amino acid residues 1–19 and configurations of the amino
acids are identical with those reported for alamethicin F30/3 of alamethicin F50/5,
respectively. Septocylindrins differ from alamethicins only in the structure of the C-
terminal alcohol, which is 2-[(2-amino-3-phenylpropyl)amino]ethanol (Phaol). Such
C-terminus has only been described for aibellin before [125]. However, the
identification of the producer as Septocylindrium sp. is questionable as the authors
did not provide taxonomic data to verify its identity [2].
2.4.13. Cyclopeptaibiotics: a New Subfamily of Peptaibiotics. In 2008, a new
subfamily of peptaibiotics, the so-called cyclopeptaibiotics, was introduced comprising
all cyclic Aib- and dl-Iva-containing cyclic peptides of natural origin that have been
described from 1974 until present [3]. Currently, seven cyclotetrapeptides and two
cycloheptapeptides are found in this small subgroup. Chlamydocin [192] can be
regarded as the classical paradigm of a cyclopeptaibiotic. For detailed information on
sequences and bioactivities, and ecophysiological and taxonomic importance of
cyclopeptaibiotics and related cyclic peptides, the reader is referred to the exhaustive
review [3].
3. 4Peptaibiomics5 and 4Intact Cell MALDI-TOF-MS5 – Two State-of-the-Art
Techniques for Rapid Screening and Sequencing of Peptaibiotics. – During the past two
years, peptaibiomics and GIntact cell MALDI-TOF-MSH (IC-MS) have increased
considerably the screening efficiency for peptaibiotics but also contributed to progress
in chemotaxonomy of Trichoderma/Hypocrea as outlined below [193]:
3.1. Peptaibiomics. The method of peptaibiomics is aimed on the characterization of
the entirety of peptaibiotics produced by a fungal strain under defined culture
conditions, the so-called peptaibiome [194]. It also may include the time-dependent
dynamics of biosynthesis and degradation of peptaibiotics as exemplified for the
extremely microheterogeneous trichobrachins from T. ghanense CBS 936.69 [7].
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The workflow comprises solid-phase extraction (SPE) of peptaibiotics on C18-
cartridges, followed by on-line reversed-phase (RP) HPLC coupled to an ion-trap
electrospray tandem mass spectrometer (ES-MS). Such LC/MS-based peptaibiomics
approach is based on the generation of so-called Gin-source fragmentsH by Gcollision-
induced decompositionH mass spectrometry (CID-MS) to the skimmer region of an ESI
mass spectrometer. Varying voltages are applied to the skimmer, thus providing the
possibility of clearly differentiating various types of ions. The CID-MS technique
provides a possibility to partially sequence peptaibiotics. The most diagnostic differ-
ence to screen for is D (m/z) 85, which indicates the presence of the a-aminoisobutyric
(Aib) residue that can be observed in the b- or y-series of acylium fragment ions.
Another diagnostic difference is D (m/z) 99, indicative for a Vxx residue (i.e., isomeric
valine or d- or l-isovaline). Complete sequencing is achieved by a combination of data
from CID-MS, MS/MS, QTOF-MS, and MSn (in the case of ion-trap instruments).
These data are generally needed to be combined with HPLC-elution profiles, the so-
called fingerprints of the samples. Peptaibiomics was first used to analyze the
peptaibiome of recently described species ofHypocrea and Trichoderma. Peptaibiotics
produced by the following strains were partially sequenced and compared to published
sequences:Hypocrea muroianaMUCL 28442,H. nigricansMUCL 28439,H. gelatinosa
CBS 724.87, H. dichromospora CBS 337.69, H. vinosa CBS 247.63, H. semiorbis CBS
244.63, andH. citrina (syn. H. lactea) CBS 853.70; Trichoderma asperellum CBS 433.97,
T. aggressivum f europaeum CBS 100526, T. inhamatum CBS 345.96, and T.
stromaticum CBS 101875 [194].
Trichobrachin (TB) has been isolated from strain CBS 936.69. This particular
Trichoderma strain has originally been identified as T. longibrachiatum but is now
reclassified as Trichoderma ghanense (syn. T. parceramosum). Three major groups
designated TB I, TB II, and TB III could be separated and isolated by preparative TLC
on silica gel. The trichobrachin mixture comprises ten 19-residue peptides with free C-
terminal Gln residues (TB I peptides), two 18-residue peptides with free C-terminal
Gln residues (TB II 1 und TB II 2), seven 20-residue peptides with C-terminal amide-
bonded Pheol (TB II 3–10), and 34 eleven-residue peptides with either C-terminal
Leuol, Ileol, or Valol (TB III 1–34). TLC Analysis of the dynamics of TB formation
and degradation unequivocally demonstrated that those two 18-residue TB I and TB II
peptides with a free carboxy terminus resulted from enzymatic C-terminal degradation
of 20-residue TB II peptides [7].
Three strains of Trichoderma brevicompactum (CBS 109720, CBS 119569, and CBS
119570) and another four, which are closely related to that species (Trichoderma cf.
brevicompactum CBS 112445, CBS 119576, CBS 119577, and NRRL 3199) were
analyzed for the formation of peptaibiotics. These isolates were selected because of an
antagonistic potential against Eutypa dieback and Esca, fungal diseases of grapevine
(Vitis vinifera) trunks that have not yet been investigated for the production of peptide
antibiotics. All strains were found to produce membrane-active alamethicins F30 (see
above). In addition to that, novel peptaibols were detected, namely fourteen twelve-
residue trichocryptins B, twelve eleven-residue trichocryptins A, nineteen eleven-
residue trichobrevins A and B, six ten-residue lipoaminopeptides – trichoferins, and
seventeen seven-residue trichocompactins. Taken together, the differential patterns of
alamethicin production as well as the production of different trichothecene-type
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mycotoxins clearly support DNA-sequencing results. Both molecular and chemo-
taxonomic approaches indicated the existence of – at least - two species within what has
been called Trichoderma brevicompactum, so far [10].
3.2. Intact-Cell MALDI-TOF-MS (IC-MS). This method permits detection of
biomolecules in unfractionated biomass down to the attomolar level. The standard IC-
MS sample preparation process involves suspending of a few mg of fungal mycelium or
spores in a mixture of organic solvents that is immediately mixed with the matrix
solution and subsequently spotted onto a well of the MALDI target plate. Finally, the
air-dried samples are analyzed by MALDI-TOF-MS. On the basis of the facile sample
preparation avoiding extensive workup procedures that may potentially generate
artefacts, this method is recommended for high-throughput screening approaches.
In the case of fungal samples, the method is routinely used for analysis of
hydrophobin patterns [195], but it also permits detection of peptaibiotics in the range
of m/z >800 [6] [12].
Using IC-MS, Neuhof et al. demonstrated that the production of chrysospermins is
rather widespread within the genus Sepedonium, although not all species screened have
been found to produce peptaibiotics. S. chrysospermum, S. ampullosporum, S.
laevigatum, and S. brunneum were positively screened, whereas S. chlorinum and S.
tulasneanum did not produce peptaibiotics under the conditions investigated. Notably,
S. chalcipori produced two novel 15-residue chalciporins A and B in addition to
chrysospermins [157].
3.3.AMultiphasic Approach: Linking Peptaibiomics and Intact-Cell MALDI-TOF-
MS with State-of-the-Art Approaches in Chemotaxonomy and Molecular Biology.
Recently, IC-MALDI-TOF-MS, peptaibiomics, and LC/HR-ESI-MS mycotoxin
screening of Trichoderma/Hypocrea were linked to morphological, molecular taxo-
nomic, and phylogenetic methods. This multiphasic approach was aimed at resolving
the inconsistencies within the different lineages of the GTrichoderma brevicompactum
complexH mentioned above [10]. It culminated in the introduction of a new lineage in
Trichoderma/Hypocrea, the Brevicompactum clade. This clade included, in addition to
T. brevicompactum, three new species in the T. brevicompactum complex, and an
additional new species, Hypocrea rodmanii.
Profiling additional isolates of T. brevicompactum (CBS 112444, CBS 112446, CBS
112447, and CBS 121154), and the new species T. arundinaceum (CBS 119575 and CBS
121153), T. protrudens (CBS 121320), and T. turrialbense (CBS 122554), 27 new eleven-
and twelve-residue trichocryptins and trichobrevins were sequenced. In this context,
the presence of alaninol (Alaol) as a new C-terminal constituent of trichocryptins C
and D was established. Notably, the two cultures ofH. rodmanii, CBS 109719 and CBS
120895, displayed a completely different inventory of peptaibiotics, namely two 20-
residue trichokonins, five new 14-residue peptaibols, hyporodicins A–E, and six new
hypocompactins I–VI. Four of the latter could be assigned as seven-residue
lipopeptaibols, carrying a C8 mono-unsaturated N-terminal fatty acid residue, probably
octenoyl [12].
By a similar profiling approach, Stoppacher et al. [196] sequenced 15 novel
trichoatrokontins, the C-terminus of which has not been elucidated yet. The
trichoatrokontin-producing strain, T. atroviride ATCC 74058, was previously shown
to produce 16 trichorzianins [197].
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4. Outlook and Future Prospective – Towards a Myriad of Peptaibiotics! –
Currently, more than 850 individual sequences of peptaibiotics are reported in
literature. Approximately half of them have been discovered within the past five years;
and the number of peptaibiotics to be discovered within the next decade is expected to
rise exponentially.
4.1. Modern Methods of Mass Spectrometry to Detect Femtogram Amounts of
Peptaibiotics. A first, major reason to explain this phenomenon is that the analytical
equipment used for screening and structural elucidation of peptide antibiotics is
becoming more and more sophisticated, as illustrated by the recently introduced
methods of peptaibiomics and IC-MS. For IC-MS, one single loop of conidia or
mycelium from a fully grown Petri dish is sufficient; for a standard peptaibiomics
approach, the material grown on a single slope or Petri dish is required.
For trace analysis, in general, HPLC-MS/MS on triple quadrupole instruments is
state-of-the-art, because both the sensitivity (down to low fg levels) and specificity are
excellent. Ion-trap mass spectrometers enable the detection and sequencing of
homologues and positional isomers, even if present in trace amounts. Thus, triple
quadrupole MS, ion-trap MS, and MALDI-TOF-MS should be regarded as comple-
mentary methods and combined – whenever possible.
4.2. Exploring the World of Fungal Biodiversity. Second, screening of fungi from
highly specialized habitats such as fungicolous [128–130] [132–136] [159] [182],
coprophilous [164] [165], and entomopathogenic [183] [187] species remarkably
enhances the probability to find new producers and sequences of peptaibiotics. During
the last few years, peptaibiotic-producing fungi from marine habits have gained
increasing interest [188] [189] [198–201]. Considering that the vast majority of
peptaibiotics known to date was isolated from terrestrial fungi, one has to keep in
mind that more than 70% of the earthHs surface is covered by oceans. Consequently,
we have to admit that we are just beginning to understand and exploit aquatic habits
as a proliferating source of novel bioactive secondary metabolites, including peptai-
biotics.
Increased sampling also revealed endophytic fungi as promising sources of new
peptaibiotics, such as Trichoderma stromaticum [11] and T. protrudens [12]. The
discovery and characterization of new fungal species in previously unexplored regions
[202–204], and in ecological niches such as woody tissues of trees [205–208], will
undoubtedly lead to the discovery of new producers, novel constituents, and eventually
uncommon building schemes of peptaibiotics.
For instance, the genus Stilbella containing many coprophilic species can still be
regarded as a promising source of peptaibiotics. Besides the antiamoebin- and
stilboflavin-producing cultures mentioned above, the following strains were positively
screened for Aib and/or Iva: S. aciculosa CBS 546.84 and CBS 476.85, S. albocitrina
CBS 649.83, S. annulata CBS 450.85, CBS 185.70, and CBS 545.85, S. fimetaria CBS
558.84 and CBS 117.84, IMI 080670 and IMI 090138 as well as S. fusca CBS 826.85, and
Remersonia thermophila (syn. S. thermophila) CBS 409.63 [86].
Less common species of ascomycetous fungi have previously been screened
positively for the presence of Aib and/or Iva in the pioneering work of Reinecke [92]
and Becker [93] but not yet investigated for peptaibiotics, which were recently compiled
and commented by Degenkolb et al. [2]. As most of those strains belong to families
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outside the Hypocreaceae and Clavicipitaceae, the detection of novel building schemes
and structural elements of peptaibiotics can be expected.
In this context, it has to be emphasized that peptaibiotics are not only
biosynthesized by highly specialized fungi occupying ecological niches. It always
should be considered that they are also produced by ubiquitous, often cosmopolitan
fungi, occurring both in temperate and tropical soils that are highly competitive habits
[12].
It appears worth mentioning here that the occurrence of Aib and racemic Iva in
sediments close to the the cretaceous– tertiar (K/T) boundary has been reported [209].
The authors attributed their occurrence to the impact of a carbonaceous meteorite.
Some meteorites, such as the Murchison, contain Aib as well as non-racemic mixtures
of chiral Ca-dialkylamino acids, indeed [210]. However, based on the abundance of
data presented here, a microbial origin of Aib and Iva in sediments cannot be excluded
[12] [104] [165]. Notably, recently peptaibiotics were partially sequenced in fresh and
frozen marine sediments collected in France [200].
4.3. Fungal Taxonomy Revolutionized by DNA Sequencing. Third, substantial
progress in the taxonomy of Trichoderma/Hypocrea, the most important source of
peptaibiotics, was achieved after the introduction of DNA sequencing in the middle of
the 1990s, providing a precision in species identification and species boundaries that
was lacking in purely morphological taxonomy. Prior to 1969, only one single species of
Trichoderma, T. viride, was known. Taxonomy of the genus was first revised by Rifai
who distinguished nine species [211]; and ca. 40 species were described in 1991 [212–
215]. In 2005, a total of 88 species was recognized [216], and, one year later, already 100
Trichoderma species were characterized by molecular methods [217]. Currently, almost
140 species are distinguished, and Trichoderma stands as one of the few species-rich
genera of microfungi for which all known species have been cultured, and for which
sequences of two or more genes have been deposited in GenBank [193]. Recently, the
species concept of Trichoderma brevicompactum, for instance, was thoroughly revised,
thus leading to the introduction of the Brevicompactum clade, which comprises, in
addition to T. brevicompactum, three closely related species, viz. T. protrudens, T.
turrialbense, and T. arundinaceum. It should be emphasized here that T. viride NRRL
3199, the classical source of alamethicins, was reidentified as T. arundinaceum [12].
Considering these recent revisions, the identity of the suzukacillin-producing strain
Trichoderma viride 63 C-I is also highly questionable, but the unavailability of this
strain precludes its taxonomic reinvestigation. Notably, most of the peptaibiotics-
producing species formerly included in Gliocladium [218] are now reclassified in
Trichoderma [219]. Prior to 2000, peptaibiotics were in most cases attributed to four
GcommonH species, T. viride, T. koningii, T. harzianum, and T. longibrachiatum.
However, the identity of those cultures that have sometimes even been deposited under
a synonym such as T. album, GT. todicaH, T. virgatum, or T. lignorum [82] [83] is generally
in doubt, or has already shown to be incorrect. In fact, the identity of none of those
Trichoderma viride cultures reported to produce peptaibiotics has been verified by
molecular methods.
Furthermore, the identity of peptaibiotics-producing strains described and depos-
ited as Hypocrea sp. need to be reinvestigated and, most probably, revised. While ca.
400 species ofHypocrea have been described over the past 175 years, few of them have
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been seen since they were first described, and even fewer have been linked to
Trichoderma stages.
Certainly, these authors cannot be criticized, as it has only been in the last few years
that sufficient sequences of correctly identified Trichoderma/Hypocrea species have
been generally available through the ISTH web site and GenBank [220]. Nevertheless,
statements about Trichoderma/Hypocrea species must always be considered with great
caution unless the authors of those reports describe how their cultures were identified.
In fact, most of the currently recognized species of Trichoderma/Hypocrea have not
yet been systematically screened for the formation of peptaibiotics. Complete or partial
sequences have been obtained from approximately 30 verified species; and another ten
recently described species were positively screened for the presence of peptaibiotics by
IC-MS [6].
Currently, other peptaibiotic-producing fungal genera such as Paecilomyces are in
the ongoing process of fundamental taxonomic revision based on DNA sequencing.
Some entomopathogenic species formerly included in Paecilomyces have already been
shown to group in the monophyletic Isaria clade [221] and were thus reclassified in the
genus Isaria. For instance, P. lilacinus [16–25] [222] and P. marquandii [26–31] will
soon be redescribed as two separate species. The leucinostatin-producing GP. abruptusB
[223] seems to be closely related to P. lilacinus ; however, it appears that this species has
never been validly described [224].
5. Conclusions. – To date, peptaibiotics have been reported from ca. 25 genera of
fungi [2] [3] [127], but we currently know several thousand fungal genera, which are
represented by an exponentially growing number of species. Considering the intra-
specific genetic variability, an infinite number of strains from different geographic
regions and habitats can be predicted – just waiting to be exploited. Owing to the
ubiquity and biodiversity of their producers, we predict that a myriad of new sequences
of peptaibiotics will be discovered within the next decade!
T. D. acknowledges the financial support by the Studienstiftung Mykologie (D-Cologne) and the
Erwin-Stein-Stiftung (D-Gießen). We wish to thank Prof. Dr. Walter Gams (Baarn; formerly
Centraalbureau for Schimmelcultures [CBS], NL-Utrecht) for valuable comments on the taxonomy of
the genus Paecilomyces.
Note Added in Proof: Applying a novel screening approach, which combines HPLC/bioactivity
profiling-microtiter plate fractionation with subsequent capillary NMR analysis [225], a new 15-residue
peptaibol, chrysaibol, from the fungicolous strain CANUE609 was characterized. The producer has been
isolated from a decaying fruiting body found in the Kamai Ranges near Kaitaki, Bay of Plenty, New
Zealand, and reported as Sepedonium chrysospermum [226]. Chrysaibol exhibits structural homology
with ampullosporin A [134], both displaying the common motif Gln-Aib-Aib-Aib-Gln-Leu-Aib and the
N-terminal AcTrp residue. Because of the latter, we predict a neuroleptic activity for chrysaibol, in
addition to the cytotoxic (P388 murine leukemia cells) and antimicrobial effects (Bacillus subtilis)
reported. Chrysaibol [225] is one of the very few peptaibols [10][12] known to date, which carry a C-
terminal Alaol residue. The marine fungusAcremonium sp., strain 021172cKZ from Papua New Guinea,
associated with the sponge Teichaxinella sp. (Halichondria, Axinellidae) [199], was shown to produce a
mixture of five efrapeptins – E, F, G, Ea, and H, the latter two being new homologues [227]. The sequence
reported here as efrapeptin H was supposed to be identical with the peak displaying a molecular ionm/z
1662 that has previously been assigned as efrapeptin H [123][228]. Notably, this strain coproduced two
cycloheptapeptaibiotics, scytalidamide A and B [3][229]. This observation led to a reinvestigation of the
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two scytalidamide-producing strains 021172cKZ and CNC310 by methods of molecular taxonomy,
confirming that both isolates belong to the genus Acremonium [227]. A new down-regulator of the
molecular chaperone GRP78, efrapeptin J, displaying a molecular ion m/z 1620, was recently isolated
from a marine fungus, Tolypocladium sp. AMB18 [230]. Further, two efrapeptin peptaibiotics exerting
interesting bioactivities have been described: adenopeptin from Chrysosporum sp. induces apoptotic cell
death in cells transformed with the adenovirus oncogens [231]; this peptaibiotic contains an unusual Ac-
Pro N-terminus as well as four Iva-residues and five Aib-residues; and efrapeptin J from a marine
Tolypocladium sp. represents as a new down-regulator of the molecular chaperon GRP78 [232].
REFERENCES
[1] C. Toniolo, E. Benedetti, Trends Biochem. Sci. 1991, 16, 350.
[2] T. Degenkolb, J. Kirschbaum, H. Br3ckner, Chem. Biodivers. 2007, 4, 1052.
[3] T. Degenkolb, W. Gams H. Br3ckner, Chem. Biodivers. 2008, 5, 693.
[4] C. Toniolo, M. Crisma, F. Formaggio, C. Peggion, R. F. Epand, R. M. Epand,Cell Mol.Life Sci. 2001,
58, 1179.
[5] J. K. Chugh, B. A. Wallace, Biochem. Soc. Trans. 2001, 29, 565.
[6] T. Neuhof, R. Dieckmann, I. S. Druzhinina, C. P. Kubicek, H. von Dçhren,Microbiology 2007, 153,
3417.
[7] C. Krause, J. Kirschbaum, H. Br3ckner, Chem. Biodivers. 2007, 4, 1083.
[8] J. Kirschbaum, C. Krause, R. K. Winzheimer, H. Br3ckner, J. Pept. Sci. 2003, 9, 799.
[9] C. Krause, J. Kirschbaum, G. Jung, H. Br3ckner, J. Pept. Sci. 2006, 12, 321.
[10] T.Degenkolb, T. GrVfenhan,H. I. Nirenberg,W.Gams,H. Br3ckner, J.Agric.FoodChem. 2006, 54, 7047.
[11] T. Degenkolb, T. GrVfenhan, A. Berg, H. I. Nirenberg, W. Gams, H. Br3ckner, Chem. Biodivers.
2006, 3, 593.
[12] T. Degenkolb, R. Dieckmann, K. F. Nielsen, T. GrVfenhan, C. Theis, D. Zafari, P. Chaverri, A.
Ismail, H. Br3ckner, H. von Dçhren, U. Thrane, O. Petrini, G. J. Samuels,Mycol. Prog. 2008, 7, 177.
[13] G. W. Kenner, R. C. Sheppard, Nature 1958, 181, 48.
[14] S. Dalby, G. W. Kenner, R. C. Sheppard, J. Chem. Soc. 1960, 968.
[15] J. S. Dalby, G. W. Kenner, R. C. Sheppard, J. Chem. Soc. 1962, 4387.
[16] T. Arai, Y. Mikami, K. Fukushima, T. Utsumi, K. Yazawa, J. Antibiot. 1973, 26, 157.
[17] Y. Mori, M. Tsuboi, M. Suzuki, K. Fukushima, T. Arai, J. Antibiot. 1982, 35, 543.
[18] Y. Mori, M. Suzuki, K. Fukushima, T. Arai, J. Antibiot. 1983, 36, 1084.
[19] K. Fukushima, T. Arai, Y. Mori, M. Tsuboi, M. Suzuki, J. Antibiot. 1983, 36, 1606.
[20] K. Fukushima, T. Arai, Y. Mori, M. Tsuboi, M. Suzuki, J. Antibiot. 1983, 36, 1613.
[21] M. Sato, T. Beppu, K. Arima, Agric. Biol. Chem. 1980, 44, 3037.
[22] A. Isogai, A. Suzuki, S. Kuyama, S. Tamura, Agric. Biol. Chem. 1980, 44, 3029.
[23] A. Isogai, A. Suzuki, S. Higashikawa, S. Kuyama, S. Tamura, Agric. Biol. Chem. 1981, 45, 1023.
[24] A. Isogai, A. Suzuki, S. Tamura, S. Higashikawa, S. Kuyama, J. Chem. Soc., Perkin Trans 1 1984,
1405.
[25] A. Isogai, Y. Nakayama, S. Takayama, A. Kusai, A. Suzuki, Biosci. Biotechnol. Biochem. 1992, 56,
1079.
[26] C. G. Casinovi, L. Tuttobello, C. Rossi, Z. Benciari, Phytopathol. Mediterr. 1983, 22, 103.
[27] C. Rossi, Z. Benciari, C. G. Casinovi, L. Tuttobello, Phytopathol. Mediterr. 1983, 22, 209.
[28] C. G. Casinovi, C. Rossi, L. Tuttobello, M. Ricci, Eur. J. Med. Chem. 1986, 21, 527.
[29] C. Rossi, L. Tuttobello, M. Ricci, C. G. Casinovi, L. Radios, J. Antibiot. 1987, 40, 130.
[30] L. Radios, M. Kajtar-Peredy, C. G. Casinovi, C. Rossi, M. Ricci, L. Tuttobello, J. Antibiot. 1987, 40,
714.
[31] C. Rossi, M. Ricci, L. Tuttobello, S. Cerrini, A. Scatturin, G. Vertuani, V. Ambrogi, L. Perioli, Acta
Technologiae et Legis Medicamenti 1990, 1, 113.
[32] T. Ooka, Y. Shimojima, T. Akimoto, I. Takeda, S. Senoh, J. Abe, Agric. Biol. Chem. 1966, 30, 700.
[33] T. Ooka, I. Takeda, Agric. Biol. Chem. 1972, 36, 112.
CHEMISTRY & BIODIVERSITY – Vol. 5 (2008) 1837
[34] C. E. Meyer, F. Reusser, Experientia 1967, 23, 85.
[35] B. Leitgeb, A. Szekeres, L. Manczinger, C. Va´gvçlgyi, L. Kredics, Chem. Biodivers. 2007, 4, 1027.
[36] A. Psurek, C. Neus3ß, T. Degenkolb, H. Br3ckner, E. Balaguer, D. Imhof, G. K. E. Scriba, J. Pept.
Sci. 2006, 12, 279.
[37] M. Dave, A. R. Laddu, R. K. Sanyal, Curr. Sci. 1967, 36, 347.
[38] M. Thirumalchar, Hindustan Antibiot. Bull. 1968, 10, 287.
[39] P. V. Deshmukh, Hindustan Antibiot. Bull. 1968, 10, 299.
[40] M. G. Vaidya, P. V. Deshmukh, S. N. Chari, Hindustan Antibiot. Bull. 1968, 11, 81.
[41] P. V. Deshmukh, M. G. Vaidya, Nature 1968, 217, 849.
[42] P. Mueller, D. O. Rudin, Nature 1968, 217, 713.
[43] G. Jung, W. A. Kçnig, D. Leibfritz, T. Ooka, K. Janko, G. Boheim, Biochim. Biophys. Acta –
Biomembranes 1976, 433, 164.
[44] G. Boheim, K. Janko, D. Leibfritz, T. Ooka, W. A. Kçnig, G. Jung, Biochim. Biophys. Acta –
Biomembranes 1976, 433, 182.
[45] G. Irmscher, G. Bovermann, G. Boheim, G. Jung, Biochim. Biophys. Acta 1978, 507, 470.
[46] G. Boheim, G. Irmscher, G. Jung, Biochim. Biophys. Acta 1978, 507, 485.
[47] G. Irmscher, G. Jung, Eur. J. Biochem. 1977, 80, 165.
[48] K. Sasaki, H. Minato, K. Katagiri, S. Hyakawa, T. Matsushima, J. Antibiot. 1971, 24, 67.
[49] C. T. Hou, A. Ciegler, C. W. Hesseltine, Appl. Microbiol. 1972, 23, 183.
[50] A. D. Argoudelis, L. E. Johnson, J. Antibiot. 1974, 27, 274.
[51] A. D. Argoudelis, A. Dietz, L. E. Johnson, J. Antibiot. 1974, 27, 321.
[52] N. Inoue, A. Inoue, M. Furukawa, N. Kanda, J. Antibiot. 1976, 29, 618.
[53] D. R. Martin R. J. P. Williams, Biochem. J. 1976, 181.
[54] R. C. Pandey, H. Meng, J. C. Cook Jr., K. L. Rinehart Jr., J. Am. Chem. Soc. 1977, 99, 5203.
[55] R. C. Pandey, J. C. Cook Jr., K. L. Rinehart Jr., J. Am. Chem. Soc. 1977, 99, 5205.
[56] K. L. Rinehart Jr., J. C. Cook Jr., H. Meng, K. L. Olson, R. C. Pandey, Nature 1977, 269, 832.
[57] R. C. Pandey, J. C. Cook Jr., K. L. Rinehart Jr., J. Antibiot. 1978, 31, 241.
[58] H. Br3ckner, W. A. Kçnig, M. Greiner, G. Jung, Angew. Chem., Int. Ed. 1979, 18, 476.
[59] H. Br3ckner, G. J. Nicholson, G. Jung, K. Kruse, W. A. Kçnig, Chromatographia 1980, 13,
209.
[60] H. Br3ckner, G. Jung, Chromatographia 1980, 13, 170.
[61] T. Fujita, Y. Takaishi, T. Shiromoto, J. Chem. Soc., Chem. Commun. 1979, 413.
[62] E. Benedetti, A. Bavoso, B. Di Blasio, V. Pavone, C. Pedone, C. Toniolo, G. M. Bonora, Proc. Natl.
Acad. Sci. U.S.A. 1982, 79, 7951.
[63] H. Br3ckner, H. Graf, Experientia 1983, 39, 528.
[64] K. L. Rinehart Jr., L. A. Gaudioso, M. L. Moore, R. C. Pandey, J. C. Cook Jr., M. Barber, R. D.
Sedgwick, R. S. Bordoli, A. N. Tyler, B. N. Green, J. Am. Chem. Soc. 1981, 103, 6517.
[65] K. L. Rinehart Jr., Trends Anal. Chem. 1983, 2, 10.
[66] P. F. Wiley, J. M. Koert, L. J. Hanka, J. Antibiot. 1982, 35, 1231.
[67] H. Br3ckner, G. Jung, M. Przybylski, Chromatographia 1983, 17, 679.
[68] H. Br3ckner, M. Przybylski, J. Chromatogr., A 1984, 296, 263.
[69] H. Br3ckner, M. Przybylski, Chromatographia 1984, 19, 188.
[70] M. Przybylski, I. Dietrich, I. Manz, H. Br3ckner, Biomed. Mass Spectrom. 1984, 11, 569.
[71] H. Br3ckner, H. Graf, M. Bokel, Experientia 1984, 40, 1189.
[72] K. Fuji, E. Fujita, Y. Takaishi, T. Fujita, I. Arita, M. Komatsu, N. Hiratsuka, Experientia 1978, 34,
237.
[73] T. Fujita, Y. Takaishi, A. Okamura, E. Fujita, K. Fuji, N. Hiratsuka, M. Komatsu, I. Arita, J. Chem.
Soc., Chem. Commun. 1981, 585.
[74] D. A. Bullough, C. G. Jackson, P. J. F. Henderson, F. H. Cottee, R. B. Beechey, P. E. Linnett,
Biochem. Int. 1982, 4, 543.
[75] D. A. Bullough, C. G. Jackson, P. J. F. Henderson, F. H. Cottee, R. B. Beechey, P. E. Linnett, FEBS
Lett. 1982, 145, 258.
[76] T. Fujita, Y. Takaishi, H. Moritoki, T. Ogawa, K. Tokimoto, Chem. Pharm. Bull. 1984, 32, 1822.
CHEMISTRY & BIODIVERSITY – Vol. 5 (2008)1838
[77] T. Fujita, Y. Takaishi, K. Matsuura, Y. Takeda, Y. Yoshioka, H. Br3ckner, Chem. Pharm. Bull. 1984,
32, 2870.
[78] F. Reusser, J. Biol. Chem. 1967, 242, 243.
[79] H. Rindfleisch, H. Kleinkauf, FEBS Lett. 1976, 62, 276.
[80] J. G. Stroh, J. C. Cook, R. M. Milberg, L. Brayton, T. Kihara, Z. Huang, K. L. Rinehart Jr., I. A. S.
Lewis, Anal. Chem. 1985, 57, 985.
[81] J. G. Stroh, K. L. Rinehart Jr., J. C. Cook Jr., T. Kihara, M. Suzuki, T. Arai, J. Am. Chem. Soc. 1986,
108, 858.
[82] C. Kussin, H. Br3ckner, FreseniusB J. Anal. Chem. 1987, 327, 33.
[83] H. Br3ckner, C. Kussin, T. Kripp, in GPeptides. Chemistry and BiologyH, Ed. G. R. Marshall,
ESCOM, Leiden, The Netherlands, 1988, p. 650.
[84] H. Br3ckner, C. Reinecke, J. High Resolut. Chrom. 1988, 11, 735.
[85] H. Br3ckner, C. Reinecke, J. High Resolut. Chrom. 1989, 12, 113.
[86] H. Br3ckner, K. Nuber, C. Reinecke, FreseniusB J. Anal. Chem. 1987, 333, 777.
[87] H. Br3ckner, I. Bosch, T. Graser, P. F3rst, J. Chromatogr., A 1987, 395, 569.
[88] H. Br3ckner, C. Keller-Hoehl, Chromatographia 1990, 30, 621.
[89] H. Br3ckner, C. Gah, J. Chromatogr., A 1991, 555, 81.
[90] R. Bhushan, H. Br3ckner, Amino Acids 2004, 27, 231.
[91] H. Br3ckner, A. Kimonyo, in GPeptides 1994H, Ed. H. L. S. Maia, ESCOM, Leiden, The Netherlands,
1995, p. 429; A. Kimonyo, Ph.D Thesis, University of Hohenheim at Stuttgart, Germany, 1997.
[92] C. Reinecke, Ph.D. Thesis, University of Hohenheim at Stuttgart, Germany, 1989.
[93] D. Becker, Ph.D. Thesis, University of Hohenheim at Stuttgart, Germany, 1996.
[94] B. Bodo, S. Rebuffat, M. El Hajji, D. Davoust, J. Am. Chem. Soc. 1985, 107, 6011.
[95] M. El Hajji, S. Rebuffat, D. Lecommandeur, B. Bodo, Int. J. Pept. Protein Res. 1987, 29, 207.
[96] S. Rebuffat, M. El Hajji, P. Hennig, D. Davoust, B. Bodo, Int. J. Pept. Protein Res. 1989, 34, 200.
[97] T. Fujita, A. Iida, S. Uesato, Y. Takaishi, T. Shingu, M. Saito, M. Morita, J. Antibiot. 1988, 41, 814.
[98] A. Iida, M. Okuda, S. Uesato, Y. Takaishi, T. Shingu, M. Morita, T. Fujita, J. Chem. Soc., Perkin
Trans 1 1990, 3249.
[99] J. Iida, A. Iida, Y. Takahashi, Y. Takaishi, Y. Nagaoka, T. Fujita, J. Chem. Soc., Perkin Trans 1 1993,
357.
[100] S. Rebuffat, Y. Prigent, C. Auvin-Guette, B. Bodo, Eur. J. Biochem. 1991, 201, 661.
[101] C. Auvin-Guette, S. Rebuffat, Y. Prigent, B. Bodo, J. Am. Chem. Soc. 1992, 114, 2170.
[102] C. Auvin-Guette, S. Rebuffat, I. Vuidepot, M. Massias, B. Bodo, J. Chem. Soc., Perkin Trans. 1 1993,
249.
[103] H. Br3ckner, T. Kripp, M. Kieß, in GPeptides 1990H, Eds. E. Giralt, D. Andreu, ESCOM, Leiden, The
Netherlands, 1991, p. 347.
[104] H. Br3ckner, J. Maisch, C. Reinecke, A. Kimonyo, Amino Acids 1991, 1, 251.
[105] S. Rebuffat, L. Conraux, M.Massias, C. Auvin-Guette, B. Bodo, Int. J. Pept. Protein Res. 1993, 41, 74.
[106] H. Br3ckner, T. Kripp, M. Kieß, in GChemistry of Peptides and ProteinsH, Vol. 5/6, Eds. D.
Brandenburg, V. Ivanov, W. Voelter, Mainz Verlag, Aachen, 1993, DWI Reports, Vol. 112AþB,
p. 357.
[107] A. Iida, M. Sanekata, T. Fujita, H. Tanaka, A. Enoki, G. Fuse, M. Kanai, P. J. Rudewicz, E.
Tachikawa, Chem. Pharm. Bull. 1994, 42, 1070.
[108] A. Iida, M. Sanekata, S.-i. Wada, T. Fujita, H. Tanaka, A. Enoki, G. Fuse, M. Kanai, K. Asami,
Chem. Pharm. Bull. 1995, 43, 392.
[109] T. Fujita, S.-i. Wada, A. Iida, T. Nishimura, M. Kanai, N. Toyoma, Chem. Pharm. Bull. 1994, 42, 489.
[110] S.-i. Wada, A. Iida, N. Akimoto, M. Kanai, N. Toyoma, T. Fujita, Chem. Pharm. Bull. 1995, 43, 910.
[111] S.-i. Wada, T. Nishimura, A. Iida, N. Toyama, T. Fujita, Tetrahedron Lett. 1994, 35, 3095.
[112] S. Rebuffat, C. Goulard, B. Bodo, J. Chem. Soc., Perkin Trans. 1 1995, 1849.
[113] C. Goulard, S. Hlimi, S. Rebuffat, B. Bodo, J. Antibiot. 1995, 48, 1248.
[114] S. Hlimi, S. Rebuffat, C. Goulard, S. Duchamp, B. Bodo, J. Antibiot. 1995, 48, 1254.
[115] I. Augeven-Bour, S. Rebuffat, C. Auvin, C. Goulard, Y. Prigent, B. Bodo, J. Chem. Soc., Perkin
Trans. 1 1997, 1587.
CHEMISTRY & BIODIVERSITY – Vol. 5 (2008) 1839
[116] A. Ritieni, V. Vogliano, D. Nanno, G. Randazzo, C. Altomare, G. Perrone, A. Botallico, L. Maddau,
F. Marras, J. Nat. Prod. 1995, 58, 1745.
[117] S. Rebuffat, S. Hlimi, Y. Prigent, C. Goulard, B. Bodo, J. Chem. Soc., Perkin Trans. 1 1996, 2021.
[118] S. Rebuffat, C. Goulard, S. Hlimi, B. Bodo, J. Pept. Sci. 2000, 6, 519.
[119] K. Matsuura, A. Yesilada, A. Iida, Y. Takaishi, M. Kanai, T. Fujita, J. Chem. Soc., Perkin Trans. 1
1993, 381.
[120] K. Matsuura, K. Shima, Y. Takeda, Y. Takaishi, Y. Nagaoka, T. Fujita, Chem. Pharm. Bull. 1994, 42,
1063.
[121] S. Gupta, S. B. Krasnoff, D. W. Roberts, J. A. A. Renwick, L. S. Brinen, J. Clardy, J. Am. Chem. Soc.
1991, 113, 707.
[122] S. Gupta, S. B. Krasnoff, D. W. Roberts, J. A. A. Renwick, L. S. Brinen, J. Clardy, J.Org.Chem. 1992,
57, 2306.
[123] S. B. Krasnoff, S. Gupta, J. Chem. Ecol. 1991, 17, 1953.
[124] S. B. Krasnoff, S. Gupta, R. J. S. Leger, J. A. A. Rewnwick, D. W. Roberts, J. Invertebr. Pathol. 1991,
58, 180.
[125] S. Kumazawa, M. Kanda, H. Aoyama, M. Utagawa, J. Kondo, S. Sakamoto, H. Ohtani, T. Mikawa, I.
Chiga, T. Hayase, T. Hino, T. Takao, Y. Shimonishi, J. Antibiot. 1994, 47, 1136.
[126] U. GrVfe, S. Heinze, B. Schlegel, A. HVrtl, J. Indust. Microbiol. Biotechnol. 2001, 27, 136.
[127] T. Degenkolb, A. Berg, W. Gams, B. Schlegel, U. GrVfe, J. Pept. Sci. 2003, 9, 666.
[128] Q. Huang, Y. Tezuka, T. Kikuchi, A. Nishi, K. Tubaki, K. Tanaka, Chem. Pharm. Bull. 1995, 43, 223.
[129] Q. Huang, Y. Tezuka, Y. Hatanaka, T. Kikuchi, A. Nishi, K. Tubaki, Chem. Pharm. Bull. 1995, 43,
1663.
[130] Q. Huang, Y. Tezuka, Y. Hatanaka, T. Kikuchi, A. Nishi, K. Tubaki, Chem. Pharm. Bull. 1996, 44,
590.
[131] A. P. New, C. Eckers, N. J. Haskins, W. A. Neville, S. Elson, J. A. Hueso-RodrXguez, A. Rivera-
Sagredo, Tetrahedron Lett. 1996, 37, 3039.
[132] U. GrVfe, W. Ihn, M. Ritzau,W. Schade, C. Stengel, B. Schlegel, W. F. Fleck, W. K3nkel, A. HVrtl, W.
Gutsche, J. Antibiot. 1995, 48, 126.
[133] K. Dornberger, W. Ihn, M. Ritzau, U. GrVfe, B. Schlegel, W. F. Fleck, J. W. Metzger, J. Antibiot.
1995, 48, 977.
[134] M. Ritzau, S. Heinze, K. Dornberger, A. Berg, W. F. Fleck, B. Schlegel, A. HVrtl, U. GrVfe, J.
Antibiot. 1997, 50, 722.
[135] M. Kronen, P. KleinwVchter, B. Schlegel, A. HVrtl, U. GrVfe, J. Antibiot. 2001, 54, 175.
[136] H. H3lsmann, S. Heinze, M. Ritzau, B. Schlegel, U. GrVfe, J. Antibiot. 1998, 51, 1055.
[137] Y. S. Tsantrizos, S. Pischos, F. Sauriol, P. Widden, Can. J. Chem. 1996, 74, 165.
[138] Y. S. Tsantrizos, S. Pischos, F. Sauriol, J. Org. Chem. 1996, 61, 2118.
[139] A. Berg, M. Ritzau, W. Ihn, B. Schlegel, W. F. Fleck, S. Heinze, U. GrVfe, J. Antibiot. 1996, 49, 817.
[140] A. Berg, B. Schlegel, W. Ihn, U. Demuth, U. GrVfe, J. Antibiot. 1999, 52, 666.
[141] G. J. Sharman, A. C. Try, D. H. Williams, A. M. Ainsworth, R. Beneyto, T. M. Gibson, C.
McNicholas, D. V. Renno, N. Robinson, K. A. Wood, S. K. Wrigley, Biochem. J. 1996, 320, 723.
[142] T. Chikanishi, K. Hasumi, T. Harada, N. Kawasaki, A. Endo, J. Antibiot. 1996, 50, 105.
[143] D. Becker, M. Kieß, H. Br3ckner, Liebigs Ann. Chem. 1997, 767.
[144] W. Aretz, M. Knauf, H. Kogler, W. Stahl, H. Stump, L. Vertesy, J. Wink, in GAbstracts of the 9th
Dechema Meeting on Natural ProductsH, Irsee Monastry, Germany, poster 18, 1997.
[145] S. Heinze, M. Ritzau, W. Ihn, H. H3lsmann, B. Schlegel, K. Dornberger, W. F. Fleck, M. Zerlin, C.
Christner, U. GrVfe, G. K3llertz, G. Fischer, J. Antibiot. 1997, 50, 379.
[146] C. Christner, M. Zerlin, U. GrVfe, S. Heinze, G. K3llertz, G. Fischer, J. Antibiot. 1997, 50,
384.
[147] H. Yano, S. Nakanishi, Y. Ikuina, K. Ando, M. Yoshida, Y. Saitoh, Y. Matsuda, J. Antibiot. 1997, 50,
992.
[148] Y. Ikuina, C. Bando, M. Yoshida, H. Yano, Y. Saitoh, J. Antibiot. 1997, 50, 998.
[149] G. Po´csfalvi, A. Ritieni, P. Ferranti, G. Randazzo, K. Ve´key, A. Malorni, Rapid Commun. Mass
Spectrom. 1997, 11, 922.
CHEMISTRY & BIODIVERSITY – Vol. 5 (2008)1840
[150] A. Jaworski, H. Br3ckner, A. Maisch, GIT Spezial Chromatographie 1998, 18, 86.
[151] G. Po´csfalvi, F. Scala, M. Lorito, A. Ritieni, G. Randazzo, P. Ferranti, K. Ve´key, A. Malorni, J.Mass
Spectrom. 1998, 33, 154.
[152] D. Duval, S. Rebuffat, C. Goulard, Y. Prigent, M. Becchi, B. Bodo, J. Chem. Soc., Perkin Trans. 1
1997, 2147.
[153] G. Leclerc, S. Rebuffat, C. Goulard, B. Bodo, J. Antibiot. 1998, 51, 170.
[154] G. Leclerc, S. Rebuffat, B. Bodo, J. Antibiot. 1998, 51, 178.
[155] S.-J. Lee, W.-H. Yeo, B.-S. Yun, I.-D.Yoo, J. Pept. Sci. 1999, 5, 374.
[156] S.-J. Lee, B.-S. Yun, D.-H. Cho, I.-D. Yoo, J. Antibiot. 1999, 52, 998.
[157] T. Neuhof, A. Berg, H. Besl, T. Schwecke, R. Dieckmann, H. von Dçhren, Chem. Biodivers. 2007, 4,
1103.
[158] T. T. Kiet, U. GrVfe, H.-P. Saluz, B. Schlegel, GDi Truyeˆn Hoc Va´ U´ng Du˛ng (Genetics and
Applications, Hanoi) Special Issue BiotechnologyH 2002, p. 62.
[159] A. Iida, T. Mihara, T. Fujita, Y. Takaishi, Bioorg. Med. Chem. Lett. 1999, 9, 3393.
[160] A. Jaworski, J. Kirschbaum, H. Br3ckner, J. Pept. Sci. 1999, 5, 341.
[161] E. Lieckfeldt, G. J. Samuels, H. I. Nirenberg, O. Petrini, Appl. Environ. Microbiol. 1999, 65, 2418.
[162] G. J. Samuels, E. Lieckfeldt, H. I. Nirenberg, Sydowia 1999, 51, 71.
[163] A. Jaworski, H. Br3ckner, J. Chromatogr., A 1999, 862, 179.
[164] A. Jaworski, H. Br3ckner, J. Pept. Sci. 2000, 6, 149.
[165] N.-A. Lehr, A. Meffert, L. Antelo, O. Sterner, H. Anke, R. W. S. Weber, FEMS Microbiol. Ecol.
2006, 55, 106.
[166] D. Ishiyama, T. Satou, H. Senda, T. Fujimaki, R. Honda, S. Kanazawa, J. Antibiot. 2000, 53, 728.
[167] T. Degenkolb, S. Heinze, B. Schlegel, K. Dornberger, U. Mçllmann, H.-M. Dahse, U. GrVfe, J.
Antibiot. 2000, 53, 184.
[168] B.-S. Yun, I.-D. Yoo, Y. H. Kim, Y.-S. Kim, S.-J. Lee, K.-S. Kim, W.-H. Yeo, Tetrahedron Lett. 2000,
41, 1429.
[169] S.-U. Oh, S.-J. Lee, J.-H. Kim, I.-D. Yoo, Tetrahedron Lett. 2000, 41, 61.
[170] A. Jaworski, H. Br3ckner, J. Pept. Sci. 2001, 7, 433.
[171] M. Schiell, J. Hofmann, M. Kurz, F. R. Schmidt, L. Vertesy, M. Vogel, J. Wink, G. Seibert, J.Antibiot.
2001, 54, 220.
[172] G. Leclerc, C. Goulard, Y. Prigent, B. Bodo, H. Wro´blewski, S. Rebuffat, J. Nat. Prod. 2001, 64, 164.
[173] V. R. Hegde, J. Silver, M. Patel, V. P. Gullo, R. Yarborough, E. Huang, P. R. Das, M. S. Puar, B. J.
DiDomenico, D. Loebenberg, J. Antibiot. 2001, 54, 74.
[174] S. B. Singh, K. Herath, Z. Guan, D. L. Zink, A. W. Dombrowski, J. D. Polishook, K. C. Silverman,
R. B. Lingham, P. J. Felock, D. J. Hazuda, Org. Lett. 2002, 4, 1431; M. De Zotti, F. Formaggio, B.
Kaptein Q. B. Broxterman, P. J. Felock, D. J. Hazuda, S. B. Singh, H. Br3ckner, C. Toniolo,
ChemBioChem 2008, in press.
[175] S.-U. Oh, B.-S. Yun, S.-J. Lee, J.-H. Kim, I.-D. Yoo, J. Antibiot. 2002, 55, 557.
[176] S. U. Oh, B. S. Yun, S. J. Lee, I. D. Yoo, J. Microbiol. Biotechnol. 2005, 15, 384.
[177] H. Br3ckner, J. Kirschbaum, A. Jaworski, in GPeptides 2002H, Eds. E. Benedetti, C. Pedone, Edizioni
Ziino, Italy, 2002, p. 362.
[178] G. A. Strobel, R. Torczynski, A. Bollon, Plant Sci. 1997, 128, 97; G. A. Strobel, W. M. Hess, Chem.
Biol. 1997, 4, 529.
[179] T. Degenkolb, S. Heinze, B. Schlegel, G. Strobel, U. GrVfe, Biosci. Biotechnol. Biochem. 2002, 66,
883.
[180] A. Berg, P. A. Grigoriev, T. Degenkolb, T. Neuhof, A. HVrtl, B. Schlegel, U. GrVfe, J. Pept. Sci. 2003,
9, 810.
[181] V. R. Hegde, J. Silver, M. Patel, V. P. Gullo, M. S. Puar, P. R. Das, D. Loebenberg, J. Antibiot. 2003,
56, 437.
[182] C. Wilhelm, H. Anke, Y. Flores, O. Sterner, J. Nat. Prod. 2004, 67, 466.
[183] S. B. Krasnoff, R. F. Rea´tegui, M. W.Wagenaar, J. B. Gloer, D. M. Gibson, J.Nat. Prod. 2005, 68, 50.
[184] E. Katz, H. Schmitt, G. Jung, M. Aydin, W. A. Kçnig, Liebigs Ann. Chem. 1985, 365.
[185] A. Fredenhagen, L.-P. Molleyres, B. Bçhlendorf, G. Laue, J. Antibiot. 2006, 59, 267.
CHEMISTRY & BIODIVERSITY – Vol. 5 (2008) 1841
[186] J. Kirschbaum, M. SlavXcˇkova´, H. Br3ckner, in GPeptides 2004H, Eds. M. Flegel, M. Fridkin, C. Gilon,
J. Slaninova´, Kenes International, Geneva, Switzerland, 2005, p. 415; H. Br3ckner, J. Kirschbaum, in
GAbstracts of the 11th Naples Workshop on Bioactive PeptidesH, Naples, Italy, 2008, p. 48; J. Weiser,
V. MatHha, J. Invertebr. Pathol. 1988, 51, 94; V. MatHha, A. Jegorov, M. Kieß, H. Br3ckner, Tissue Cell
1992, 24, 559; A. Jegorov, V. MatHha, T. Trnka, M. Cˇerny´, J. High Resolut. Chrom. 1990, 13, 718.
[187] H. He, J. E. Janso, H. Y. Yang, V. S. Bernan, S. L. Liu, K. Yu, J. Nat. Prod. 2006, 69, 736.
[188] M. Mohamed-Benkada, M. Montagu, J. F. Biard, F. Mondeguer, P. Verite, M. Dalgalarrondo, J.
Bissett, Y. F. Pouchus, Rapid Commun. Mass Spectrometry 2006, 20, 1176.
[189] N. Ruiz, G. Wielgosz-Collin, L. Poirier, O. Grovel, K. E. Petit, M. Mohamed-Benkada, T. R. du
Pont, J. Bissett, P. Ve´rite´, G. Barnathan, Y. F. Pouchus, Peptides 2007, 28, 1351.
[190] N. Hosotani, K. Kumagai, S. Honda, A. Ito, T. Shimatani, I. Saji, J. Antibiot. 2007, 60, 184.
[191] M. Y. Summers, F. Kong, X. Feng, M. M. Siegel, J. E. Jasno, E. I. Graziani, G. T. Carter, J.Nat. Prod.
2007, 70, 391.
[192] A. Closse, R. Huguenin, Helv. Chim. Acta 1974, 57, 533.
[193] T. Degenkolb, H. von Dçhren, K. F. Nielsen, G. J. Samuels, H. Br3ckner, Chem. Biodivers. 2008, 5,
671.
[194] C. Krause, J. Kirschbaum, H. Br3ckner, Amino Acids 2006, 30, 435.
[195] T. Neuhof, R. Dieckmann, I. S. Druzhinina, C. P. Kubicek, T. Nakari-SetVlV, M. PenttilV, H. von
Dçhren, FEBS J. 2007, 274, 841.
[196] N. Stoppacher, S. Zeilinger, M. Omann, P.-G. Lassahn, A. Roitinger, R. Krska, R. Schuhmacher,
Rapid Commun. Mass Spectrom. 2008, 22, 1889.
[197] N. Stoppacher, B. Reithner, M. Omann, S. Zeilinger, R. Krska, R. Schuhmacher, Rapid Commun.
Mass Spectrom. 2007, 21, 3963.
[198] A. Landreau, Y. F. Pouchus, C. Sallenave-Namont, J.-F. Biard, M.-C. Boumard, T. R. du Pont, F.
Mondeguer, C. Goulard, B. Bodo, J.-F. Verbist, J. Microbiol. Meth. 2002, 48, 181.
[199] C. M. Boot, K. Tenney, F. A. Valeriote, P. Crews, J. Nat. Prod. 2006, 69, 83.
[200] L. Poirier, M. Montagu, A. Landreau, M. Mohamed-Benkada, O. Grovel, C. Sallenave-Namont, J.-
F. Biard, C. Amiard-Triquet, J.-C. Amiard, Y. F. Pouchus, Chem. Biodivers. 2007, 4, 1116.
[201] L. Poirier, J.-C. Amiard, F. Mondeguer, F. Quiniou, N. Ruiz, Y. F. Pouchus, M. Montagu, J.
Chromatogr., A 2007, 1160, 106.
[202] J. Bissett, G. Szakacs, C. A. Nolan, I. Druzhinina, C. Gradinger, C. P. Kubicek, Can. J. Bot. 2003, 81,
570.
[203] W. M. Jaklitsch, M. Komon, C. P. Kubicek, I. S. Druzhinina, Mycologia 2005, 97, 1365.
[204] W. M. Jaklitsch, M. Komon, C. P. Kubicek, I. S. Druzhinina, Mycologia 2006, 98, 499.
[205] G. J. Samuels, C. Suarez, K. Solis, K. A. Holmes, S. E. Thomas, A. A. Ismaiel, H. C. Evans, Mycol.
Res. 2006, 110, 381.
[206] G. J. Samuels, S. L. Dodd, B.-S. Lu, O. Petrini, H.-J. Schroers, I. S. Druzhinina, Stud.Mycol. 2006, 56,
67.
[207] W. M. Jaklitsch, G. J. Samuels, S. L. Dodd, B.-S. Lu, I. S. Druzhinina, Stud. Mycol. 2006, 56,
137.
[208] R. E. Hanada, J. T. de Souza, A. W. V. Pomella, K. P. Hebbar, J. O. Pereira, A. Ismaiel, G. J.
Samuels, Mycol. Res., in press, doi: 10.1016/j.mycres.2008.06.022.
[209] M. Zhao, J. L. Bada, Nature 1989, 339, 463; J. R. Cronin, Nature 1989, 339, 423.
[210] J. R. Cronin, S. Pizzarello, Science 1997, 275, 951; H. Br3ckner, S. Haasmann, M. Langer, T.
Westhauser, R. Wittner, H. Godel, J. Chromatogr., A 1994, 666, 259; R. PVtzold, S. Haasmann, H.
Br3ckner, in GAbstracts 17th International Symposium on ChiralityH, Parma, Italy, 2005, p. 120.
[211] M. A. Rifai, Mycol. Pap. 1969, 116, 1.
[212] J. Bissett, Can. J. Bot. 1984, 62, 924.
[213] J. Bissett, Can. J. Bot. 1991, 69, 2357.
[214] J. Bissett, Can. J. Bot. 1991, 69, 2373.
[215] J. Bissett, Can. J. Bot. 1991, 69, 2418.
[216] I. S. Druzhinina, C. P. Kubicek, J. Zhejiang Univ. SCI. 2005, 6B, 100.
[217] I. S. Druzhinina, A. G. Kopchinskiy, C. P. Kubicek, Mycoscience 2006, 47, 55.
CHEMISTRY & BIODIVERSITY – Vol. 5 (2008)1842
[218] H. Br3ckner, P. Wunsch, C. Kussin, in GSecond Forum on Peptides.H Eds. A. Aubry, M. Marraud, B.
Vitoux, Colloque INSERM/John Libbey Eurotext Ltd., Vol. 174, 1989, p. 103.
[219] K. H. Domsch, W. Gams, T.-H. Anderson GCompendium of soil fungiH, 2nd, taxonomically revised
edition by W. Gams, IHW-Verlag, Eching, Germany, 2007.
[220] G. J. Samuels, Phytopathology 2006, 96, 195.
[221] J. J. Luangsa-Ard, N. L. Hywel-Jones, L. Manoch, R. A. Samson, Mycol. Res. 2005, 109, 581.
[222] J.-O. Park, J. R. Hargreaves, E. J. McConville, G. R. Stirling, E. L. Ghisalberti, K. Sivasithamparam,
Lett. Appl. Microbiol. 2004, 38, 271.
[223] L. J. Hanka, P. F. Wiley, US Pat. 4282327 (currently found at http://www.freepatentsonline.com/
4282327.html)
[224] W. Gams (Baarn; formerly Centraalbureau for Schimmelcultures [CBS], Utrecht, The Nether-
lands), personal communication, July 2008.
[225] M. I. Mitova, A. C. Murphy, G. Lang, J. W. Blunt, A. L. J. Cole, G. Ellis, M. H. G. Munro, J. Nat.
Prod., in print, doi: 10.1021/np800221b.
[226] M. I. Mitova, B. G. Stuart, G. H. Cao, J. W. Blunt, A. L. J. Cole, M. H. G. Munro, J. Nat. Prod. 2006,
69, 1481.
[227] C. M. Boot, T. Amagata, K. Tenney, J. E. Compton, H. Pietraszkiewicz, F. A. Valeriote, P. Crews,
Tetrahedron 2007, 63, 9903.
[228] G. Nagaraj, M. V. Uma, M. S. Shivayogi, H. Balaram, Antimicrob. Agents Chemother. 2001, 45, 145.
[229] L. T. Tan, X. C. Cheng, P. R. Jensen, W. Fenical, J. Org. Chem. 2003, 68, 8767.
[230] Y. Hayakawa, Y. Hattori, T. Kawasaki, K. Kanoh, K. Adachi, Y. Shizuri, K. Shin-ya, J. Antibiot.
2008, 61, 365.
[231] Y. Hayakawa, H. Adachi, J. W. Kim, K. Shin-ya, H. Seto, Tetrahedron 1998, 54, 15871.
[232] Y. Hayakawa, Y. Hattori, T. Kawasaki, K. Kanoh, K. Adachi, Y. Shizuri, K. Shin-ya, J. Antibiot.
2008, 61, 365.
Received July 17, 2008
CHEMISTRY & BIODIVERSITY – Vol. 5 (2008) 1843
Aib and Iva in the Biosphere: Neither Rare nor Necessarily Extraterrestrial
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Fourty-nine species and strains of filamentous fungi of the genera Acremonium, Bionectria,
Clonostachys, Emericellopsis, Hypocrea/Trichoderma, Lecythophora,Monocillium, Nectriopsis, Niesslia,
Tolypocladium, and Wardomyces, deposited with the culture collection of the Centraalbureau voor
Schimmelcultures (CBS) in Utrecht, The Netherlands, were grown on nutrient agar plates. Organic
extracts of mycelia were analyzed after acidic total hydrolysis and derivatization by GC/SIM-MS on
Chirasil-l-Val for the presence of Aib (¼a-aminoisobutyric acid, 2-methylalanine) and dl-Iva (¼
isovaline, 2-ethylalanine). In 37 of the hydrolysates, Aib was detected, and in several of them d-Iva or
mixtures of d- and l-Iva. Non-proteinogenic Aib, in particular, is a highly specific marker for a distinctive
group of fungal polypeptides named peptaibols or, comprehensively, peptaibiotics, i.e., peptides
containing Aib and displaying (anti)biotic activities. The biotic synthesis of these amino acids by
filamentous fungi contradicts the still widespread belief that a,a-dialkyl-a-amino acids do not or rarely
occur in the biosphere and, if detected, are of extraterrestrial origin. The abundant production of
peptaibiotics by cosmopolitan species of microfungi has also to be considered in the discussion on the
occurrence of Aib and Iva in ancient and recent sediments. The detection of trace amounts of Aib in ice
samples of Antarctica that are devoid of meteorites might also be related to the presence of Aib-
producing microorganisms, being either indigenous psychrophiles, or being transported and localized by
mechanisms related to bioaerosols and cryoconites. The presence of microfungi being capable of
producing a,a-dialkyl a-amino acids in terrestrial samples, and possible contamination of extraterrestrial
materials are pointed out to be of relevance for the reliable interpretation of cosmogeochemical data.
1. Introduction. – Certainly, nobody could have predicted half a century ago that the
detection of the non-proteinogenic a,a-dialkyl amino acid Aib (¼a-aminoisobutyric
acid or 2-methylalanine) in a peptide antibiotic produced by a taxonomically
unidentified species of the microfungus Paecilomyces [1] would result in the character-
ization of ca. 850 microheterogeneous peptide sequences, produced by at least 23
genera of ascomycetous fungi or their anamorphs. Owing to its unique constituent, the
acronym peptaibiotics became established for this group of peptides containing Aib
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and showing (anti)biotic activities. The ubiquitous anamorphic genus Trichoderma
(with teleomorphs in Hypocrea) is generally regarded as the richest source of
peptaibiotics. To date, the presence of Aib and/or Iva has been reported from ca. 32
genera of fungi (including those described here) that comprise hundreds of accepted
species and a literally unlimited number of strains, being omnipresent in the biosphere
[2].
Since the history and the current status of peptides containing Aib, its chiral
homologue Iva, and some other a,a-dialkyl amino acids have extensively been treated
in recent reviews, we refer to the literature, which also includes two special issues of
journals and a book devoted to this unique group of peptides [3]. Structures and
configuration of a,a-dialkyl amino acids detected in natural peptaibiotics are presented
in Fig. 1.
Knowledge of the non-ribosomal synthesis of peptaibiotics and characterization of
the multi-enzyme complexes involved, as well as the biosynthesis of their uncommon
constituents [4] and the interaction of these helical peptides with other biomolecules is
of interest not only for academia but also for the industry that is particularly interested
in new biocides and plant-protecting agents [5].
Beyond such application-oriented considerations, one should keep in mind that
fungi represent an ancient kingdom of eukaryotic, multicellular organisms, apart from
plants and animals. Owing to their common feature of absorptive heterotrophy or
chemoorganotrophy, i.e., exploitation of nutrients from digestion of living or dead
tissues, fungi play a decisive role in the biosphere that cannot, or only less effectively, be
accomplished by other organisms.
Since ca. 1.5 million species of fungi are estimated to exist of which ca. 90,000 have
been described [6], a multitude of bioactive secondary metabolites produced is waiting
to be explored. Among those, the definite role of peptaibiotics and their constituting
a,a-dialkyl amino acids in the life styles and survival strategies of their fungal producers
in their natural habitats still has to be unravelled.
Microbiologists, chemists, and pharmacologists have become increasingly aware of
the potential of the peptaibiotics in recent years. They are excited by the challenges of
their sequence determination [7], problems encountered in the total syntheses of the
natural peptides and synthetic analogues [8], biocidal activities [9], and their unique
capability of forming transmembrane channels in lipid bilayer membranes [10].
Notably, the majority of astrobiologists as well as geo- and cosmochemists still
consider Aib and Iva as exotic amino acids, being absent or extremely rare in the
biosphere and, if detected, of abiotic origin. Therefore, Aib and Iva are still regarded as
Fig. 1. Structures and configurations of a,a-dialkyl amino acids
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relatively safe markers for extraterrestrial materials, in particular carbonaceous
meteorites [11].
In continuation of previous work and ongoing research, here, we present data
resulting from the screening of filamentous fungi that have not or only sporadically
been investigated for the production of peptaibiotics, and we discuss possible aspects
regarding the occurrence and release of Aib and Iva in the biosphere.
2. Results. – Based on previously reported screening procedures for Aib and Iva [2],
filamentous fungi were grown on solid agar media in Petri dishes. After vigorous growth
had been observed, the cultures were treated with MeOH/CH2Cl2, the organic extracts
were filtered, totally hydrolyzed, derivatized, and analyzed for the presence of Aib and
Iva by using GC/SIM-MS. Although free Aib and Iva, serving as building blocks for the
non-ribosomal enzymatic synthesis of peptaibiotics, are also detectable in unhydro-
lyzed extracts of the corresponding fungi, hydrolysis was performed in order to release
peptide-bonded Aib and Iva.
Achiral Aib as well as Iva could be detected, and the enantiomers of the latter were
partly (N-PFP-d,l-Iva-2-Pr esters) or completely (N-Ac-d,l-Iva-1-Pr esters) separated
on Chirasil-l-Val capillary columns (cf. Fig. 2).
Table 1 comprises names of fungi studied; CBS accession numbers, geographic
origin and substrates (if known), presence or absence of Aib and Iva, and the
configuration of the latter, whenever possible. Sections of chromatograms displaying
the presence of Aib and, in many cases, Iva are presented in Fig. 2.As can be seen, Aib
is of higher abundance, and Iva is present either in (R) (¼d)-configuration [12], or as a
mixture of (R)- and (S)-(¼l)-enantiomers. Using Ac-dl-Iva-1-Pr esters, resulting in
baseline separation of enantiomers in Clonostachys rosea (syn. Gliocladium roseum,
teleomorph Bionectria ochroleuca), 41.4% of d-Iva and 56.6% of l-Iva could be
detected corresponding formally to an enantiomeric excess (ee) of 15.5% l.
As shown in Table 1, 37 strains of fungi were tested positively for the production of
Aib and, in part, Iva. The geographic origins of the fungi given in the Table also
demonstrate that they are cosmopolitan, and their natural habitats comprise in
particular soil and decaying plant materials. These fungi had been selected mainly in
view of morphological diversity and without emphasis on geographical diversity.
Notably, three species ofAcremonium were also involved in fungal infections or lesions
of man.
Species of Trichoderma (with teleomorphs in Hypocrea) have already been
recognized as abundant producers of peptaibiotics; many of these peptaibiotics have
been sequenced, and their bioactivities have been characterized. In addition to
Trichoderma/Hypocrea, species and strains of the genera Acremonium, Bionectria,
Clonostachys (incl. Sesquicillium), Emericellopsis, Lecythophora, Monocillium, Nec-
triopsis, Niesslia, Tolypocladium, and Wardomyces, which have not or less intensively
been screened for the production of Aib and Iva, are shown here to be potential
producers of peptaibiotics and are listed in Table 1.
The fungi were grown in surface culture on standard media selected to maintain
morphological characteristics. Consequently, growth represents just a small section of
the life style of the corresponding organism. To exploit the complete potential of
peptaibiomics, i.e., the sequential characterization and dynamics of the entirety of
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Table 1. CBS Strains Investigated in This Study
Species CBSa) Habitat; geographic origin Aibb) Ivab) CMc)
Acremonium berkeleyanum 234.70 Fomes fomentarius ; Poland,
Białowiez˙a National Park
þ  1
A. charticola 219.70 Old leaf of Tussilago farfara ;
Germany, Kiel-Kitzeberg
þ d 1
A. crotocinigenum 217.70 Decaying wood; Germany,
Kr. Plçn, Schttbrehm
þ d 1
A. chrysogenum 144.62 Soil; India, Maharashtra,
Pimpri-Poona
þ  1
A. curvulum 523.72 Leaf litter of Acacia karroo;
South Africa
þ  1
A. curvulum 430.66 Wheat-field soil; Germany,
Kiel-Kitzeberg
  1
A. curvulum 384.70A Greenhouse soil; Netherlands þ  1
A. inflatum 305.74 Cereal stem; UK, Rothamsted   1
A. ochraceum 797.69 Decaying leaf of Canna indica ;
Netherlands, Baarn
  1
A. radiatum 142.62 Soil; India, Karad   1
A. recifei 362.76 Soil under Saccharum officinarum ;
Taiwan
  2
A. recifei 402.89 Forest soil; Brazil, Para´,
Capita˜o PoÅo
þ d 2
A. recifei 188.82 Ulcus corneae of man; Netherlands,
Akad. Ziekenhuis, University of
Amsterdam
þ d 2
A. recifei 485.77 Granulomatous lesion, man; India þ  2
A. recifei 647.93 Bark and wood of declining
Macadamia integrifolia ; USA,
Hawaii
þ  2
A. recifei 442.66 Nut of Bertholletia excelsa þ  1
A. sclerotigenum 384.65 Deformed toe nail of man þ d 1
A. strictum 376.70H Peat bog; Ireland þ  1
Bionectria pityrodes 322.78 Vitis ; Venezuela, Edo Miranda,
near El Bachiller
þ d,l 2
Clonostachys rosea (anamorph)/ 906.72D Decaying angiosperm wood;
Netherlands
þ d,l 3
Bionectra ochroleuca (teleomorph) 194.57 Decaying bulb of Lilium auratum ;
USA
þ d,l 2
Clonostachys candelabrum
(syn. Sesquicillium candelabrum)
205.69 Equisetum hyemale ; dead stem þ d,l 2
Emericellopsis glabra 376.64 Soil, under Solanum tuberosum ;
Netherlands
þ d 2
E. minima 107.64 Soil; Turkey þ  1
E. minima 716.73 Upjohn Comp. ; USA, Kalamazoo þ d 1
Hypocrea atrogelatinosa 237.63 Bondarzewia berkeleyi ;
New Zealand, Auckland, Mamaku
þ d 1
H. citrina var. citrina 977.69 Fomitopsis pinicola ; Canada,
British Columbia, North Vancouver
þ  1
H. tawa 246.63 Coprosma robusta ; New Zealand,
Little Barrier Island
þ  2
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Table 1 (cont.)
Species CBSa) Habitat; geographic origin Aibb) Ivab) CMc)
H. vinosa 247.63 New Zealand, Auckland, Te Aroha þ d 1
Lecythophora mutabilis 303.62 Soil; Netherlands þ  3
Monocillium mucidum 306.70 Soil þ  1
M. nordinii 101.63 Wood of Pinus contorta v. latifolia;
Canada, Alberta, Stracham
þ  1
M. nordinii 116.70 Wood of Pinus contorta var. latifolia; Canada,
Alberta, Kananaskis Forest Exp. Station
  1
Nectriopsis candicans 627.72 Leocarpus fragilis, on Prunus laurocerasus;
Netherlands, Doorwerth
þ d,l 1
Niesslia aemula 556.75 Burnt soil; Netherlands, Noordoostpolder,
Schokland
þ d 1
N. exigua 152.68 Chamaerops humilis in greenhouse;
Netherlands, Baarn, Cantonspark
þ  1
N. exilis 560.74 Decayed needle of Pinus sylvestris ; UK,
England, Warwicksh., Hay Wood
þ d 1
N. exilis 389.70A Wooden clog; Netherlands, Andijk   1
N. ilicifolia 459.74 Decaying leaf of Ilex aquifolium ; UK,
Warwicksh., Banzey, Mockley Wood
  1
N. subiculosa 326.77 Rachis of Cyathea dealbata ; New Zealand,
Auckland Prov., Thames Co., Coromandel
Forest Park, Kawaeranga Valley
  1
N. exosporioides 359.70 Dead leaf of Canna indica ; Netherlands,
Baarn, Cantonspark
  3
Tolypocladium
cylindrosporum
717.70 Litter of Pteridium aquilinum ; UK, England,
Cumbria, Roudsea Wood
þ d 2
T. nubicola 944.72 Alpine tundra soil; Canada, Alberta,
Rocky Mountains
þ d 3
Trichoderma
pseudokoningii
817.68 Soil; Sri Lanka, Agalawatta, near Dartonfield,
Rubber Research Institute
þ  1
Wardomyces anomalus 299.61 Air cell of an egg, in cold storage in salt
solution; Canada, Ontario, Ottawa,
National Research Council Laboratory
  1
W. columbinus 233.66 Sandy soil; Germany, Giessen þ  1
W. humicola 368.62 Wheat-field soil; Germany, Kiel-Kitzeberg þ  2
W. inflatus 367.62 Greenhouse soil under
Lycopersicon esculentum; Belgium, Heverlee
þ  2
W. inflatus 216.61 Decaying wood of Acer sp.; Canada, Quebec,
Gatineau County, Ste Ce´cile de Masham
  1
a) CBS, Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands. Numbers refer to accession
numbers of CBS; names listed in Table 1 are used according to the CBS filamentous fungi database
currently found at http://www.cbs.knaw.nl/databases/. Note that the identity of CBS 523.72, 305.74, and
647.93 has not yet been verified by DNA sequencing, and CBS 485.77 has to be placed outside
Acremonium but still within the Bionectriaceae. b) Production/absence of Aib and Iva is denoted with þ
and  , resp.; d,l refers to a mixture of enantiomers detected, and d to single enantiomer (cf. Table).
c) CM, culture medium: 1, oatmeal agar; 2, cornmeal agar; 3, malt extract agar.
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Fig. 2. Detection of Aib and Iva enantiomers in derivatized total hydrolysates of organic extracts of fungal
mycelia. Sections of GC/SIM-MS of representative fungi from Table 1 are shown. Numbers under the
names of fungi refer to CBS strain numbers. Amino acids were analyzed as N-PFP-2-propyl esters on
Chirasil-l-Val with the exceptions of CBS 906.72D that was analyzed as N-acetyl-1-propyl ester, and
CBS 246.63 that was analyzed as N-TFA-1-propyl ester on a Lipodex E column.
peptides synthesized under defined conditions, fungi should be grown under varying
culture conditions, including submerged fermentation.
3. Discussion. – 3.1. Aib and Iva in Filamentous Fungi. Total hydrolysates of fungal
extracts were used for screening for Aib and Iva by GC/SIM-MS because of specificity
and sensitivity for these marker amino acids. Instead of chiral stationary phases, use of
capillary columns coated with thermally stable silicon oils, or complementary methods
based on HPLC are possible [13]. The methods described enable the rapid screening of
fungi for the presence of peptaibiotics prior to techniques of higher experimental and
financial expenditure such as LC/ESI-MSn or MALDI-TOF-MS. The latter methods,
however, are the basis of the technical approach named peptaibiomics, i.e., the
complete sequential characterization of the entirety of individual peptaibiotics
synthesized by a fungus under well-defined conditions in the laboratory or in its
natural habitat [2].
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Fig. 2 (cont.)
Considering the microheterogeneity of these peptides, ca. 850 sequences of linear
and cyclic peptaibiotics are currently reported in literature, many of which have not yet
been included in the peptaibol database [2]. Consequently, Aib and Iva cannot be
considered a priori as abiotic or rare in the biosphere. Remarkably, the CH2 homologue
of Iva, i.e., 2-ethylnorvaline (EtNva; sometimes abbreviated EtNor) [14] as well as the
cyclic analogue of Aib, i.e., 1-aminocyclopropane-1-carboxylic acid (Acc) have also
been detected as constituents of peptaibiotics [15]. This indicates that further a,a-
dialkyl amino acids are fairly common in fungi. Thus, we predict that many more
peptaibiotics are still waiting to be discovered by established screening methods.
Despite the fact that fungi are preferably grown or fermented aseptically as pure
cultures, production of antiamoebins (cf. Fig. 1) [16] by the coprophilous Stilbella
fimetaria (syn. S. erythrocephala) has also been proven when growing on rabbit dung in
the field. Production of up to 624 mg peptide/g fresh weight was observed [17]. Species
of Stilbella and Emericellopsis produce particularly large amounts of peptaibiotics [18].
Names and sequences of representative peptaibiotics containing Iva in either the
(R)- or (S)-configuration, corresponding to d- and l-Iva, respectively, or even both
enantiomers, are compiled in Table 2. This Table also comprises all hitherto known
peptaibiotics displaying Acc or EtNva residues. Fungal producers of the sequences are
given in the Tables legend.
The production of peptaibiotics, without exceptions, was also demonstrated by a
recent thorough investigation of Trichoderma/Hypocrea, comprising ca. 30 contempo-
rary, accepted as well as newly described species. They were characterized by modern
methods of DNA sequencing and analyzed by Intact-Cell (IC) MALDI-TOF mass
spectrometry [19]. This work supports our considerations outlined below.
3.2. Occurrence and Global Distribution of Filamentous Fungi as Potential
Producers of Aib and Iva. Biosynthesis of the a,a-dialkyl amino acids and peptaibiotics
is correlated with growth and life styles of the fungal producers in their natural
terrestrial or aquatic habitats. Like bacteria, fungi are found almost everywhere in the
biosphere and constitute a considerable part of the terrestrial and aquatic biomass,
particularly taking into account mycorrhizal and soil fungi. In forest soils, fungi exceed
by far the volume of bacteria and may account for up to 445 kg dry mycelial matter per
hectare.
For instance, Trichoderma spp., known as potential producers of peptaibiotics, were
isolated from litter, soils, and the rhizosphere of Populus sp. and Salix sp. in the Danube
National Park in Austria, representing a primeval floodplain-forest, and identified at
the species levels by morphological and molecular techniques [20]. Consequently,
global distribution of fungi and localization even in extreme environments as outlined
below is to be expected, and long-range distribution of fungal materials has been
established. Active discharge of spores of Asco- and Basidiomycota, resulting in the
formation of biogenic aerosols in the atmosphere, is considered to account for a large
proportion of the air particulate matter, reaching up to 100 mm in size, e.g., in tropical
rainforest regions. Such biogenic aerosols and airborne fungi are ubiquitous in the
Earths atmosphere, and thus play an important role in the spread of living
microorganisms [21] [22]. Air-borne propagules can serve as nuclei to initiate the
formation of clouds, fog, and rain and, depending on temperature, also for snow, hail,
and ice crystals [23]. Sand and dust loaded with fungi are globally distributed, and even
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Table 2. Selected Sequences of Peptaibiotics Containing Acc, d-Iva (¼ (R)) , l-Iva (¼ (S)) , and/or EtNvaa)
Residueb)
1 2 3 4 5 6 7 8
Acretocin
1a Ac Pip Aib Pip d-Iva Aib Leu b-Ala Gly
1b Ac Pip Aib Pip Aib Aib Leu b-Ala Gly
2 Ac Pip Aib Pip d-Iva d-Iva Leu b-Ala Gly
3 Ac Pip Aib Pip d-Iva Aib Leu b-Ala Gly
4 Ac Pip Aib Pip d-Iva d-Iva Leu b-Ala Gly
5 Ac Pip Aib Pip d-Iva Aib Leu b-Ala Gly
6 Ac Pip Aib Pip d-Iva d-Iva Leu b-Ala Gly
Neoefrapeptin
A Ac Pip Aib Pip d-Iva Aib Leu b-Ala Gly
C Ac Pip Aib Pip d-Iva Aib Leu b-Ala Gly
D Ac Pip Aib Pip Aib Aib Leu b-Ala Gly
E Ac Pip Aib Pip d-Iva d-Iva Leu b-Ala Gly
Efrapeptin G Ac Pip Aib Pip l-Iva Aib Leu b-Ala Gly
Adenopeptin Ac Pro Iva Iva b-Ala Gly Aib Aib Iva
Cephaibol A Ac Phe Aib Aib Aib Aib Gly Leu d-Iva
Cephaibol P Ac Phe d-Iva Gln Aib Ile Thr Aib Leu
Integramide A Ac d-Iva Hyp Ile l-Iva Leu Aib Aib Aib
Clonostachin Ac Aib Hyp Leu d-Iva Hyp Leu l-Iva Hyp
Chrysospermin D Ac Phe Aib Ser Aib d-Iva Leu Gln Gly
Boletusin Ac Phe Aib Ala Aib d-Iva Leu Gln Gly
Tylopeptin A Ac Trp Val Aib d-Iva Ala Gln Ala Aib
XR 586 Ac Trp d-Iva Gln Aib Ile Thr Aib Leu
Antiamoebin I Ac Phe Aib Aib Aib d-Iva Gly Leu Aib
Emerimicin II B Ac Trp Ile Gln d-Iva Ile Thr Aib Leu
Emerimicin III Ac Phe Aib Aib Aib Val Gly Leu Aib
Zervamicin I A Ac Trp Ile Glu d-Iva Va Thr Aib Leu
Bergofungin A Ac Val Aib Aib Aib Val Gly Leu Aib
Trichotoxin
A-40/5 Ac Aib Gly Aib Leu Aib Gln Aib Aib
A-50/E Ac Aib Gly Aib Leu Aib Gln Aib Aib
Peptavirin A Ac Phe Aib Ala Aib l-Iva Leu Gln Gly
Harzianin HB I Ac Aib Asn Leu Ile Aib Pro d-Iva Leu
Harzianin HCIII Ac Aib Asn Leu Aib Pro Ser Val Aib
Trichokindin-Ia Ac Aib Ser Ala Aib Aib Gln d-Iva Leu
Trichokonin VII Ac Aib Ala Aib Ala Aib Ala Gln Aib
Saturnisporin SA II Ac Aib Ala Aib Ala Aib Ala Gln Aib
Trichosporin B-IVd Ac Aib Ala Ala Ala Aib Aib Gln Aib
Trichovirin II 6b Ac Aib Gly Ala Leu d-Iva Gln d-Iva Val
Trichorzin HAVII Ac Aib Gly Ala Aib d-Iva Gln Val Val
Trichorzin MA III Ac Aib Ser Ala Aib d-Iva Gln d-Iva Leu
Trichorzin PAVI Ac Aib Ser Ala Aib d-Iva Gln Aib Val
Trichorzin PAVII Ac Aib Ser Ala d-Iva d-Iva Gln Aib Val
Trichorzianine AVII Ac Aib Ala Ala Aib d-Iva Gln Aib Aib
Trichorzianine B VII Ac Aib Ala Ala Aib d-Iva Gln Aib Aib
Longibrachin A IV Ac Aib Ala Aib Ala Aib Aib Gln Aib
Longibrachin B III Ac Aib Ala Aib Ala Aib Ala Gln Aib
Trichobrachin I B Ac Aib Ala Aib Ala Aib Ala Gln Aib
Atroviridin C Ac Aib Pro Aib Ala Aib Aib Gln Aib
Neoatroviridin D Ac Aib Gly Ala Leu d-Iva Gln d-Iva Leu
Hypomurocin A-2 Ac d-Iva Gln Val Val Aib Pro Leu Leu
Hypomurocin B-5 Ac Aib Ser Ala Leu Aib Gln Aib Val
Trichocellin A-II Ac Aib Ala Aib Ala Aib Ala Gln Aib
Trichocellin B-II Ac Aib Ala Aib Ala Aib Ala Gln Aib
Hypelcin A-VII Ac Aib Pro Aib Ala Aib Ala Gln Aib
Hypelcin BIII Ac Aib Pro Aib Ala Aib Aib Gln Aib
MS-681d Ac Phe l-Iva Aib Ala d-Iva Gly Phe l-Iva
Trikoningin KB II Oc d-Iva Gly Val Aib Gly Gly Val Aib
LP237-F 8 Oc Aib Pro Phe Aib Gln Gln Aib EtNva
LP237-F 5 Oc Aib Pro Tyr Aib Gln Gln Aib EtNva
Chlamydocin cyclo (Aoe d-Pro Phe Aib)
FR235222 cyclo (Aoh t-4-d-MePro Phe l-Iva)
Scytalidamide A cyclo (Phe Leu Pro N-MeLeu Aib Phe N-MePhe)
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9 10 11 12 13 14 15 16 17 18 19 20
Acc Aib Pip Aib Gly Leu Aib PIHPPE
Acc Aib Pip Aib Gly Leu Iva PIHPPE
Acc Aib Pip Aib Gly Leu Aib PIHPPE
Acc Aib Pip Aib Gly Leu Iva PIHPPE
Acc Aib Pip Aib Gly Leu Iva PIHPPE
Acc Aib Pip Aib Ala Leu Iva PIHPPE
Acc Aib Pip Aib Ala Leu Iva PIHPPE
Acc Aib Pip Aib Gly Leu l-Iva PIHPPE
Acc l-Iva Pip Aib Gly Leu l-Iva PIHPPE
Acc Aib Pip Aib Gly Leu l-Iva PIHPPE
Acc Aib Pip Aib Gly Leu l-Iva PIHPPE
Aib Aib Pip Aib Ala Leu l-Iva PIHPPE
Aib Aib Aib Pip Iva PIHPPE
Aib Hyp Gln d-Iva Hyp Aib Pro Pheol
Aib Hyp Gln Aib Hyp Aib Pro Phe Ser
Hyp Leu l-Iva Aib Hyp l-Iva d-Iva Gly
Aib l-Iva Aib Hyp d-Iva Ile Mannitol
Aib Aib Ala Ala Aib Pro d-Iva Aib Aib Gln Trpol
Aib Aib Ala Ala Aib Pro Aib Aib Aib Gln Trpol
Ser Aib Ala Leu Aib Gln Leuol
Aib Pro Gln Aib Hyp d-Iva Pro Phe Gly
Aib Hyp Gln d-Iva Hyp Aib Pro Pheol
Aib Hyp Gln Aib Hyp Aib Pro Pheol
Aib Hyp Gln d-Iva Hyp Aib Pheol
Aib Hyp Gln Aib Hyp Aib Pro Pheol
Aib Hyp Gln l-Iva Hyp Aib Pheol
Aib Ala Aib Aib Pro Leu Aib d-Iva Glu Valol
Aib Ala Aib Aib Pro Leu Aib d-Iva Gln Valol
Aib Aib Ala Ala Aib Pro l-Iva Aib Aib Gln Trpol
Aib Pro Leuol
Pro d-Iva Leu Aib Pro Leuol
Aib Ala Aib Aib Pro Leu Aib Aib Gln Ileol
Val Aib Gly Leu Aib Pro Val Aib d-Iva Gln Gln Pheol
Leu Aib Gly Aib Aib Pro Val Aib d-Iva Gln Gln Pheol
Val Aib Gly Leu Aib Pro Val Aib d-Iva Gln Gln Pheol
Aib Gly d-Iva Aib Pro Leu Aib Aib Gln Leuol
Aib Gly Leu Aib Pro Leu Aib d-Iva Gln Leuol
Aib Gly Leu Aib Pro Leu Aib Aib Gln Valol
Aib Gly Leu Aib Pro Leu Aib Aib Gln Pheol
Aib Gly Leu Aib Pro Leu Aib Aib Gln Trpol
Aib Ser Leu Aib Pro Val Aib Ile Gln Gln Pheol
Aib Ser Leu Aib Pro Val Aib Ile Gln Glu Pheol
Val Aib Gly Leu Aib Pro Val Aib d-Iva Gln Gln Pheol
Val Aib Gly Leu Aib Pro Val Aib d-Iva Glu Gln Pheol
Val Aib Gly Leu Aib Pro Val Aib d-Iva Gln Gln
Val Aib Gly Leu Aib Pro Val Aib d-Iva Gln Gln Pheol
Aib Gly d-Iva Aib Pro Leu Aib Aib Gln Leuol
Aib Pro Leuol
Aib Gly d-Iva Aib Pro Leu Aib Aib Gln Leuol
Leu Aib Gly Aib Aib Pro Val Aib d-Iva Gln Gln Pheol
Leu Aib Gly Aib Aib Pro Val Aib d-Iva Glu Gln Pheol
Leu Aib Gly Aib Aib Pro Val Aib d-Iva Gln Gln Leuol
Leu Aib Gly Aib Aib Pro Val Aib d-Iva Glu Gln Leuol
APPS
Gly Ile Leuol
Gln Ala Leuol
Gln Ala Leuol
marine aerosols have been found to contain viable fungi [24]. Aircraft, balloon, and
rocket measurements have shown that such particles are ubiquitous over land and
oceans. They also are transported to high altitudes (up to 80 km) and over long
distances.
3.3. Extraterrestrial Aib and Racemic Iva in Ancient Marine Sediments Close to the
K-T Boundary. The detection of Aib together with racemic Iva in outcrop sediments at
Stevns Klint, Denmark, above and below a very thin layer of clay, named the
cretaceous-tertiary (K-T) boundary [25] attracted some attention. This boundary
marks the extinction of estimated 75% of organisms, including dinosaurs, ca. 65 million
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a) List of producers: acretocin, Acremonium crotocinigenum CBS 217.70 (note that the configuration of
Iva15 has not been assigned definitely!); neoefrapeptin, Geotrichum candidum SID 22780; efrapeptin,
Tolypocladium inflatum (syn. T. niveum, teleomorph: Elaphocordyceps subsessilis) IMI 202309, T.
inflatum 1897, T. inflatumARSEF 616, 3277, 3278, 3279, 3280, 3281, 3321, 3394, 3395, 3396, 3398, 3432; T.
geodes ARSEF 2684, 3271, 3272, 3274, 3275, 3276; T. cylindrosporum 705, 961, 962, 963, 976, 1028, 1580,
2005, 2912, 3392, 3393, 4561, 4562, 4563, 4996; T. tundrense ARSEF 3401; T. parasiticum (syn. Pochonia
parasitica) ARSEF 3436; Tolypocladium sp. AMB18; Acremonium sp. 021172cKZ, Acremonium sp.
CNC-310; adenopeptin, Chrysosporium sp. PF1201; cephaibol, Acremonium tubakii DSM 12774;
integramide A, Dendrodochium sp. MF 6888; clonostachin, Clonostachys sp. F5898; chrysospermin,
Sepedonium chrysospermumDSM 7444, S. chrysospermum S39, S.microspermum S6, S. ampullosporum
S158, S. laevigatum S13, S. brunneum S171; boletusin/tylopeptin, Sepedonium sp. (the production of both
peptaibols was originally misattributed to fruiting bodies of Boletus sp. and Tylopilus neofelleus being
preferred hosts of Sepedonium sp.); XR 586, Acremonium persicinum X21488; antiamoebin, Stilbella
fimetaria (syn. S. erythrocephala) ATCC 28144, CBS 548.84, Clonostachys rosea f. catenulata (syn.
Gliocladium catenulatum) CBS 511.66; Emericellopsis synnematicola CBS 176.60; E. salmosynnemata
CBS 382.62, Verticillium epiphytum (syn. Cephalosporium pimprima), Emericellopsis poonensis ;
emerimicin, Emericellopsis microspora 333; zervamicin, E. salmosynnemata 336; bergofungin, E.
donezkii HKI 0059; trichotoxin A40/A50, T. asperellum NRRL 5242 (originally misidentified as T.
viride); peptavirin, Sepedonium sp. KCTC 8921P; harzianin HB I, T. harzianum MNHN-903603;
harzianin HC, T. harzianumMNHN-903603, MNHN-903614; trichokindin, T. harzianum; trichokonin, T.
koningii; saturnisporin, T. saturnisporum; trichosporin, T. polysporum TMI 60146; trichovirin I/II, T. cf.
harzianum (originally misidentified as T. viride); trichorzin HA, T. harzianumMNHN-903602; trichorzin
MA, T. harzianum MNHN-922835; trichorzin PA, T. harzianumMNHN-902608; trichorzianine A/B, T.
harzianumATCC 20672; longibrachin, T. longibrachiatum LCP-853431; trichobrachin, T. ghanense (syn.
T. parceramosum) CBS 936.69; atroviridin/neotatroviridin, T. atroviride F80317; hypomurocin A/B, T.
atroviride IFO 31288 (originally misidentified as Hypocrea muroiana); trichocellin A/B, T. viride ;
hypelcin A/B, Hypocrea peltata ; MS-681, Myrothecium sp. KY6568; trikoningin KB II, T. koningii
MNHN-903589; LP237, Tolypocladium geodes LP 237; chlamydocin, Pochonia chlamydosporia S 3440
(originally described asDiheterospora chlamydosporia); FR235222, Acremonium cf.murorum 27082 (¼
strain FERM BP-6539); Scytalidamide A, Acremonium sp. CNC-310 (originally misidentified as
Scytalidium sp.). Note that the identity of most producers originally reported as T. viride, T. harzianum,
T. longibrachiatum, or T. koningii has not been verified by molecular methods. b) List of Abbreviations
not explained in the text: Pip, l-pipecolic acid; PIHPPE, N-peptido-1-isobutyl-2-(2,3,4,6,7,8-hexahydro-
1-pyrrolo[1,2-a]pyrimidinio)ethylamine; APPS, (2’R,S)-N1-(2-amino-3-phenylpropyl)spermidine; Aoe,
l-2-amino-9,10-epoxy-8-oxodecanoic acid; Aoh, l-(2S,9R)-2-amino-9-hydroxy-8-oxodecanoic acid; t-d-
4-MePro, trans-4-d-MePro¼ (2R,4S)-4-MePro.
Table 2 (cont.)
years ago. The presence of Aib as well as Iva in these sediments was attributed to the
impact of a large bolide, as proposed by Alvarez et al. [26]. Alternatively, influx of
abiotic Aib and Iva by comet dust has also been suggested [27].
Curiously enough, Aib and racemic Iva are absent in the boundary clay layer itself,
but present in the layers above and below it, for which diffusion or geochromatography
were considered as feasible explanations [28].
3.4. Aib in Non-Marine Sediments Close to the K-T Boundary. In subsequent
analyses, sediments from the originally coastal K-T-boundary sites of Stevns Klint as
well as non-marine sediments from Starkville South/Colorado and Raton Pass/New
Mexico were investigated for the presence of Aib as well as common proteinogenic
amino acids (Iva and enantiomers could not be assigned definitely). Presence of Aib
was reported for Stevns Klint and Starkville South but not for Raton Pass [29].
However, no d(13C) values of Aib were determined, and Iva could not be detected by
HPLC after derivatization with o-phthaldialdehyde. By GC on a Chirasil-Val column,
Aib and Iva were only tentatively assigned in the elution profiles of the TFA-amino
acid-2-propyl esters, and the configuration of Iva was not determined. From the
presence of proteinogenic l-amino acids and the d-enantiomers of Ala, Asp, and Glu,
as well as their 13C-compositions, terrestrial, biogenic origin of these amino acids was
concluded.
3.5. Possible Formation of Abiotic Aib and Iva in Sediments as Result of Volcanic
Action. Intrusion of volcanic magma into natural coal beds could have led to a
geothermal gasification and formation of hydantoins in the presence of water in a
Bucherer hydantoin reaction, which provides an alternative explanation for the
formation of Aib and racemic Iva. The resulting 5,5-dimethyl- and 5-ethyl-5-
methylhydantoins may serve as precursors for Aib and racemic Iva [30], which may
subsequently be formed by aqueous or enzymatic hydrolysis [31]. This scenario, in
principle, might also be applied to contemporary volcanic activities, thus leading to the
formation and local or global distribution of abiotically formed amino acids following
the mechanisms outlined here.
3.6. Aib and d,l-Iva in Young Marine Sediments of Tokyo Bay, Japan. Aib and d,l-
Iva were also detected by HPLC in young marine sediments (<100 y) of Tokyo Bay,
Japan [32]. Based on the lack of evidence for volcanic action and meteoritic origin, the
occurrence of Aib and Iva enantiomers in surface samples as well as in 30–35-cm depth
of marine sediments was attributed to the inlet of industrial waste waters containing
5,5-dialkyl-substituted hydantoins that are used as pharmaceutical drugs or as raw
materials for polymers. The authors used GC/MS of N-(trifluoroacetyl)-butyl esters on
Chirasil-l-Val capillary columns for the detection of Aib, and separation of d- and l-
Iva. Because of the unavailability of optically pure standards of Iva, the elution order of
the enantiomers could not be assigned (but d-Iva is eluted prior to l-Iva on Chirasil-l-
Val, according to our experience; see Exper. Part). The ratio of the former peak area to
the latter one was estimated to be ca. 0.9 in a surface sample, indicating that l-Iva
actually was present in small excess.
3.7. Isolation of Peptaibiotics from Trichoderma in Recent Marine Sediments.
Peptaibiotic-producing species of Trichoderma were isolated from recent marine
sediments of Fier dArs at the French Atlantic coast, and bioaccumulation of these
peptides in Blue Mussels (Mytilus edulis) was reported [33]. Therefore, biotic synthesis
CHEMISTRY & BIODIVERSITY – Vol. 6 (2009) 49
of Aib and Iva by marine fungi is an alternative explanation for the occurrence of these
amino acids in hydrolysates of Tokyo Bay sediments.
3.8. Possible Fungal Origin of Aib and Iva in Ancient Sediments. In the light of the
data and arguments presented here, fungal origin of Aib and Iva in ancient sediments
has to be considered. Regarding the mass extinction marked by the K-T boundary, it is
of interest that fungal proliferation (fungal spike), indicated by fungal spores and
hyphae, was detected in the Moody Creek Mine, Greymouth Coalfield, New Zealand,
coincident with the iridium anomaly that marks the extinction event [34]. This is
interpreted as dramatic and global dieback of photosynthetic organisms, and replace-
ment by saprotrophic fungi that dominated the biosphere for a certain period of time.
These findings indicate at least the capability of fungi to occupy and even dominate
favorable ecosystems. The palaeomicrobial records indicate that fungi were abundant
at the geological time periods discussed [35–38]. However, since outcrop sediments at
the K-T boundary at Stevns Klint and related sites are still exposed, and have been
exposed for long periods of time to the environment, and since samples have neither
been collected nor stored under aseptic conditions, biotic origin of Aib and Iva from
recent fungi in such samples cannot be excluded. Indeed, lipid biomarkers indicating
microbial activity have been detected in K-T boundary sediments of Stevns Klint and
related sites [39]. Notably, peptaibiotics are extremely stable towards proteolytic
enzymes [2].
3.9. Abiotic Aib and Iva in Meteorites. There is consensus, and we completely agree
about the conclusion that the abundance of organic materials in carbonaceous
meteorites, such as theMurchison or theMurray, is the result of cosmochemical, abiotic
synthesis. In particular the a,a-dialkyl amino acids are the results of basically known
synthetic pathways such as the Strecker cyanohydrin synthesis or its variations. The
building blocks (synthons) of amino acids abundantly occur in space [40].
Whereas Iva in K-T-boundary sediments was reported to be completely racemic,
Iva as well as other a,a-dialkyl amino acids in carbonaceous Murchison and Murray
meteorites were found to be non-racemic, and even result in a moderate excess of the l-
enantiomers [11] [41].
Some proteinogenic l-amino acids that are usually detected together with non-
proteinogenic a,a-dialkyl a-amino acids in the classical carbonaceous meteorites are
considered to be the result of terrestrial, in particular, microbial contamination, since
these meteorites have been exposed to the terrestrial environment for extended periods
of time and have not been stored under aseptic conditions [42]. It is not unlikely that
peptaibiotic-producing fungi had or have the opportunity to grow in such meteorites.
Then, certain amounts of biotic a,a-dialkyl amino acids might be added to those
formed abiotically, and even result in changes of the ratio of Iva enantiomers. The ee
excess of the series of chiral non-proteinogenic a,a-dialkyl amino acids of these
meteorites has been ascribed to discrimination by circularly polarized light [43] or,
recently, to enantiomeric amplification mechanisms related to the Soai reaction
[44]
3.10.Aib in Meteorites and Ice Samples from Antarctica. Aib and Iva have also been
detected in carbonaceous meteorites collected in Antarctica, serving as a giant collector
and freezer thus considered to minimize terrestrial, in particular, microbial, contam-
ination [45].
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Besides solid pieces of carbonaceous meteorites, the so-called Antarctic micro-
meteorites (AMMs), typically ranging between 100–200 mm in size, were collected
from molten ice, together with non-meteoritic materials [46].
Remarkably, Aib and Iva have been detected in solid pieces of carbonaceous
meteorites collected from ice fields of Antarctica [47] [48] [49] but also from an ice
block extracted from the La Paz region, Antarctica, that was devoid of solid pieces of
meteorites [49]. Therefore, AMMs were considered as potential sources for Aib,
provided that at least parts of those amino acids survived the heating process on
entering the atmosphere [49] [50]. Indeed, steady influx of interplanetary dust and
micrometeorites in the terrestrial atmosphere takes place, and materials accreted in
Antarctica and the Arctic have been analyzed [51]. Recently, cosmic dust has been
detected together with the much more common terrestrial dust in an ice core drilled in
Dronning Maud Land, Antarctica, covering the time period from 6,800 to 29,000 ybp,
using 4He/3He isotope ratios [52]. Therefore, and in extension of our considerations, it
is reasonable to assume that cosmic dust particles, together with terrestrial materials,
form part of the aerosols in the atmosphere.
3.11. Possible Biotic Origin of Aib in Ice Samples Devoid of Meteorites. Localized
deposits of materials originating from Aib-containing bio- or mycoaerosols or related
dust particles serving as ice nuclei as described above might be an explanation, with Aib
being released and concentrated as result of lyophilization or/and freeze-concentration
of solutes. Active fungal growth and biosynthesis of Aib under conditions favoring
freeze-thaw cycles is also to be expected.
Indeed, viable microorganisms, including fungi, have been detected in all ice
samples and sites analyzed for their presence.
Two expeditions to Antarctica were aimed at answering the question whether biotic
materials in ice could contaminate carbonaceous meteorites. Microorganisms, includ-
ing fungi, were present in all ice samples from Patriot Hills, Thiel Mountains, and South
Pole Station, and cryoconite ice also contained viable microorganisms [53]. In
meteorites and ice samples collected in the blue ice fields near Pecora Escarpment, it
was shown that microbial life was present in every ice sample [54]. In this context, it is
noteworthy that psychrophilic (cryophilic) fungi have been isolated from Arctic as well
as Antarctic soils, cryopegs (i.e., lenses of supercooled water in permafrost regions),
and Antarctic lakes [55].
Presence of fungi entombed in ancient glacial ice has also been recognized. Among
those, species of Acremonium, Geomyces pannorum, and Cladosporium have been
identified, and, among many other fungi, viable Lecytophora hoffmannii AY 781227
was isolated from an ice core from Greenland estimated to originate from <500 ybp
[56].
In cold regions, the dark, powdery dust deposited on the surface of snow or ice
(cryoconite) might accumulate in cryoconite holes. Consequently, a localized deposit
and release of Aib and Iva from airborne dust loaded with relevant fungi can be expected.
3.12. Fungal Taxa from Antarctica as Potential Producers of Aib, Iva, and
Peptaibiotics. Production of Aib and Iva, and peptaibiotics from recent psychrophilic
microorganisms, reported to occur in Antarctica, is likely. Indeed, some of the Aib-
producing fungal genera presented in Table 1 have been detected in Antarctica as well
as extremophiles in other cold regions.
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Acremonium strictum, Isaria farinosa (syn. Paecilomyces farinosus), and Verticil-
lium sp. have been isolated, among other fungi, from soil and biomaterials from the
Victoria Land in Antarctica [57]. The isolation of Acremonium antarcticum, Acre-
monium psychrophilum, Paecilomyces variotii, and Trichoderma sp. was reported from
soils of Schirmacher Oasis, East Antarctica [58], and Antarctic microfungi serve as
models for exobiology [59].
The fungi from North-east Bailey, Windmill Islands, continental Antarctica, have
been investigated in detail [60]. Among others, Acremonium crotocinigenum (cf.
Table 1 and Fig. 1) was isolated from the lichens Xanthoria candelaria, Umbilicaria
decussata, andUsnea sphacelata, as well as anAcremonium sp. from the mossGrimmia
antarctica. Further, Hydropisphaera peziza (syn. Nectria peziza) was isolated from the
mosses Bryum pseudotriquetrum and Grimmia antarctica, and two Trichoderma
species, then identified as T. harzianum and T. pseudokoningii, were isolated from
soil. It is expected that carbonaceous meteorites, owing to the low temperatures, are
not less prone to vigorous microbial growth. However, the formation of water as a
result of thaw-freeze cycles on the surface and/or supercooled water in micro-
pores might enable growth of psychrophilic microorganisms, both fungi and bacteria,
feeding on these potential sources of organic C, N, P, and S. Notably, these
considerations might be extended even to meteorites sunken at depths up to several
meters in the Blue Ice of Antarctica owing to the relative transparency of that ice and
the absorption of solar radiation by solids that can promote formation of liquid water
[45].
4. Conclusions and Perspectives. – Screening of filamentous fungi for the
production of Aib, and d- and l-Iva, grown under standard conditions on agar plates,
revealed the biosynthesis of peptaibiotics in taxa not recognized as producers before.
Owing to the ubiquity of these fungi in the biosphere and the abundance of sequence
data compiled in the literature and rapidly expanding databases, these amino acids are
no longer considered rare in the biosphere. [2] [3].
We dare predict that Aib and related a,a-dialkyl amino acids are to be expected in
all environments associated with peptaibiotic-producing fungi, and the detection of Aib
and Iva is just dependent on knowledge and the application of advanced analytical
techniques as described here and elsewhere.
Detection of trace amounts of Aib and Iva in sediments, soil, or ice samples from
Antarctica devoid of carbonaceous meteorites as potential sources of abiotically
formed Aib and Iva should be considered in the light of the results and arguments
presented here. In particular, the concomitant presence of carbonaceous meteorites or
cosmic dust and of fungi, being potential producers of peptaibiotics, will make the
distinction difficult and requires methods to distinguish among abiotic and biotic Aib
and Iva. It is highly recommended that analyses of meteoritic and palaeogeological
samples for Aib and other a,a-dialkyl a-amino acids should be accompanied by a
thorough evaluation of the microbial flora of these materials. Besides standardmethods
such as light-microscopic inspection or scanning electron microscopy, and growth
studies of microorganisms in suitable culture media, advanced state-of-the-art
molecular-diagnostic techniques that are specific for the detection of contaminating
microorganisms should be applied. Examples comprise rRNA-based PCR amplifica-
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tion or DNA-specific fluorescence staining possibly combined with confocal laser
scanning electron microscopy [61].
Finally, it should be emphasized that the considerations outlined here on the fungal
occupation of materials and production of peptaibiotics can be extended to other
microorganisms, including bacteria that might also be associated in symbiosis or
biocoenosis. Examples are lichenized fungi, fungicolous algae, microbial mats, biofilms,
and (crypto)endolithic communities, all of which represent biosystems that should be
screened for the production of a,a-dialkyl amino acids. Yeasts, in particular, are
potential candidates as has already been shown with the yeast-like fungus Geotrichum
candidum (Saccharomycetales) – notably also occurring in Antarctica – that
incorporates Aib as well as equal amounts of d- and l-Iva in certain neoefrapeptin
sequences [15].
The authors are indebted to Dr. Richard C. Summerbell (Sporometrics Inc., Toronto, Ontario,
Canada) for valuable comments on the molecular identification of Acremonium isolates with curved
conidia. T. D. gratefully acknowledges the financial support by the Erwin-Stein-Stiftung (D-Gießen).
Experimental Part
General. Chemicals. MeOH, PrOH, i-PrOH, CH2Cl2, AcCl, Ac2O, pentafluoropropionic acid
anhydride (PFPAA) (Merck, D-Darmstadt), Dowex 50W-X8 (Serva, Heidelberg, Germany), NH3
(24%); HCl in PrOH was prepared by slowly adding AcCl (3 ml) to PrOH (7 ml) with chilling. Aib
was from Senn Chemical Comp., CH-Liesberg. Enantiomers l- and d-Iva for comparison as reference
standards were prepared from dl-Iva synthesized in our laboratory according to the Strecker procedure
and converted intoN-monochloroacetyl(MCA)-dl-Iva. Treatment with porcine renal acylase released l-
Iva that was separated from the remaining MCA-d-Iva by ion-exchange treatment according to [12] [62].
Strains and Culture Conditions. Strains with CBS numbers are accessible from the Centraalbureau
voor Schimmelcultures (CBS), NL-Utrecht. Cultures were transferred aseptically onto agar plates (9.5-
cm diameter Petri dishes) and grown at r.t. for 9 d under ambient daylight. Sterilized culture media used
were [g/l]: OA (oatmeal 30, agar 15), CMA (cornmeal 2 (Difco, Detroit, USA), agar 15; pH 6.0), MA2
(malt extract 20 (Servabacter Light, Serva, D-Heidelberg), agar 15).
Extraction of Peptides fromMycelia. MeOH/CH2Cl2 1 :1 (v/v ; 5 ml) was added to vigorously growing
fungi on agar plates, the org. layers were filtered through fluted filter papers (125-mm diameter,
Schleicher and Schll, D-Dassel), and the filtrate was evaporated to dryness with a rotary evaporator.
MeOH (2 ml) was added to the remaining residue, and the soln. was filtered through an Anatop 10
disposable filter disk (0.2 mm,Merck, D-Darmstadt) into 10-ml conical flasks and evaporated to dryness.
Accordingly, blanks were prepared from culture media in Petri dishes not inoculated with fungi and
analyzed as described below.
Total Hydrolyses of Extracts. 6m HCl (0.5 ml) was added to the residues, and the resulting solns.
transferred into 1-ml-thick-walled reaction vials (Reacti-Vial, Wheaton, Milville, USA). The vials were
closed with Teflon-lined screw caps and heated for 24 h at 1108. The acid was removed in a stream of N2,
0.1n HCl (1 ml) was added to the dry residue, and the resulting solns. were passed through a glass column
(5-cm length, 0.6-cm diameter) filled with cation exchanger. The resin was washed with dist. H2O (4 ml),
and amino acids adsorbed were eluted with 4n aq. NH3 (4 ml). The eluate was evaporated to dryness in
vacuo, 0.1n HCl (0.5 ml) was added, and the soln. was transferred into reaction vials as described above
and evaporated to dryness in a stream of N2.
Derivatization Procedures for GC. HCl in i-PrOH (or PrOH) was added to the dry residue for
esterification, and the closed vial was heated for 1 h at 1008. The solvent was removed in a stream of N2,
then PFPAA (10 ml) and CH2Cl2 (250 ml) were added to the residue, and the closed vial was heated for
20 min at 1008. Accordingly, Ac derivatives were prepared by derivatization of hydrolysates with HCl in
PrOH and subsequent treatment with Ac2O. Derivatizing reagents were carefully removed in a cold
CHEMISTRY & BIODIVERSITY – Vol. 6 (2009) 53
stream of N2 at r.t., CH2Cl2 (30 ml) was added, and 2–5 aliquots were subjected to GC/MS analysis. The
split ratio was set 1 :30. Between analyses, CH2Cl2 was injected into the GC, and the complete temp.
program was run, followed by inspection of the baseline in order to detect possible contamination or
carryover of Aib and Iva from previous analyses.
Instruments. For GC/MS, a GC-17A instrument (Shimadzu, Tokyo, Japan) was used equipped with
a) Chirasil-l-Val cap. column (25 m0.25 mm ID, Chrompack, NL-Middelburg) or b) in one case (CBS
246.63) a Lipodex E cap. column (25 m0.25 mm ID;Macherey-Nagel, D-Dren). Temp. and pressure
programs used for a) and b) were: initial temp. 708, then 2.58/min to 908, then 78/min to 1908, held for
10 min; pressure 5 kPa for 5 min, then 0.2 kPa/min to 6.7 kPa, then 0.6 kPa/min to 15 kPa, held for
10 min. The MS detector was a QP 5000 instrument (Shimadzu) used in the selected ion monitoring
(SIM) mode; detector gain was 1.5 kV, sampling rate 0.2 s.
Characteristic mass fragments used for SIM-MS of PFP-Aib-2-Pr esters were at m/z 204
([MCOOCH(CH3)2]þ ) and for PFP-Iva-2-Pr esters at m/z 218 ([MCOOCH(CH3)2]þ ). For analysis
of CBS 906.72D (cf. Fig. 2), Ac-Aib-1-Pr ester at m/z 100 ([MCOOC3H7]þ ) and for Ac-Iva-1-Pr ester
at m/z 114 ([MCOOCH3H7]þ ) were used.
The elution order of enantiomers of dl-Iva from Chirasil-l-Val (d-Iva eluting prior to l-Iva) was
determined by comparison with pure enantiomers (see above). Blanks were made from hydrolyzed org.
solvent extracts of batches of nutrient agar used forPetri dishes not inoculated with fungi, and analyzed as
described above.
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Studies on the Selective Trifluoroacetolytic Scission of Native Peptaibols and
Model Peptides Using HPLC and ESI-CID-MS
by Christoph Theis, Thomas Degenkolb1), and Hans Brckner*
Interdisciplinary Research Centre for Biosystems, Land Use and Nutrition (IFZ), Department of Food
Sciences, Institute of Nutritional Science, University of Giessen, Heinrich-Buff-Ring 26–32, D-35392
Giessen (phone: þ49-611-99-39140; fax: þ49-611-99-39149;
e-mail: christoph.theis@ernaehrung.uni-giessen.de, hans.brueckner@ernaehrung.uni-giessen.de)
Representative members of a group of linear, N-acylated polypeptide antibiotics (peptaibols)
containing a-aminoisobutyric acid (Aib) and, in part, isovaline (Iva), as well as proteinogenic amino
acids and a C-terminal-bonded 2-amino alcohol, were treated with anhydrous trifluoroacetic acid (TFA)
at 378 for 0.5–26 h. The resulting fragments were separated by HPLC and characterized by electrospray
ionization collision-induced dissociation mass spectrometry (ESI-CID-MS). The following 16–20-
residue peptaibols were investigated: natural, microheterogeneous mixtures of antiamoebins and
alamethicin F50, uniform paracelsin A, and synthetic trichotoxin A50/E. In the natural peptides, bonds
formed betweenAib (Iva) and Pro (Hyp) were rapidly and selectively cleaved within 0.5 h. Furthermore,
TFA esters of the C-terminal amino alcohols were formed. Depending on time, release of C-terminal tri-
and tetrapeptides as well as amino acids from the major fragments was observed. Synthetic
homooligopeptides, namely Z- and Ac-(Aib)10-OtBu and Z-(Aib)7-OtBu, were analyzed for comparison.
On treatment with TFA, a regular series of Z-(Aib)10–5-OH from Z-(Aib)10-OtBu were detected within
0.5 h, and, after 3 h, release of a regular series of Z-(Aib)7–3-OH from Z-(Aib)7-OtBu were observed.
Moreover, concomitant release of the series of H-(Aib)10–3-OH from the decapeptide occurred. From
these data, a repetitive cleavage mechanism via intermediate formation of C-terminal oxazolones on
trifluoroacetolysis is proposed. Furthermore, their formation and stability in native peptaibols are
correlated with subtle structural differences in protein amino acids linked to Aib. From the conspicuous
concordance of the formation and abundance of regular series of trifluoroacetolytic fragments and of
positive ions of the b-series in CID-MS, the generation of intermediate oxazolonium ions in both gas and
liquid phase is concluded.
1. Introduction. – The carboxamide groups in peptides and proteins are remarkably
stable against treatment with organic acids, and use of protecting groups and linkers,
which are selectively cleaved by acids of varying strengths under controlled conditions,
is of major importance in both solution and solid-phase peptide synthesis. However,
several unexpected and selective cleavage reactions of peptide bonds formed in
particular by non-proteinogenic amino acids have been reported. Consequently, such
reactions have to be taken into account not only when planning classical or advanced,
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fully automated syntheses, but also in the course of workup and purification of synthetic
and natural peptides, as well as their sequence determination. Regarding the aim of the
work presented here, we focus on more recent results of the selective acidolytic amide-
bond cleavage of special amino acids. However, readers interested in the selective
nonenzymatic cleavage of proteins and peptides are referred to the classical review [1].
Recently, Rubini et al. [2] reported that synthetic peptides containing consecutive
Pip2) residues, e.g., H-Pip1-Pip2-Pip3-Leu4-Pip5-Pip6-Lys(Boc)7-Pip8-Lys(Boc)9-Phe10-
O-Wang resin, have been cleaved between Pip5-Pip6 on treatment with 95–50%
CF3COOH (TFA) and scavenger.
Contrary to that, no cleavage of the Pip bonds was observed by treatment with 1%
TFA in CH2Cl2 when using the extremely acid-sensitive 2-chlorotrityl chloride resin.
Analogously, the peptide Ac-Pip1-Pip2-Pip3-Leu4-Pip5-Pip6-Lys(Ac)7-Pip8-Lys(Ac)9-
Phe10-O-Wang showed cleavage of the Pip1-Pip2 as well as the Pip5-Pip6 bond on
treatment with 95–50% TFA.
Jiang et al. [3] observed that the C-terminal amide of a series of N-acyl-N,a,a -
trialkylglycine amides (acyl, benzoyl; amide, Pmb or cyclohexyl), such as N-acyl-
(dibenzylglycine)cyclohexylamide, was cleaved on treatment with 5% TFA in MeCN.
Mannekens et al. [4] reported that the amide bond of (S)-2-pivaloyl-Tic and structurally
related derivatives, such as (1R,3S)-1-[3-(benzyloxy)benzyl]-2-pivaloyl-Tic-Phe-OBn,
were easily cleaved by treatment with MeOH, saturated with HClg at 08.
Creighton et al. [5] found that the cyclic hexapeptides c[(NMe)Aib-Phe-d-Trp-Lys-
Thr-Phe] and c[(NMe)a Ac5c-Phe-d-Trp-Lys-Thr-Phe] as well as c[Phe-Ser(Bn)-
Ser(Bn)-Phe-NMeAib] showed unexpected amide bond cleavage on the terminal side
of (NMe)Aib or its analogue (NMe)Ac5c on treatment with a mixture of anhydrous
TFA/CH2Cl2 1 :1 at 08 for 1 h. This mixture was used for the simultaneous removal of
the Boc and t-Bu-ether protecting groups in the last steps of the syntheses. To get
insight into the cleavage mechanisms, a series of benzoyl-dipeptide derivatives of the
general structure p-X-C6H4C(O)-(NMe)Aib-Phe-OMe were synthesized. The X-group
was varied from NO2 to Cl. Fast cleavage and release of Phe-OMe was observed in 1 :1
mixtures of TFA/CH2Cl2 or TFA/MeCN. Extremely fast amide-bond cleavage was
observed for p-Me-C6H4C(O)-(NMe)Aib-Phe-OMe using 2% TFA in MeCN.
Anteunis and van der Auwera [6] reported on the acidolytic cleavage of a large
number of protected di- and tripeptides. They found that, in peptides containing C-
terminal N-methylamino acid carboxamides, such as Z-Pro-(NMe)Ala-NMe2, the
Me2NH is already cleaved by TFA within 30 min.
In the course of their intensive studies on the use of the so-called azirine/oxazolone
method [7] for the synthesis of Aib-containing peptides and peptaibols [8], the group of
Heimgartner recognized that the amide bond in the dipeptide Z-Ala-Aib-NMe2 was
selectively cleaved by treatment with 3m HCl in H2O/THF 1 :1 within 12 h at 358, and
Z-Ala-Aib-OH was released in 87% yield [9].
Selective, repetitive amide cleavage of N-acyl-(Aib)n-NMe2 using HClg/toluene and
reaction of the resulting N-protected peptide acids with 3-(dimethylamino)-2,2-
dimethyl-2H-azirine was used for the synthesis of oligo-Aib-peptides [10].
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Except for the above azirine/oxazolone approach, cleavages of amide bonds were
considered as rather undesired side reactions. In contrast to that, the selective scission
of peptide bonds formed by Aib and Pro attracted considerable attention, because the
former is the characteristic and predominant constituent of a group of polypeptides
comprehensively named peptaibiotics, i.e., peptides containing Aib and displaying
antibiotic as well as a plentitude of other biotic activities [11].
Notably, it was already recognized by Closse and Huguenin in 1974 [12] that the
cyclotetrapeptaibiotic chlamydocin could be selectively cleaved on the carboxy side of
Aib by treatment with TFA at 508 for 2 h, resulting in the formation of the linear
peptide H-Phe-d-Pro-Aoe-Aib-OH, which has subsequently been sequenced by
Edman degradation.
Selective trifluoroacidolysis of the Aib–Pro bond was also used by Pandey et al. for
the mass spectrometric sequence determination of alamethicins and antiamoebins
[13] [14].
Subsequently, analytical and preparative trifluoroacetolysis of the peptaibols
trichotoxin and suzukacillin was intensively used by Jung and co-workers [15] [16].
It was shown that release of C-terminal peptides occurs, besides the fast scission of
the Aib–Pro bond that is followed by cleavages of certain Aib–Aaa bonds (Aaa:
Gly, Ala). This sequential work was accompanied by systematic investigations of
the acid-sensitivity of synthetic peptides representing partial sequences of native
peptaibols (i.e., peptides containing Aib and a C-terminal 2-amino alcohol). Re-
cently, preferred acidolytic cleavage of the Aib(Iva)-Hyp bonds in the 16-residue
peptaibiotics integramides A and B was observed. Treatment with 1n HCl for
1 h at 1108 was used for chiral sequence determination of d- and l-Iva in fragments
[17] [18].
From the above reports, it was evident that peptide bonds formed by Aib and Pro
are particularly sensitive to trifluoroacetolysis. Notably, bonds formed by other
C(a),C(a)-dialkylated glycines, such as isovaline (Iva, 2-ethylalanine), and amino
acids related to Pro, such as Hyp or Pip, show a similar cleavage behavior. However, the
slow release of C-terminal Aib as well as tri- and tetrapeptides from N-acetylpeptide
acids, resulting from preparative TFA scission of trichotoxin [15] and suzukacillin [16],
had been recognized, indicating further cleavage preferences.
To evaluate the cleavage mechanisms proposed for small peptides and amino acid
derivatives, a series of native and synthetic peptaibols were subjected to time-
dependent trifluororacetolysis. Their cleavage behavior was compared to synthetic
homooligo-Aib model peptides treated in parallel. Fast separation and reliable
assignment of the acidolytic fragments was achieved by on-line-HPLC coupled to ESI-
CID-MS.
2. Results. – 2.1. Trifluoroacetolysis of Homooligo-Aib-Peptides. Sequences of
model peptides and peptaibiols and preferential cleavage sides are compiled in Fig. 1.
Z-(Aib)10-OtBu (1). Peptide fragments resulting from the trifluoroacetolysis of 1,
separated by HPLC and analyzed by total ion current (TIC)-MS, are compiled in
Table 1, together with their characteristic protonated molecular ions. The ESI-MS of 1,
establishing its identity and showing a regular series of acylium ions b2 –b10 with the
characteristic difference of 85 Da for Aib residues, is presented in Fig. 2.
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Fig. 2. Mass spectrum of synthetic Z-(Aib)10-OtBu (1) showing the protonated molecular ion at m/z 1059
and sodiated molecular ion at m/z 1081. Regular series of fragment ions b2 to b10 , distinguished by the
characteristic mass difference for Aib residues (85 Da), can be observed.
Table 1. Peptides 2–16 Resulting from Trifluoroacetolysis of Z-(Aib)10-OtBu (1) and Protonated
Molecular Ions [M þH]þ Used for the Characterization of Peptides
Detection
after
Disappearance
after
1 2 3 4 5 6 7 8 9 10 [MþH]þ
[m/z]
1 0.5 h Z Aib Aib Aib Aib Aib Aib Aib Aib Aib Aib OtBu 1059
2 0.5 h Z Aib Aib Aib Aib Aib Aib Aib Aib Aib Aib 1003
3 0.5 h Z Aib Aib Aib Aib Aib Aib Aib Aib Aib 918
4 0.5 h Z Aib Aib Aib Aib Aib Aib Aib Aib 833
5 0.5 h Z Aib Aib Aib Aib Aib Aib Aib 748
6 0.5 h Z Aib Aib Aib Aib Aib Aib 663
7 0.5 h Z Aib Aib Aib Aib Aib 578
8 0.5 h 15 h Aib Aib Aib Aib Aib Aib Aib Aib Aib Aib 869
9 0.5 h 15 h Aib Aib Aib Aib Aib Aib Aib Aib Aib 784
10 0.5 h Aib Aib Aib Aib Aib Aib Aib Aib 699
11 0.5 h Aib Aib Aib Aib Aib Aib Aib 614
12 0.5 h Aib Aib Aib Aib Aib Aib 529
13 0.5 h Aib Aib Aib Aib Aib 444
14 0.5 h Aib Aib Aib Aib 359
15 0.5 h Aib Aib Aib 274
16 1 h Z Aib Aib Aib Aib 493
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After 0.5 h of trifluoroacetolysis, the starting material disappeared owing to the fast
and complete cleavage of the tBu group and the formation of the peptide acid Z-
(Aib)10-OH (2). Unexpectedly, concomitant generation of a mixture of individual
peptides, i.e., 3–16, with decreasing ion intensities and retention times were observed.
Peptides 2–10 were well resolved by HPLC, whereas peptides 11–15 co-elute. After
1 h, Z-(Aib)4-OH (16), appeared, co-eluting with peptide 8. Despite this, peptides 8
and 16, as well as 11–15, can be distinguished by their characteristic molecular ions (see
Table 1). Z-Peptide acids 2–7 correspond to the series Z-(Aib)10–5-OH, whereas
peptides 8–10 correspond to the free peptides H-(Aib)10–8-OH. The co-eluting free
peptides 11–15 represent the mixture of H-(Aib)7–3-OH. Inspection of Fig. 3 shows
that, with increasing reaction time, the intensity of the Z-decapeptide acid 2 decreases,
and those of the series Z-(Aib)9-OH (3) to Z-(Aib)5-OH (7), increase. After 1 h,
formation Z-(Aib)4-OH (16 ; co-eluting with H-(Aib)10-OH (8)) was also observed.
This indicates successive cleavage of C-terminal Aib residues, one after the other.
However, after 0.5 h reaction time, concomitant release of the series of free peptides 8–
15 was observed, representing H-(Aib)10–3-OH. This establishes that also the Z-group
of the respective peptides is cleaved off. From the ion abundances, it appears, however,
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Fig. 3. HPLC/TIC-MS of peptides 2–16 resulting from the trifluoroacetolysis of Z-(Aib)10-OtBu (1).
Numbers refer to sequences presented in Table 1.
that cleavage of the Z-group proceeds slower, compared to the release of C-terminal
Aib residues.
Ac-(Aib)10-OtBu (26). Although this peptide contained some impurities resulting
from the synthesis, the molecular ion at m/z 967 ([M þ H]þ ) could be used as the
precursor, and the acidolytic cleavage kinetics could be analyzed. After 0.5 h,
formation of the series Ac-(Aib)10–8-OH was observed. After 3 h, Ac-(Aib)7-OH and
Ac-(Aib)6-OH were recognized, and, after 8 h, formation of Ac-(Aib)5-OH. After 15 h
reaction time, Ac-(Aib)10-OH and Ac-(Aib)9-OH could not be detected anymore. In
contrast to Z-(Aib)10-OH, no formation of free H-(Aib)10-OH or lower homologues
from Ac-(Aib)10-OtBu, even after longer reaction times (up to 26 h), could be
observed. This indicates that the Ac-Aib terminus is more stable in comparison to the
Z-Aib terminus. This is in agreement with the relative stability of acetylpeptides or Ac-
Aib-OH released from peptaibols (see Fig. 1).
Z-(Aib)7-OH (27). In analogy to the protected decapeptide, the t-Bu group was
completely cleaved after 0.5 h reaction time, and formation of Z-(Aib)7-OH was
observed, as well as formation of the series Z-(Aib)6-OH to Z-(Aib)5-OH. After 3 h of
acidolysis, formation of Z-(Aib)4-OH and Z-(Aib)3-OH were recognized as well as
release of H-(Aib)7-OH. This result clearly indicates that the Z-group was also cleaved
in that case. Basically, the acidolytic cleavage behavior of the heptapeptide is in
agreement with that of the decapeptide.
2.2. Trifluoroacetolysis of Peptaibols. Trichotoxin (17). The sequences of the
peptaibols discussed in the following and fragments released are also presented in
Fig. 1.
TICs of HPLC/MS resulting from time-dependent trifluoroacetolysis of the
synthetic octadecapeptide 17 and the corresponding pseudomolecular ions of the
resulting fragments recorded in CID off-mode are presented in Fig. 4.
Consecutive numbers of peptides resulting from trifluoroacetolysis and their
corresponding sequences are presented in Table 2. Uniformity of trichotoxin (17) in
HPLC and the peak at m/z 1690 ([MþH]þ ) established the authenticity of the
synthetic octadecapeptide. After 0.5 h of trifluoroacetolysis, the starting material 17
decreased, and the acetylpeptide acids 18 and 20–22, as well as the TFA esters of 18 and
the prolylhexapeptide 24, appeared. After 1 h, peptide 23 and, after 3 h, peptide 19 was
detected. The free prolylhexapeptide 25 was observed after 8 h.
Comparison with the sequence of trichotoxin (see Fig. 1) shows that, after 0.5 h,
fast, but not complete, cleavage of the Aib–Pro bond takes place with release of the N-
terminal dodecapeptide Ac-Aib1-Aib12-OH (21). Notably, concomitant formation of
the trifluoroacetyl esters 18 of the C-terminal Valol from the intact trichotoxin (17), as
well as the C-terminal prolylhexapeptide 24, was recognized (see m/z in Table 2 and
Fig. 4). Furthermore, cleavage of the C-terminal Aib12 from the acetyldodecapeptide
acid 21 and formation of Ac-Aib1-Ala11-OH (22) from that were observed. From 22, the
tripeptide Aib9-Ala10-Ala11 was subsequently released within 1 h, resulting in the
formation of the acetyloctapeptide acid Ac-Aib1-Aib8-OH (23). After 3 h of acidolysis,
cleavage of the C-terminal Gln17-Valol18 from trichotoxin (17) was observed with
release of the acetylhexadecapeptide acid Ac-Aib1-Aib16-OH (19). Notably, some
trichotoxin (17) still remained intact even after 26 h of trifluoroacetolysis. These data
are in excellent agreement with those of the preparative trifluoroacetolysis of native
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Fig. 4. HPLC/TIC-MS of peptides 17–25 resulting from the trifluoroacetolysis of synthetic trichotoxin
(17; top) , and the corresponding diagnostic ions, 17a–25a, used for their characterization (bottom).
Numbers refer to sequences presented in Table 2. Peptide 20 could not be assigned unambiguously.
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2
trichotoxins [15], aimed on the isolation of fragments suitable for sequence
determination. Compound 20, however, appearing after 0.5 h and still detectable after
26 h, could not be characterized unambiguously. The acidolytic scission of the Gln17-
Valol18 C-terminus of 17 via simultaneous or subsequent formation of a pyroglutamic
acid derivative has been treated in previous reports and, therefore, is not considered
here [19].
Paracelsin (28). Fragments resulting from trifluoroacetolysis of peptaibols 28–30
are presented in Fig. 1, but TICs of HPLC/MS are not shown. Therefore, peptide
fragments treated in the following paragraph are not assigned by numbers as done in
the cases of Z-(Aib)10-OtBu (1) and trichotoxin (17). After 0.5 h of trifluoroacetolysis,
cleavage between Aib13-Pro14 was observed with release of the acetyltridecapeptide
acid Ac-Aib1-Aib13-OH and the prolylheptapeptide H-Pro14-Pheol20. In addition,
scission of the C-terminal dipeptide H-Aib12-Aib13-OH from Ac-Aib1-Aib13-OH,
resulting in the formation of Ac-Aib1-Gly11-OH, was observed. After 8 h of acidolysis,
cleavage of C-terminal Gly therefrom occurred, resulting in the formation of the
acetyldecapeptide acid Ac-Aib1-Aib10-OH. After 15 h of acidolysis, no starting material
remained, anymore.
Alamethicin (29). The major difference between paracelsin and alamethicin is that
the latter contains an additional acid-sensitive Aib–Pro bond in the Ac-Aib1-Pro2
terminus (see Fig. 1).
After 0.5 h of acidolysis, partial formation of the TFA ester of 29 was observed as
well as scission of the Aib–Pro bonds, resulting in the detection of H-Pro2-Pheol20 and
its TFA-ester, H-Pro14-Pheol20 and its TFA-ester, as well as the free dodecapeptide H-
Pro2-Aib13-OH. The N-terminal Ac-Aib-OH was not observed under the MS
conditions applied, but its formation and use of this particular selective cleavage for
sequencing was demonstrated previously [15] [16]. After 3 h, the fragment H-Pro2-
Aib13-OH increased in intensity, indicating the faster cleavage of the N-terminal Ac-
Aib1–Pro2 bond in comparison to the Aib13–Pro14 bond. After 8 h of acidolysis, starting
material 29was no longer detectable. The data are also in good agreement with those of
isolated fragments resulting from the preparative trifluoroacetolysis of the alamethicin-
related peptaibol suzukacillin [16].
Antiamoebin (30). Owing to its microheterogeneity and the presence of two Hyp as
well as a C-terminal Pheol residue, separation of fragments and interpretation of mass
spectra were more difficult in comparison to the above peptaibols. After 0.5 h of
trifluoroacetolysis, formation of a mixture of mono-, di-, and tri-TFA esters, resulting
from the esterification of the OH groups of the two Hyp residues and the C-terminal
Pheol residue, were observed. Cleavage of Iva12-Hyp13 and Aib14-Pro15 was observed
after 0.5 h. After 1 h, cleavage of Aib9-Hyp10 with formation of Ac-Phe1-Aib9-OH was
recognized. Also after 1 h, partial cleavage of Ac-Phe1-Aib9-OH between Iva5(Aib5)-
Gly6, resulting in the release of Ac-Phe1-Iva5(Aib5)-OH, was observed (amino acids in
parentheses indicate exchange positions in the natural peptaibol mixture used,
resulting in the detection of the corresponding homologous fragments). After 3 h,
further cleavage of C-terminal Aib9 from remaining Ac-Phe1-Aib9-OH occurred,
resulting in the release of Ac-Aib1-Aib8-OH. After 15 h, cleavage between Aib4-
Iva(Aib)5 and Aib3-Aib4 was recognized, resulting in the formation of Ac-Phe1-Aib3-
OH and Ac-Phe1-Aib4-OH.
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3. Discussion. – The fast acidolytic cleavage of the Aib–Pro bond, the release of
Aib and small C-terminal peptides from the C-termini of fragments, as well as the
apparently successive scission of C-terminal Aib from the Z- or Ac-protected or free
homooligo-Aib-peptides, require an explanation. The latter peptides, in particular,
have the advantage of consisting of uniform amino acid constituents. Thus, subtle steric
or electronic effects of the varying side chains as known from peptides that exclusively
consist of proteinogenic amino acids must not be considered in this case.
Consequently, the multitude of information about the acidolytic scission of amino
acid derivatives or simple model peptides reported in the literature or observed in our
laboratory should be discussed. Thus, they can be taken into account for mechanistic
considerations on homooligo-Aib-peptides and native peptaibols/peptaibiotics.
Rapid scission of the Aib–Pro bond by TFA or HCl/AcOH has also been reported
for Ac-Aib-Pro-NH2 [20], serving as a model for the N-termini of peptaibols such as
alamethicin or hypelcin. Notably, the Aib–Pro bond is more stable if mixtures of TFA/
CH2Cl2 are used at ambient or lower temperatures. This was established for Boc-Gly-
Ala-Aib-Pro-Ala-Aib-Aib-Glu(OBzl)-Gln-OMe. Using a 9.3% solution in TFA/
CH2Cl2 5 :2 at 228, it has been observed that the Boc group was completely cleaved
within 0.5 h. However, no prolylpeptides could be detected by TLC after that time [20].
Trifluoroacetolytic cleavage of the Aib–Aaa bond has previously been investigated
using the synthetic model peptides Ac-Aib-Ala-OH, Ac-Aib-Gly-OH, Ac-Ala-Aib-
OMe, and Ac-Ala-Aib-Ala-OMe in the laboratory of Gnther Jung, Tbingen
University, Germany [19].
Whereas ca. 50% of the peptide bonds in Ac-Aib-Ala-OH and Ac-Aib-Gly-OH
were cleaved with TFA within 3 h at 378, cleavage of the peptide Ac-Ala-Aib-OMe
started slowly after 6 h of acidolysis, but little cleavage was observed even after 19 h.
Notably, only cleavage of the peptide bond was observed but not release of the Ac
group. The tripeptide Ac-Ala-Aib-Ala-OMe remained almost unaffected on treatment
with TFA for 23 h.
Based on the model peptide Ac-(NMe)Aib-Phe-OMe, Creighton et al. [5]
postulated the formation of the oxazolone via an intermediate, tetrahedral oxazoli-
nolium ion, from which the amino acid is ejected. The resulting Ac-(NMe)AibOx
cation was postulated to be rapidly hydrolyzed by traces of H2O with release of Ac-
(NMe)Aib-OH.
Notably, Obrecht and Heimgartner [10] had already demonstrated that Me2NH·
HCl is released from peptides of the general structure Acyl-(Aib)n-NMe2 (n ¼ 1–3),
following treatment with HClg in toluene. Formation of intermediate oxazolones in this
series was established by IR spectroscopy, as well as preparative isolation of the
corresponding oxazolones. These authors also pointed out the experimental evidence
for an equilibrium between the protonated oxazolone as well as the respective
intermediate acylium ion or acid chloride.
This view is supported by the fact that the simple derivative Bz-Aib-NMe2,
considered as model for, e.g., the Ac-Aib-Pro bond, is easily converted into the
respective oxazolone by treatment with HClg in toluene at 80–1008. Such treatment
resulted in the release of Me2NH·HCl [9]. This oxazolone is easily hydrolyzed to Bz-
Aib-OH by heating with mixtures of aqueous HCl/organic solvents. Analogously, the
model peptides Z-Aaa-Aib-NMe2 (Aaa: Ile, Ala) were directly converted into the
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oxazolone by treatment with HClg/toluene (5–8 min, 1008). The corresponding
dipeptide acids were obtained therefrom by treatment with 2n HCl for 0.5 h at room
temperature. Intermediate formation of oxazolones in the latter cases was also deduced
from the high degree of racemization of Ile and Ala as result of tautomerism. The
problem of the racemization of the preceding chiral amino acids on prolonged
activation of C-terminal Aib is well-known [21].
We found that treatment of Ac-Aib-NEt2 with anhydrous TFA (10% solution,
15 min at 608) resulted in the complete amide-bond cleavage with release of Et2NH·
TFA and Ac-Aib-OH within that time. This was evidenced by TLC and comparison
with reference compounds. Notably, no formation of an oxazolone could be detected by
TLC (H. Brckner, unpublished results). If one assumes protonation of the Ac O-atom
in Ac-Aib-NEt2 by TFA with formation of an oxonium ion, as has been proposed by
Klotz et al. [22] for Ac-NHMe (N-methylacetamide), an intramolecular nucelophilic
attack on the positive C-atom of the carboxamide group is not likely. In anhydrous
TFA, representing a highly polar, ion-solvating solvent, however, concomitant release
of the protonated amine and formation of an intimate ion-pair between the carbonium
cation and trifluoroacetyl anion is favored that might result in an equilibrium with the
respective covalently bonded mixed anhydride (Scheme 1, Route A). These inter-
mediates are very reactive and will react quickly with traces of H2O. This mechanism is
related to that one formulated in [10], and, at least for Ac-Aib-NEt2, does not require
formation of an oxazolone, but excludes its formation neither directly (Scheme 1,Route
B) nor via cyclization of an intermediate carbonium/acylium cation as shown inA. This
mechanismmight also be applied on the fast cleavage of N-terminal Ac-Aib-Pro bonds.
However, most reports and studies presented in the introduction discuss or focus on
the formation of an intermediate oxazolonium ion, indeed. This results from the
intramolecular nucleophilic attack of the Aib C¼O O-atom on the C-atom of the
neighboring amide bond with release of the adjacent amino acid or substituted amine.
4. General Cleavage Mechanism. – Taking the aforementioned data into account, a
general mechanism is proposed based on the facileness of the formation of the
oxazolones and fragility of the protonated intermediates formed in Aib-peptides and
their instability under the acidolytic cleavage conditions used.
Scheme 1. Possible Trifluoroacetolytic Cleavage of Ac-Aib-NEt2 via Intermediate Formation of an Ion
Pair or Mixed Anhydride (Route A) or oxazolone (Route B). R¼Et, HX¼TFA; X ¼CF3COO.
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The considerations on homooligo-Aib-peptides are extended to peptaibols and
model peptides, and a mechanism is presented in Scheme 2. With regard to the
following discussion, the encircled residue R represents a C-terminal Aib residue. The
considerations can be extended on Pro (Hyp, Pip), or a disubstituted amide or, with
limitations, to peptaibols containing Aib–Gly(Ala) bonds.
4.1. Trifluoroacetolysis of Z- and Ac-(Aib)10-OtBu and Z-(Aib)7-OtBu. Taking the
large excess of TFA into account, the t-Bu groups of the peptides are cleaved
immediately, and scission of the peptide bonds of the resulting peptide acids is
discussed in the following.
Internal nucleophilic attack of the C¼O O-atom of the carboxamide group of the
second to last Aib on the carboxy group of the last Aib residue is probably favored by
the geminal dimethyl or Thorpe– Ingold effect [7] [23]. This leads to the fast formation
of an unstable tetrahedral oxazolinolium intermediate [4], which is subsequently
stabilized by proton transfer and release of the original C-terminal Aib. The resulting
oxazolonium peptides are easily hydrolyzed by traces of H2O which are always present,
even in TFA labelled as anhydrous.
From the fast release of a complete series of Z-(Aib)9–4 from Z-(Aib)10-OH, a
repetitive cleavage of the respective C-terminal Aib is proposed. The series ends
with the formation of Z-(Aib)4-OH. This might be explained by the acidolytic stability
of tri- and tetrapeptides as a result of their particularly stable secondary struc-
tures.
This stability against trifluoroacetolysis of the smaller acylpeptides is also supported
by the release of Ac-Phe1-Aib-Aib3-OH from antiamoebins after 15 h. This tripeptide,
however, remained resistant against further cleavage (see Fig. 1).
Remarkably, oxazolones are not formed from the C-terminal Aib but from the
preceding ones. From a C-terminal oxazolone, the precursor peptide would be
reconstituted on hydrolysis. Therefore, it is assumed that the C-terminal carboxy groups
form H-bridges with TFA, and the resulting solvent clusters shield the C-atom of
the carboxy group from nucleophilic attack of the O-atom by the adjacent carbox-
amide group. This effect might also explain the observed stability of Ac-Aib-OH in
TFA.
However, concomitant cleavage of the Z-group leading to the series H-(Aib)10–3-
OH is also observed. This observation contradicts experiences from non-Aib-peptide
chemistry: the Z-group, commonly used for orthogonal protection in peptide chemistry,
is usually stable towards TFA under the conditions applied and requires, e.g., boiling
TFA for its removal. Unexpected cleavage of the Z-group from Z-Ala-Aib-NMe2 on
treatment with HClg in MeOH was also reported [9].
The release of Aib residues from the N-terminus of the free peptides is assumed not
to take place because the protonated N-terminus decreases the nucleophilicity of the
corresponding carboxamide group of Aib. This phenomenon is attributed to its
electron-withdrawing properties.
From the data obtained from prolonged trifluoroacetolysis of peptaibols and
release of C-terminal di- to tetrapeptides therefrom (see Fig. 1), formation of
oxazolones at certain positions in the peptide backbone is also concluded according
to the general mechanism proposed (in Scheme 2, encircled R in these cases represent
C-terminal peptide sequences).
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The considerations outlined for homooligo-Aib-peptides can be extended on
peptide bonds formed between Aib and Pro or homologues. The scission of the amide
bond proceeds fast and can take place at any position of the polypeptide chain.
4.2. Trifluoroacetolysis of Peptaibols. The above considerations can also be applied
to alamethicin and paracelsin. In the case of alamethicin, fast cleavage of the Aib1–Pro2
and Aib13–Pro14 bonds with release of the respective fragments, according to the
proposed mechanism, was observed. In paracelsin, fast cleavage of the Aib13–Pro14
bond occurs. From the resulting Ac-Aib1-Aib13-OH, release of the dipeptide H-Aib12-
Aib13-OH and of the tripeptide H-Gly11-Aib12-Aib13-OH on prolonged trifluoroace-
tolysis are also observed. Again, release of stable tripeptides and nucleophilic attack of
constrained Aib on the sterically least constrained Gly were recognized. With the
exception of this amino acid, sequence of -Aib-Aaa-(Aib-Aaa)n-Aib- (Aaa, proteino-
genic amino acid; exceptions C-terminal Aib-Gln-Xol bonds [15] [19]) are stable
against trifluoroacetolysis.
In paracelsin, release of C-terminal dipeptide Aib12-Aib13 from Ac-Aib1-Aib13-OH
(the latter resulting from scission of the C-terminal prolylheptapeptide) is assumed to
proceed also via formation of an intermediate oxazolone. Cleavage of the Aib10–Gly11
bond after 8 h indicates moderate acid-sensitivity of this bond.
In trichotoxin, the fragment Ac-Aib1-Ala11-OH formed on trifluoroacetolysis
behaves conspicuously different because the C-terminal tripeptide Aib9-Ala10-Ala11
was released therefrom and not the C-terminal Ala11. This is explained by the fact that
the Ala residues, in contrast to Aib, contain Ca-hydrogens and oxazolone formation is
not favored. Intramolecular attack of the carbonyl of Aib8 on Aib9, however, might
proceed via formation of oxazolone and release of the tripeptide as outlined before.
The stability of the tripeptide is in principal agreement with that of the model Ac-Ala-
Aib-Ala-OMe mentioned above. The remaining Ac-Aib1-Aib8-OH remains stable in
TFA for hours; possibly formed smaller fragments could not be detected.
Generally, cleavage of Aib-peptides is much slower if mixtures of TFAwith organic
solvents such as CH2Cl2 are used. This is explained by the decrease of the dissociation as
well as concentration of TFA. Cleavage is also much lowered when acidic aqueous
solvents are used or water is added to TFA. This is explained by a much lower capability
to form oxazolones in aqueous solution. Heating at elevated temperature at prolonged
time, however, enables acidolytic cleavage under these conditions (see examples in
introduction). It is assumed that a change from the oxazolone mechanism to the
common acid-catalyzed cleavage of amide bonds proceeds, with preference for
disubstituted amides.
4.3. Considerable Accordance of Trifluoroacetolytic Scission Pattern and Mass-
Spectrometric Fragmentation. Inspection of the trifluoroacetolytic fragments of Z-
(Aib)10-OtBu, resulting in the series Z-(Aib)10–5-OH, and the Low-CID-MS of the
decapeptide, shows that there is considerable agreement between the generation of
homooligo-Aib-peptide fragments in the protic solvent and gas-phase dissociation,
since corresponding regular series of b ions, corresponding to the Z-(Aib10–2)þ acylium
(or oxonium/oxazolonium) cations (see Fig. 2), can be observed in the positive-ion
mode (see Scheme 2).
Analogously, a regular series of b2 to b10 cations is also generated from Ac-(Aib)10-
OtBu, and of b2 to b7 cations from Z-(Aib)7-OtBu.
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Notably, generation of acylium ions at low collision energy in peptides has been
proposed to proceed via nucleophilic attack of the peptide bond C¼O at the
protonated carbonyl group of the preceding C-terminal amino acid, formation of an
intermediate oxazolol, and proton transfer onto the N-atom of the amino acid that is
released with formation of an oxazolonium/oxazonium cation [24–26]. Regarding
peptaibols, prolyl residues are the best leaving groups and give rise to the respective
intensive y series [27] [28].
The abundances of the corresponding acylium ions are also in striking agreement:
highest intensities are observed for ions resulting from Aib residues owing to the
stabilization by the geminal dimethyl groups, lower intensities are observed for acylium
ions from protein amino acids. For example, in the partial sequence -Aib9-Ala10-Aib11-
Aib12-Pro13- of trichotoxin A40/5, the resulting b12 acylium ion is most intensive, and the
b9 and b11 ions are comparatively more intensive than the b10 ion [27]. The notable
moderate acid sensitivity of the -Aib–Gly- bond can also be observed in the positive-
ion MS of suzukacillin A4. The MS/MS of the b13 fragment ion resulting from the
partial sequence -Aib8-Aaa9-Aib10-Gly11-Aib12- displays the highest ion abundance of
b10 , and, lower abundance of b9 and, in particular, of b11 in comparison to b8 and b12
acylium ions [28].
Finally, it should be emphasized that the results presented here for oligo-Aib-
peptides and peptaibols, and the mechanistic aspects deduced therefrom are in
excellent agreement with the data and postulates resulting from the azirine/oxazolone
approach promoted for many years by the group of Heimgartner [10].
5. Consequences and Outlook. – Beyond the mechanistic considerations outlined
above, the potential acid-sensitivity of peptaibiotics has to be considered in the course
of isolation and handling of natural products, as well as in planning of classical or solid-
phase syntheses of peptaibiotics or peptides containing the special amino acids or
analogues mentioned in the text.
From an applied point of view, the selective acidolytic scission of peptaibols and
analysis of their fragments is of importance for their sequence determination in order to
generate fragments suitable for the assignments of the position and configuration of
amino acids, such as Iva enantiomers [15–18].
Use of proteases for the selective cleavage of peptaibiotics is of limited value, since
bonds formed by repetitive Aib(Iva) residues or adjacent protein amino acids are
completely resistant towards proteolytic degradation. For example, the 15-residue
peptaibols of the native ampullosporin mixture displaying N-terminal Ac-Trp and C-
terminal leucinol could neither be cleaved by the action of pepsin, chymotrypsin, or
pronase, nor by treatment with liver homogenates [29].
This is in agreement with our and others attempts to cleave trichotoxin or
alamethicin with common proteases [30]. However, special peptaibiotics comprising
bonds between consecutive proteinogenic amino acids, a-amino acids and b-amino
acids, are cleaved at certain positions. This has been shown by the cleavage of the
Gly13–Leu14 and Leu6–b-Ala7 bonds of neoefrapeptins with papain [31], and for
synthetic ampullosporin analogues in which Aib residues had been replaced by a series
of subsequent Ala residues [29].
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However, since formation and degradation of peptaibiotics under fermentation
conditions was observed for trichobrachins [32], fungal enzymes must exist being
capable of cleaving Aib-peptide bonds. The search for such enzymes being capable of
cleaving such sterically constrained bonds is thus encouraged. It might provide a novel
class of enzymes being capable of degrading related polymers such as plastic fibres or
detergents.
The extreme enzymatic resistance of the peptaibiotics, together with their
microheterogeneity, might be the result of the defence strategy of their fungal
producers [11] in order to overcome degradation of their arsenal of antibiotic and
membrane-modifying peptides in their natural environments [33].
Experimental Part
Abbreviations.Aib, a-aminoisobutyric acid; Iva, isovaline (2-ethylalanine); Pheol, l-phenylalaninol;
Valol, l-valinol; Xol, 2-amino alcohol; (NMe)Aib, 2-amino-N-methylisobutyric acid; (NMe)Ala, N-
methylalanine; (NMe)aAc5c, 1-amino-N-methylcyclopentanecarboxylic acid; Ser(Bn), serine-O-ben-
zyl; Me2N, dimethylamino; Tic, 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; Pmb, 4-methoxybenzyl;
Bn, benzyl; Aaa, proteinogenic amino acids; oxazolone refers to oxazole-5(4H)-one and pseudoaromatic
oxazolone intermediates; AibOx in the synthesis part refers to the oxazolone of the C-terminal Aib; Pip,
pipecolic acid; SPip, g-thiapipecolic acid; Aoe, l-2-amino-9,10-epoxy-8-oxodecanoic acid.
Chemicals. MeCN and MeOH were obtained from Riedel-de Hae¨n (Sigma Aldrich, D-Seelze);
CF3COOH (TFA) was from Fluka (CH-Buchs) and used without further treatment.
Homooligo-Aib-Peptides. The homooligo-Aib-peptides were synthesized according to the oxazolone
method [34–36] but instead of stepwise elongation of the peptide segments condensation was used [37].
Briefly, coupling of Z-Aib-Aib-AibOx and H-(Aib)2-OtBu in butyronitrile at 1008 for 24 h yielded Z-
(Aib)5-OtBu. Hydrogenolysis in MeOH in the presence of Pd/C provided H-(Aib)5-OtBu, and treatment
of Z-(Aib)5-OtBu with TFA/CH2Cl2 for 1 h at r.t. yielded Z-(Aib)5-OH. The pentapeptide was converted
into the respective oxazolone by treatment with Ac2O for 1.5 h at 1008.
Reaction of Z-(Aib)4-AibOx and H-(Aib)5-OtBu in butyronitrile at 1008 for 36 h provided Z-
(Aib)10-OtBu (1). Hydrogenolysis, followed by acetylation with Ac2O/CH2Cl2 1 :1 at ambient temp. for
4 h, provided Ac-(Aib)10-OtBu (26) that, after precipitation from MeOH/CH2Cl2/petroleum ether, was
obtained in ca. 65% purity as calculated fromHPLC. Reaction of Z-(Aib)4-AibOx and H-(Aib)2-OtBu in
butyl acetate/1,1,2,2-tetrachloroethane 10 :1 at 1008 for 18 h provided Z-(Aib)7-OtBu (27). Protected
peptides were characterized by MS, uniformity in TLC, and HPLC. For crystal structures of 1 and 27, see
[38] [39]; the ESI-MS of 1 is depicted in Fig. 2.
Native Peptaibols. Native peptaibols were isolated in our laboratories as natural, microheteroge-
neous mixtures from the culture broths of the producing fungi. Alamethicin F50 containing the major
componentent alamethicin F50/5 (29 ; see Fig. 1) was isolated from Trichoderma viride NRRL 3199 [40]
(recently redescribed as T. arundinaceum [11]), crude paracelsins A–D were isolated from Trichoderma
reeseiQM 9414 [41], and the pure component paracelsin A (28) was isolated from the paracelsin mixture
by HPLC; microheterogeneous antiamoebins were isolated from Emericellopsis salmosynnemata CBS
176.60 [42], and contained antiamoebin I as the major component 30 (see Fig. 1); trichotoxin A50/E (17)
was synthesized by conventional soln.-phase synthesis [43] and also characterized by X-ray crystallog-
raphy [44].
Trifluoroacetolysis of Peptides. TFA (100 ml) was added to 0.1 mg amounts of peptides in 1-ml screw-
cap vials (size 25 mm10 mm ID). The tightly closed vials were immediately placed in a sand bath and
incubated at 3718 for various periods of time.
After 0.5, 1, 3, 8, 15, 20, and 26 h treatment, TFAwas immediately removed in a cold stream of N2,
CH2Cl2 was added to the dry residue, and vials were flushed again with N2 in order to remove traces of
TFA. The remaining residues were dissolved in MeOH (100 ml), and aliquots (10 ml) were subsequently
analyzed by LC/ESI-CID-MS.
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Instruments and Conditions for HPLC. For HPLC, a HP 1100 series instrument comprising a model
G1322A degasser, G1312A binary pump, G1313A autosampler, G1316A column thermostat, G1314A
UV/VIS detector, and HP ChemStation software for LC (Rev. A.04.02) was used (all from Agilent, D-
Waldbronn, or Palo Alto, CA, USA). The HPLC column used (150 mm4.6 mm ID) was filled with
Kromasil 100–3 C8 material, particle size 3 mm. The column was kept at 358. Elution profiles of peptides
were recorded at a wavelength of 205 nm or as total ion currents (TIC) in on-line-ESI-MS. The following
LC gradient was used: eluent A: MeOH/MeCN/H2O 32 :32 :36; eluent B: MeOH/MeCN 50 :50. TFA
(0.1%) was added to both eluents.
Mass Spectrometry. For ESI-CID-MS, a calibrated LCQ-MSTM (Thermo Quest, Finnigan MAT, San
Jose, CA, USA) was used. N2 served as sheath and auxiliary gas. He (purity >99.9990%, Messer-
Griesheim, D-Krefeld) was used as collision gas. The temp. of the heated capillary was 2508 ; sheath gas
and auxiliary gas were set at 40 and 10 relative units, resp. Ion source collision-induced dissociation
(CID)MS was performed at 0 and 45% relative collision energy. Sequence analyses were carried out
in the positive ionization mode. Them/z values were recorded in centroid mode and have an accuracy of
0.5 Da.
T. D. gratefully acknowledges the financial support by the Erwin-Stein-Stiftung (D-Gießen). We
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Breakthrough Technologies
Profiling of Arabidopsis Secondary Metabolites by
Capillary Liquid Chromatography Coupled to Electrospray
Ionization Quadrupole Time-of-Flight Mass Spectrometry1
Edda von Roepenack-Lahaye, Thomas Degenkolb, Michael Zerjeski, Mathias Franz, Udo Roth,
Ludger Wessjohann, Ju¨rgen Schmidt, Dierk Scheel, Stephan Clemens*
Department of Stress and Developmental Biology (E.R., M.Z., M.F., U.R., D.S., S.C.) and Department of
Bioorganic Chemistry (T.D., L.W., J.S.), Leibniz Institute of Plant Biochemistry, Weinberg 3, 06120
Halle/Saale, Germany
Large-scale metabolic profiling is expected to develop into an integral part of functional genomics and systems biology. The
metabolome of a cell or an organism is chemically highly complex. Therefore, comprehensive biochemical phenotyping
requires a multitude of analytical techniques. Here, we describe a profiling approach that combines separation by capillary
liquid chromatography with the high resolution, high sensitivity, and high mass accuracy of quadrupole time-of-flight mass
spectrometry. About 2,000 different mass signals can be detected in extracts of Arabidopsis roots and leaves. Many of these
originate from Arabidopsis secondary metabolites. Detection based on retention times and exact masses is robust and
reproducible. The dynamic range is sufficient for the quantification of metabolites. Assessment of the reproducibility of
the analysis showed that biological variability exceeds technical variability. Tools were optimized or established for the
automatic data deconvolution and data processing. Subtle differences between samples can be detected as tested with
the chalcone synthase deficient tt4 mutant. The accuracy of time-of-flight mass analysis allows to calculate elemental
compositions and to tentatively identify metabolites. In-source fragmentation and tandem mass spectrometry can be used
to gain structural information. This approach has the potential to significantly contribute to establishing the metabolome of
Arabidopsis and other model systems. The principles of separation and mass analysis of this technique, together with its
sensitivity and resolving power, greatly expand the range of metabolic profiling.
Metabolomics, the comprehensive analysis of me-
tabolites present in a biological sample, has emerged
as the third major path of functional genomics beside
mRNA profiling (transcriptomics) and proteomics
(Fiehn, 2002; Sumner et al., 2003). Metabolomic ap-
proaches seek to profile metabolites in a nontargeted
way, i.e. to reliably separate and detect as many
metabolites as possible in a single analysis. Com-
bined with information on transcript and protein
abundance, this would ideally lead to a nearly com-
plete molecular picture of the state of a particular
biological system at a given time.
A characteristic of plant life is the production of a
vast number of natural compounds, often called sec-
ondary metabolites. Secondary metabolites have cru-
cial roles in plant development as well as in the
interaction of a plant with its biotic and abiotic envi-
ronment (Kutchan, 2001). They are “secondary” only
in the sense that in different plant species, different
sets of metabolites occur (Pichersky and Gang, 2000).
Ample evidence has been obtained in the past three
decades for a wide range of functions of secondary
metabolites. Arrays of antimicrobial compounds help
defend against pathogens (Dixon, 2001; Hahlbrock et
al., 2003) and deter herbivores. Secondary metabo-
lites can function as signals internally or in commu-
nication with a symbiont (Peters et al., 1986). They
provide protection against abiotic stresses such as
UV light, drought, or high salt concentrations (Jin et
al., 2000).
The majority of steps in the biosynthesis of second-
ary metabolites is assumed to be catalyzed by specific
enzymes (Pichersky and Gang, 2000). Appropriately,
completion of the Arabidopsis genome sequence
revealed that a significant proportion of the approx-
imately 25,000 predicted genes encode proteins
assumed to function in secondary metabolism. The
Arabidopsis genome contains 250 cytochrome
P450 genes (The Arabidopsis Genome Initiative,
2000), 100 acyl transferase genes, 300 glycosyl
transferase genes, 300 glycoside hydrolase genes
(http://www.Arabidopsis.org/info/genefamily/
genefamily.html), and a large number of genes en-
coding enzymes such as dioxygenases, O-methyl
transferases, terpene synthases, or polyketide syn-
thases. There is a huge discrepancy between the
number of these genes and the number of known
reactions catalyzed by these types of enzymes in
1 This project has been part of the German plant genome project,
GABI, and was supported by the Ministry of Research and Edu-
cation. This work was additionally supported by the Deutsche
Forschungsgemeinschaft (grant no. SCHE 235/11–1) and by the
Fonds der Chemischen Industrie.
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Arabidopsis, leading to the conclusion that a large
number of metabolites have yet to be identified.
Some of them might even belong to compound
classes that so far have not been known to occur in
Arabidopsis at all (The Arabidopsis Genome Initia-
tive, 2000). Thus, understanding a significant part of
Arabidopsis biology requires methods allowing the
sensitive detection and quantification as well as the
identification of secondary metabolites. Applying
such techniques to various genetic backgrounds,
and to different environmental and developmental
conditions then would help elucidate the function of
such compounds and of the genes involved in their
biosynthesis.
Profiling schemes for Arabidopsis and other plants
have been developed in recent years (Roessner et al.,
2000, 2001; Fiehn et al., 2000; Wagner et al., 2003). The
main focus of these mostly gas chromatography
(GC)-mass spectrometry (MS)-based approaches
have been metabolites of the primary metabolism
such as sugars, amino acids, organic acids, or sugar
alcohols. Several hundred compounds can be ro-
bustly and reliably detected. However, these first
pioneering reports already emphasize the need for
complementary liquid chromatography (LC)-MS-
based approaches to allow a more comprehensive
profiling of metabolites (Roessner et al., 2000). The
coupling of electrospray ionization (ESI) MS with
capillary (Cap) electrophoresis (Soga et al., 2002) and
hydrophilic interaction chromatography (Tolstikov
and Fiehn, 2002) has been successfully applied to
metabolomics problems. Every analytical procedure
is necessarily limited as to what type of compounds
can be separated and detected. GC-MS is predomi-
nantly applied to very polar or unpolar substances,
and the main application range of LC-MS is more
related to compounds of medium polarity. Further-
more, LC coupled to an MS technique providing soft
ionization and high mass accuracy has the potential
to generate information useful for the identification
of unknown compounds because molecular ions and
characteristic fragments can be detected (De Hoff-
mann, 1996; Niessen, 1999).
We initiated a project aiming at exploiting the po-
tential of hybrid mass spectrometers developed in
the past few years for the profiling of Arabidopsis
metabolites. Here, we introduce an experimental sys-
tem based on Cap LC coupled to ESI quadrupole
time-of-flight MS (CapLC-ESI-QqTOF-MS). Using
this approach, we were able to detect more than 800
mass signals (m/z values) in root extracts and more
than 1,400 mass signals (m/z values) in leaf extracts of
Arabidopsis. Electrospray as a soft ionization method
combined with the enhanced resolution and mass
accuracy of the TOF instrument and tandem MS
make the identification of unknown compounds fea-
sible, and examples are presented.
RESULTS
The major objective of the work described here was
to develop a metabolite profiling scheme using the
robust and well-established separation of extracts by
LC on reversed-phase material in combination with
state-of-the-art MS. The basic assumption was that
such an approach would very well complement the
pioneering GC-MS-based schemes by extending the
range of metabolome analysis to those compound
classes not amenable to GC analysis. These would
include a significant fraction of the plant secondary
metabolism.
A few years ago, QqTOF mass spectrometers were
introduced. They combine TOF mass analysis with
the established technique of ESI, resulting in high
sensitivity, high mass resolution and high mass ac-
curacy (Chernushevich et al., 2001), and are therefore
principally well suited for comprehensive metabolite
profiling. However, to our knowledge, no reports of
such an application of hybrid mass spectrometers
have yet been published.
Plant Growth, Extraction, and Cap LC
To be able to grow Arabidopsis with high repro-
ducibility and to have easy access to leaf and root
material, we established an aseptic hydroponic
growth system. This more laborious approach limits
throughput to some extent. The major benefit in ad-
dition to a more complete analysis of plant biology is
that this system allows us to also biochemically pro-
file the responses in a plant organ not directly ex-
posed to a certain change in the environment.
Plant tissues were routinely harvested after 6
weeks and were frozen in liquid nitrogen. Freeze-
drying was omitted to minimize loss of potentially
susceptible compounds, such as volatiles, glucosino-
lates, and glycosides. Frozen plant material was ho-
mogenized in liquid nitrogen and was extracted
twice with 80% (v/v) aqueous methanol. A third
extraction did not produce any considerable gain in
yield. Extracts were separated by Cap LC using C18
material. Flow rate and composition of the gradient
had to be optimized to obtain good separation and
maximum stability of the electrospray. A flow rate of
5.5 L min1 and a gradient starting from 5% (v/v)
acetonitrile were found to produce the best results.
Manual Data Analysis and Reproducibility
Cap LC was coupled to ESI-QqTOF-MS analysis
operated in positive ion mode. Instrument parame-
ters were set in such a way that the mass range from
106 to 1,000 D was monitored simultaneously. The
signals generated by ions arriving at the detector
were routinely summarized in a spectrum every 2 s
for a total of 1,590 spectra during a 53-min run. The
resulting total ion chromatogram did not resolve dis-
tinct peaks (Fig. 1A). Extensive data deconvolution
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was required to extract defined mass spectra. This
was done manually by dividing the mass range of
106 to 1,000 D into mass windows of 25 D (Fig. 1B).
Mass spectra were then extracted from peaks appar-
ent within a particular mass window (Fig. 1C). Sev-
eral hundred mass signals are extractable in this way
from a single run.
At this stage of manual data deconvolution, quan-
tifiability of mass signals, as well as the reproducibil-
ity of the mass spectrometric analysis, of the extrac-
tion and of the biological material were assessed. The
isoflavone biochanin A was selected as an internal
standard. A calibration curve was recorded, and 5
pmol was determined to lie within the range of lin-
earity between amount and signal intensity. When
added to a plant extract, the recovery rate of biocha-
nin A was practically 100%. Twenty-one and 24 mass
signals in root and leaf extracts, respectively, across
the Cap LC run and representing a wide variety of
intensities and masses were then randomly chosen
(Tables I and II). Analysis of different dilutions of
extracts and inspection of resulting calibration curves
showed that, for most signals, the linear range cov-
ered almost two orders of magnitude. Up to 50-fold
dilution resulted in a linear decrease in intensity.
Untreated wild-type Arabidopsis Columbia (Col-O)
plants were analyzed in four independent experi-
ments. To obtain maximum mass accuracy, each run
was recalibrated against five characteristic fragment
or adduct ions of sinapoylmalate (Fig. 1C, left) in the
case of leaf samples, and five characteristic fragment
or adduct ions of hirsutin in the case of root samples.
The selected signals were then quantified by integrat-
ing the peak areas using AnalystQS and by normal-
izing them to the fresh weight of the plant material
extracted.
The reproducibility of the CapLC-ESI-QqTOF anal-
ysis was determined by extracting the same material
three times and by running three times the same
extract. The cumulative sd for repeated analysis of
the same extract was 11.1% (Fig. 2, A and C). When
different extracts of the same material were com-
pared, an average variability of 25%  17.9% was
found for leaves, and 21.6%  13.4% for roots. The
numbers indicate that the technical reproducibility
varies considerably, indicating a dependence on the
mass signal in question. When four independent ex-
periments were analyzed, an average biological vari-
ation was measured of 35.5%  14.0% for leaf signals
and 55.9%  26.0% for root signals (Fig. 2, B and D).
Again, the degree of variation was dependent on the
mass signal.
Signals were identified based on tR and mass. The
stability of tR was determined for six mass peaks
eluting between 25 and 51 min. Seventeen analyses of
six different extracts were performed over a period of
several days. The maximum sd was 0.3 min and the
average sd was 0.25 min, indicating the stability of
the Cap LC separation. The mass accuracy was eval-
Figure 1. Manual deconvolution of data generated by CapLC-ESI-
QqTOF-MS. A 53-min LC-MS analysis generated a total ion chro-
matogram consisting of 1,590 single MS spectra. A, The total ion
chromatogram was manually deconvoluted in 25-D slices resulting
in single extracted ion chromatograms (XICs) covering, for example,
a mass range from 200 to 225 D. B, Mass spectra were then extracted
from peaks apparent within a particular time frame of the XIC. The
extracted peak at tR 26.0 min (C, left) represents sinapoyl malate
([MNa] m/z 363.0717;[2 sinapoyl malateK] m/z 719.1148;
in-source fragment at m/z 207.0658). The extracted XIC valley at
26.6 min (C, right) represents a typical background mass spectrum.
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uated by averaging the mass difference for 11 signals
from known compounds. Signal intensities covered a
range of about two orders of magnitude. The average
mass difference through 18 runs was 9.0  3.3 ppm.
Thus, we concluded at this stage that CapLC-ESI-
QqTOF-MS can be a valuable tool for the robust and
reproducible simultaneous detection and quantifica-
tion of several hundred mass signals.
Identification of Known Compounds
As mentioned above, it has to be assumed that
most of the Arabidopsis metabolites are as yet un-
known. Moreover, unlike in the analysis of the major
primary metabolites, standards are available for only
very few compounds monitored by LC-MS and, in
contrast to GC-MS, extensive mass spectral libraries
do not exist for LC-MS. Therefore, being able to
directly gain structural information on metabolites
detected in profiling experiments is a key require-
ment for metabolomics. The QqTOF-MS technology
has the potential to provide this information because
the HR mass of a single ion can be used for calcula-
tion of a number of elemental compositions corre-
sponding to those within a window of less than 30
ppm, usually 5 to 15 ppm. As shown, this mass
accuracy is routinely achievable in profiling experi-
ments with complex samples. A first evaluation of
the potential of QqTOF-MS was carried out with the
list of mass signals selected for the assessment of
reproducibility. Elemental compositions were calcu-
lated. To further restrict the number of possible ele-
mental compositions, the isotopic patterns of the ions
of interest were checked for the presence of charac-
teristic heteroatoms, such as sulfur, by comparing the
calculated with the measured isotopic distribution.
The possible presence of nitrogen can be deduced
from even-mass numbered [MH] and/or
[MNa] ions, respectively. With this information, a
literature search for known natural products could
now be performed using commercially available
sources such as SciFinder, the Chapman & Hall Dic-
tionary of Natural Products on CD-ROM, the NIST
database, etc. Tables I and II list the information
obtained on these peaks based on the exact mass and
literature data. In leaf extracts, nine out of 24 signals
could tentatively be identified, and in root extracts,
Table I. Mass signals from root extracts used for assessing the variance of the CapLC-ESI-QqTOF-MS analysis
A total of 21 signals and the internal standard biochanin A were chosen. Listed here are their high-resolution (HR) masses and retention times
(tR) as identifiers. Based on the mass, elemental compositions were calculated and the corresponding compounds were tentatively identified.
HR Mass tR
Elemental
Composition (if
available)
Compound Substance Class
m/z min
138.1277 46.5 C9H16N 9-Methylthiononanenitrile
[M  H-CH3SH]

Nitrile
138.1277 26.5 C9H16N 9-Methylsulphinylnonanenitrile
[M  H-CH4SO]

Nitrile
160.0756 38.8 C10H10NO Methoxy-substituted indole Indole
160.0756 30.1 C10H10NO Methoxy-substituted indole Indole
179.0722 24.2
202.1251 26.5 C10H20NOS 9-Methylsulphinylnonanenitrile
[M  H]
Nitrile
234.0986 35.9 C10H20NOS2 8-Methylsulphinyloctyl ITC (hirsutin
[M  H])
Isothiocyanate
256.0798 35.9 C10H19NOS2Na 8-Methylsulphinyloctyl ITC (hirsutin
[M  Na])
Isothiocyanate
277.1416 43.4
285.0756 40.7 C16H13O5 Biochanin A (internal standard) Isoflavone
317.1200 4.6
381.0858 4.7
429.2454 4.7
438.1396 24.0
441.1396 24.2 C20H25O11 Substituted ferulic acid glucoside?
457.1134 24.2 C23H21O10 Substuituted phenylpropane
glucoside?
489.1708 35.9 C20H38N2O2S4Na 8-Methylsulphinyloctyl ITC (hirsu-
tin. [2M  Na])
Isothiocyanate
537.3151 43.4
553.2743 43.4
699.3608 38.8
810.2553 27.9
844.2019 28.0
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10 out of 21 signals could tentatively be identified.
For six additional peaks in leaf extracts, it was found
that they represent glycosides.
Automatic Data Deconvolution and Analysis
Using manual data deconvolution, we were able to
demonstrate the potential of CapLC-QqTOF-MS for
metabolomics with respect to sensitivity and robust-
ness, as well as the ability to quantify and identify
compounds. However, manual data deconvolution is
time consuming and therefore obviously not accept-
able for any type of metabolomic analysis that is
aiming at a considerable throughput. To overcome
this limitation, we tested and optimized Metabo-
liteID, a metabolite processing software (Applied
Biosystems, Foster City, CA). MetaboliteID allows us
to automatically extract mass spectra from the total
ion chromatogram and to generate peak lists display-
ing tR, and mass and intensity of a peak. We first
evaluated MetaboliteID by comparing its output with
the results of manual data deconvolution. Following
the optimization of data extraction parameters such
as minimum signal strength (50 counts s1, 2.5-fold
higher than background) and XIC window width
(0.35), we analyzed the same set of mass signals as
before in the reproducibility experiments. The aver-
age variability calculated from the same data sets
with the unsupervised method was only slightly
higher than that determined manually. The technical
variability changed from 25.0% to 34.1% for leaf ex-
tracts and from 21.6% to 26.9% for root extracts.
Values for the biological variability changed from
35.5% to 40.7% and from 55.9% to 67.5% for leaves
and roots, respectively. Thus, the cumbersome man-
ual data deconvolution could be replaced by unsu-
pervised automatic deconvolution without signifi-
cant losses in reproducibility.
Next, the number of detectable mass signals was
determined using the optimized MetaboliteID pa-
rameter settings. Through 72 runs of 24 extracts from
four independent experiments, on average, 1,415 sig-
Table II. Mass signals from leaf extracts used for assessing the variance of the CapLC-ESI-QqTOF-MS analysis
A total of 24 signals and the internal standard biochanin A were chosen. Listed here are their HR masses and tR as identifiers. Based on the
mass, elemental compositions were calculated and the corresponding compounds tentatively were identified.
HR Mass tR
Elemental
Composition
(if available)
Compound
Substance
Class
m/z min
114.0371 23.8 C5H8NS 4-Methylsulphinylbutyl-ITC
(sulforaphan, [M  H-CH4SO]

Isothiocyanate
116.0706 4.9 C5H10NO2 Proline [M  H]
 Amino acid
170.0997 35.9 C9H16NS 8-Methylsulphinyloctyl ITC
(hirsutin, [M  H-CH4SO]

Isothiocyanate
200.0180 23.8 C6H12NOS2Na 4-Methylsulphinylbutyl-ITC
(sulforaphan, [M  Na]
Isothiocyanate
207.0652 25.4 C11H11O4 Sinapoyl malate Phenylpropanoid
[CVF: sinapic acid  H-H2O]

285.0756 40.7 C16H13O5 Biochanin A (internal standard) Isoflavone
321.1960 30.3 [M  H] or [M  H-H2O]

349.2379 31.2
363.0687 25.4 C15H16O9Na Sinapoyl malate [M  Na]
 Phenylpropanoid
365.1536 31.2 [M  H]/2 Glycoside
423.2202 49.9 [M  H]/2
431.2107 50.4 [M  H]/2
494.2567 45.0 [M  H]/2 Glycoside
502.2501 45.0 [M  H]/2 Glycoside
510.2358 45.0 [M  H]/2 Glycoside
579.1708 23.7 C27H31O14 Kaempferol-3-O-a-L-
rhamnopyranoside-7-O-a-L-
rhamnopyranoside
Flavone glycoside
[M  H]
675.2524 31.4
703.1481 25.4 C30H32O18Na [2 Sinapoyl malate  Na]
 Phenylpropanoid
719.1220 25.4 C30H32O18K [2 Sinapoyl malate  K]
 Phenylpropanoid
735.0755 25.3
802.4232 47.6
815.4580 46.6
829.4661 50.3
965.5394 45.0 [M  H] Glycoside
984.5030 45.0 [M  H] Glycoside
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nals were detected in leaf extracts and 827 in root
extracts. The sd was 204 for the number of leaf
signals and was 180 for the number of root signals.
When the same extract was analyzed three times, the
numbers varied on average by only 5.8% for leaves
and 5.5% for roots.
Tools are required for the processing of such large
data sets. We decided to use Excel macros and pro-
gramming in Visual Basic to establish automatic
analysis of peak lists generated by MetaboliteID. As a
first step, a procedure for establishing master lists for
each analysis was developed. This was necessary to
summarize ions that were detected more than once;
for instance, because of problematic peak shape. The
correct assignment of corresponding signals is essen-
tial for comparing different CapLC-ESI-QqTOF-MS
Figure 2. Technical and biological variance of the CapLC-ESI-
QqTOF-MS analysis assessed by analyzing 25 mass signals from leaf
extracts and 22 mass signals from root extracts. Signals are identified
by mass and tR. Technical reproducibility of the LC-MS analysis of
Figure 3. Mass spectra of two metabolites differentially accumulat-
ing in Arabidopsis wild-type (Ler WT) and mutant plants (Ler tt4
mutant). The flavonoid glycoside Rha-Rha-kaempferide ([MH] at
m/z 579.1731, in-source fragments at m/z 433.1107 and 287.0500)
was not detected in leaves of the tt4 mutant line (A), whereas the
glucosinolate gluconasturtiin ([MNa] at m/z 446.0611) accumu-
lated to much higher amounts in the roots of tt4 plants (B).
methanolic root (A) and leaf extracts (C) was determined by extract-
ing the same material three times as well as performing three repe-
titions of the LC-MS measurements. Quantification of 22 selective
ion traces in root extracts and 25 ion traces in leaf extracts was
carried out. The SD of the three independent LC-MS analyses of a
single extract is represented in the white, gray, and black bars of the
charts. The cumulative SD for repeated analysis of the same extract
showed a value of 11.1%. Comparison of the three different extracts
of the same material (striped bar) resulted in an average variability of
25%  17.9% for leaves and 21.6%  13.4% for roots. When four
independent experiments were analyzed, an average biological
variation was measured of 35.5%  14.0% for leaf signals (D) and
55.9%  26.0% for root signals (B).
Arabidopsis Secondary Metabolite Profiling
Plant Physiol. Vol. 134, 2004 553
runs. Identifiers of signals are the mass and the tR.
The demonstrated accuracy and robustness of the
analysis allowed us to define narrow mass windows
of 0.02 to 0.06 m/z. Because the mass error increases
slightly with increasing mass, we divided the mass
range into three areas: m/z  106 to 300 (mass win-
dow 0.02), m/z  301 to 600 (mass window 0.03), and
m/z  601 to 1,000 (mass window 0.06). An adjust-
ment of tR was introduced based on the simplifying
assumption of a linear shift across a particular LC
run. A routinely used tR window for signal identifi-
cation is 0.4 min. When these windows were applied,
it was possible to correctly assign corresponding sig-
nals from different CapLC-ESI-QqTOF-MS runs.
Based on this, signal intensities can be averaged and
compared between different experiments.
To provide a reference list for future use of this
technology, we listed in Table III the five strongest
signals in root and leaf extracts for each 100-D mass
window between 100 and 1,000 D. Thirty-six Metabo-
liteID analyses of the reproducibility experiments
were scanned for the mass signals that showed high-
est intensity (given as area per milligram) and were
present in at least 75% of the LC-MS runs. For the
mass ranges above 600 D, few signals are detectable
in root extracts. In these cases, we included manually
integrated signals that were below the routinely used
MetaboliteID threshold of 50 counts s1.
Example for Detection of Metabolic
Differences between Samples
Having established rapid unsupervised automatic
data extraction and processing, we assessed the ap-
plicability of our profiling scheme by analyzing a
well-characterized mutant with a metabolic defect.
Landsberg erecta (Ler) tt4 plants lack a functional
chalcone synthase (Shirley et al., 1995) and are there-
fore deficient in flavonoid biosynthesis. Kaempferol
glycosides are the main flavonoids biosynthesized by
Arabidopsis plants under normal laboratory condi-
tions (Veit and Pauli, 1999). When Ler and tt4 mutant
plants were compared by CapLC-ESI-QqTOF-MS,
the expected lack of kaempferol and its glycosides
rha-rha-kaempferide and rha-kaempferide in leaves
of tt4 plants was detected (Fig. 3A; Table IV). Addi-
Table III. List of the most abundant mass signals from root (top) and leaf (bottom) extracts incremented in 100-Da steps
From left to right and indicated by the shading, the five strongest signals are listed. HR mass (m/z) and tR (min) are used as identifiers. Intensities
(Int.) are given as area per milligram of fresh weight. Doubly charged ions are marked with the charge state in brackets (2).
a Mass signals detected in 75% of the runs. b Signal manually integrated because it was below the 50 cps threshold normally used for
MetaboliteID analysis.
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tionally, two methoxy-substituted indole carboxalde-
hydes, probably the 1- and 4-methoxy isomers,
8-methylthiooctyl amine (m/z 176.1472; Kawabata et
al., 1989), and probably a methoxy-substituted
indole-glutathione conjugate, such as l--glutamyl-
S-[(1-methoxy-1H-indol-3-yl) methyl]-l-cysteinyl-
Gly (m/z 467.1600; Bjergegaard et al., 2000), were
found to be reduced in amount. However, both sub-
stances have not been obtained from natural sources.
To also test the feasibility of handling very diverse
data sets, we performed a comparison of metabolite
composition of root and leaf tissue. Through nine
samples each, the average overlap was only 8.7%
(1.1%).
Identification of Compounds by Tandem MS
Frequently, specific metabolites display changes
correlated to a particular genetic background or elic-
ited by an environmental or developmental stimulus.
After detection of such changes by nontargeted
metabolomic analysis, the identification of the re-
spective metabolites is of key importance for bio-
chemical phenotyping and gene function analysis.
Additionally, identification is desirable to extend the
catalog of known metabolites for Arabidopsis or any
other plant species under study.
In-source fragmentation of compounds can already
provide valuable structural information sufficient for
identification. This was demonstrated above for the
mass signals used in the reproducibility experiments
(see Tables I and II). Tandem MS represents an ad-
ditional powerful option. The first quadrupole of the
mass spectrometer can be used as a mass filter and
the second quadrupole can be used as a collision cell.
Collision-induced dissociation (CID) yields frag-
ments that can be used for elucidation of structures.
In the following three examples from the method
evaluation experiments are documented.
Roots of tt4 mutants were found to accumulate
high amounts of gluconasturtiin, whereas only minor
amounts were found in the corresponding root ex-
tracts of the Ler plants (Fig. 3B). The isotopic pattern
of the observed ion at m/z 446.0623 ([MNa])
clearly indicates the presence of two sulfur atoms
(see Fig. 4A). The CID spectrum is dominated by
fragment ions at m/z 284 {[MNa-162(glucosyl)]},
m/z 266 ([m/z 284-H2O]
), whereas m/z 186
Figure 4. Identification of significant metabo-
lites of Arabidopsis by HR-ESI-MS/MS (product
ion scan). A, Positive ion CID-MS of gluconas-
turtiin (in the box: calculated and measured iso-
topic pattern of the [MNa]ion at m/z 446). B,
Positive ion ESI-CID-MS of hirsutin.
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([phenylethylisothiocyanateNa]) represents the
phenylethyl moiety. Hirsutin was used for our root
analysis as a stably occurring reference compound.
It is known to arise as a myrosinase-catalyzed
degradation product from its parent compound,
8-methylsulphinyloctyl glucosinolate (glucohirsu-
tin). Both metabolites were originally obtained from
the seeds of rock cress (Arabis hirsuta) by Kjær and
Christensen (1958). EI-MS spectra were given by
Kjær et al. (1963) as well as by Spencer and Daxen-
bichler (1980). The ESI-TOF mass spectrum displays a
[MH] ion at m/z 234 (see Fig. 4B). The CID spec-
trum displays a prominent key ion at m/z 170 ([MH-
CH4SO]
), also appearing as an intense in-source
fragment, which is a group-characteristic ion of
methylsulphinyl isothiocyanates (ITCs). Additional
typical ions are m/z 161 ([MH-CH3-NCS]
), which
is a key fragment of mustard oils, and the stable
cyclic immonium ion at m/z 114.
We could confirm the expected reduction of
kaempferol-3-O--l-rhamnopyranoside-7-O--l-
rhamnopyranoside in tt4 mutants compared with Ler
control plants. Its ESI-CID mass spectrum showed a
subsequent loss of the two rhamnosyl moieties from
the [MH] ion at m/z 579 generating fragments at
m/z 433 and 287, respectively, and was found to be
identical with that of a standard sample (data not
shown). The structure of the aglycon was established
by comparing the CID-MS of m/z 287 with the
[MH] ion of authentic kaempferol. Thus, charac-
teristic aglycon fragments are formed by subsequent
losses of water and carbon monoxide, respectively, or
from the retro-Diels-Alder reaction.
DISCUSSION
The current status of metabolomics can be viewed
as being in some ways equivalent to the situation of
sequencing programs such as the Human Genome
Project around 1990 (Sumner et al., 2003). The enor-
mous potential of comprehensive biochemical phe-
notyping for the functional analysis of biological sys-
tems is realized and numerous projects have been
initiated. However, major technological limitations
need to be overcome. For instance, the chemical di-
versity of the metabolome necessitates the use of
different analytical techniques to cover the wide
range of polarities found among the metabolites oc-
curring in a cell.
Metabolomic approaches aim at monitoring the
biochemical status of an organism by simultaneously
measuring as many metabolites as possible. A robust
and reproducible analysis that provides qualitative
and quantitative data and allows high sample
throughput is desired. Maybe equally important at
this stage is to contribute to cataloging the metabo-
lome of an organism. No metabolome is completely
known as of yet. Systematic identification of the me-
tabolites occurring in a species is particularly rele-
vant for plants, given the wealth of natural products
they produce. Sequence data indicate that Arabidop-
sis expresses a large number of enzymes for which
substrates and products are unknown (The Arabi-
dopsis Genome Initiative, 2000).
LC coupled to HR-MS has great potential to play
an important role in metabolomics as a complement
Table IV. Mass signals differentially expressed between Ler wild-type and tt4 mutant plants Tentative identification is listed whenever
possible.
HR Mass tR
Average
Fold Change
Molecular
Formula
(if available)
Substance
Class
Compound
m/z min
Leaf, reduced 287.0550 23.7 17 (/7) C15H11O6 Flavone Glycoside Kaempferol [M  H]

[m/z 5792x146(Rha)]
579.1708 23.8 88 (/12) C27H31O14 Flavone Glycoside Rrha-rha-kaempferide [M  H]

433.1129 24.0 11 (/7) C21H21O10 Flavone Glycoside Rha-kaempferide [M  H]

[(m/z 579–146 (Rha)]
Leaf, higher 661.3178 38.8 4.2 (/1.2)
789.4299 49.4 4.2 (/1.5)
Root, reduced 116.0500 33.6 3 (/0.1) C8H6N Methoxy-subst. indole Methoxyindolecarboxaldehyde
133.0521 33.6 3.4 (/0.4) C8H7NO Methoxy-subst. indole Methoxyindolecarboxaldehyde
144.0443 33.6 4.2 (/0.9) C9H6NO Methoxy-subst. indole Methoxyindolecarboxaldehyde
176.0711 33.6 3.2 (/0.1) Methoxy-subst. indole Methoxyindolecarboxaldehyde
176.1472 22.9 3.5 (/0.9) C9H22NS Amine 8-Methylthiooctylamine
136.0579 5.3 4.7 (/0.1)
467.1600 23.7 5.1 (/0.9) C20H27N4O7S Methoxy-subst. indolyl-
GSH conjugate
L--glutamyl-S-[(1-methoxy-1H-indol-3-yl)
methyl]-L-cysteinyl-glycine [M  H]
Root, higher 419.2765 52.1 11.8 (/3.2)
423.0106 6.1 7.8 (/3.2) S-Containing compound
446.0555 26.6 581.5 (/418) C15H21NO9S2Na 2-Phenylethyl glucosinolate
(gluconasturtiin [M  Na])
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to GC-MS. However, reports of such a use are few,
and thus far, most concern targeted profiling ap-
proaches (Lange et al., 2001; Huhman and Sumner,
2002). Our objective was to explore Cap LC coupled
to state-of-the-art ESI-QqTOF-MS for the nontargeted
profiling of Arabidopsis extracts. Reversed-phase LC
on C18 was chosen because this was found to be
suitable and highly reproducible for secondary me-
tabolite profiling in a number of plant species includ-
ing Arabidopsis (Graham, 1991). In principle, other
techniques such as Cap electrophoresis could also be
coupled to ESI-QqTOF-MS to further expand the
range of metabolite profiling. Hallmarks of TOF-MS
are the HR and high mass accuracy that make it an
invaluable tool for the identification of compounds
and its use for the sensitive simultaneous detection of
large numbers of metabolites separable by LC on
reversed-phase material. Major question marks con-
cerning this approach were the robustness of the
analysis, its reproducibility, and its suitability for
high-throughput and quantitative analysis. Our re-
sults demonstrate that CapLC-ESI-QqTOF-MS prin-
cipally meets all the necessary criteria for powerful
metabolic analysis.
tRs of compounds eluting from the Cap LC column
were found to show only little variation. Optimized
flow rate and gradient composition produced a stable
ion spray. Evaluation of the mass accuracy showed
that the target value in the range of 5 ppm error
(Chernushevich et al., 2001) can be reached for many
signals even in a complex mixture of compounds,
allowing, as discussed below, the calculation of ele-
mental compositions and thereby the tentative iden-
tification of compounds. Obviously, the accuracy is
correlated with signal strength and the error is higher
for signals with intensities closer to background. Ro-
bustness of the analysis is illustrated by the fact that
the average deviation in intensity for a range of mass
signals was no higher than 11% when the same ex-
tract was run several times. Reproducibility of tR and
mass accuracy provided a sufficient basis for the
unequivocal detection and identification of mass
signals.
Quantification of metabolites is a serious hurdle for
metabolomics (Sumner et al., 2003). There are inher-
ent limitations to the dynamic range of MS and, as
emphasized by Trethewey et al. (1999), for nontar-
geted approaches, compromises have to be made
concerning the quantification of metabolites. Dilution
series of Arabidopsis extracts indicated a satisfactory
linear range of the CapLC-ESI-QqTOF-MS analysis
for many of the signals tested. However, the linear
range is dependent on the metabolite in question,
and there is currently no feasible way of exactly
assessing it for every signal. As predicted by Fiehn
(2002), we therefore see the immediate application of
CapLC-ESI-QqTOF-MS predominantly in the highly
sensitive and rapid detection of qualitative and also
pronounced quantitative metabolic differences.
The potential for such a use is very high because of
the large number of mass signals that can be re-
solved. On average, about 1,400 signals were de-
tected in leaf extracts and about 800 signals were
detected in root extracts. Given the limited overlap
between root and leaf metabolites, a total of about
2,000 different signals can be detected in extracts
from Arabidopsis plants grown under control condi-
tions. Most likely, the numbers will be significantly
higher once the analysis is extended to other tissues
such as flowers (Chen et al., 2003), to different devel-
opmental stages, and to plants exposed to environ-
mental stimuli. Increases in the number of detectable
mass signals can be achieved by extending the anal-
ysis to the negative mode, which is less effective yet
allows the measuring of metabolites not seen in pos-
itive mode, such as the intact glucosinolates or sali-
cylic acid (data not shown).
The robustness of the analysis is again indicated by
the stability of mass signal numbers when the same
extract was analyzed repeatedly. The average varia-
tion was no greater than 6%. Because of in-source
fragmentation and the formation of adduct ions, the
number of mass signals detected is definitely higher
than the number of metabolites. It is impossible at
this stage to reliably estimate the actual number of
metabolites detected.
Technical variance (as the sum of variation intro-
duced by the extraction and by chromatography and
mass spectrometric analysis) was below 30% for all
but two of the chosen mass signals. This provides a
solid basis for the detection of differences between
samples. The biological variability of around 40% is
similar to what has been reported for other large-
scale profiling techniques. Technical and biological
variance are dependent on the mass signal in ques-
tion. Possible causes are, for instance, a coelution of
ions that affects quantification through ion suppres-
sion and high metabolic fluctuation. Processing of a
large number of profiling experiments will be re-
quired to eventually define the range of variability
for individual mass signals.
The efficient use of CapLC-ESI-QqTOF-MS for
gene function analysis implies a considerable
throughput of samples. Automatic unsupervised de-
convolution of MS data and processing of the ex-
tracted information is a must. After extensive opti-
mization, we found the MetaboliteID software able to
function sufficiently well for deconvolution. A com-
parison with the results from manual stepwise ex-
traction and integration of a range of mass signals
showed only small differences. Peak lists generated
by MetaboliteID are further processed using Excel
macros and Visual Basic programs. These allow us to
assign peaks correctly based on tR and mass. The
tools are tailored to discover qualitative and quanti-
tative differences between samples and sets of sam-
ples. We tested the procedures by analyzing Ler
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wild-type and tt4 mutant plants. The expected differ-
ence in kaempferol glycosides due to the lack of a
functional chalcone synthase was detected. In addi-
tion, we found several as yet unknown differences.
Comparison between root and shoot samples dem-
onstrated that very diverse data sets can also be
handled. The limited overlap we found is further
proof for the fundamental difference between root
and leaf metabolism.
CapLC-QqTOF-MS is to be used for the detection
and elucidation of metabolic changes elicited by en-
vironmental or developmental stimuli, as well as for
the determination of metabolic differences attribut-
able to a particular genetic background. Furthermore,
substantial progress in establishing the metabolome
of Arabidopsis and other model species is envi-
sioned. All of these uses will rely on the potential to
identify metabolites. We explored a nontargeted and
a targeted way of gaining structural information. The
highly accurate mass of the molecular ion and in-
source fragments obtained during routine analysis
can be used to tentatively identify metabolites with a
good success rate. By systematically analyzing the
mass data generated, we predict the ability to iden-
tify a large number of compounds that to date have
not been known to occur in Arabidopsis. In selected
cases of mass signals showing a change of immediate
biological interest, CID can be used to generate frag-
ments that, in many cases, provide a basis for an
assignment of structure.
As is the case for other profiling schemes, aqueous
methanol is used here for the extraction of Arabidop-
sis metabolites. Obviously, the choice of solvent lim-
its the scope of the analysis, and the use of additional
extraction methods is likely to result in the detection
of further substance classes. A survey of the com-
pounds tentatively identified in this study shows that
the relevant known classes of Arabidopsis secondary
metabolites such as indole-derived compounds (e.g.
indole acetic acid derivatives), degradation products
of glucosinolates (sulfinylnitriles and isothiocya-
nates), phenylpropanoids (sinapoylmalate), and
flavonoids as well as their glycosides (e.g.
kaempferol-3-O--L-rhamnopyranosid-7-O--L-
rhamnopyranosid) can be detected by the method
described. Indole derivatives, for instance, can be
clearly classified by LC-ESI-MS/MS measurements
according to their substitution pattern at the ring
skeleton (e.g. methoxyindoles). The same is true for
the ITCs (e.g. hirsutin). The example of gluconastur-
tiin, which contains two sulfur atoms, demonstrates
the usefulness of the isotopic pattern as an addi-
tional feature to support the proposed elemental
composition. Arabidopsis secondary metabolites
not covered by this method are mono- and sesquit-
erpenoids, triterpenoid alcohols, phytosterols,
waxes, and carotenoids.
MATERIALS AND METHODS
Plant Growth
Surface-sterilized seeds of the Arabidopsis ecotypes Col-O and Ler as
well as of the tt4 mutant line were sown on agarose plugs (0.5%, w/v) and
were grown hydroponically in one-tenth Hoagland nutrient solution No. 2
(pH 5.3–5.5; Sigma, St. Louis). The medium was supplemented with iron,
chelated by N,N-di-(2-hydroxybenzoyl)-ethylenediamine-N,N-diacetic
acid to a final concentration of 5 m Fe-N,N-di-(2-hydroxybenzoyl)-
ethylenediamine-N,N-diacetic acid (Chaney, 1988). Seedlings were grown
for 6 weeks in hydroponic greenhouse boxes containing 10 plantlets each.
The nutrient solution in the boxes was changed on a weekly basis and was
aerated through 0.2-m filters. Light conditions in the growth cabinet were
fixed to 230 to 240 E m2 s1 and a photoperiod of 8 h of light/16 h of dark
at 23°C, day and night. Leaves and roots of plants were harvested separately
approximately 1 h into the light period, pooled, and stored at 80°C.
Extraction and CapLC-ESI-QqTOF-MS
For the metabolite LC-MS analysis, freshly ground plant material (about
100 mg) was subjected twice to the following extraction procedure: mixing
of the plant material with 200 L of 80% (v/v) MeOH, sonication for 15 min
(20°C–22°C), and centrifugation at 19,000g for 10 min. The extracts were
combined, filtered (polytetrafluoroethylene filter, pore size of 0.2 m), and
analyzed by LC-MS. Positive LC-ESI-TOF mass spectra were recorded on an
API QSTAR Pulsar Hybrid Quadrupole TOF instrument (Applied Biosys-
tems) coupled to a capillary HPLC system (Ultimate; Dionex, Sunnyvale,
CA). Typical MS instrument settings were an electrospray voltage of 5.5 kV
with nebulizer gas being N2 and collision gas being N2, as well. The LC
separation was performed on a Fusica C18 column (3 m, 0.3  150 mm,
PepMap; Dionex) applying a gradient system starting from 95% eluent A
(0.1% [v/v] HCOOH/water) and 5% eluent B (0.1% [v/v] HCOOH/aceto-
nitrile) to 95% eluent B in 45 min at a flow rate of 5.5 L min1 (sample
injection volume: 1 L). Formic acid was used because of its compatibility
with MS analysis.
Data Analysis
Peak finding and quantification of selective ion traces was accomplished
using the instrument’s AnalystQS software. Automatic raw mass data de-
convolution was performed using the MetaboliteID software (Applied Bio-
systems). Peak lists generated by MetaboliteID were further analyzed using
Excel and Visual Basic.
CID-MS
2-Phenylethyl glucosinolate (gluconasturtiin): tR, 26.69 min; collision en-
ergy (CE), 20 eV; declustering potential (DP), 50 V; m/z (relative intensity, in
percentages), 446.0556 (calculated for 446.0555: C15H21NO9S2Na, [MNa]
,
10); 284.0124 (calculated for 284.0021: C9H11NO4S2Na, [MNa-
162(glucosyl)], 100); 266.0101 (calculated for 265.9922: C9H9NO3S2Na, [m/z
284-H2O]
, 45); 186.0300 (calculated for 186.0353: C9H9NSNa [2-phenylethyl
ITCNa], 8). 8-Methylsulphinyloctyl isothiocyanate (hirsutin, 8-MSOO-
ITC): tR, 26.54 min; CE, 30 eV; DP, 50 V; m/z, 234.0993 (calculated for
234.0986: C10H20NOS2, [MH]
, 80); 170.1044 (calculated for 170.0997:
C9H16NS, [MH-CH4SO]
, 100); 161.1029 (calculated for 161.0994: C8H17OS
[MH-CH3NCS]
, 18); 137.1201 (calculated for 137.1198: C9H15N, [m/z 170-
SH], 20); 114.0407 (calculated for 114.0371: C5H8NS, 18); 69.0711 (calcu-
lated for 69.0698: C5H9, 19). Kaempferol-3-O--l-rhamnopyranoside-7-O--
l-rhamnopyranoside: tR, 23.54 min; CE, 20 eV; DP, 50 V; m/z (relative
intensity, in percentages), 579.1697 (calculated for 579.1708: C27H31O14,
[MH], 3); 433.1197 (calculated for 433.1129: C21H21O10, [MH-
146(rhamnosyl)], 100); 287.0538 (calculated for 287.0550: C15H11O6, [m/z
433 - 146], 31). Kaempferol (reference compound): CE, 40 eV; DP, 75 V; m/z
(relative intensity, in percentages), 287.0557 (calculated for 287.0550:
C15H11O6, [MH]
, 66); 258.0514 (calculated for 258.0528: C14H10O5,
[MH-CHO], 14); 241.0503 (calculated for 241.0500: C14H9O4, [MH-H2O-
CO], 8); 213.0584 (calculated for 213.0547: C13H9O3, [MH-H2O-2CO]
,
21); 185.0602 (calculated for 185.0597: C12H9O2, [MH-H2O-3CO]
, 10);
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165.0206 (calculated for 165.0176: C8H5O4, [rings A&C-CO]
, 56) 157.0653
(calculated for 157.0653: C11H9O, [MH-H2O-4CO]
, 14); 153.0188 (calcu-
lated for C7H5O4, [retro-Diels-Alder fragment from rings A & C]
, 100);
147.0439 (calculated for 147.0446: C9H7O2, 10); 137.0269 (calculated for
137.0238: C7H5O3, 14); 121.0339 (calculated for 121.0289: C7H5O2,
OC-
C6H4OH (ring B), 13).
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